Information
-
Patent Application
-
20030211476
-
Publication Number
20030211476
-
Date Filed
April 04, 200222 years ago
-
Date Published
November 13, 200321 years ago
-
CPC
-
US Classifications
-
International Classifications
Abstract
Methods of increasing of or decreasing the levels of a protein in a PP cell; methods of increasing antigen, vaccine, DNA vaccine delivery to M cells, use of human serum albumin and other transport enhancing proteins to enhance oral drug delivery; use of calreticulin to enhance oral antigen delivery, use of other cell surface proteins, receptors, and transporters to enhance delivery to M cells of antigens or vaccine delivery vehicles, use of other cytoplasmic proteins to regulate intracellular trafficking and delivery to mucosal immune sampling and processing systems.
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. provisional application No. 60/281,387 filed Apr. 4, 2001, and U.S. provisional application No. 60/302,591 filed Jul. 2, 2001.
FIELD OF THE INVENTION
[0002] This invention relates to the genetic analysis of M cells and methods and compositions targeting M cell receptors.
BACKGROUND OF THE INVENTION
[0003] The Peyer's patch of the intestinal lining is a specialized tissue that allows the immune system to identify foreign antigens that require an immune response. It is also a potential pathway for orally delivered drugs to cross the intestinal barrier into the bloodstream. Central to these properties are M cells, which populate the patch's epithelial sheet. In view of the importance of the Peyer's patch and its M cells for the immune response and drug delivery, it is desirable to identify the cell proteins important for these phenomena. It is also desirable to increase the amounts of such important proteins in order to either facilitate the immune response and drug delivery or promote the conversion of non-M cells to M cells.
[0004] Similarly, it is important to identify and further decrease the levels of proteins whose absence or down-regulation in expression facilitates the immune response and drug delivery, or promotes the conversion of non-M cells to M cells.
BRIEF SUMMARY OF THE INVENTION
[0005] Increasing the Levels of a Protein or Antigen-Protein Combination
[0006] In a first general aspect, the invention is a method of increasing the levels of a protein in a Peyer's patch cell, said method comprising delivering to said cell a nucleic acid coding for a protein, wherein absent said increase, the levels of said protein or its mRNA is greater than in a non-Peyer's patch cell.
[0007] Peyer's patch cells of particular interest are M cells. The levels of a protein or its mRNA in Caco-2 cells co-cultured with Raji B cells are considered herein to be representative of such levels in a human Peyer's patch M cell. Monoculture Caco-2 cells are considered herein to be an appropriate non-Peyer's patch cell for purposes of comparison of such protein or mRNA levels.
[0008] The levels of a protein or its mRNA in rat Peyer's patch epithelial cells can be compared to their respective levels in a culture of rat normal gut epithelial cells. Absent evidence to the contrary, results of rat cells are assumed to be predictive of the results in human cells.
[0009] The presence of Increased levels of an mRNA, and therefore presumptively its protein, are indicated in the Table 2 and 3 by a ** a *, or an expression Fold Change greater than 1.00. Preferred are those indicated by a ** or an expression Fold Change greater than 2.00. Most highly preferred are those indicated by a **. The presence of decreased levels of an mRNA, and presumptively its protein, are indicated by a minus sign (−) or an expression Fold Change less than 1.00. Preferred targets are those indicated by a minus sign or an expression Fold Change less than 0.50.
[0010] In embodiments of particular interest, the protein is a receptor, a transporter, cell surface antigen, or cell adhesion molecule, especially a receptor. In other embodiments of particular interest, the protein is selected from the group consisting of nucleoside diphosphate kinases and member of the 14-3-3 family.
[0011] In the methods of greatest interest, the nucleic acid is delivered to a human cell. There are many delivery options, one of which is to deliver it by the oral route with the cell in a human, another to deliver it to a cell outside a human.
[0012] In an important variation of the method, a nucleic acid coding for a tumor antigen or foreign peptide is also delivered to the Peyer's patch cell. The purpose of this aspect of the invention is to improve the immune response to a tumor antigen or the foreign peptide. Normally, therefore, the foreign peptide will be that of a virus or infectious microorganism. A tumor antigen is one that is more abundant in a tumor cell than its normal counterpart.
[0013] Decreasing the Levels of a Protein
[0014] Another general aspect of the invention is a method of decreasing the levels of a protein in a Peyer's patch cell, said method comprising delivering to said cell an anti-sense nucleic acid molecule, a ribozyme nucleic acid molecule, an RNA interference (RNAi) nucleic acid molecule, said anti-sense, ribozyme or RNAi nucleic acid being complementary to a sequence of at least 10 nucleotides of the mRNA for said protein, wherein absent said anti-sense nucleic acid molecule, ribozyme or RNAi nucleic acid, the levels of said protein or its mRNA are less than in a non-Peyer's patch cell. More preferably the anti-sense nucleic acid is complementary to a sequence of at least 15 nucleotides of the mRNA of the protein, and most preferably to a sequence of at least 30 nucleotides of the mRNA of the protein. It is preferred that the protein is coded for by a gene with an expression Fold Change denoted by a minus sign (−) or an expression Fold Change less than 0.50.
[0015] In a particular embodiment, the latter method comprises delivering to said cell an anti-sense nucleic acid molecules, a ribozyme or RNAi nucleic acid molecules, said anti-sense, ribozyme or RNAi nucleic acid being complementary to a sequence of at least 10 nucleotides of the mRNA for at least 5 different proteins, wherein absent said anti-sense, ribozyme or RNAi nucleic acid molecule, the levels of each of said proteins or its mRNA are less than in a non-Peyer's patch cell.
[0016] Alternatively described, the latter invention is a method of deceasing the levels of a protein in a Peyer's patch cell, said method comprising delivering to said cell an anti-sense nucleic acid molecule, ribozyme or RNAi nucleic acid molecules, said anti-sense, ribozyme or RNAi nucleic acid forming a double-stranded molecule with part or all of the mRNA for said protein, wherein absent said anti-sense, ribozyme or RNAi nucleic acid molecule, the levels of said protein or its mRNA are less than in a non-Peyer's patch cell.
[0017] Cells of the Invention
[0018] A human or rat cell to which any of the above methods in this Brief Summary of the Invention section has been applied, or the progeny of said cell, is also an aspect of the present invention.
[0019] Delivery Enhancement using a Targeting Ligand which Targets a Receptor, a Transporter or a Cell-Surface Molecule Expressed on Surface of M Cells or Pever's Patch Tissue Cells
[0020] In another general aspect, the invention is a method of targeting an antigen or a drug delivery vehicle containing an antigen, or a drug delivery vehicle containing an antigen and adjuvant, or a drug delivery vehicle containing a drug, or a viral vector, or a bacterio-phage vector such as, but without limitation M13 or Fd, or a bacterial vector or a gene delivery vector expressing an antigen of interest, or a viral vector, or a bacterio-phage vector such as, but without limitation M13 or Fd, or a bacterial vector or a gene delivery vector expressing a gene product(s) to M cells of Peyer's patch tissue, by targeted delivery to receptors, or to transporters or to other cell surface proteins which are found to be expressed on the cell surface of M cells or other cells found within Peyer's patch tissue, or which are found to be differentially expressed on these cells. Said gene product(s) coded by the viral vector, or a bacterio-phage vector such as, but without limitation M13 or Fd, or a bacterial vector or a gene delivery vector regulate the function of Peyer's patch cells to M cell phenotype or regulate M cell function to increase their immuno-surveillance or antigen presentation to the mucosal immune system.
[0021] In one embodiment, a phage display library such as M13 or Fd which express random peptide sequences on the surface of the phage, coded by example gene III or gene VII of M13 or Fd bacteriophage, can be screened by in vivo panning against example Peyer's patch tissue found in vivo in the GIT, in order to discover and identify phage or targeting ligands which specifically target M cells or Peyer's patch tissue in vivo in the GIT; such phage which target M cells and Peyer's patch tissue can subsequently be genetically engineered to encode a gene or genes of interest such as a DNA vaccine gene, a gene coding for an antigen of interest together with gene(s) which modify M cell function and which enhance the immuno-responsiveness of the M cells to the antigen or DNA vaccine product coded by the genetically engineered bacteriophage genome.
[0022] Delivery Enhancement using Transport Enhancing Proteins
[0023] Another invention disclosed herein is a method for enhancing transport of a drug through the gastrointestinal tract, said method comprising orally administering said drug in a composition that comprises a transport-enhancing protein, said transport-enhancing protein selected from the group consisting of human serum albumin (HSA), clusterin, T-cell surface glycoprotein CD5 precursor, HSP84, and Ca2+-dependant phospholipase A2 (Ca2+ pla2), or a homolog that has at least 80% amino acid identity with said transport-enhancing protein over a length of said transport-enhancing protein identical to the homolog. In a preferred embodiment, the homolog has at least 90% amino acid identity with the transport-enhancing protein over a length of the transport-enhancing protein identical to the homolog. In a more preferred embodiment, the transport-enhancing protein is selected from the group consisting of human serum albumin (HSA), clusterin, T-cell surface glycoprotein CD5 precursor, HSP84, and Ca2+ pla2.
[0024] Method of Delivering a Vaccine to a Target Cell
[0025] Further invention disclosed herein is a method of delivering a vaccine to a target cell, said method comprising utilizing as the target cell a Peyer's patch cell in which a protein or mRNA is upregulated.
[0026] Method of Decreasing the Levels of a Protein
[0027] Yet, another invention disclosed herein is a method of decreasing the levels of a protein in a Peyer's patch cell, said method comprising delivering to said cell a DNA molecule coding for an anti-sense nucleic acid molecule, a ribozyme nucleic acid molecule, an RNA interference nucleic acid molecule (RNAi), said anti-sense molecule, ribozyme or RNAi nucleic acid being complementary to a sequence of at least 10 nucleotides of the mRNA for said protein, wherein absent said anti-sense molecule, ribozyme or RNAi nucleic acid, the levels of said protein or its mRNA is less than in a non-Peyer's patch cell.
[0028] Method of Increasing the Extent to which the Function of a Protein is Carried Out
[0029] Another invention disclosed herein is a method of increasing the extent to which the function of a protein is carried out in a Peyer's patch cell, said method comprising delivering to said cell a nucleic acid coding for said protein, wherein absent said delivery, the level of said protein or its mRNA is greater in said cell than in a non-Peyer's patch cell.
[0030] Chimeric Protein that Comprises Two or More Segments, each of said Segments Enhancing a Different Step in the Peptide Transport Process
[0031] Another invention disclosed herein is a chimeric protein that comprises two or more segments, each of said segments enhancing a different step in the peptide transport process, said steps selected from the group consisting of binding to a cell such as an M cell, transporting the peptide into the cell such as an M cell, presenting the chimeric protein to a protein processing pathway within a cell such as an M cell in order to maximise processing in a way to optimize presentation of the processed chimeric peptides to epitopes suitable for immune activation, transporting the peptide through the cell such as an M cell, and transporting the peptide out of the cell such as an M cell to an underlying immune cell such as a B-cell or T-cell.
[0032] Delivery Enhancement using Calreticulin and other Proteins
[0033] Another method disclosed herein is a method to facilitate intracellular trafficking of an antigen that has been orally delivered by itself or as part of a composition or particle, said method comprising administering calreticulin.
[0034] Related to the latter invention is a chimeric protein comprising the amino acid sequences for (1) calreticulin, rab family proteins and and/or a ribosomal protein, and (2) a second polypeptide. Also related is a method of administering a polypeptide, where said polypeptide is part of the chimeric protein and wherein said chimeric protein is orally administered.
DETAILED DESCRIPTION OF THE INVENTION
[0035] The present invention and the related research were intended to improve targeted vaccine delivery and targeted gene delivery methods, especially as they relate to Peyer's patch cells. In significant part, this was achieved by identifying proteins whose up-regulation or down-regulation would indicate their possible or probable role in cellular functions important to vaccine and or drug delivery. In some cases, such as receptors, the proteins are important from the point of view of cell specificity during the delivery process. In many cases, the proteins have functions that are important after the vaccine or drug enter the cell.
[0036] Closely related to those inventions and research goals, was the concept that in M cells there would be proteins that, as compared to M cell precursors, were up-regulated or down-regulated. The identification of such proteins provides a strategy for altering M cell precursors so as to shift their phenotype toward that of M cells.
[0037] As indicated, one aim of the research related to the present invention was to determine if there were detectable differences in protein/gene expression between: (1) Peyer's patch (PP) and non-Peyer's patch (NPP) rat gastrointestinal tract (GIT) tissue and (2) M cell enriched follicle-associated epithelium of Peyer's patch (PP FAE) tissue. This was done with a view to finding novel or highly expressed ligand targeting sites on the Peyer's patch or M cells as well as other protein relevant to the delivery of drugs across the GIT.
[0038] This invention is based in part on the discovery of over-expression of a range of genes in Peyer's patch (PP) tissue from rat small intestine in comparison to normal non-Peyer's patch (NPP) small intestine tissue.
[0039] This invention is also based on the discovery of over-expressed genes in co-cultures of Caco-2 cells. The idea was to use genetic mapping of the M cell co-culture, e.g. Caco-2 cells co-cultured with Raji cells versus a monolayer of Caco-2 cells, to ascertain the differences in epithelial gene expression between M cells and enterocytes. It became immediately apparent that some of these gene products are going to be unique apical membrane proteins (e.g. receptors, transporters, adhesion proteins) in M cells. By examining the differences between M cells and enterocytes in vitro and in vivo, one could identify key targets that can be used to generate M cell specific ligands. These ligands can then be used for targeting oral vaccines in particles.
[0040] The identification of over-expressed ribosomal proteins or homologues/related proteins thereof indicates a generally higher protein turnover or protein synthesis capacity in PPs or a possible role for such ribosomal proteins (or homologues thereof) in other cellular functions such as protein chaperoning, endocytosis, trafficking of proteins/antigens/particulates/viruses uptaken from the lumen of the gastrointestinal tract (GIT) and/or from the M cells to underlying immune cells, antigen presenting cells, dendritic cells, B cells, other cell types.
[0041] The identification of a series of transcription factors (TFs) that are over-expressed in PP tissue versus the control enterocyte GIT tissue is considered herein to indicate a role for such TFs in the development of M cell phenotype, in conferring M cell phenotype and/or in programming M cells to prime other downstream cellular events leading to a better or more efficacious immune outcome following antigen presentation. The co-delivery of genes coding for such TFs with either antigens themselves and/or with gene(s) coding for antigen(s) of question to M cells and/or PP tissue following oral administration provides the basis for a more efficacious and pronounced immune outcome when the TF coding genes are key or vital for driving M cells/PP tissue to an effective immune outcome.
[0042] The general over-expression of a number of proteins species in PPs versus NPPs, both membrane and cytosolic-associated was also determined by a novel technique of enrichment and M cell selection following enrichment of the follicle-associated epithelium (FAE) of Peyer's patch (PP FAE) by ethylene-diamine tetra-acetic acid (EDTA) extraction and recovery of M cells/PP FAE. Such novel or differentially expressed proteins have significant implications for the use of this protein expression information and methods of selection/enrichment of M cells/PP tissue for the targeting of drug/vaccine uptake to Peyer's patches. Among proteins found to be over expressed in rat PP tissue following this enrichment technique was the human serum albumin homolog which is considered here to have implications for drug/cargo transport from the GIT either into oracross intestinal tissue including PP tissue and systemic delivery of same to the blood.
Incorporation by Reference
[0043] All references cited herein are incorporated herein by reference in their entireties.
[0044] All GenBank records specified bytheiraccession numbers are incorporated herein by their entireties.
[0045] The GenBank amino acid sequences and nucleotide sequences specified by their GenBank ID number are incorporated by reference herein. All GenBank records corresponding to those ID numbers are incorporated herein in their entirety. Absent a date specifying the date of the record, the date of the record is the filing date of this application.
[0046] Many of GenBank sequences specified by their GenBank ID numbers are reproduced herein in the section “Amino acid sequences and nucleotide sequences corresponding to selected GenBank ID numbers.” The CDS line refers to the exon(s).
[0047] Any GenBank ID numbers specified herein, absent a decimal point and an integer following that decimal point, is for GenBank version 1 of that sequence. Any GenBank ID number that has a decimal point and an integer following it is the GenBank version number.
[0048] The invention will be illustrated in more details with reference to the following Examples, but it should be understood that the present invention is not deemed to be limited thereto.
Preparation of Cytosolic (S100) and Membrane (P100) Proteins from Rat PP and NPP Tissues
[0049] Protein samples were prepared from PP and NPP tissue extracted from freshly sacrificed rats. These protein samples underwent electrophoresis on denatured SDS-PAGE gels and were stained using two different standard proteins Commassie Blue stains. Subsequently, fresh PP and NPP tissue samples were fractionated into cytosolic (S100) and membrane (P100) proteins and these samples were also electrophoresed on SDS-PAGE in order to compare S100 and P100 fractions in both PP and NPP tissues.
Preparation of GIT Tissue or Co-Culture Cell Membrane (P100) and Cytosolic (S 100) Fractions
[0050] The fractions were prepared using the following procedure:
[0051] 1. Scrape the co-culture cells into PBS and pool cells into a universal.
[0052] 2. Centrifuge the cells for 5 minutes at 1,500 rpm.
[0053] 3. Remove the supernatant.
[0054] 4. Re-suspend the cell pellet in 3 volumes of ice-cold HED buffer, and allow it to swell for 5 minutes on ice.
[0055] 5. Homogenize the cells for 30 seconds.
[0056] 6. Centrifuge the homogenate in hard walled tubes at 40,000 rpm for 45 minutes at 4° C. in a Beckmann Ultra Centrifuge (rotor Ti90).
[0057] 7. Remove the supernatant (S 100) and re-suspend the pellet (P100) in 3 volumes of HEDG buffer, before centrifugation again at 1000 rpm for 2 min. Remove the supernatant and store on ice. Repeat the procedure and add the second supernatant to the first.
[0058] 8. Determine the protein concentration (using the Bio-Rad protein assay).
[0059] 9. All fractions were stored at −80° C.
[0060] The following reagents were used in the above methods: HED buffer (20 mM HEPES pH 7.67), 1 mM EGTA, 0.5 mM dithiothreitol, 1 mM phenylmethylsulphonyl fluoride (PMSF):
1|
|
HEPES (pH to 7.67)0.5206g
EGTA38.04mg
Dithiothreitol7.71mg
Distilled waterto 100ml
|
[0061] 10 μl PMSF stock solution was added to 1 ml of buffer prior to use.
[0062] HEDG buffer (the same as HED buffer plus 100 mM NaCl, 10% glycerol)
2|
|
NaCl0.584g
Glycerol11.4ml
HEPES (pH to 7.67)0.5206g
EGTA38.04mg
Dithiothreitol7.71mg
Distilled waterto 100ml
|
[0063] 10μl PMSF stock solution was added to 1 ml of buffer prior to use.
[0064] PMSF(100 mM) stock solution
3
Isolation of Epithelial Sheaths from Rat Pever's Patch and Non-Pever's Patch Tissue
[0065] The M cell is a very elusive cell type, at least in terms of isolating a purified population. Previous attempts have found that when M cells are separated and purified and put into culture they very quickly lose their characteristic morhphology and probably gene/protein expression profile. In many cases this is due to the length of time taken to isolate and purify the cells from the very homogenous mix of cells in a Peyer's patch. We desired a quick and routine method to enrich for M cells is Peyer's patch samples. M cells are only contained in the epithelium of Peyer's patches, the so-called follicle associated epithelium (FAE), while underneath the epithelial layer lays all the B and T lymphocytes, dendritic cells etc. So by isolating the epithelium away from the rest of the Peyer's patch dome, we are greatly enriching it for the M cell population. Previously, treatment of mouse intestinal tissue with EDTA was shown to cause separation of the epithelium as a sheet from the rest of the tissue, allowing for it's specific isolation (Bjerknes M and Cheng H (1981). Methods for the isolation of intact epithelium from the mouse intestine. Anat. Rec., (199):565). This method was adapted for the isolation of FAE from rat Peyer's patch. Control epithelium from normal gut tissue (no Peyer's patches) was used as a control.
[0066] Epithelial sheaths were prepared using EDTA method comprising the following steps:
[0067] 1. Sacrifice the rats (Wistar) by cervical dislocation.
[0068] 2. Remove the entire length of the GIT tract from (but not including) the stomach to the caecum and place in a dish of PBS (at room temperature).
[0069] 3. Excise the Peyer's patches, taking care to remove as much normal non-PP GI tissue as is visible. Rinse briefly in PBS.
[0070] 4. Also take samples of normal non-Peyer's (N PP) tissue close to the patches, rinse in PBS and treat as for the PPs (steps 5-9,11-12).
[0071] 5. Pool the PP's from the entire GI section in Hank's Buffered Saline Solution (HBSS, Gibco Life Sciences) with 0.011 M glucose and 25 mM Hepes.
[0072] 6. When pooling is complete, place PP sections into 15-20 ml of HBSS (with 0.011M glucose and 25 mM Hepes) along with 40 mM of EDTA into a small conical flask.
[0073] 7. Add a stirrer bar to the flask, place on a stirring plate and spin the PP's for 15 min at RT.
[0074] 8. After 15 minutes pipette the PP solution vigorously with a wide-bore 3 ml plastic pasteur pipette.
[0075] 9. Strain the supernatant through a 100 micron nylon cell strainer (from FALCON™, 352360).
[0076] 10. Move the filter to another 50 ml tube and wash out the residue material on the filter with HBSS (with 0.011M glucose and 25 mM Hepes, no EDTA). This residue contains the majority of the PP dome epithelial sheaths.
[0077] 11. Centrifuge the PP residue material at 3000 rpm for 5 min. Also centrifuge the NPP tissue supernatant at 3000 rpm for 5 min.
[0078] 12. Snap freeze the cell pellets and store at −70° C.
Identification of Over-Expressed Proteins in Enriched M cells/PP FAE Cells
[0079] Epithelial cell layers of Wistar rat PP (representing enriched M cells/PP FAE cells) and normal villi were extracted using EDTA as described in Example 3 above. Epithelial layers from numerous Patches and rats were pooled and the protein isolated into either cytosolic and membrane fractions following centrifugal separation. 2D gel electrophoresis (between isoelectric points pH 3.5 to 10) was performed on 50 μg of each fraction, wherein the gels were silver stained. The gels were overlaid, and numerous differentially expressed proteins between the membrane fractions of PP and normal villi epithelia were observed. Further, protein samples underwent a second 2D gel electrophoresis, this time the gel was stained with a “special” silver stain, that did not inhibit the mass spectrometry analysis of individual spots. The differentially expressed proteins were identified and highlighted by gel overlay.
[0080] Thirty-seven protein spots were identified that were increased in PP over villi epithelial membrane fractions. Of these, 16 spots (the most highly over-expressed) were chosen for mass spectrometry analysis. The spots were digested with endoproteinase Lys-C/trypsin (8:1 ratio) and analyzed on a MALDI-MS. The spots, however, gave very poor spectra and only 4 of the 16 were identifiable. These were:
[0081] serum albumin;
[0082] calreticulin;
[0083] 14-3-3 zeta (tentative ID; mouse); and
[0084] nucleoside diphosphate kinase B.
[0085] One protein showed homologyto human serum albumin (HSA). Work byA. Fasano at Maryland had suggested that Zonulin, the human homologue of ZOT, showed sequence homology to human serum albumin (85% homology across the limited sequence available from the Fasano's work). Given our finding that a protein differentially expressed in rat PP tissue shows homology to HSA, we propose that HSA (or a homologue or splice variant thereof) is involved in drug transport in the GIT, in particular Peyer's patch tissue of the GIT.
[0086] Calreticulin is a 46-kDa Ca (2+)-binding chaperone of the endoplasmic reticulum membranes. This protein binds Ca (2+) with high capacity, affects intracellular Ca (2+) homeostasis, and functions as a lectin-like chaperone. Given the over-abundance of expression of this protein in epithelial layers selected from PP tissue and the role of this protein as a lectin-like chaperone, we propose that this protein is a valuable protein target to aid or facilitate the intracellular trafficking of antigens or antigens in particles following targeted delivery to M cells or PP tissue. Proteins comprising chimerics of calreticulin plus a polypeptide with an antigen of choice would therefore prove valuable in that regard.
[0087] Members of the 14-3-3 protein family have been identified as regulatory elements in intracellular signaling pathways and cell cycle control. There had been reports that 14-3-3 protein can be used as a marker for Creutzfeldt-Jacob Disease (CJD) in cerebrospinal fluid (CSF). It is proposed that this protein or the gene coding for it is valuable in the control of the M cell phenotype, and as a result it would be advantageous to co-deliver that protein or gene with a protein, antigen, or DNA vaccine.
[0088] Nucleoside diphosphate kinases (NDP kinases) form a family of oligomeric enzymes present in all organisms. Eukaryotic NDP kinases are hexamers composed of identical subunits (approximately 17 kDa). A distinctive property of human NDPK-B is its ability to stimulate gene transcription. This property is independent of its catalytic activity and is possibly related to the role of this protein in cellular events including differentiation and tumor metastasis. Given our discovery of the increased expression of nucleoside diphosphate kinase B in M cell enriched PP FAE cells, we propose the importance of this protein in determining or controlling M cell phenotype, in M cell development, and optimal activation or priming of the mucosal immune system.
Gene Expression Analysis of Rat PP and NPP Tissue Samples
[0089] In addition to the proteomic studies highlighted above, PP and NPP tissue samples were sent for gene expression analysis to CLONTECH Laboratories Inc. (a division of Becton Dickinson (BD) Biosciences) who then extracted RNA from the tissues to probe on ATLAS™1.2 rat arrays. The data containing differential expression levels of 1,200 genes many of which are presented in Table 1 below. The data show over-expression of many proteins. In Table 1, over-expressed genes are shown in bold and italicized.
[0090] In Table 1, “N/C” means not calculated due to manually-determined inconsistencies in one or both spots, and “?” means low confidence level (small difference).
[0091] Also, over-expressed genes from Table 1 that had a fold change above 0, as well as over-expressed genes are shown in Table 2 below with corresponding GenBank accession numbers for rat and human origin.
[0092] Based on the results (ratio PP/Normal epithelial tissue) in Table 1, the following proteins are of the particular interest: clusterin, T-cell surface glycoprotein CD5 precursor, HSP84, Ca2+-dependant phospholipase A2 precursor, ribosomal proteins S12, S11, L12, L11, S29, S19, L21, L19, L13, L44, and L36A.
[0093] In addition a series of genes coding for different TFs was noted including the following:
[0094] Jun-B; c-jun related TF,
[0095] Jun-D; c-jun related TF,
[0096] STAT 3-signal transducer and activator of transcription 3,
[0097] NF-kappaβ Tf p105 subunit,
[0098] CREB active TF,
[0099] New england deaconess TF,
[0100] C-jun proto-oncogene; TF AP-1; RJG-9,
[0101] S-myc proto-oncogene; myc related,
[0102] Nm23-M2; nucleoside diphosphate kinase B; metastasis reducing protein,
[0103] NDK-B; nucleoside diphosphate kinase B; metastasis reducing protein,
[0104] Lim-2; embryonic motor neuron topographic organizer; homeobox protein LIM-2, and
[0105] C-est-I proto-oncogene; p54.
[0106] TF coding genes such as these are considered here to be important in the development of M cell phenotype and in priming the immune system. Their co-delivery or co-targeting with DNA vaccine genes and/or with vaccines is expected to enhance activation of mucosal immunity to the co-delivered DNA vaccine and/or antigen by virtue of their priming of the cells to give a better mucosal immunity outcome.
4TABLE 1
|
|
GENE EXPRESSION DATA FROM ATLAS 1.2 RAT ARRAY ANALYSIS
Spot Intensity
#coordinatePP1NE1RATIODifferenceGENE
|
1A03c3860.16−32T-cell surface glycoprotein CD5 precursor; lymphocyte glycoprotein LY1
2A03g31571.8426CD4 homologue, W3/25 antigen
3A04f20723.6052signal transducer CD24 precursor; heat stable antigen (HSA); nectadrin
4A04i17402.3523CD2, membrane glycoprotein, T-cell marker
5A04i8344.2526scavenger receptor class B type I
6A04m16311.9415SR13 myelin protein, peripheral myelin protein 22 (PMP-22), CD25 protein
7A05a4174.2513glutamyl aminopeptidase A
8A05i52290.56−23I-kB (I-kappa B) alpha chain; RL/IF-1 gene product
9A05m6183.0012interferon regulatory factor 1 (IRF1)
10A06a7213.0014LIM domain protein CLP36, homologous to rat RIL
11A06c152780.51−74Gax. growth-arrest-specific protein
12A07c42240.57−18G1/S-specific cyclin D3 (CCND3)
13A07l1730.18−14M-phase inducer phosphatase 2 (MPI2); cell division control protein 25 B (CDC25B)
14A07n37200.54−17p55cdc; cell division control protein 20
15A08e56240.43−32prothymosin-alpha (PTMA)
16A08n321053.2873antigen peptide transporter 1
17A09g13362.7723proteasome delta subunit precursor; macropain delta; multicatalytic endopeptidase
complex delta;
18A09i15271.8012proteasome component C13 precursor; macropain subunit C13; multicatalytic
endopeptidase
19A09j3418932.62552apolipoprotein A-I precursor (APO-AI)
20A09k7272310.04651apolipoprotein A-IV precursor (APO-AIV)
21A11l11313.0012ErbB3 EGF receptor-related proto-oncogene; HER3
22A12c21482.2927A-raf proto-oncogene
23A12i19452.3726rac-alpha serine/threonine kinase (RAC-PK-alpha); protein kinase B (PKB), AKT1
24A13k208600.29−148HSP84; HSP90-beta; heat shock 90 kD protein
25A14c7385.4331glutathione S-transferase Ya subunit (GST YA); liqandin subunit 1 alpha
26A14d651622.4997microsomal glutathione S-transferase (GST12; MGST1)
27A14e941601.7066glutathione S-transferase Yb subunit; GST subunit 4 mu (GSTM2)
28A14q1292652.05136glutathione S-transferase P subunit; GST subunit 7 pi (GST7-7)
29A14n7192.7112NADPH-cytochrome P450 reductase (CPR); POR
30B01h1212071.7186copper-zinc-containing superoxide dismutase 1 (Cu—Zn SOD1)
31B02f4256.2521fructose (glucose) transporter
32B05k13362.7723sodium channel SCNB2, beta 2 subunit, brain
33B06d28120.43−16potassium channel, inward rectifier 11
34B07k2189.0016proton-coupled dipeptide cotransporter
35B08b591813.07122fibroblast ADP/ATP carrier protein; ADP/ATP translocase 2, adenine nucleotide
translocator 2
36B09i7436.1436sodium-glucose cotransporter 1
37B09l401152.8875Na+/K+ ATPase alpha 1 subunit
38B09n43781.8135vacuolar ATP synthase 16-kDa proteolipid subunit, ATP6C; MVP; ATPL
39B10b10787.8068sodium/potassium-transporting ATPase beta 1 subunit (ATP1B1)
40B12e10686.8058urate transporter/channel
41B12f1432972.08154ATP synthase lipid-binding protein P1 precursor, ATPase protein 9, ATP5G1
42B12q211125.3391ATP synthase, subunit c, P2 gene
43B12m18382.1120annexin IV(ANX4); lipocortin IV;36-kDa zymogen granule membrane-associated
protein (ZAP36)
44B13f371273.4390lipocortin 2
45B14d593265.53267fatty acid-binding protein (liver; L-FABP); Z-protein; squalene - & sterol-carrier
protein (SCP); P14
46B14f491573.20108fatty acid-binding protein (intestinal; I-FABP; FABPI)
47C02f19784.1159fructose-bisphosphate aldolase B (ALDOB); liver-type aldolase
48C02g37762.0539fructose-bisphosphate aldolase A (ALDOA); muscle-type aldolase
49C02j15302.0015testis fructose-6-phosphate 2-kinase/fructose 2,6-biphosphate
(testis 6PF-2-K/fru-2,6-P2ase); 6-
50C02n60411231.86519cytochrome c oxidase subunit Vb & Vla precursor (COX5B)
51C03a9202.2211cytochrome B5 (CYB5)
52C03e651382.1273mitochondrial hydroxymethylglutaryl-CoA synthase precursor (HMG-CoA synthase);
3-hydroxy-3-
53C03f1777604.29583cytochrome oxidase, subunit I, Sertoli cells
54C03q27471.7420ATPase, subunit F, vacuolar (vatf)
55C03i64110871.70446cvtochrome c oxidase, subunit IV, mitochondrial
56C03l461473.20101cytochrome c oxidase, subunit Va, mitochondrial
57C03l3171800.57−137cytochrome c oxidase, subunit VIIIh
58C04b1893511.86162mitochondrial ATP synthase beta subunit precursor (ATP5B)
59C04q231275.52104creatine kinase, ubiquitous, mitochondrial
60C06c6528.6746fatty acid amide hydrolase
61C06j731752.40102cytochrome P450 17 (CYP17), P450C17, CYPXVII, steroid 17-alpha-hydroxylase/17,20
lyase
62C07i9515.6742cytochrome P-450 4F1, hepatic tumour
63C07l19392.0520cytochrome P-450 4F4
64C08a17331.9416cytochrome P-450 4F5
65C08l8243.0016adenylate kinase 3
66C08m32652.0333cAMP-dependent protein kinase type I-alpha regulatory chain
67C09e7304.2923glutathione synthetase (GSH synthetase; GSH-S; GSS). glutathione synthase
68C10e25100.40−15carbonic anhydrase 4
69C10j1990.47−10alkaline phosphatase
70C10k2150.24−16dopamine beta-hydroxylase
71C10l29110.38−18acetylcholinesterase, T subunit, glycolipid-anchored
72C10m2284451.95217NADP+ alcohol dehydrogenase; aldehyde reductase (ALR); 3-dG-reducing enzyme
73C11b19331.7414calcium bindinq protein 2 (CABP2), endoplasmic reticulum stress protein (ERP72);
protein disulfide
74C11d97550.57−4260S ribosomal protein L44; L36A
75C11e17285270.30−120140S ribosomal protein S12
76C11q4001790.45−221ribosomal protein L11
77C11h6703550.53−315ribosomal protein L13
78C11i9674240.44−543ribosomal protein L12
79C11k8124130.51−399S19; 40S ribosomal protein S19
80C11l5542860.52−26860S ribosomal protein L21
81C11m14057370.52−66860S ribosomal protein L19 (RPL19)
82C11n3151090.35−20640S ribosomal protein S11
83C12b158480.30−110Fte-1; putative v-fos transformation effector protein; yeast mitochondrial protein
import homolog; 40S
84C12d14517870.54−664elongation factor 2 (EF2)
85C12l346100.03−336clusterin (CLU); testosterone-repressed prostate message 2 (TRPM2); apolipoprotein
J; sulfated
86C12m140Undefined−14activator of apoptosis harakiri (HRK); neuronal death protein 5 (DP5); BID3
87C13c1950.26−14SURVIVAL OF MOTOR NEURON(RSMN)
88D08i6172.8311retinoid X receptor alpha (RXR alpha; RXRA); NR2B1
89D12c6183.0012INOSITOL TRIPHOSPHATE RECEPTOR SUBTYPE 3
90E01m10505.0040neurotrophin 3 precursor (NTF3); neurotrophic factor, HDNF, nerve growth
factor 2 (NGF2)
91E02c1980.42−11transforming growth factor, beta 1
92E03k401854.63145C-type natriuretic peptide precursor (CNP; NPPC)
93E04b1770.41−10thyroid stimulating hormone, beta
94E07c33150.45−18c-src-kinase (CSK) & negative regulator; tyrosine-protein kinase
95E08a1052492.37144extracellular signal-regulated kinase 1 (ERK1); mitogen-activated protein kinase 1
(MAP kinase 1:
96E08l8222.7514protein kinase C delta type (PKC-delta)
97E09l36681.8932insulin receptor-related receptor-alpha (sIRR-1)
98E10f3175.6714CamK II; calcium/calmodulin-dependent protein kinase brain type II beta
99E10q3134.3310CamK I, calcium/calmodulin-dependent protein kinase type I + CaM-like protein kinase
100E10l18422.3324Casein kinase I delta, CKId; 49-kDa isoform
101E11e15291.9314cyclin-dependent kinase 4 (CDK4); cell division protein kinase 4, PSK-J3
102E12g23451.9622protein phosphatase 2C isoform; Mg2+ dependent protein phosphatase beta isoform
103E13i40190.48−21quanine nucleotide-bindinq protein G(I) alpha 2 subunit (GNAI2); adenylate cyclase-
104E14i2686612.47393rab12, ras related GTPase
105F01e10292.9019RalGDSB; GTP/GDP dissociation stimulator for a ras-related GTPase
106F02a189970.51−92calcium-dependent phospholipase A2 precursor (PLA2); phosphatidylcholine 2-
107F02h15795.2764phospholipase C beta 3 (PLC-beta 3)
108F04e33571.732414-3-3 protein zeta/delta, PKC inhibitor protein-1, KCIP-1, mitochondrial import
stimulation factor
109F04k15291.931414-3-3 protein epsilon; PKC inhibitor protein-1, KCIP-1; mitochondrial import
stimulation factor L
110F05e8212.6313presenilin 1 (PSNL1; PSEN1; PS1); S182 protein
111F05j6172.8311PDGF-associated protein
112F06a591432.4284ADP-ribosylation factor 5 (ARF5)
113F06j12221.8310dipeptidase (DPEP1)
114F07m7294.1422granzyme M precursor (GZMM). MET-ASE; natural killer cell granular protease;
RNK-MET-1
115F08e111009.0989angiotensin converting enzyme (ACE; somatic; dipeptidyl carboxypeptidase I, kininase II
116F08h18482.6730amonipeptidase B
117F08i39922.3653kidney aminopeptidase M (APM)
118F08k19814.2662metalloendopeptidase meprin beta subunit
119F08l5153.0010endothelin converting enzyme
120F09a3165.3313gelatinase A
121F09g13272.0814cathepsin L
122F09l14282.0014proteasome component C3
123F12a6162.6710leukocyte common antigen-related tyrosine phosphatase (LAR)
124G3112393.2527ornithine decarboxylase (ODC)
125G4328711323.94845cytoplasmic beta-actin (ACTB)
126G47732736140.49−371340S ribosomal protein S29 (RPS29)
|
[0107]
5
TABLE 2
|
|
|
RAT GENES (PP VS. NPP)
|
Fold
GenBank ID
GenBank ID
|
GENE
change
Human
Rat
|
|
activator of apoptosis harakiri (HRK); neuronal death
**
U76376.1
D83697
|
protein 5 (DP5); BID3
|
RET ligand 1 (RET1)
**
—
U97142
|
P2X purinoceptor 1; ATP receptor P2X1; purinergic
**
P51575
U14414
|
receptor; RP-2 protein
|
leukocyte common antigen precursor (LCA); CD45
**
Y00638
M10072
|
antigen; T200; PTPRC
|
amphiphysin II (AMPH2)
**
AF001383.1
Y13380
|
Jak3 tyrosine-protein kinase; Janus kinase 3
**
XM_038595.3
D28508
|
DCC; netrin receptor; immunoglobulin gene superfamily
**
M32292.1
AH002168.1
|
member; former tumor suppressor protein candidate
|
c-fgr proto-oncogene
**
AAA52762.1
X57018.1
|
small inducible cytokine A3 precursor (SCYA3);
**
P10147
AF119381.1
|
macrophage inflammatory protein 1 alpha precursor
|
(MIP1-alpha; MIP1A)
|
protein kinase C beta-If type (PKC-beta I) + protein kinase
**
X06318
P04410
|
C beta-II type (PKC-beta II)
|
E-selectin precursor; endothelial leukocyte adhesion
**
P16581
L25527
|
molecule 1 (ELAM-1); leukocyte-endothelial cell adhesion
|
molecule 2 (LECAM2); CD62E
|
T-cell receptor CD3 zeta subunit
**
J04132.1
L08447.1
|
Protein kinase C-binding protein beta15; RING-domain
**
—
U48248
|
containing
|
G1/S-specific cyclin C (CCNC)
**
AAC50825.1
D14013
|
maspin; protease inhibitor 5 (PI5); tumor suppressor
**
U04313.1
U58857
|
peptide/histidine transporter
**
—
AB000280
|
acetyl-CoA carboxylase (ACC); biotin carboxylase
**
X68968.1
AH002123.1
|
fibroblast growth factor receptor subtype 4
**
L03840.1
M91599
|
LCR-1; putative chemokine and HIV coreceptor homolog;
**
—
U54791
|
G protein-coupled receptor
|
tumor necrosis factor alpha precursor (TNF-alpha; TNFA);
**
AF043342.1
X66539
|
cachectin
|
CC chemokine MIP3 alpha exodus
**
—
U90447.1
|
luteinizing hormone, alpha
**
NM_000735.2
V01252
|
Ctk; non-receptor protein tyrosine kinase (batk)
**
P42679
L34542.1
|
RhoGAP; p122
**
—
S54293
|
Adenylyl cyclase type V
**
M83533.1
M96159
|
cathepsin S precursor (CTSS)
**
P25774
L03201.1
|
O-6-methylguanine-DNA methyltransferase (MGMT);
**
M31767.1
NM_012861.1
|
methylated-DNA-protein-cysteine methyltransferase
|
clusterin (CLU); testosterone-repressed prostate message
34.60
X14723
U02391.1
|
2 (TRPM2); apolipoprotein J; sulfated glycoprotein 2
|
(SGP2); dimeric acid glycoprotein (DAG)
|
T-cell surface glycoprotein CD5 precursor; lymphocyte
6.33
X04391.1
D10728
|
glycoprotein LY-1 (LYT1)
|
M-phase inducer phosphatase 2 (MPI2); cell division
5.67
S78187.1
D16237
|
control protein 25 B (CDC25B)
|
dopamine beta-hydroxylase
4.20
Y00096.1
L12407
|
SURVIVAL OF MOTOR NEURON(RSMN)
3.80
AAC50473.1
U75369
|
HSP84; HSP90-beta; heat shock 90kD protein
3.47
XM_055551.3
S45392
|
Fte-1; putative v-fos transformation effector protein; yeast
3.29
M84711.1
M84716.1
|
mitochondrial protein import homolog; 40S ribosomal
|
protein S3A; RPS3A
|
40S ribosomal protein S12
3.28
X53505
M18547
|
40S ribosomal protein S11
2.89
X06617
K03250
|
acetylcholinesterase, T subunit, glycolipid-anchored
2.64
M55040.1
X71089.1
|
carbonic anhydrase 4
2.50
NM_000717.2
I52551
|
thyroid stimulating hormone, beta
2.43
S70587.1
M13897.1
|
transforming growth factor, beta 1
2.38
M34057
NM_021578.1
|
prothymosin-alpha (PTMA)
2.33
AF257099.1
M20035
|
potassium channel, inward rectifier 11
2.33
—
D42145
|
ribosomal protein L12
2.28
L06505.1
X53504.1
|
ribosomal protein L11
2.23
X79234.1
X62146.1
|
c-src-kinase (CSK) & negative regulator; tyrosine-protein
2.20
X59932.1
X58631
|
kinase
|
alkaline phosphatase
2.11
AAA98616.1
S18408
|
guanine nucleotide-binding protein G(I) alpha 2 subunit
2.11
XM_041507.1
NM_031035.1
|
(GNAI2); adenylate cyclase-inhibiting G alpha protein
|
40S ribosomal protein S29 (RPS29)
2.03
NM_001032.2
X59051
|
S19; 40S ribosomal protein S19
1.97
P39019
P17074
|
Gax, growth-arrest-specific protein
1.95
—
Z17223.1
|
calcium-dependent phospholipase A2 precursor (PLA2);
1.95
M22430.1
U38376.1
|
phosphatidylcholine 2-acylhydrolase (PLA2-10; PLA2G5)
|
60S ribosomal protein L21
1.94
P46778
M27905
|
60S ribosomal protein L19 (RPL19)
1.91
X63527
J02650
|
ribosomal protein L13
1.89
P26373
X78327.1
|
p55cdc; cell division control protein 20
1.85
AF099644.1
AF052695.1
|
elongation factor 2 (EF2)
1.84
X51466
Y07504.1
|
I-κB (I-kappa B) alpha chain; RL/IF-1 gene product
1.79
X63594.1
AF388201.1
|
60S ribosomal protein L44; L36A
1.76
M15661
P10661
|
cytochrome c oxidase, subunit VIIIh
1.76
J04823.1
NM_012786.1
|
G1/S-specific cyclin D3 (CCND3)
1.75
NM_001760.2
NM_012766.1
|
cytochrome c oxidase, subunit IV, mitochondrial
0.59
AF017115.1
X14209
|
glutathione 3-transferase Yb subunit; GST subunit 4 mu
0.59
—
X04229.1
|
(GSTM2)
|
copper-zinc-containing superoxide dismutase 1 (Cu-Zn
0.58
—
NM_017050.1
|
SOD1)
|
14-3-3 protein zeta/delta; PKC inhibitor protein-1; KCIP-1;
0.58
U28964.1
L07913.1
|
mitochondrial import stimulation factor S1 subunit
|
calcium binding protein 2 (CABP2); endoplasmic reticulum
0.58
XM_012077.4
M86870
|
stress protein (ERP72); protein disulfide isomerase-
|
related protein precursor
|
ATPase, subunit F, vacuolar (vatf)
0.57
AF047436.1
U43175.1
|
proteasome component C13 precursor; macropain subunit
0.56
P28062
NM_080767.1
|
C13; multicatalytic endopeptidase complex subunit C13
|
PSMB8
|
vacuolar ATP synthase 16-kDa proteolipid subunit;
0.55
NM_001695.1
M62762.1
|
ATP6C; MVP; ATPL
|
dipeptidase (DPEP1)
0.55
NM_004413.1
M94056
|
CD4 homologue, W3/25 antigen
0.54
BC025782.
M15768.1
|
mitochondrial ATP synthase beta subunit precursor
0.54
NM_001686.1
M19044.1
|
(ATP5B)
|
cytochrome c oxidase subunit Vb & VIa precursor
0.54
M59250.1
X14208.1
|
(COX5B)
|
insulin receptor-related receptor-alpha (sIRR-1)
0.53
—
M90660.1
|
cyclin-dependent kinase 4 (CDK4); cell division protein
0.52
P11802
P35426
|
kinase 4; PSK-J3
|
14-3-3 protein epsilon; PKC inhibitor protein-1; KCIP-1;
0.52
XM_088041.1
D30739.1
|
mitochondrial import stimulation factor L subunit
|
SR13 myelin protein; peripheral myelin protein 22 (PMP-
0.52
—
M69139.1
|
22); CD25 protein
|
cytochrome P-450 4F5
0.52
—
AF288818.1
|
NADP+ alcohol dehydrogenase; aldehyde reductase
0.51
J04794.1
D10854.1
|
(ALR); 3-dG-reducing enzyme
|
protein phosphatase 2C isoform; Mg2+ dependent protein
0.51
—
S90449.1
|
phosphatase beta isoform
|
testis fructose-6-phosphate 2-kinase/fructose 2,6-
0.50
NM_002625.1
X15579.1
|
biphosphate (testis 6PF-2-K/fru-2,6-P2ase); 6-
|
phosphofructo-2-kinase; fructose-2,6-bisphosphatase
|
proteasome component C3
0.50
D00760
J02897.1
|
cAMP-dependent protein kinase type I-alpha regulatory
0.49
P10644
P09456
|
chain
|
cytochrome P-450 4F4
0.49
—
U39206.1
|
fructose-bisphosphate aldolase A (ALDOA); muscle-type
0.49
XM_043948.2
NM_012495.1
|
aldolase
|
glutathione S-transferase P subunit; GST subunit 7 pi
0.49
—
X02904.1
|
(GST7-7)
|
ATP synthase lipid-binding protein P1 precursor; ATPase
0.48
NM_005175.1
NM_017311.1
|
protein 9; ATP5G1
|
cathepsin L
0.48
M20496.1
Y00697.1
|
annexin IV(ANX4); lipocortin IV;36-kDa zymogen granule
0.47
XM_031596.3
NM_024155.1
|
membrane-associated protein (ZAP36)
|
mitochondrial hydroxymethylglutaryl-CoA synthase
0.47
P54868
P22791
|
precursor (HMG-CoA synthase); 3-hydroxy-3-
|
methylglutaryl-CoA synthase; HMGCS2
|
cytochrome B5 (CYB5)
0.45
M22865.1
D13205.1
|
A-raf proto-oncogene
0.44
P10398
X06942
|
Casein kinase I delta; CKId; 49-kDa isoform
0.43
P48730
Q06486
|
CD2, membrane glycoprotein, T-cell marker
0.43
M14362.1
X05111.1
|
kidney aminopeptidase M (APM)
0.42
XM_087746.1
M26710
|
rac-alpha serine/threonine kinase (RAC-PK-alpha); protein
0.42
P31749
Y15748.1
|
kinase B (PKB); AKT1
|
extracellular signal-regulated kinase 1 (ERK1); mitogen-
0.42
P27361
P21708
|
activated protein kinase 1 (MAP kinase 1; MAPK1);
|
insulin - stimulated microtubule-associated protein-2
|
kinase; MNK1; PRKM3; ERT2; p44-MAPK
|
cytochrome P450 17 (CYP17); P450C17; CYPXVII;
0.42
NM_000102.2
X69816.1
|
steroid 17-alpha-hydroxylase/17,20 lyase
|
ADP-ribosylation factor 5 (ARF5)
0.41
NM_001662.
NM_024149.1
|
rab12, ras related GTPase
0.41
—
M83676.
|
microsomal glutathione S-transferase (GST12; MGST1)
0.40
XM_048886.3
J03752
|
apolipoprotein A-I precursor (APO-AI)
0.38
X02162
M00001
|
presenilin 1 (PSNL1; PSEN1; PS1); S182 protein
0.38
XM_007441.1
D82363
|
amonipeptidase B
0.38
|XM_087242.1
U61696
|
leukocyte common antigen-related tyrosine phosphatase
0.38
—
U00477.1
|
(LAR)
|
NADPH-cytochrome P450 reductase (CPR); POR
0.37
S90469
NM_031576.1
|
protein kinase C delta type (PKC-delta)
0.36
NM_006254.1
M18330
|
proteasome delta subunit precursor; macropain delta;
0.36
X61971.1
NM_057099.1
|
multicatalytic endopeptidase complex delta; proteasome
|
subunit Y; proteasome subunit 5; PSMB6
|
sodium channel SCNB2, beta 2 subunit, brain
0.36
AAC05208.1
NM_012877.
|
retinoid X receptor alpha (RXR alpha; RXRA); NR2B1
0.35
XM_088424.1
NM_012805.1
|
PDGF-associated protein
0.35
U41745.1
U41744.1
|
Na+/K+ ATPase alpha 1 subunit
0.35
AAA51801.1
M28647
|
RalGDSB; GTP/GDP dissociation stimulator for a ras-
0.34
—
NM_019250.1
|
related GTPase
|
interferon regulatory factor 1 (IRF1)
0.33
XM_034862.1
M34253
|
LIM domain protein CLP36, homologous to rat RIL
0.33
AJ310549.1
U23769.1
|
adenylate kinase 3
0.33
XM_016642.3
NM_13218.1
|
INOSITOL TRIPHOSPHATE RECEPTOR SUBTYPE 3
0.33
—
L06096.1
|
endothelin converting enzyme
0.33
Z35307.1
D29683
|
fibroblast ADP/ATP carrier protein; ADP/ATP translocase
0.33
J02683
D12771
|
2; adenine nucleotide translocator 2 (ANT2)
|
cytochrome c oxidase, subunit Va, mitochondrial
0.31
M22760.1
X15030
|
fatty acid-binding protein (intestinal; I-FABP; FABPI)
0.31
M18079
M18080.1
|
ornithine decarboxylase (ODC)
0.31
X16277
D11372.1|
|
antigen peptide transporter 1
0.30
X57522
P36370
|
lipocortin 2
0.29
D00017.1
S73557
|
signal transducer CD24 precursor; heat stable antigen
0.28
P25063
U49062
|
(HSA); nectadrin
|
cytoplasmic beta-actin (ACTB)
0.25
M10277.1
V01217
|
fructose-bisphosphate aldolase B (ALDOB); liver-type
0.24
XM_042788.1
M10149
|
aldolase
|
granzyme M precursor (GZMM); MET-ASE; natural killer
0.24
NM_005317.2
Q03238
|
cell granular protease; RNK-MET-1
|
scavenger receptor class B type I
0.24
—
AB002151.1
|
glutamyl aminopeptidase A
0.24
XM_003595.2
S73583
|
metalloendopeptidase meprin beta subunit
0.23
—
M88601.1
|
glutathione synthetase (GSH synthetase; GSH-S; GSS);
0.23
U34683.1
L38615.1
|
glutathione synthase
|
cytochrome oxidase, subunit I, Sertoli cells
0.23
S79304
S79304
|
CamK I; calcium/calmodulin-dependent protein kinase
0.23
Q14012
L24907
|
type I + CaM-like protein kinase
|
C-type natriuretic peptide precursor (CNP; NPPC)
0.22
NM_024409.1
D90219
|
neurotrophin 3 precursor (NTF3); neurotrophic factor;
0.20
M37763.1
M34643
|
HDNF; nerve growth factor 2 (NGF2)
|
phospholipase C beta 3 (PLC-beta 3)
0.19
NM_000932.1
M99567
|
ATP synthase, subunit c, P2 gene
0.19
D13119.1
D13124
|
gelatinase A
0.19
NM_004530.1
U65656
|
glutathione S-transferase Ya subunit (GST YA); ligandin
0.18
NM_000852.2
K01932
|
subunit 1 alpha
|
creatine kinase, ubiquitous, mitochondrial
0.18
XM_016524.4
X59737
|
fatty acid-binding protein (liver; L-FABP); Z-protein;
0.18
NM_001443.1
M35991
|
squalene- & sterol-carrier protein (SCP); P14
|
cytochrome P-450 4F1, hepatic tumour
0.18
—
NM_019623.1
|
CamK II; calcium/calmodulin-dependent protein kinase
0.18
NM_001220.1
M16112
|
brain type II beta
|
sodium-glucose cotransporter 1
0.16
P13866
U03120
|
fructose (glucose) transporter
0.16
AAB60641
D13871.1
|
urate transporter/channel
0.15
—
U67958
|
sodium/potassium-transporting ATPase beta 1 subunit
0.13
NM_001677.1
NM_013113.1
|
(ATP1B1)
|
fatty acid amide hydrolase
0.12
U82535.1
U72497
|
proton-coupled dipeptide cotransporter
0.11
—
D50306.1
|
angiotensin converting enzyme (ACE; somatic; dipeptidyl
0.11
NM_000789.1
NM_012544.1
|
carboxypeptidase I; kininase II
|
apolipoprotein A-IV precursor (APO-AIV)
0.10
XM_052144.2
P02651
|
ErbB3 EGF receptor-related proto-oncogene; HER3
0.08
M29366.1
NM_017218.2
|
Jun-B; c-jun related TF,
**
M29039.1
X54686
|
S-myc proto-oncogene; myc related,
**
M29069
|
C-est-I proto-oncogene; p54.
5
AF193068.1
X55787.1
|
Jun-D; c-jun related TF,
1.79
X56681.1
D26307(mouse)
|
NF-kappaβ Tf p105 subunit,
1.67
P19838
L26267.1
|
Nm23-M2; nucleoside diphosphate kinase B;
1.47
X68193.1
|
metastasis reducing protein,
(mouse)
|
STAT 3 —signal transducer and activator of
1.16
NM_003150.1
NM_012747.1
|
transcription 3,
|
CREB active TF,
1
M34356.1
|
New england deaconess TF,
1
U09229
|
Lim-2; embryonic motor neuron topographic
1
L35572
|
organizer; homeobox protein LIM-2, and
|
NDK-B; nucleoside diphosphate kinase B;
0.81
U29200.1
|
metastasis reducing protein,
|
C-jun proto-oncogene; TF AP-1; RJG-9,
0.5
J04111.1
X17215.1
|
|
Symbols indicating fold changes in Table 2:
|
** expressed in PP but not NPP, or in co-culture but not in Caco-2 cells.
|
* expressed in co-culture but not in Caco-2 cells (only repeated once).
|
— expressed in Caco-2 but not in co-culture.
|
ATLAS Array Data on Co-Culture of Human Caco-2 Cells and Raji B-Cells
[0108] In order to facilitate the routine study of M cell biology, there was a desire to establish a suitable and representative in-vitro model. In the work carried out by Kernéis et al. (Kerneis S, Caliot E, Stubbe H, Bogdanova A, Kraehenbuhl J, Pringault E (2000). Molecular studies of the intestinal mucosal barrier physiopathology using co-cultures of epithelial and immune cells: a technical update. Microbes Infect Jul. 2, 2000 (9):1119-24), it was reported that Peyer's patch lymphocytes co-cultured with Caco-2 cells trigger the phenotypic conversion of enterocytes into cells that express morphological and functional M-cell properties. This work was further developed by Gullberg et al. (Gullberg E, Leonard M, Karlsson J, Hopkins A M, Brayden D, Baird A W, Artursson P. Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem Biophys Res Commun Dec. 29, 2000; 279(3): 808-13) to create a simplified in vitro model of the human M-cell. Co-cultures of physically separated human intestinal epithelial Caco-2 cells and B-cell lymphoma Raji cells were established. The co-cultures were characterized under the criteria of morphology, integrity, expression of M-cell markers and cell adhesion molecules (CAMs), and altered particle transport. Using this construct, the epithelial cells were transformed to cells with an M-cell-like morphology and had altered expression of potential human M-cell markers (alkaline phosphatase down-regulation and Sialyl Lewis A antigen up-regulation). The expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule was altered, and there was an increased binding of lectins wheat germ agglutinin and peanut agglutinin with a 40-fold increase in microparticle transport. The particle transport was size-dependent and could be inhibited at 4° C. or by replacing the Raji B-cells with Jurkat T-cells. Thus the comparison of RNA isolated from co-cultured Caco2 cells to that isolated from normal Caco2 cells was designed to simulate a comparison of M cell RNA to normal gut enterocyte RNA.
Isolation of Total RNA from Co-Cultured Caco-2 Cells
[0109] Caco-2 Cell Culture
[0110] Caco-2 cells were cultured in Dulbecco's Modified Eagles Medium (DMEM), 4.5 g/L glucose supplemented with 1% Mem, 10% FCS and 1% penicillin/streptomycin a t 37° C. and 5% CO2 in 95% relative humidity. Cells were grown and expended in Falcon culture flasks and passaged once they attained 100% confluence. Caco-2 cells were seeded on Transwell Clear filters (Costar, 12 mm diameter, 3.0 μm pore size)) at a density of 5×105 cells/cm2 and incubated in a 12 well culture plate with a medium change every second day. 1.0 ml was added to the basolateral side and apical sides.
[0111] Raji Cell Culture
[0112] Raji B-lymphoma cells were cultured in RPMI 1640 Medium, with 1% (v/v) non-essential amino-acids, 10% FCS and 1% penicillin/streptomycin, 1% L-glutamine at 37° C. and 5% CO2 in 95% relative humidity. Cells were grown in suspension in Falcon tissue culture flasks and passaged by dilution every 5-7 days.
[0113] Co-Culture: Day 14 (Treating with Raji B-Cells)
[0114] After 14 days of culturing Caco-2 monolayers, 15-20 ml of Raji cells were removed from the T75 flask and placed in a 20 ml universal. The cells were centrifuged at 1000 rpm for 3 min. Cells were re-suspended at a concentration of 1×106 cells/ml. 1 ml of fresh complete DMEM was added to the apical and basolateral sides of the Caco-2 monolayer filters. 0.5 ml of 1×106 Raji cells/ml cells was added to the basolateral side of the filters. For control filters (non co-culture) 0.5 ml of Raji medium only was added to the basolateral side.
[0115] Isolation of Total RNA from Co-Cultured Caco-2 Cells
[0116] After 4 days of co-culture the filters were rinsed in PBS. 0.5 ml of PBS was added to the apical side of each filter and the Caco-2 cells were scraped off the filter surface into suspension in the PBS. The cells from all the co-cultured Caco-2 filters were pooled, centrifuged at 1000 rpm for 3 min, the supernatant PBS was removed and the pellet was used for RNA extraction.
[0117] Analysis of mRNA Expression
[0118] Total cellular RNA was extracted using an acid guanidinium thiocyanate-phenol-chloroform method. RNA's integrity was confirmed by gel electrophoresis and ethidium bromide staining. mRNA was reverse transcribed in the presence of P32 dATP, and the transcribed cDNA was purified by chromatography before being hybridized over night to the array membrane. Membranes were exposed to x-ray film using an intensifying screen for 3 days and the mRNA expression levels were analyzed by scanning the films with a densitometer. Expression levels were normalized relative to internal standards, and relative increases in mRNA levels in co-cultured cells versus monoculture controls were calculated. Two hybridization experiments were performed using mRNA from two separate cell harvests. Results from the two experiments were pooled, and a summary of the findings was tabulated in Tables 3(a)-3(f). The identified genes are from the following groups: oncogenes, tumor suppressor genes, genes involved in the cell cycle, ion channels and transport, stress response genes, modulators and effectors, genes involved in intracellular transduction, genes linked to apoptosis, DNA synthesis, repair & recombination, transcription factors, DNA binding proteins, receptors, cell surface antigens, genes involved in cell adhesion, growth factors, cytokines, chemokines and hormones.
[0119] In Table 3, genes which were found to be exclusively over-expressed in the co-culture and not in the control Caco-2 monolayer are represented by **. A single asterisk represents genes that also were expressed in the co-culture and not in the control Caco-2 monolayer. However, these particular genes have been distinguished from the genes labeled with two asterisks as they were not expressed in both hybridization experiments performed, and will require confirmation in the future by PCR so as to rule out false positives/negatives. Genes not expressed in the co-culture but expressed in the Caco-2 monolayer controls are indicated by a minus symbol, “−”.
6TABLE 3 a
|
|
Oncogenes, Tumor Suppressors, Cell Cycle Regulators
GeneFold changeGenBank ID
|
Myeloid cell nuclear differentiation*M81750
antigen (MNDA)
G1/S-specific cyclin D1 (CCND1);*X59798
cyclin parathyroid adenomatosis 1
(PRAD1); bcl-1 oncogene
cyclin-dependent kinase 4 inhibitor 2*L27211.1
(CDK4I; CDKN2); p16-INK4; multiple
tumor suppressor 1 (MTS1)
cyclin-dependent kinase inhibitor 1C*U22398
(CDKN1C); p57-KIP2
ezrin; cytovillin 2; villin 2 (VIL2)1.69X51521
proto-oncogene tyrosine-protein1.55L04143.1
kinase kit; c-kit; mast/stem cell
growth factor receptor
precursor(SCFR); CD117 antigen
proliferating cell nucleolar anti-1.52M32110
gen P120; NOL1
jun proto-oncogene; avian sarcoma1.47J04111
virus 17 oncogene homolog;
transcription factor AP-1
C-src proto-oncogene (SRC1)1.35X59932
CDC-like kinase 3 (CLK3)1.35L29220
cell division cycle protein 251.34M91815.1
nucleotide exchange factor (CDC25)
prothymosin alpha (PROT-alpha; PTMA)1.32M26708
40S ribosomal protein S19 (RPS19)1.31M81757
avian myelocytomatosis viral1.30V00568
oncogene homolog (MYC)
CDC-like kinase 1 (CLK1)1.27L29219.1
cyclin-dependent kinase 4 inhibitor0.69U49399.1
2D (CDKN2D); p19-INK4D
vascular endothelial growth factor0.62XM_039993.2
receptor 1 (VEGFR1); tyrosine-
protein kinase receptor flt +
soluble VEGFR; tyrosine-protein
kinase receptor SFLT
neogenin—U61262.1
webB2 receptor protein-tyrosine—M11730.1
kinase; neu proto-
oncogene; c-erbB2 +
HER2 receptor
N-ras; transforming p21 protein—AAA60255
|
[0120]
7
TABLE 3 b
|
|
|
Ion Channels, Modulators, Effectors
|
Gene
Fold change
GenBank ID
|
|
extracellular signal-regulated
**
X14798.1
|
kinase 3 (ERK3); mitogen-activated
|
protein kinase 6 (MAP kinase 6;
|
MAPK6; PRKM6); p97-MAPK
|
40-kDa heat-shock protein 1 (HSP40);
**
D49547
|
DNAJ protein homolog 1 (HDJ1; DNAJ1)
|
70-kDa heat shock protein 1
**
M11717
|
(HSP70.1; HSPA1)
|
glutaredoxin
**
X76648
|
tyrosine kinase receptor tie-1
*
AAB84296
|
precursor
|
ras-related protein RAB3B
*
NM_002867.1
|
macMARCKS; MARCKS-related protein
*
P49006|
|
(MRP); MLP
|
mitogen-activated protein kinase 3
*
P27361
|
(MAPK3; PRKM3); MAPK1; extra-
|
cellular signal-regulated kinase
|
1 (ERK); microtubule-associated
|
protein 2 kinase, insulin-
|
stimulated MAP2kinase
|
mitgoen-activated protein kinase 9
*
NM_002752.1
|
(MAP kinase 9; MAPK9; PRKM9); c-jun
|
N-terminal kinase 2 (JNK2); JNK55
|
60-kDa heat shock protein (HSP60);
*
M22382.1
|
HSPD1; 60-kDa chaperonin;
|
mitochondrial matrix protein
|
P1 precursor; p60 lymphocyte
|
protein; HUCHA60; GROEL
|
serine kinase
2.24
U09564.1
|
transferrin receptor (TFRC); CD71
1.80
M11507.1
|
antigen
|
Neurotrophic tyrosine kinase
1.63
U55017.1
|
receptor-related 3: TKT percursor
|
phospholipase C (PLCL)
1.62
X14034.
|
cAMP-response element binding
1.59
M27691.1|
|
protein (CREB)
|
ephrin type-A receptor 1 precursor;
1.55
M18391
|
tyrosine-protein kinase receptor eph
|
27-kDa heat-shock protein (HSP27);
1.42
X54079.1
|
stress-responsive protein 27
|
(SRP27); estrogen-regulated 24-kDa
|
protein; HSPB1
|
tyrosine kinase tnk1
1.42
XM_012654.3
|
ras-related protein RAB3A
1.38
XM_054457.2
|
janus kinase 3 (JAK3); leukocyte
1.33
XM_038595.3
|
janus kinase (L-JAK)
|
dual-specificity mitogen-activated
1.29
NM_002755.2
|
protein kinase kinase 1 (MAP kinase
|
kinase 1; MAPKK 1; MKK1);
|
extracellular signal-regulated
|
kinase 1; ERK activator kinase 1
|
calcium/calmodulin-dependent protein
1.27
NM_001744.1
|
kinase type IV catalytic subunit
|
(CAMK IV); CAM kinase-GR
|
ras-related protein RAB5A
0.75
XM_053461.2
|
colon carcinoma kinase 4 precursor
0.68
U33635.1
|
(CCK4) + transmembrane receptor
|
PTK7
|
epithelial discoidin domain receptor
0.63
XM_004559.5
|
1 precursor (EDDR1; DDR1); cell
|
adhesion kinase (CAK); TRKE;
|
RTK6; protein tyrosine kinase 3A
|
(PTK3A); neuroepithelial tyrosine
|
kinase (NEP)
|
ras-related protein RAB6
0.27
M28212.1
|
cAMP-dependent protein kinase type I
0.23
M65066.1
|
beta regulatory subunit (PRKAR1B)
|
tyrosine-protein kinase ack
—
CAC15525
|
T-lymphocyte maturation-associated
—
P21145
|
protein MAL
|
orphan hormone nuclear receptor
—
U04897.1
|
LIM domain kinase 1 (LIMK-1)
—
P53667
|
protein kinase C alpha polypeptide
—
NM_002737.1
|
(PKC-alpha; PKCA)
|
dual specificity mitogen-activated
—
P46734
|
protein kinase kinase 3 (MAP kinase
|
kinase 3; MAPKK3; MKK3); ERK
|
activator kinase 3; MAPK/ERK
|
kinase 3 (MEK3)
|
Yamaguchi sarcoma viral-related
—
M16038.1
|
oncogene homolog; tyrosine-protein
|
kinase lyn
|
protein-tyrosine phosphatase 1E
—
U12128.1
|
|
[0121]
8
TABLE 3.c
|
|
|
Apoptosis, DNA Synthesis, Repair & Recombination
|
Gene
Fold change
GenBank ID
|
|
ubiquitin-conjugating enzyme E2 17-
**
NM_003336.1
|
kDa (UBE2A); ubiquitin-protein
|
ligase; ubiquitin carrier protein,
|
HR6A
|
growth arrest & DNA-damage-inducible
**
S40706.1
|
protein 153 (GADD153); DNA-damage-
|
inducible transcript 3 (DDIT3); C/EBP
|
homologous protein (CHOP)
|
growth factor receptor-bound protein
*
M96995.1
|
2 (GRB2); ASH protein
|
glutathione S-transferase A1 (GTH1;
*
M21758.1
|
GSTA1); HA subunit 1; GST-epsilon
|
cytoplasmic dynein light chain 1
*
U32944.1
|
(HDLC1); protein inihibitor of
|
neuronal nitric oxide synthase (PIN)
|
xeroderma pidmentosum group G
*
NM_021141.2
|
complementing protein (XPG); X-ray
|
repair-complementing defective repair
|
in Chinese hamster cells 5 (XRCC5)
|
xeroderma pigmentosum group D
*
AF035587.1
|
complementing protein (XPD); X-ray
|
repair-complementing defective repair
|
in Chinese hamster cells 2 (XRCC2)
|
RAD23 homolog A (RAD23A; hHR23A)
*
NM_005053.1
|
ataxia telangiectasia (ATM)
*
AAB38309
|
apoptosis regulator bcl-x
1.60
Z23115.1
|
caspase 9 percursor (CASP9); ICE-like
1.42
AB020979.1
|
apoptotic protease 6 (ICE-LAP6);
|
apoptotic protease MCH6;
|
apoptotic protease activating factor
|
3 (APAF3)
|
CD40 receptor-associated factor 1
1.39
U21092.1
|
(CRAF1)
|
SL cytokine precursor; FMS-related
1.35
NM_001459.1
|
tyrosine kinase 3 ligand (FLT3
|
ligand; FLT3LG)
|
cytochrome P450 reductase
1.33
AAD45961.1
|
X-ray repair complementing defective
1.25
M36089
|
repair in
|
Chinese hamster cells 1 (XRCC1)
|
Ku (p70/p80) subunit; ATP-dependent
0.74
X57500.1
|
DNA helicase II 86-kDa subunit; lupus
|
ku autoantigen protein; thyroid-lupus
|
autoantigen (TLAA); CTC box
|
binding factor 85-kDa subunit (CTCBF;
|
CTC85); nuclear factor IV
|
caspace 10 precursor (CASP10); ICE-
0.45
Q92851
|
LIKE apoptotic protease 4 (ICE-LAP4);
|
apoptotic protease MCH4; fas-
|
associated death domain
|
protein; interleukin 1 beta-
|
converting enzyme 2 (FLICE2);
|
inhibitor of apoptosis protein 2
—
Q13490
|
(HIAP2; IAP2) + IAP homolog B;
|
TNFR2-TRAF signaling complex
|
protein 2; MIHB
|
recA-like protein HsRad51; DNA repair
—
BAA02962.1
|
protein RAD51 homolog
|
DNA damage repair & recombination
—
B56529
|
protein 52 (RAD52)
|
DNA ligase III (LIG3); polydeoxyribo-
—
CAA59230.1
|
nucleotide synthase
|
|
[0122]
9
TABLE 3 d
|
|
|
Transcription Factors, DNA Binding Proteins
|
Gene
Fold change
GenBank ID
|
|
transcriptional activator hSNF2-alpha
**
D26155.1|
|
early growth response protein 1
2.71
M62829.1
|
(EGR1); transcription factor ETR103;
|
KROX24; zinc finger protein 225
|
(ZNF225); AT225
|
homeobox A1 protein (HOXA1); HOX1F
2.17
U10421.1
|
transcription factor NF-ATc
1.67
U08015.1
|
R kappa B DNA-binding protein
1.66
U08191.1
|
transcription initiation factor IID
1.57
M55654
|
31-kDa subunit (TFIID); TATA-box-
|
binding protein-associated factor RNA
|
polymerase II G 32-kDa subunit
|
(TAFII32; TAF2G); TAFII31
|
homeobox protein hLim1; LHX1
1.51
NM_005568.1
|
helix-loop-helix protein HLH 1R21;
1.49
X69111.1
|
DNA-binding protein inhibitor Id-3;
|
HEIR-1
|
guanine nucleotide-binding protein
1.46
NP_000507.1
|
G-s alpha subunit (GNAS); adenylate
|
cyclase-stimulating G alpha protein
|
CCAAT-binding transcription factor
1.45
AAA40889.1
|
subunit B (CBF-B); NF-Y protein sub-
|
unit A (NF-YA); Hap2; CAAT-box DNA-
|
binding protein subunit A
|
transcription factor LSF
1.37
B53771
|
homeobox 2.1 protein (HOX2A); HOXB5;
1.35
M92299.1
|
HU1; HHO.C10
|
endothelial transcription factor
1.34
M68891.1
|
GATA2
|
transcription factor Sp1 (TSFP1)
1.30
XM_028606.2
|
transcription factor ZFM1
0.62
G02919
|
zinc finger protein 161 (ZNFI61);
0.26
NP_009077.1
|
putative transcription activator DB1
|
stem cell protein (SCL); T-cell
—
AAA36598.1
|
leukemia/lymphoma-5 protein (TCL5);
|
T-cell acute lymphocytic leukemia-1
|
protein (TAL1)
|
neural retina-specific leucine zipper
—
NP_006168
|
protein (NRL)
|
MSX-1 homeobox protein; HOX7
—
P28360
|
basic transcription factor 62-kDa
—
AAA58399.1
|
subunit (BTF2)
|
paired box homeotic protein (PAX8)
—
BAB59039.1
|
isoforms 8A/8B + isoforms 8C/8D
|
brain-specific homeobox/POU domain
—
AAA65605.1
|
protein 3A (brn-3A); RDC-1; octamer
|
binding transcription factor 1 (OTF1)
|
transcription factor E2-alpha (E2A);
—
AAA61146.1
|
immunoglobulin enhancer binding
|
factor E12; transcription factor-3
|
(TCF3)
|
transcriptional enhancer factor
—
P28347
|
(TEFI); protein GT-IIC; transcription
|
factor 13 (TCF13)
|
thioredoxin perodxidase 2 (TDPX2);
—
Q06830
|
thioredoxin-dependent peroxide
|
reductase 2; proliferation-
|
associated gene (PAG); natural killer
|
cell enhancing factor A (NKEFA)
|
|
[0123]
10
TABLE 3 e
|
|
|
Receptors, Cell Surface Antigens, Cell Adhesion
|
Gene
Fold chance
GenBank ID
|
|
interleukin-2 receptor gamma subunit
*
AAA59145.1
|
(IL-2R gamma; IL2RG); cytokine
|
receptor common gamma chain
|
precursor; p64
|
interferon gamma receptor (IFNGR)
*
NM_000416.1|[
|
interleukin-1 receptor type I
*
M27492.1
|
precursor (IL-1R1); IL-1R-aplha; p80;
|
CDW121A antigen
|
neural-cadherin precursor (N-
*
L34059
|
cadherin; NCAD); cadherin 2 (CDH2)
|
neural cell adhesion molecule L1
*
M77640
|
precursor (N-CAM L1); MIC5
|
integrin alpha 3 (ITGA3); galacto-
*
M59911.1
|
protein B3 (GAPB3); very late antigen
|
3 alpha subunit (VLA3 alpha); CD49C
|
antigen
|
leukocyte adhesion glycoprotein p150,
*
M81695.1
|
95 alpha subunit precursor; leukocyte
|
adhesion receptor p150, 95; CD11C
|
antigen; leu-M5; integrin alpha X
|
(ITGAX)
|
integrin beta 4 (ITGB4); CD104
*
X51841.1
|
antigen
|
CD44 antigen precursor (CD44);
1.51
XP_030326.1
|
phagocytic glycoprotein I (PGP1);
|
HUTCH I; extracellular matrix
|
receptor III (ECMR III); gp90
|
lymphocyte homing/adhesion receptor
|
(LHR); hermes antigen; hyaluronate
|
receptor; heparan sulfate
|
proteoglycan; epican
|
glutamate receptor subunit epsilon 3
1.44
NP_000826.1
|
precursor (GRIN2C); N-methyl D-
|
aspartate receptor subtype 2C
|
(NMDAR2C; NR2C)
|
CD27L antigen receptor precursor;
0.7
P26842
|
tumor necrosis factor receptor
|
superfamily member 7 (TNFRSF7); T14
|
integrin alpha L (ITGAL); leukocyte
0.45
P20701
|
adhesion glycoprotein alpha subunit
|
precursor; leukocyte function-
|
associated molecule 1 alpha chain
|
(LFAI); CD11A antigen
|
interleukin 2 receptor alpha subunit
0.41
P01589
|
precursor (IL-2 receptor alpha
|
subunit; IL2RA); TAC antigen; CD25
|
antigen
|
CDW40 antigen; CD40L receptor
0.35
CAA43045.1
|
precursor; nerve growth factor
|
receptor-related B-lymphocyte
|
activation molecule
|
granulocyte colony stimulating factor
—
Q99062
|
receptor precursor (GCSF-R); CD114
|
antigen
|
low-affinity nerve growth factor
—
AAB59544.1
|
receptor (NGF receptor; NGFR); GP80-
|
LNGFR
|
neuromedin B receptor (NMBR);
—
NP_002502.1
|
neuromedin-B-preferring bombesin
|
receptor
|
granulocyte-macrophage colony-
—
Q00941
|
stimulating factor receptor alpha
|
(GM-CSFR-alpha); CSW116 antigen
|
platelet membrane glycoprotein IIIA
—
P05106
|
precursor (GP3A); integrin beta 3
|
(ITGB3); CD61 antigen
|
integrin alpha 7B precursor (IGA7B)
—
CAA52348.1
|
|
[0124]
11
TABLE 3 f
|
|
|
Growth Factors, Cytokines, Hormones
|
Gene
Fold change
GenBank ID
|
|
Interleukin-10 precursor (IL-10);
**
M57627
|
cytokine synthesis inhibitory factor
|
(CSIF)
|
Granulocyte-macrophage colony
*
AAA52578.1
|
stimulaitng factor (GM-CSF); CSF2
|
FMLP-related receptor I (FMLPRII);
*
AAA58482.1
|
RMLP-related receptor I (RMLPRI)
|
Glia maturation factor beta
*
P17774
|
(GMF-beta)
|
Hepatoma-derived growth factor (HDGF)
*
P51858
|
Macrophage inflammatory protein 1
*
P10147
|
alpha precursor (MIP1-alpha);
|
tonsillar lymphocyte LD78 alpha
|
protein; G0S19-1 protein; PAT 464.2;
|
SIS-beta; small inducible cytokine
|
A3 (SCYA3)
|
Monocyte chemotactic protein 1
*
P13500
|
precursor (MCP1); monocyte
|
chemotactic and activating factor
|
(MCAF); monocyte secretory protein
|
JE; monocyte chemoattractant protein
|
1; HC11; small inducible cytokine A2
|
(SYCA2).
|
Oncostatin M (OSM)
*
NP_065391.1
|
Renin-binding protein (RENBP; RNBP)
XP_013053.3
|
Calgranulin B (CAGB); migration
1.49
B31848
|
inhibitory factor-related protein 14
|
(MRP14); leukocyte L1 complex heavy
|
chain; S100 calcium binding protein
|
A9 (S100A9)
|
Placenta growth factors 1 + 2
1.42
CAA38698.1
|
(PLGF1 + PLGF2)
|
Vascular endothelial growth factor
1.42
AAA35789.1
|
precursor (VEGF); vascular
|
permeability factor (VPF)
|
Hepatocyte growth factor activator
1.40
BAA74450.1
|
(HGF activator)
|
Follistatin-related protein precursor
1.34
AAA66062.1
|
Hepatocyte growth factor-like protein;
1.29
AAA59872.1
|
macrophage stimulating protein (MSP)
|
Interferon gamma precursor (IFN-
1.29
P01579
|
gamma, IFNG); immune interferon
|
WSL protein + TRAMP + Apo-3 +
0.69
AAB41432.1
|
death domain receptor 3 (DDR3)
|
Neurotrophin-4 (NT4)
0.68
AAA60154.1
|
Interleukin-13 precursor (IL-13);
0.39
P35225
|
NC30
|
Small inducible cytokine A5 (SYCA5);
0.38
XP_035842.1
|
regulated on activation normal T-
|
cell-expressed & secreted
|
protein precursor (RANTES); SIS delta
|
Estrogen sulfotransferase (STE; EST1)
—
CAA72079.1
|
Keratinocyte growth factor (KGF);
—
AAA63210.1
|
fibroblast growth factor 7 (FGF7)
|
Endothelial-monocyte activiting
—
AAA62202.1
|
polypeptide II (EMAP II)
|
Leukemia inhibitory factor precursor
—
B36282
|
(LIF); differentiation-stimulating
|
factor (D factor); melanoma derived
|
LPL inhibitor (MLPLI); HILDA
|
Acidic fibroblast growth factor
—
AAA51672.1
|
(AFGF) + heparin-binding growth
|
factor 1 precursor (HBGF-1) +
|
beta-endothelial cell growth
|
factor (ECGF-beta)
|
Insulin-like growth factor-binding
—
P17936
|
protein 3 precursor (IGF-binding
|
protein 3; IGFBP3; IBP3)
|
|
Symbols (Fold Changes)
|
**Expressed in PP but not NPP, or in Co-culture but not Caco2.
|
*Expressed in Co-culture but no Caco2 (only repeated once)
|
—Expressed in Caco2 but not in co-culture.
|
Immunity
[0125] The events of the cell cycle occur under normal circumstances in a fixed sequence. Traditionally, the cycle is divided into two stages: cell division and the interphase. Cell division or mitosis is followed by cytokinesis and together they constitute the ‘M phase’ of the cell cycle. The interphase is divided up into the S, G1 and G2 phases. Briefly, during the S phase, DNA is replicated in preparation for mitosis, while the intermediate G phases are transitional periods involved in protein synthesis and cell growth. Activation of regulatory genes that control and maintain a cell's proliferative state by intracellular signals (discussed below) stimulates proliferation of the cell and initiates cell growth. A number of genes involved in these processes were differentially expressed in the co-culture model (as estimated by relative mRNA abundance) and discussed below.
[0126] The epithelial cells of the gut play an important part of the innate and specific immunity. IEC's are considered to be in a continuous controlled state of “physiological” inflammation and active processes continually take place to ensure that the tone of immunosuppression is maintained (Mayer, 2000). These unique regulators appear to control the mucosal immune system's condition. These distinct factors govern the immune response, whether it's immune suppression/tolerance, inflammation or a systemic immune response. A clearer understanding of the immunoregulatory features involved in mucosal immunity is clearly desirable and may lead to new approaches in disease and drug therapy. Genes detected in the co-culture model that may be related to or are involved in immune function in GALT are discussed below.
[0127] The gamma subunit if IL-2 receptor plays a pivotal role in formation of the full-fledged IL-2 receptor (Di Santo et al., 1995). In an interesting study where infant rats were studied from pre- to post weaned life Masjedi et al. (1999) assessed alterations in expression and phenotype of cells in the gut-associated lymphoid tissue. At an age when the immune system is believed to be immature and functionally naive they discovered interleukin-2 receptor (IL-2R) expression peaked approximately four-fold at midweaning in Peyer's patches, compared with adult animals (day 70) suggesting that IL-2R expression is an adaptation to the host's environment. In a similar way, the presence of IL-2R specific for cells in the co-culture could be a direct result of the environment. The common gamma c chain of the interleukin 2 receptor, gamma is also a component of the receptors for IL-4, 1 L-7, and IL-9 and plays a critical role in lymphoid development through its participation in the receptors for IL-2, IL-4, IL-7, IL-9, and IL-15 (Di Santo et al., 1995)
[0128] Interferon-γ (IFN-γ) exhibits various properties including antigrowth activity in neoplastic and normal cells, and regulatory roles in immune responses (Tsuji et al., 1998). Kjerrulf et al. (1997) found that in IFN-γ receptor knockout mice (IFN-γR−/−) reduced mucosal antibody responses and decreased Th1 and Th2 activity after oral immunization. The presence of IFN-γ receptor in the M cell co-culture model could possibly augment a cross-regulation between the two Th subsets in the gut mucosa. It is noteworthy that the ligand, IFN-γ, mRNA was increased in the co-culture that was supported further by the significant secretion of IFN-γ from co-culture monolayers.
[0129] The C-C chemokines macrophage inflammatory protein 1 (MIPLα) and monocyte chemotactic protein (MCP1) are synthesized and expressed by epithelial cells (Vainer et al., 1998; Kolios et al., 1999). The purpose of these chemokines expression in the co-culture model could be to function not only in leukocyte migration, but also as adhesins in the interaction between leukocytes and colonic epithelium. However, another C-C chemokine, RANTES, mRNA was observed to be reduced in the co-culture. The reasons for this are unclear. Perhaps, the chemoaffractant activities of other chemokines such as IL-8, MIP1α and MCP1 are sufficient for the M cell and in the absence of T cells the need for RANTES is not required.
[0130] From a gene delivery perspective, a higher capacity for translation and protein synthesis in PP tissue indicates that PP tissue is a preferred tissue to which to deliver genes coding for DNA vaccines or antigens. Thus the proposed higher translational capacity of PP tissue has implications for gene delivery especially DNA vaccine delivery and correspondingly antigen expression and local presentation to the mucosal immune system in the gastrointestinal tract. The TF coding genes may be important in priming M cells or precursor cells to M cells to adopt M cell phenotype and/or to facilitate priming of M cells to give a better immune cell outcome.
[0131] M cell receptors identified in Table 3(e) above are of particular interest in that they can be used for vaccine and delivery.
[0132] In view of the foregoing, in the method of the invention for increasing the level of a protein in a PP cell, which comprises delivering a nucleic acid coding for a protein, the protein may be selected from the group consisting of an IL-2 receptor, a gamma c chain of an IL-2 receptor, intereron-γ, and a C—C chemokine.
Proliferation and Growth
[0133] Cyclin DI is a protein involved in regulation of the cell cycle. Over-expression of the protein is associated with abnormal growth or neoplasia. This protein is positively induced by the p42/p44 MAP kinases (Lavoie et al., 1996). It would be interesting if the neoplasia seen in M cells resulted from activation of this protein considering the coincidental induction of the p44 MAP kinase (ERK1) below. The reduction in cyclin-dependent kinase 4 inhibitor 2D (CDKN2D) mRNA that normally inhibits cell cycle progression (Guan et al., 1996) would insinuate a similar function in the proliferation of these ‘M cells.’
[0134] In contrast, the induction of cell cycle inhibitors such as cyclin-dependent kinase inhibitor (CDKI) and cyclin-dependent kinase 4 inhibitor (CDK4J) would appear to be working to counterbalance proliferative stimuli present in the M cell.
[0135] PLC-L (phospholipase C-deleted in lung carcinoma) is a putative tumor suppressor gene. It is believed that irregular (in fact deletion) expression of the PLC-L gene contributes to the growth of human lung carcinoma (Kohno et al., 1995). It is possible then that its upregulation in the M cell model is acting as a negative regulator of growth in the cells, counterbalancing the many proliferative signals present.
[0136] Growth factor receptor-bound protein 2, GRB2, involved in growth factor control of ras signalling (Lowenstein et al., 1992).
[0137] The intracellular signaling pathways responsible for cell cycle arrest and establishment of differentiated cells along the gut axis remain largely unknown particularly in the case for the development of M cells and the FAE. ERK3/MAPK6 is expressed solely in the co-culture. Extracellular signal-regulated kinases-1 (ERK1) also known as the p44 mitogen-activated protein (MAP) kinase (p44mapk) is also induced specifically in the co-culture model. ERK1 and ERK3 are proline-directed serine/threonine kinases that are activated in response to a variety of extracellular signals, including growth factors, hormones and, neurotransmitters. These MAP kinases are key molecules involved in intracellular signal transduction, and are key regulators of cell proliferation in mammalian cells (Davis, 1995). Results indicate that elevated p42/p44 MAPK activities stimulate cell proliferation of intestinal cells, whereas low sustained levels of MAPK activities have correlated with cell cycle arrest and an increased expression of sucrase isomaltase (Aliaga et al., 1999). It is tempting to speculate that the presence of ERK3 together with the other MAP kinases apart from their proliferative effects are in part responsible for a reduction in sucrase isomaltase, a characteristic effect in M cells.
[0138] Lying upstream in the ERK signal cascade the tyrosine/threonine protein kinase, MAPK kinase (MAPKK1) is implicated in the regulation of cell growth and differentiation through the activation of ERK. In addition it is interesting to note that MAPKK3 was deleted in the co-culture cells. MAPKK3 phosphorylates and activates p38 MAP kinase alpha and gamma isoforms (Enslen et al., 1998). The induction of the MAPKK1 gene along with serine kinase coincides with the induction of ERK1, highlighting the ERK cascade as an important signalling cascade in M cell maintenance. It is interesting to note that ERK activation is responsible for terminal differentiation of components of the crypt-villus. (Taupin and Podolsky, 1999)
[0139] However, glia maturation factor-β (GMF-β) is potentially offsetting the ERK cascade effects. It is known to inhibit MAP kinases particularly ERK1 and ERK2 and yet promotes the p38 MAPK (Zaheer and Lim, 1996 and 1998).
[0140] Findings suggest that positive and negative regulation of MAPK activity are associated with loss of normal growth control and may be involved in carcinogenesis of colon cancers. Jun kinases such as JNK2 (MAP kinase 9) mediate signal transduction of pro-inflammatory cytokines and cellular stress (Uciechowski et al., 1996).
[0141] CD40 is a receptor on the surface of B-lymphocytes, the activation of which plays critical role in B cell proliferation and differentiation. CRAF1, (CD40 receptor-associated factor 1) encodes a protein that interacts directly with CD40 receptor (Cheng et al., 1995). Its upregulation in the co-culture is perhaps a main determinant of lymphoepithelial crosstalk as discussed above.
[0142] The c-myc gene is commonly amplified and over-expressed in many human tumors (Ryan and Birme, 1996). A member of the myc family of helix-loop-helix transcription factors, c-myc is integral in controlling cell growth and promotes cell proliferation and transformation by activating growth-promoting genes (Thompson, 1998). Prothymosin-α (PT-α) is a nuclear protein and its expression is associated with alterations in the proliferative state of cells and has been reported to be regulated by the c-myc gene in vitro. (Smith, 1995; Mon et al., 1993). The increased activity of c-myc in this model is likely to result in the increase in RT-α mRNA.
[0143] PKC-α protein levels regulate certain pathways that lead to the expression of differentiation-dependent genes. In a series of antisense transfection experiments where PKC-α expression in CaCo-2 cells was almost completely deleted, enhanced proliferation and a marked decrease in differentiation was observed, as well as a more aggressive transformed phenotype (Scaglione-Sewell et al., 1998). In a similar fashion, the lack of PKC-α mRNA detected in the co-culture ‘M cells’ may underlie some of the phenotype changes featured.
[0144] Glutathione S-transferase A1 (GSTA1) is a member of a multigene family of detoxification and metabolizing enzymes. Induction of GST enzyme activity has been demonstrated to act as a potent anti-proliferative and differentiating agent in Caco-2 cells (Stein et al., 1996) suggesting a similar role in the ‘M cell.’
[0145] Transcription factor GATA-2 is thought to maintain and promote the proliferation of early haematopoietic progenitor cells.
[0146] The placenta growth factor (PLGF) is a member of the vascular enciotheial growth factor (VEGF) family of growth factors. In addition to PLGF, VEGF mRNA was enhanced in the co-culture cells. These growth factors play a crucial role in angiogenesis during development and/or repair (Andre et al., 2000). The augmented transcription of their mRNA is consequently not a surprising find. However, hypoxia and energy depletion are known to induce angiogenesis by increasing VEGF, expression and so the possibility that the co-culture conditions are responsible for these genes induction cannot be ruled out ratherthan a deliberate mechanism of neogenesis in M cell formation. VEGF receptor 1 (VEGFR1); the receptor for VEGF and PLGF, mRNA is down-regulated and is possibly a consequence of desensitization of the receptor by VEGF and PLGF binding, initiating a reduction in the receptor's RNA.
[0147] Coinciding with the above actions, the absence of growth factors such as insulin-like growth factor-binding protein 3 (IGFBP3) and keratinocyte growth factor (KGF) may be modulating enterocytic cell proliferation and differentiation.
[0148] Caco-2 cells have been shown to express the type I IL-1 R. (Varilek et al., 1994) II-1Rα binds IL-1 and mediates cell signalling particularly signalling involved in cell proliferation (French et al., 1996). The expression of IL-1 R can be enhanced by IFN-γ (Varilek et al., 1994). Therefore, the expression of IL-1 R type 1 mRNA in the co-culture is interesting when considering the significant expression of IFN-1 expressed in supernatants of the co-culture model.
[0149] In view of the foregoing, in the method of the invention for increasing the level of a protein in a PP cell, which comprises delivering a nucleic acid coding for a protein, the protein may be selected from the group consisting of cyclin D1, PLC-L, GRB2, ERK3/MAPK6, ERK1, ERK3, JNK2, CD40, CRAF1, C-MYC, PT-α, IL-R, PKC-α, GSTA1, GATA-2, and PLGF.
Differentiation
[0150] Development of cells or differentiation is dictated by the expression of a cell's genes specific to that cell. This is a particularly important aspect with regards to M cells.
[0151] The cortical cytoskeleton not only provides structural support to the plasma membrane but also contributes to important dynamic processes such as endocytosis, exocytosis, and transmembrane signalling pathways. Ezrin, or villin 2, is an F-actin associated molecule and is concentrated in surface projections such as microvilli and membrane ruffles where they link the microfilaments to the membrane and has been reported to be in abundance during development and differentiation of the intestinal epithelium. It was reported that hepatocyte growth factor (HGF/SF) could stimulate the tyrosine phosphorylation of ezrin in a human colon epithelial cell line, which induced the ezrin associated membrane ruffling. It is interesting to note that both hepatocyte growth factor activator (HGF activator) and hepatocyte growth factor-like protein were both upregulated in the co-culture model and taken with the augmented ezrin mRNA the induction of these genes would appear to underlie the mechanism involved in the morphogenesis observed in M-cells.
[0152] These data demonstrate that the expression of the ezrin gene is being regulated at the level of mRNA due to effects incurred by the B-cells. It is particularly relevant considering the observations of villin diffusely displayed in M-cells.
[0153] One method of actin cytoskeletal reorganization is controlled by the LIMK-1 serine/threonine kinase, which acts by phosphorylating cofilin and subsequently Rac (as previously reported). However, LIMK-1 was deleted in the co-culture model and would appear to rule out the Rac-mediated mechanism of actin reorganization in the M cell model.
[0154] The cadherin family of cell adhesion molecules play important role in cell-cell adhesion during tissue differentiation. They have been reported to be linked to the actin cytoskeleton by catenins located in the cytoplasmic compartment of the cell. The specific expression of NCAD in the co-culture suggests a distinct gene involved in the cytoskeletal structure.
[0155] Previous reports have shown that neogenin is closely related to the human tumor suppressor molecule DCC (deleted in colorectal cancer) and together they constitute a subgroup of Ig superfamily proteins that have shown to be essential for terminal differentiation of specific cell types in the adult including the human colon. These parallels suggest that neogenin, like DCC, is functionally involved in the transition from cell proliferation to terminal differentiation of specific cell types. Its absence in the co-culture model might represent a period of continued proliferation for the cells and allow a longer period of proliferation.
[0156] The helix-loop-helix (HLH) family of transcription factors has been shown by others to play a central role in the regulation of cell growth, differentiation and tumorigenesis. Of particular interest, when HLH 1 R21 was over-expressed in mouse NIH3T3 cells, it induced a morphologically transformed phenotype.
[0157] Other genes associated with differentiation including Myeloid cell nuclear differentiation antigen (MNDA) and the LHX1 gene. The LHX1 gene is a member of the LIM/homeobox (Lhx) gene family. It has been shown that it codes for a transcriptional regulatory protein involved in the control of differentiation and development.
[0158] In view of the foregoing, in the method of the invention for increasing the level of a protein in a PP cell, which comprises delivering a nucleic acid coding for a protein, the protein may be selected from the group consisting of HGF activator, ezrin, NCAD, MNDA, and LHX1.
Adhesion
[0159] It is clearly evident that modification of the M cell apical surface is a determining factor in M cell apical membrane adherence, and thus, uptake and transport of macromolecules/microorganisms and targeting epitopes on the surface of M cells has been used to promote further adherence and uptake of particles in vaccinology. The specificity of these markers is not only useful for vaccine strategies but also represents targets for understanding adhesion and uptake of bacteria and viruses. Adhesion is not privy to the apical surface. Adhesion molecules on the basolateral surface of M cells, such as cadherin 2, neural cell adhesion molecule, integrin alpha 3, leukocyte adhesion glycoprotein p150, integrin beta 4 are understood to be involved in leukocyte migration and in the development/organization of lymphoid nodules in Peyer's patches. Genes expressed/induced in the co-culture can provide an insight into the mechanisms involved and are discussed below.
[0160] The tyrosine kinase receptor TIE 1 is normally located in vascular endothelial and haematopoietic cells and is largely involved in the proliferation and differentiation of miniature haematopoietic cells and would be an appropriate gene specific for M cells. In the brain, TIE mRNA and protein is significantly elevated in lesions composed of abnormal vasculature called arterioyenous malformations (AVMs) and the surrounding vasculature. Like AVMs, the significant upregulation of TIE in M cells may indicate some ongoing neogenesis, and depending on the receptor's polarity could be of potential use in vaccine targeting.
[0161] The neuronal cell adhesion molecule L1 (NCAML1) is a transmembrane glycoprotein belonging to the immunoglobulin superfamily and is generally associated with development of the nervous system. As a potent promoter of neurite growth, it is allied with plastic changes. In nerve growth it interacts with the actin cytoskeleton via an ankyrin linkage and promotes specific distribution of F-actin. Such flexibility is ideal in the M cell scenario.
[0162] The integrin family consists of a series of related alpha beta heterodimers involved in a variety of cell-matrix and cell-cell adhesion functions. The α3β1 integrin is a multiligand extracellular matrix receptor found on many cell types and can function as a receptor for fibronectin, laminin, and collagen. Phagocytosis of molecules by breast cells has also been reported to involve this adhesion molecule, thus, it would appear a suitable candidate as an adhesion target on M cells.
[0163] The leukocyte adhesion glycoprotein p150 (CD11 C antigen), also a member of the integrin family, is involved in leukocyte sequestration via interaction of CD11/CD18 similar to that of ICAM-1.
[0164] In stratified epithelia p4 integrin (CD104 antigen) has been shown to be important for proper differential expression and crucial for stable adhesion to die basement membrane through its ability to attach externally to laminin and internally to the keratin cytoskeleton. Interestingly, during human intestinal organogenesis receptors have been shown to occur. This integrin would appear to play an important role in epithelial cell-matrix interactions during development but particularly in M cell development.
[0165] CD44 is a major surface adhesion molecule involved in cell-cell and cell-matrix interactions and lymphocyte homing and activation. The observed enhanced expression suggests that this molecule is an important feature in the activities of M cells. A non-receptor tyrosine kinase, C-src protooncogene (SRC1) has been shown to cause overexpression of CD44 in the intestine. As well as its effects on proliferation, the enhanced activity of SRC1 seen in the M cell model would appear to have major effects on cell adhesion properties of the M cell. Hepatocyte growth factor activator (HGF activator) is a serine protease produced and normally secreted by the liver. It has been documented as stimulating reparative processes in intestinal epithelial cells and could be why its activity is enhanced in this model. However, stimulation of CD44 in colonic epithelial cells has been reported to augment c-met, the HGF receptor. This in turn stimulates the “inside-out signalling causing an amplified expression of integrins that leads to an increase in vascular adhesion to the epithelium.
[0166] It has been reported that the glutamate receptor (NMDA) is generally associated with learning and memory, highly plastic processes in the brain. The high density of NMDA receptors reflects similar plastic changes seen in the co-culture model but would also act as a target epitope for drug delivery.
[0167] TKT is a tyrosine-kinase receptor related to TRK and is a member of cell adhesion kinase receptor family. Ephrin (type A) is a tyrosine kinase receptor that has been reported to be involved in neogenesis and tumor formation. Sp1 is a nuclear protein constitutively expressed and mediates basal promoter activity and is the main Vitamin-D receptor promoter in intestine. These are all potential target sites relevant to M cells.
[0168] Many of the receptors/cell surface antigen ‘deleted’ (not detectable) in the co-cultures could be putative negative markers of M cells. A good example is the laminin receptor a7β1 integrin. Expression of the a7β1 integtin correlates with human intestinal cell differentiation and could be used in a similar fashion that was applied with sucrase isomaltase and alkaline phosphatase.
[0169] In view of the foregoing, in the method of the invention for increasing the level of a protein in a PP cell, which comprises delivering a nucleic acid coding for a protein, the protein may be selected from the group consisting of cadherin 2, neural cell adhesion molecule, integrin alpha 3, leukocyte adhesion glycoprotein p150, integrin beta 4, TIE, NCAML1, α3β1 integrin, CD11C antigen, CD104 antigen, CD44, NMDA, TKT, ephrin (type A), and Sp1.
Transport
[0170] The RAB proteins are reported to be regulators of polarized membrane traffic in epithelial cells. The RAB3B is localized to the apical pole very near the tight junctions between adjacent epithelial cells where it is reported to be a possible regulator of apical and/or jupctional protein traffic in epithelial tissues. RAB3B is highly homologous to a brain-specific RAB3 isoform (RAB3A) that targets the presynaptic nerve terminal, where it is reported to regulate exocytosis.
[0171] In polarized cells, the small GTPase Rab5a is localized to the plasma membrane, clathrin-coated vesicles, and early endosomes and is a regulator of transport between the plasma membrane and early endosomes. The decreased expression of RAB5a seen in the co-culture may deregulate the rate of endocytosis and/or vesicle fusion and could possibly release ‘the brake’ on vesicle trafficking.
[0172] RAB6 is another ras related protein also a regulator of intracellular transport in mammalian cells. It controls intra-Golgi transport, either acting as an inhibitor in anterograde transport or as a positive regulator of retrograde transport. Like RAB5a, the pronounced decrease seen in mRNA transcription could be a means of subverting transport regulation in epithelial cells and so optimize the process as observed in M cells.
[0173] Protein kinase C (PKC) and the actin cytoskeleton are critical effectors of membrane trafficking in mammalian cells. The F-actin cross-linking protein myristoylated alanine-rich C kinase substrate (MARCKS), a substrate for PKC, has been reported to be a component of the mechanism of endocytosis.
[0174] TIR or p71 plays a key role in the control of cell proliferation through the binding of transferrin, the major iron-carrier protein. Located on both apical and basolateral surfaces, the transferring receptor has the ability to internalize and recycle to the surface. Indeed experiments by Hughson and Hopkins (1990) demonstrate pathways from the apical and basolateral surfaces meet in an endosomal compartment. Furthermore, Shah and Shen (1994) discovered that the fungal metabolite brefeldin A (BFA) could relocate receptor distribution and enhance TfR mediated transcytosis. The increased expression of this mRNA in the M cell model suggests a potential delivery mechanism of protein drugs across the intestinal epithelium present in M cells that could be exploited.
[0175] In view of the foregoing, in the method of the invention for increasing the level of a protein in a PP cell, which comprises delivering a nucleic acid coding for a protein, the protein may be selected from the group consisting of a RAB protein, PKC, and TfR.
Signal Transduction
[0176] In order for a cell to respond to extracellular signals, which cause it to alter gene expression or cellular function, it must involve the activation of a signal transduction cascade. There are many different types of signalling cascades, which can be unique to a specific type of stimulus. There are two main mechanisms by which these cascades transmit their signal, either through the regulation of enzymes, which produce second messenger molecules or through the regulation of protein phosphorylation. The activation of these cascades is usually mediated through specific cell surface or intracellular receptor proteins. The receptor protein recognizes the incoming extracellular signal and responds accordingly, initiating a specific series of intracellular signal that direct the cell's behavior. A number of genes involved in intracellular signalling were upregulated or induced in the M cell model and are discussed below.
[0177] A member of the Janus family of tyrosine kinases, which are non-receptor protein kinases, Jak3 is involved in intracellular signalling mediated by cytokines and growth factors such as IL-2, IL-4, and IL-7. Jak3 has been reported to play a crucial role in Peyer's patch organogenesis. Mutant mice deficient in Jak3 presented defects in lymphocyte production and the absence of Peyer's patch structures. Its induced expression suggests a greater level of activity and possibly a major requirement underlying the M cell phenotype ‘switch’.
[0178] The nuclear zinc-finger transcription factor, early growth response factor-I (EGR-1) is an immediate-early gene product expressed in response to diverse stimuli and is involved in growth, development, and differentiation. EGR-1 has been reported to function in growth regulation and suppression of cell transformation by transactivation of the TGFβ gene. TGFβ is capable of stimulating the synthesis of extracellular matrix proteins that can potentially stabilize epithelial cell contact with the substratum. In addition EGR-1 also plays a role in the immune response, regulating targets such as IL-2, CD44, ICAM-1, and TNF. Taken together the considerable induction of EGR-1 mRNA emphasizes the importance of this protein's involvement in M cell behavior.
[0179] CaM kinase IV (CAMK IV) is involved in Ca2+-dependent mechanism for regulating MAP kinase pathways. Many kinases activity has been observed to be enhanced in this model and so it is logical that CAMK IV expression is induced as a requirement to function.
[0180] The tyrosine kinase Tnk1 has been reported to be involved in signalling pathways involving development in adult tissues and in cells of the lymphohaematopoietic system.
[0181] Epithelial discoidin domain receptor 1 (EDDR1) mRNA was reduced in the co-culture. EDDR1 is a collagen receptor involved in controlling cellular responses to the extracellular matrix (ECM). The decrease in this gene would implicate it in the reorganization of the M cell in relation to the ECM.
[0182] cAMP-dependent protein kinase type I beta regulatory subunit (PRKAR1 B) stimulates growth by modulating the signalling of camp via its regulation of cAMP-dependent protein kinase (PKA). PRKAR1 B's reduction in the co-culture model may represent an inhibitory role in the cell's growth counterbalancing the proliferative signals.
[0183] In view of the foregoing, in the method of the invention for increasing the level of a protein in a PP cell, which comprises delivering a nucleic acid coding for a protein, the protein may be selected from the group consisting of Jak 3, EGR-1, TNK1 and CAMK IV.
Protection and Repair
[0184] Chaperones such as HSP40 and HSP70 participate in many biological processes in which protein folding is involved. These include protein translocation, protein translation, protein assembly and disassembly, and protein degradation. It is understandable that such genes would be induced considering the evolving processes of a phenotype ‘switch.’ However heat shock protein production has been reported to be induced as a result of harsh changes in their environmental conditions such as stress, ishaemia or hypoxia resulting in protein damage. Therefore it cannot be ruled out that the induction of these genes is in fact a protective measure as a consequence of the adverse conditions in the co-culture.
[0185] HSP60 has been observed in highly replicating cells e.g. short-living epithelial cells of the intestine. Involved in the import and refolding of nuclear-encoded proteins destined for the mitochondrial matrix.
[0186] The 27-kDa heat shock protein (HSP27) is expressed in a variety of tissues, including gut epithelia and in the absence of stress has been reported to regulate actin filament dynamics. Hsp27 induction in the M cell model like the other heat shock proteins (IISPs) may be active in development of resistance to stressful conditions. Activation of HSP27 can contribute to agonist-induced phosphorylation-modulated reorganization of the actin cytoskeleton and, in the case of stress activation, provides an actin-based adaptive response of cells to the new environmental conditions, and is ideal candidate for the plasticity seen in M cells.
[0187] Expression of receptors for fMLP on human phagocyles is well established, but there is conflicting evidence regarding the potential expression of fMLP receptors on other cells within the mucosa, particularly the epithelial cells. The reported observation of the receptor for the chemotactic peptide fMLP supports the notion of the intestinal epithelial cell as an early “sensor” of infection and inflammation. It has been reported that, fMLP, present in abundance in the lumen of the gut and that activation of fMLP receptors induces cytotoxic effects such as lysosomal release and superoxide generation. Thus, it would appear that their presence would be a defensive role in the event of infection of microorganisms.
[0188] Glutaredoxin (thioltransferase) is a small, heat-stable protein catalyzing glutathione-dependent disulfide oxdoreduction reactions in a coupled system with NADPH, GSH and glutathione reductase. It is important in regulating cell metabolism through the inactivation of oxidated transcription factors thought to be important in cellular responses to oxidant stress. This modulation of transcription factors' binding activity has been demonstrated for a number of transcription factors, including NF-kB/Rel proteins, Fos and Jun proteins and nuclear factor I (NFI) family of transcription factors. The induction of such a gene would appear to provide a protective role and is particularly influential on a number of key transcription factors.
[0189] CREB has been implicated as having prominent role in protection. Over-expression of the gene was reported to reverse hypoxia elicited TNF induction. This infers that the increase in the cAMP responsive element binding protein (CREB) mRNA is possibly a protective response to conditions.
[0190] Inactive in cells under normal conditions, gadd153 expression is markedly induced in response to a variety of cellular stresses, including nutrient deprivation, DNA damage, and oxidative stress (e.g. free radicals) which normally leads to growth arrest. The arrest in growth is thought to allow critical repair processes to be carried out before any further cell cycling. It would appear that the gadd153 expression in the co-culture is for reparative purposes.
[0191] The excision repair proteins XPG and XPD have been reported to be involved in nucleotide repair. In addition, mRNA for ubiquitin-conjugating enzyme (likely to be involved in post-replication repair and induced mutagenesis, RAD23, and ataxia telangiectasia are also expressed in the co-culture. Their expression, coinciding with gadd153 suggests there is a high degree of impairment to genes in the M cell model.
[0192] Interleukin-13 (IL-13) is a potent anti-inflammatory cytokine and has been reported to have the same protective properties in inflammation as IL-4 through its ability to modulate and suppress pro-inflammatory cytokines. It is puzzling that in an environment with a high level of pro-inflammatory cytokines produced that IL-13 mRNA is in fact reduced. One possible explanation might be its anti-adhesion effect. It has been reported that IL-13 (secreted from lymhocytes) down regulated cell adhesion molecules in colonic epithelium and so the role of IL-13 in the co-cultured cells is modulating cell adhesion properties and not inflammation.
[0193] In view of the foregoing, in the method of the invention for increasing the level of a protein in a PP cell, which comprises delivering a nucleic acid coding for a protein, the protein may be selected from the group consisting of HSP40, HSP70, HSP60, HSO27, fMLP-related receptor, HSP27, glutaredoxin, CREB, gadd 153, XPG, XPD, ubiquitin, conjugating enzyme, RAD 23, and ataxia telengiectasia.
Apoptosis and Programmed Cell Death
[0194] In programmed cell death, apoptosis is programmed in the sense that a genetically directed ‘clock’ selects a given time for the death of certain cells. It has been reported that it provides an important mechanism for the maintenance and renewal of cells in the gut and in development. However, for the epithelium to maintain its barrier functions, the level of apoptosis needs to be regulated, and this is ‘checked’ by several signal transduction systems. Toxic insult or lack of factors that maintain cell survival can also lead to apoptotic death of the cell.
[0195] It has been reported that over-expression of c-fos and c-jun (constituents of the AP-1 transcription factor) in the intestine correlates with programmed cell death and subsequent cellular regeneration. Other studies have demonstrated increases in both proximal jejunum and colon jun mRNA level coincide with a period of major changes in intestinal cell proliferation). The c-jun protein product involved in activation of AP-1, transcription is enhanced when it is phosphorylated by stress-activated protein kinases of which there are many in the M cell model.
[0196] As intestinal epithelial cells reach the villus apex they undergo apoptosis and, are shed and, in normal circumstances, caspases, a family of cysteine proteases, play a central role in initiating, amplifying, and executing apoptosis. The pattern of caspase activation in this process is not understood. It is interesting to note that the apoptosis regulator, bcl-x, and caspase 9 are induced in the co-culture. The bcl-x gene plays an important role in the regulation of programmed cell death (PCD), depending on its splice variant the bcl-x protein can accelerate apoptosis or delay/prevent programmed cell death (as previously reported). Bcl-x controls apoptosis mechanisms at points upstream of caspase activation. Perhaps, it is responsible for the marked induction of caspase-9. Caspase-9 is a caspase initiator. Once activated, it can proteolytically activate other caspases (including 3, 6 and 7), which in turn activate caspase-2 and 6 (as previously reported). Inhibitor of apoptosis protein 2 (HIAP2) binds to and inhibits caspase-3. Its expression is a mechanism of regulating cell death depending on the particular cellular or environmental signals. Therefore, its absence in the co-culture cells and the increased activity of caspase-9 allows caspase-3 unchecked pro-apoptotic activity.
[0197] The death domain receptor 3 (DDR3) member of the TNFR family can induce apotosis as previously reported. Its mRNA expression is also reduced in the co-culture model.
[0198] In view of the foregoing, in the method of the invention for increasing the level of a protein in a PP cell, which comprises delivering a nucleic acid coding for a protein, the protein may be selected from the group selected from: bcl-x and capase-9 and more generally in view of the foregoing may be selected from the group consisting of
[0199] cyclin D1, PLC-L, GRB2, ERK3/MAPK6, ERK1, ERK3, JNK2, CD40, CRAF1, C-MYC, PT-α, IL-R, CD40, C-MYC, PKC-α, GSTA1, GATA-2, PLGF, ezrin, HGF activator, hepatocyte growth factor-like protein, NCAD, MNDA, LHX1, TIE-1, NCAML1, CD104, CD44, SRC1, NMDA, TKT, ephrin (type A), Sp1, RAB proteins, PKC, TIR, Jak3, EGR-1, TNK1, CAMK IV, HSP40, HSP70, HSP60, HSO27, fMLP-related receptor, HSP27, glutaredoxin, CREB, gadd153, XPG, XPD, ubiqitin-conjugating enzyme, RAD23, cadherin 2, neural cell adhesion molecule, integrin alpha 3, leukocyte adhesion glycoprotein p150, integrin beta 4, TIE, NCAML1, α3β1 integrin, CD11C antigen, CD104 antigen, CD44, NMDA, TKT, ephrin (type A), and Sp1, a RAB protein, PKC, and TfR, bcl-x and capase-9
Targeted Gene Delivery
[0200] Delivery of genes, gene fragments, oligonucleotides or other nucleotide fragments or analogues of the present invention to a living organism can be accomplished by methods currently available in the prior art. For example, various recombinant viruses have been used for the oral delivery of genes, such as adenovirus, retrovirus, adeno-associated virus, vaccinia virus, lenti-virus and plant-derived viruses, wherein the viral genome is replaced with an expression vector for the gene of interest. See, David T. Page and Sally Cudmore (2001). Innovations in oral gene delivery: challenges and potentials. Drug Discovery Today, Vol. 6, No. 2, pp 92-101. Viral mimetic particles such as virosomes and various types of polymers and liposomes, such as cationic and fusogenic, are also employed for gene delivery. See, U.S. Pat. Nos. 4,885,172, 5,047,245, 5,171,578, 5,059,421, 5,399,331, 5,204,112, 1,252,263, 5,376,452, 5,552,155, 6,120,797, 6,087,325, 6,143,716. Examples of polymers are PLGA, PLA co-polymers, chitosan, and fumaric acid/sebacic acid co-polymers. For these systems, the polymer or liposome is formed from component parts in a solution of the gene expression vector, thus encapsulating the genes when particles are formed. Cationic lipids such as DOTAP and polyethylenimine are commonly used whereby the gene expression vector is complexed with and protected by the lipids. (See, Ogris M. et al. (2001). DNA/polyethylenimine transfection particles: Influence of ligands, polymer size, and pegylation on internalization and gene expression. AAPS PharmSci, 3 (3), article 21). Agents such as protamine are used to condense DNA, which due to the reduction in size of the DNA particles are more easily taken up by cells. Recombinant live bacteria (e.g. Shigella spp, Salmonella spp.) have also been exploited for gene delivery to the gut. Oral bioavailability enhancers, (e.g. sodium caprate, Elan's PROMDAS technology) could be used to increase uptake of a gene or encapsulated gene formulation.
[0201] In all cases the delivery systems can be targeted with various ligands on the surface of the particles in order to enhance binding to specific cells type and/or to enhance uptake. These ligands could be peptides, proteins, antibodies, peptidomimetics, and lipids that recognize or are being recognized by specific sites/receptors on the cell surface (Maruyama K. (2000). In vivo Targeting by Liposomes. Biol. Pharm. Bull., 23(7), 791-799).
[0202] The targeting ligands may be peptide based, peptidomimetic based, antibody based, single chain antibody based, small organic molecule based. The targeting ligands may also be natural substrates for such receptors, transporters or other cell surface molecules found on the surface of M cells or other cell types found in Peyer's patch. The targeting ligands may be engineered so as to be genetically expressed on the surface of viruses, bacteriophages, virosomes, bacteria or other organisms, which can be utilized for vaccine delivery in the gut. Furthermore the targeting ligands can be presented either as direct conjugates to antigens, or on the surface of drug-loaded particulates such as liposomes, PLGA particles, other particulates and at the same time retain recognition by and interaction with the receptors, transporters or other cell surface molecules found on the surface of M cells and/or other cells of Peyer's patch tissue.
[0203] Examples of peptides that target the gastro-intestinal tract, in particular, membrane translocating peptides useful for vaccine delivery to M cells along with M cell specific targeting ligands are described in Table 4.
[0204] Further, targeting ligands can be genetically engineered into the surface coats of viruses, bacteriophages or bacteria, conjugated directly to antigens conjugated to the lipids in liposomes by covalent methods or streptavidin-biotin linkages, or coated onto the surface of polymers after particle formation (Torchilin V. P. et al. (2001) Proc. Natl. Acad. Sci. USA, Vol. 98, Issue 15, 8786-8791, July 17.
[0205] TAT peptide on the surface of the liposomes affords their efficient delivery even at low temperature and in the presence of metabolic inhibitors; Lestini et al. (2002). Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. J. Controlled Release, 78, 235247; Dokka S. et al. (1997) Cellular delivery of oligonucleotides by synthetic import peptide carrier. Pharm. Res., vol. 14, No. 12, 1759-1764); Wu Y et al. (2000). Gene transfer facilitated by a cellular targeting molecule, retrovirus protein σ1. Gene Therapy, 7, 61-69).
[0206] When the delivery of the gene to M cells in the gut is designed to prime or boost the immune system, the genes can be co-delivered/co-encapsulated with adjuvants (e.g. MF59, alum, saponin, QS21, MPL, bacterial toxins such as Lt, CT or mutants there-of, CPG motif nucleotides). Immune response could be boosted at a later stage by methods such as subcutaneous administration of an adjuvant.
[0207] In some cases it may be desired to shut off expression of certain genes, so as to enhance the adoption by enterocytes of an M cell phenotype. This can be achieved by the delivery, by methods outlined above, of antisense oligonucleotides, ribozyme, or RNA-interference molecules specific to the gene of interest.
12TABLLE 4
|
|
Peptides that Target to and/or Enhance Uptake Across the GIT
SEQ. ID NO:PEPTIDE SEQUENCES
|
SEQ. ID NO:ADDFMGCMLTLPTSLGGEGSPYNYYDTHEANGPH
|
SEQ. ID NO:TPTTTATWGTTGPVDLSSLHLLRHPCREF
|
SEQ. ID NO:MSPDHQYALQSSPVLPCCRPLLVDSDYIHS
|
SEQ. ID NO:RGYGRLAESCCVNRCIRTVGGCGNSPASDILSAT
|
SEQ. ID NO:STPGRGSGRDTGANNPADTPYANPSHRDTILSLDPSLL
|
SEQ. ID NO:RQHLWRDLHGPRFRDTNTGVAGTFSPPVSVADTHRTPD
|
SEQ. ID NO:SFSNLTAGDEEDDHFSGGRFNHANLTSRSHNRGQLASSA
|
SEQ. ID NO:RQSVLDSWGGKTSVTGLSERYYASHSHTSAPTPHYASHS
|
SEQ. ID NO:RQWVGDRDAGEGNTWVDEKYSRDANVISYRSHNHASQGTL
|
SEQ. ID NO:RASDCDVECNLRWVEDVGGVWYAKTVSRMLSTT
|
SEQ. ID NO:RQSAGFLGFAPTNIDDTSFNAGCGDTLAIPCRHRSSLISPARPP
|
SEQ. ID NO:RSGAYESPDGRGGRSYVGGGGGCGNIGRKHNLWGLRTASPACWD
|
SEQ. ID NO:SPRSFWPWSRHESFGISNYLGCGYRTCISGTMTKSSPIYPRHS
|
SEQ. ID NO:SSSSDWGGVPGKWRERFKGRGCGISITSVLTGKPNPCPEPKAA
|
SEQ. ID NO:RVGQCTDSDVRRPWARSCAHQGCGAGTRNSHGCITRPLRQASAH
|
SEQ. ID NO:SHSGGMNRAYGDVFRELRDRWNATSHHTRPTPQLPRGPN
|
SEQ. ID NO:SPCGGSWGRFMQGGLFGGRTDGCGAHRNRTSASLEPPSSDY
|
SEQ. ID NO:RGAADQRRGWSENLGLPRVGWDAIAHNSYTFTSRRPRPP
|
SEQ. ID NO:SGGEVSSWGRVNDLCARVSWTGCGTARSARTDNKGFLPKHSSLR
|
SEQ. ID NO:SDSDGDHYGLRGGVRCSLRDRGCGLALSTVHAGPPSFYPKLSSP
|
SEQ. ID NO:RSLGNYGVTGTVDVTVLPMPGHANHLGVSSASSSDPPRR
|
SEQ. ID NO:RTTTAKGCLLGSFGVLSGCSFTPTSPPPHLGYPPHSVN
|
SEQ. ID NO:SPKLSSVGVMTKVTELPTEGPNAISIPISATLGPRNPLR
|
SEQ. ID NO:RWCGAELCNSVTKKFRPGWRDHANPSTHHRTPPPSQSSP
|
SEQ. ID NO:RWCGADDPCGASRWRGGNSLFGCGLRCSAAQSTPSGRIHSTSTS
|
SEQ. ID NO:SKSGEGGDSSRGETGWARVRSHAMTAGRFRWYNQLPSDR
|
SEQ. ID NO:RSSANNCEWKSDWMRRA.CIARYANSSGPARAVDTKAAP
|
SEQ. ID NO:SKWSWSSRWGSPQDKVEKTRAGCGGSPSSTNCHPYTFAPPPQAG
|
SEQ. ID NO:SGFWEFSRGLWDGENRKSVRSGCGFRGSSAQGPCPVTPATIDKH
|
SEQ. ID NO:SESGRCRSVSRWMTTWQTQKGGCGSNVSRGSPLDPSHQTGHATT
|
SEQ. ID NO:REWRFAGPPLDLWAGPSLPSFNASSHPRALRTYWSQRPR
|
SEQ. ID NO:RMEDIKNSGWRDSCRWGDLRPGCGSRQWYPSNMRSSRDYPAGGH
|
SEQ. ID NO:SHPWYRHWNHGDFSGSGQSRHTPPESPHPGRPNATI
|
SEQ. ID NO:RYKHDIGCDAGVDKKSSSVRGGCGAHSSPPRAGRGPRGTMVSRL
|
SEQ. ID NO:SQGSKQCMQYRTGRLTVGSEYGCGMNPARHATPAYPARLLPRYR
|
SEQ. ID NO:SGRTTSEISGLWGWGDDRSGYGWGNTLRPNYIPYRQATNRHRYT
|
SEQ. ID NO:RWNWTVLPATGGHYWTRSTDYHAINNHRPSIPHQHPTPI
|
SEQ. ID NO:SWSSWNWSSKTTRLGDRATREGCGPSQSDGCPYNGRLTTVKPRT
|
SEQ. ID NO:SGSLNAWQPRSWVGGAFRSHANNNLNPKPTMVTRHPT
|
SEQ. ID NO:RYSGLSPRDNGPACSQEATLEGCGAQRLMSTRRKGRNSRPGWTL
|
SEQ. ID NO:SVGNDKTSRPVSFYGRVSDLWNASLMPKRTPSSKRHDDG
|
SEQ. ID NO:TNAKHSSHNRRLRTR
|
SEQ. ID NO:SDNAKEPGDYNCCGNGNSTG
|
SEQ. ID NO:RTRLRRNHSSHKANT
|
SEQ. ID NO:PEPTIDE SEQUENCES
|
SEQ. ID NO:GPHRRGRPNSRRSSKT
|
SEQ. ID NO:GTSNGNGCCNYDGP
|
Pevers patch and/ or M cell specific targeting ligands:
SEQ. ID NO:ATPPPWLLRTAP
|
SEQ. ID NO:DGSIHKRNIMPL
|
SEQ. ID NO:DYDSLSWRSTLH
|
SEQ. ID NO:GEPTTDMRWRNP
|
SEQ. ID NO:GLWPWNPVTVLP
|
SEQ. ID NO:HMLNDPTPPPYW
|
SEQ. ID NO:KPAYTHEYRWLA
|
SEQ. ID NO:LETTCASLCYPS
|
SEQ. ID NO:LGTDWHSVSYTL
|
SEQ. ID NO:LGTLNAGVPGFP
|
SEQ. ID NO:LTHSKNPVFLST
|
SEQ. ID NO:LVPTTHRHWPVT
|
SEQ. ID NO:LVSNARGFNNLS
|
SEQ. ID NO:NTRIPEPIRFYM
|
SEQ. ID NO:NVYTFHSMSPMP
|
SEQ. ID NO:QHTTLTSHPRQY
|
SEQ. ID NO:SDFSDTMPHRPS
|
SEQ. ID NO:SIDTIQILSLRS
|
SEQ. ID NO:SISWASQPPYSL
|
SEQ. ID NO:SMVKFPRPLDSR
|
SEQ. ID NO:SPTLGASVAQTN
|
SEQ. ID NO:TMSPNVYYTAFG
|
SEQ. ID NO:TQIPSRPQTPSQ
|
SEQ. ID NO:VCSNMYFSCRLS
|
SEQ. ID NO:VPPHPMTYSCQY
|
SEQ. ID NO:VPRLEATMVPDI
|
SEQ. ID NO:VPTKPELPVNFT
|
SEQ. ID NO:WSSDLPQPASTY
|
SEQ. ID NO:YITPYAHLRGGN
|
SEQ. ID NO:NVYTDNTLSPTP
|
SEQ. ID NO:LETTAASLCYPS
|
SEQ. ID NO:SPYCLSACTTEL
|
SEQ. ID NO:LETTCASLCYPS
|
SEQ. ID NO:VPPHPMTYSCQY
|
SEQ. ID NO:VPPHPMTYSAQY
|
SEQ. ID NO:VPPHPMTYSSQY
|
SEQ. ID NO:YQCSYTMPHPPV
|
SEQ. ID NO:VCSNMYFSCRLS
|
SEQ. ID NO:VSSNMYFSSRLS
|
SEQ. ID NO:DYDSLSWRSTLHGGHESSH
|
SEQ. ID NO:GNPTSTMRW
|
SEQ. ID NO:PWNSATVL
|
SEQ. ID NO:NDPTAPPY
|
Membrane Translocating Peptides:
(underline denotes cyclization)
SEQ. ID NO:KKAAAVLLPVLLAAPFITC-LC
|
SEQ. ID NO:KKKAAAVLLPVLLAAP
|
SEQ. ID NO:KKAAAVLLPVLLAAPREDL
|
SEQ. ID NO:KKCAAVLLPVLLAAPC
|
SEQ. ID NO:CAAVLLPVLLAAC
|
SEQ. ID NO:KKCAAVLLPVLLAC
|
SEQ. ID NO:CAAVLLPVLLC
|
SEQ. ID NO:CAAVLLPVLC
|
SEQ. ID NO:CAVLLPVLLAAPC
|
SEQ. ID NO:CVLLPVLLAAPC
|
SEQ. ID NO:CLLPVLLAAPC
|
SEQ. ID NO:CLPVLLAAPC
|
SEQ. ID NO:AAVLLPVLLAAP
|
SEQ. ID NO:AAVLLPVLLAA
|
SEQ. ID NO:KKAAVLLPVLLA
|
SEQ. ID NO:AAVLLPVLL
|
SEQ. ID NO:AAVLLPVL
|
SEQ. ID NO:AVLLPVLLAAP
|
SEQ. ID NO:VLLPVLLAAP
|
SEQ. ID NO:LLPVLLAAP
|
SEQ. ID NO:LPVLLAAP
|
SEQ. ID NO:AAVLLPVLLAAKKKRKA
|
SEQ. ID NO:KKKRKAAAAVLLPVLLA
|
Example 7
[0208] Use of Bacterial Coatings to Convert Enterocytes to M Cells
[0209] Might be nice to have some type of claim capturing the concept from this section Use of bacterial coatings on PLGA particles, co-administered bacterial particles or pro-biotic yogurts as adjuvants for oral vaccination with PLGA particles. The invention is based on converting enterocytes to M cells by using specific bacteria in advance of, or along with the oral vaccine particle of interest. In doing so the capability of absorbing particles through M cells will be increased. This idea is not based on targeting but on the ability of live bacteria or active bacterial components to stimulate cytokine production in Peyer's patches, thus, enabling enterocyte-M cell conversion. As a result, an invention disclosed herein is a method of promoting enterocyte-M cell conversion, said method comprising orally administering an antigen, antigenic composition, or antigen-carrying particle to a person and either simultaneously with, or prior to, said administration, also orally administering a bacteria, or pro-biotic yogurts, or bacterial component to said person.
[0210] All references cited herein are incorporated herein by reference in their entireties.
13TABLE 5
|
|
Miscellaneous GenBank Accession Numbers
Human Serum AlbuminNM_000477.3
CalreticulinM84739
|
Dates for GenBank Records
[0211] To the extent the date of a GenBank record, ratherthan its version number, is relevant for purposes of incorporation by reference, the date of the record is the filing date of this application with the following exceptions:
14|
|
TABLE 2 Rat genes
Mar. 27, 2002D83697 through M10149
Mar. 28, 2002Q03238 through NM_017218.2
TABLE 3 Human genes with a fold change of 0.5 or less
Apr. 02, 2002
TABLE 2 Human genes with a fold change of 0.5 or less
Apr. 02, 2002U76376.1 through XM_087242.1
Apr. 03, 2002S90469 through M29366.1
|
[0212] The records specified for Mar. 27, 2002, Mar. 28, 2002, Apr. 2, 2002, and Apr. 3, 2002, do not include those of GenBank IDs: Q07912, P21145, P46734, Q92851, Q13490, NP—006168, P28360, P28347, Q06830, P20701, P01589, P05106, P35225, P17936, S18408, P17074, P10661, P35426, P09456, P22791, Q06486, P21708, Q03238, P10644, P54868, P10398, P48730, P31749, P27361, P25063, Q14012, P13866
15|
|
AMINO ACID SEQUENCES AND NUCLEOTIDE SEQUENCES CORRESPONDING TO SELECTED
CENBANK ID NUMBERS
|
|
GENBANK ID: M81750
VERSION M81750.1 GI:895928
MVNEYKKILLLKGFELMDDYHFTSIKSLLAYDLGLTTKMQEEYN
|
RIRITDLMEKKFQGVACLDKLIELAKDMPSLKNLVNNLRKEKSKVAKKIKIQEKAPVK
|
KINQEEVGLAAPAPTARNKLTSEARGRIPVAQKRKTPNKEKTEAKRNKVSQEQSKPPG
|
PSGASTSAAVDHPPLPQTSSSTFSNTSFTPNQETQAQRQVDARRNVPQNDFVTVVVLK
|
ATAPFKYESPENGKSTNFHATVASKTQYFHVKVPDINLKEKFVRKKVITISDYSECKC
|
VMEIKEASSVSDFNQNFEVPNRIIEIANKTPKISQLYKQASGTMVYGLFMLQKKSVHK
|
KNTIYEIQDNTGSMDVVGSGKWENIKCEKGDKLRLFCLQLRTVDRKLKLVCGSHSFIK
|
VIKAKKNKEGPMNVN
|
GENBANK ID: X59798
VERSION X59798.1 GI:35631
MEHQLLCCEVETIRRAYPDANLLNDRVLRAMLKAEETCAPSVSY
|
FKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLL
|
GATCMFVASKMKETIPLTAEKLCIYTDNSIRPEELLQMELLLVNKLKMNLAAMTPHDF
|
IEHFLSKMPEAEENKQIIRKHAQTFVALCATDVKFISNPPSMVAAGSVVAAVQGLNLR
|
SPNNFLSYYRLTRFLSRVIKCDPDCLRACQEQIEALLESSLRQAQQNMDPKAAEEEEE
|
EEEEVDLACTPTDVRDVDI
|
GENBANK ID: L27211.1
VERSION L27211.1 GI:558656
MEPAAGSSMEPSADMLATAAARGRVEEVRALLEAGALPNAPNSY
|
GRRPIQVMMMGSARVAELLLLHGAEPNCADFATLTRPVNDAAREGFLDTLVVLHRAGA
|
RLDVRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDAAEGPSDIPD
|
GENBANK ID: U22398
VERSION U22398.1 GI:790247
MSDASLRSTSTMERLVARGTFPVLVRTSACRSLFGPVDNEELSR
|
ELQARLAELNAEDQNRWDYDFQQDMPLRGPGRLQWTEVDSDSVPAFYRETVQVGRCRL
|
LLAPRPVAVAVAVSPPLEPAAESLDGLEEAPEQLPSVPVPAPASTPPPVPVLAPAPAP
|
APAPVAAPVAAPVAVAVLAPAPAPAPAPAPAPAPVAAPAPAPAPAPAPAPAPAPAPDA
|
APQESAEQGANQGQRGQEPLADQLESGISGRPAAGTAAASANGAAIKKLSGPLISDFF
|
AKRKRSAPEKSSGDVPAPCPSPSAAPGVGSVEQTPRKRLR
|
GENBANK ID: X51521
VERSION X51521.1 GI:31282
MPKPINVRVTTMDAELEFAIQPNTTGKQLFDQVVKTIGLREVWY
|
FGLNYVDNKGFPTMLKLDKKVSAQEVRKENPLQFKFRAKFYPEDVAEELIQDITQKLF
|
FLQVKEGILSDEIYCPPETAVLLGSYAVQAKFGDYNKEVEKSGYLSSERLIPQRVMDQ
|
HKLTRDQWEDRIQVWHAERRGMLKDNAMLEYLKIAQDLEMYGINYFEIKNKKGTDLWL
|
GVDALGLNIYEKDDKLTPKIGFPWSEIRNISFNDKKFVIKPIDKKAPDFVFYAPRLRI
|
NKRILQLCMGNHELYMRRRKPDTIEVQQMKAQAREEKHQKQLERQQLETEKKRRETVE
|
REKEQMMREKEELMLRLQDYEEKTKKAERELSEQIQRALQLEEERKRAQEEAERLEAD
|
RMAALRAKEELERQAVDQIKSQEQLAAELAEYTAKIALLEEARRRKEDEVEEMQHRAK
|
EAQDDLVKTKEELHLVMTAPPPPPPPVYEPVSYHVQESLQDEGAEPTGYSAELSSEGI
|
RDDRNEEKRITEAEKNERVQRQLVTLSSELSQARDENKRTRNDIIHNENMRQGRDKYK
|
TLRQIRQGNTKQRIDEFEAL
|
GENBANK ID: L04143.1
VERSION L04143.1 GI:180574
THIS ENTRY IS NOT CONTIGUOUS CENOMIC DNA. IT CONTAINS NUMEROUS PIECES OF
INTRONS.
1GAGCTCGGAT CCCATCGCAG CTACCGCGAT GAGAGGCGCT CGCGGCGCCT GGGATTTTCT
|
61CTGCGTTCTG CTCCTACTGC TTCGCGTCCA CACAGGTGGG ACACCGCGGC TGGCTCCCCC
|
121ACCGTGCCAC TACTCGCGAA CCCTGTGCCC TGGGAGGGTG CTACCGCCAT GGCATCCGCA
|
181GACAGGACTG CGGGCCCTCA GTGGGCCTGC GTTCCAGCCT CCGGGGAGAC TCCAGGTGGC
|
241CCTCGGACTC TCCGGCGCCC TGCCTCGCTC ACCTGCGCGA GGAGACCCCA GCTGCTGGTG
|
301GTGGGGGACG CGAATCCGGG GTTCTTCGGG AATGGGGACA GCAAGAGGGG GTTAGGCGTG
|
361AGCGAGGCTG CAGGCTCCGT GCGAGTTTGG GGTGGCTTTT GTGCCGACGT TGCGCGGGGG
|
421CGGAGGCGGG GGCTCAGGGT TTGCACCGAG CGCCTTCTCT CTCGGTGCGA GGCCGGCCGC
|
481AGCTTCCTTT TGTTAAAAGT TGCGTGTGTG TGACGGCGCC CGGGCTGCAG CCTCAACCTC
|
541CTGGGCTTAA GTGATCTCCC ACCTCAGCCT CCCGCCTCAG CCTCCCATGT AGCTGGGAAA
|
601ACAGGTTCCC ACTACCATGC CCAGCTAATG TTTTTTCTAG TTTTTGTAGA TGTGTTGGGC
|
661GGTGGGGGCG TCTCACTGCG TTGCCCAGGC TGGTCTCGAA CTCCTAGGCT CAAGCAATCT
|
721TCCCACCTCA GCCTCCCAGA GTGCTGGGAT TACAGGCGTG ACGACGGCAC CTGGCCAGCA
|
781GTTTGTTCTT TAAACCCTGA AATGTATGTG AGGACCATGT GTCACACTAG CATGGACGTT
|
841TTCCCAGCAT CTAGCATGGT GCTTTGTAGA TGATAATTAA TGAATAGGTA TTTGAATACA
|
901TGGAGGCATG CATGGCTGAA TGAAGTGGCT GTTGTAAAAT TTCTAGGGTT CAGGTTTCAT
|
961ATTCAGAGCC TAAAGTTTGC ATCTTATAAA CTAAATAGTT TCCTATCTAG GAAACCTATT
|
1021TAGGCATTAG GGTGTTAAAA CAGGTGTATC ATTTTCTGCC TTAGTGTTTA GAGATTTGTG
|
1081AATAGTTCTC CTTTTGATGA ACATTGCCAT GTAAAGAGAG TTATACAGAA ATAACTGAAT
|
1141TCACACAGTT TTAAGGAAAA GCTATTCTAT GTCATGGTCA TGTATATTCT GCCAAAGAGA
|
1201GTGACAGGCC AGTAGTTTCT TTTTTCTTTT TCCCCATAGT GTGAGATTTT GTTTCTGTTG
|
1261TTTCTAAGCT GGGTGTCTGC ATGTCCACAC TGCGAAGATG GCCCATATCA GAATGAAAAC
|
1321TTGACCCAAT TGTATGTTTA GCCCAGAGAA GGCTGGGGCA TTCAGCACAT CCTGGCTTGG
|
1381GGACCAAATG TGACCCTCAG GATTAATTGA GGGTTGGAGA AAATAATTTT ATAGATGAAC
|
1441TTAAGACATT TTAGACAGAA CTCTCTTTTC AGCCATAAAT AGCAGGGCAG CTTTGTCCTA
|
1501TTTTTATTGT AGAGTACACA GAAGATGGAA CTCAGTATTG GAAGAAGTGC TTTATTTCGC
|
1561CAAGGAAGAA GATCATACTC AACACGATTC TGTTTTTCTT GGCAGGCTCT TCTCAACCAT
|
1621CTGTGAGTCC AGGGGAACCG TCTCCACCAT CCATCCATCC AGGAAAATCA GACTTAATAG
|
1681TCCGCGTGGG CGACGAGATT AGGCTGTTAT GCACTGATCC GGGCTTTGTC AAATGGACTT
|
1741TTGAGATCCT GGATGAAACG AATGAGAATA AGCAGAATGA ATGGATCACG GAAAAGGCAG
|
1801AAGCCACCAA CACCGGCAAA TACACGTGCA CCAACAAACA CGGCTTAAGC AATTCCATTT
|
1861ATGTGTTTGT TAGAGGTAAA TGCTTGGCTT TCTGCAGCAG GTCATGTCAC TTTAGGAGGG
|
1921TTGCTTTTAT GACACCGCAG TTTCATCTAT GAAATGGCAA TAATGATAGT ACTGATCATG
|
1981GGAGGGGCAA TTTGAAGATT AAATGAGATT AAGTGTAATG GTCCAAGCTT AGTGCGTGAT
|
2041ACATGGAAAG CGTTTAATAA ATGTTAATTC TCAATAGTAC TAGATGGATA AATTTTGCTT
|
2101TTGTTTACAC AGAAAAAAGC AGCCATTTGG GCCACTAGTC ATGAAAGGCA ACATATTAGA
|
2161TCTTTAAAAG TGTTTCAGTG TCTGTGACCA GCCATTCCAA CTACTGATTT GGATATGCTT
|
2221CTTATAGATC CTGCCAAGCT TTTCCTTGTT GACCGCTCCT TGTATGGGAA AGAAGACAAC
|
2281GACACGCTGG TCCGCTGTCC TCTCACAGAC CCAGAAGTGA CCAATTATTC CCTCAAGGGG
|
2341TGCCAGGGGA AGCCTCTTCC CAAGGACTTG AGGTTTATTC CTGACCCCAA GGCGGGCATC
|
2401ATGATCAAAA GTGTGAAACG CGCCTACCAT CGGCTCTGTC TGCATTGTTC TGTGGACCAG
|
2481GAGGGCAAGT CAGTGCTGTC GGAAAAATTC ATCCTGAAAG TGAGGCCAGG TACCTTGCTT
|
2521TCTTATCTGC CTCTGGAGTT GAGAACTCAC TTATCTAAAG AGACTTCTCT TCTCGTTGAT
|
2581CGTAAGCTGT ACACATTTGA GGAGAAATGG TAAATCAAAA TTTCATGCTA TAATACAAAT
|
2641TATTTGAGGG GCCACATTTC TTTTCATTCT AGCCTTCAAA GCTGTGCCTG TTGTGTCTGT
|
2701GTCCAAAGCA AGCTATCTTC TTAGGGAAGG GGAAGAATTC ACAGTGACGT GCACAATAAA
|
2761AGATGTGTCT AGTTCTGTGT ACTCAACGTG GAAAAGAGAA AACAGTCAGG TGAGTGAATC
|
2821GCTTCATTCT TCTCATGTTC TGTCTCTGTG GGAGATGATA AGTTTTCTCT TTCAGAAGAG
|
2881TCTGTCCTGA AACTGCCTCG ACTAGTGCGT CTGTCAGAGG AGAAGTTAAT TGCTGCTATT
|
2941TTTAATTTAT CTAGGAAAGA TTCTGAATAT AAATTATATG GTAATCTTCA TTTTTTTTTC
|
3001TCCTTTTCTG AAACCAGCAG ACTAAACTAC AGGAGAAATA TAATAGCTGG CATCACGGTG
|
3061ACTTCAATTA TGAACGTCAG GCAACGTTGA CTATCAGTTC AGCGAGAGTT AATGATTCTG
|
3121GAGTGTTCAT GTGTTATGCC AATAATACTT TTGGATCAGC AAATGTCACA ACAACCTTGG
|
3181AAGTAGTAGG TAAATACCTC TATGGGAATG TTTAAATTAC TGGCAGTAGT GAAAGAAGAA
|
3241ATTATTAGAC AGTTTCTTTT TTATGTAAAT GGAATGTTGA ACAGATTCTT AGAATTTTGT
|
3301TATCACTGAA TGAATGAAAA TTATCCTTGT AGCCTCTTGC AATGAAAGCA CAATTCTGTT
|
3361TTTTTTGTCC AGTAGTTGTA GATAATGTTT CTTTCTGTCT TATTTCATTC TAATTAGATA
|
3421AAGGATTCAT TAATATCTTC CCCATGATAA ACACTACAGT ATTTGTAAAC GATGGAGAAA
|
3481ATGTAGATTT GATTGTTGAA TATGAAGCAT TCCCCAAACC TGAACACCAG CAGTGGATCT
|
3541CTCTGAACAG AACCTTCACT GATAAATGGG AAGATTATCC CAAGTCTGAG AATGAAAGTA
|
3601ATATCAGGTA AGAAATGGAC CTTGCCCTGG GGATTACACA TTACCCCCTT TTCCAGTGGG
|
3661CTTATCAGAT CTTATTTCTG TAACCCGTAA ATCCACGAGA AGATACCTGG TAAAGAAGAA
|
3721AGTCTATTTT GCTAATACTT TACTGAATTA AATGAGTTAT ATTTTTCCTC AAACAGGCAT
|
3781AGATTTCCAG GTAGAAACTG AAAAAGACAT GCCTTCCAAG GCATGCTATC CACAGGTGAT
|
3841TGACTAGTTG TCTTTTCTTT GTAGATACGT AAGTGAACTT CATCTAACGA GATTAAAAGG
|
3901CACCCAAGGA CCCACTTACA CATTCCTAGT GTCCAATTCT GACGTCAATG CTGCCATAGC
|
3961ATTTAATGTT TATGTGAATA GTAACTAACA TGAAGGGCTC TTTTAATTTT TTATTCTTTT
|
4021AAGTTGTGGC TCGTGTTTGT AACAGCTGCA AGGACTCAAC TTGCTGTACT AAAGGTTGTA
|
4081CGGATTTAGA GAGGGAGTGA AGTGAATGTT GCTGACGTTT TCCAGCACTC TGACATATGC
|
4141CCATTTCTGT TTTCCTGTAG CAAAACCAGA AATCCTGACT TACGACAGGC TCGTGAATCC
|
4201CATGCTCCAA TGTGTGGCAC CAGGATTCCC AGAGGCCACA ATAGATTGGT ATTTTTGTCC
|
4261AGGAACTGAG CAGAGGTGAG ATGATTATTT TTGGCACTGC TTATAATGCA GAGGGGAAGG
|
4321ACTGCAATTC ACTTGAATTT CAAATATGTT TTCTGATTTT TTTTAAAAAA GCTTTAACTT
|
4381TGTTTTAAAA GTATGCCACA TCCCAAGTGT TTTATGTATT TATTTATTTT CCTAGAGTAA
|
4441GCCAGGGCTT TTGTTTTCTT CCCTTTAGAT GCTCTGCTTC TGTACTGCCA GTGGATGTGC
|
4501AGACACTAAA CTCATCTGGG CCACCGTTTG GAAAGCTAGT GGTTCAGAGT TCTATAGATT
|
4561CTAGTGCATT CAAGCACAAT CGCACGGTTG AATGTAAGGC TTACAACGAT GTGGGCAAGA
|
4621CTTCTGCCTA TTTTAACTTT GCATTTAAAG GTAACAACAA AGGTATATTT CTTTTTAATC
|
4681CAATTTAAGG GGATGTTTAG GCTCTGTCTA CCATATCAGT CATGATTTTG AGCTCAATTA
|
4741ACCCTCACTA AAGGGAGTCG ACTCGATCCC ATCCTGCCAA AGTTTGTGAT TCCACATTTC
|
4801TCTTCCATTG TAGAGCAAAT CCATCCCCAC ACCCTGTTCA CTCCTTTGCT GATTGGTTTC
|
4861GTAATCGTAG CTGGCATGAT GTGCATTATT GTGATGATTC TGACCTACAA ATATTTACAG
|
4921GTAACCATTT ATTTGTTCTC TCTCCAGAGT GCTCTAATGA CTGAGACAAT AATTATTAAA
|
4981AGGTGATCTA TTTTTCCCTT TCTCCCCACA GAAACCCATG ATGAAGTACA GTGGAAGGTT
|
5041GTTGAGGAGA TAAATGGAAA CAATTATGTT TACATAGACC CAACACAACT TCCTTATGAT
|
5101CACAAATGGG AGTTTCCCAG AAACAGGCTG AGTTTTGGTC AGTATGAAAC AGGGGCTTTC
|
5161CATGTCACCT TTTTGGGTAC ACATAACAGT GACTTTAAGG AACTCCAGTG GCTTCCTTTG
|
5221TTTTGTTCCA CCTGAAACAA TGAGTTTTCT GTGAAATTGC GCCCCTTTTG ATAGGTTTGC
|
5281CATAGAGAAC ATCGTAGGAA AATGTCTCTG GACAACATTG TTTTTAATTC CTTTATTGAT
|
5341TTTGAAACTG CACAAATGGT CCTTCAATTC CACCACCAGC ACCATCACCA CTTACCTTGT
|
5401TGTCTTCCTT CCTACAGGGA AAACCCTGGG TGCTGGAGCT TTCGGGAAGG TTGTTGAGGC
|
5461AACTGCTTAT GGCTTAATTA AGTCAGATGC GGCCATGACT GTCGCTGTAA AGATGCTCAA
|
5521GCGTAAGTTC CTGTATGGTA CTGCATGCGC TTGACATCAG TTTGCCAGTT GTGCTTTTTG
|
5581CTAAAATGCA TGTTTCCAAT TTTAGCGAGT GCCCATTTGA CAGAACGGGA AGCCCTCATG
|
5641TCTGAACTCA AAGTCCTGAG TTACCTTGGT AATCACATGA ATATTGTGAA TCTACTTGGA
|
5701GCCTGCACCA TTGGAGGTAA AGCCGTGTCC AAGCTGCCTT TTATTGTCTG TCAGGTTATC
|
5761AAAACATGAC ATTTTAATAT GATTTTGGCA ATGCTAGATT ATAAACTGCT TGGAACATTT
|
5821TTTTACCCAG ACTGTTGTTC TCTCTTGCTA GATTTTGTTT TCCTCATTGT TCTTAAGAAT
|
5881ATATGGGATT GTATTGGGAC TAAGTAGTCT GATCCACTGA AGCTGAATAT TAATGGCCAT
|
5941GACCACCCTT GGGTATTTTT ATGGGAGGCA GAATTAATCT ATATATCTCA CCTTCTTTCT
|
6001AACCTTTTCT TATGTGCTTT TACCGCCGAC CCTGGTCATT ACAGAATATT GTTGCTATGG
|
6061TGATCTTTTG AATTTTTTGA GAAGAAAACG TGATTCATTT ATTTGTTCAA AGCAGGAAGA
|
6121TCATGCAGAA GCTGCACTTT ATAAGAATCT TCTGCATTCA AAGGAGTCTT CCTGGTAAGA
|
6181CTGATTTACA TAAATAGTTA GCTGTTGACA GGCAGTTCAT GGGGAACTCT TTATTCAAAC
|
6241TTTACATGAC TTTCCTCAAA TTGGTCCAGT CTATTATGTA GCAAAGGGGA TGAGGAGGTA
|
6301GAGCATGACC CATGAGTGCC CTTCTACATG TCCCACTTGA TTCAGTCATG ACTTGTTTCA
|
6361TCTCTCCCAG CAGCGATAGT ACTAATGAGT ACATGGACAT GAAACCTGGA GTTTCTTATG
|
6421TTGTCCCAAC CAAGGCCGAC AAAAGGAGAT CTGTGAGAAT AGGTCAGTAC CTACCTATCA
|
6481AGCAACCAAG AGTAACTTTA CAGAGAGTAT GTATATCATG CTAATGTGGA ATATAACATC
|
6541ATTCCAGTAG CAATGATGCA GACCAGTTCT GCTTTATGGT AGCAGTGCCA ATGGTCAATG
|
6601GCAGTTAGGG GCAAGTTCAC ATTAGTTCAT TGATTACCAG CCTTTGGTAT GTCATTGCCA
|
6661CTGTCTTTTC CTTTCCTGAC CTTTATGGTT GTAATTGCTA AGAAAAATCC TCTCTTCCTC
|
6721ACAGGCTCAT ACATAGAAAG AGATGTGACT CCCGCCATCA TGGAGGATGA CGAGTTGGCC
|
6781CTAGACTTAG AAGACTTGCT GAGCTTTTCT TACCAGGTGG CAAAGGGCAT GGCTTTCCTC
|
6841GCCTCCAAGA ATGTAAGTGG GAGTGATTCT CTAAAGAGTT TTGTGTTTTG TTTTTTTGAT
|
6901TTTTTTTTTT TTTTTTTTTT TTTTGAGAAC AGAGCATTTT AGAGCCATAG TTAAAAGCAG
|
6961AATGTCATTT AAAACAAAAG TATTGGATTT TTTATAATAT AAGCAACACT ATAGTATTAA
|
7021AAAGTTAGTT TTCACTCTTT ACAAGTTAAA ATGAATTTAA ATGGTTTTCT TTTCTCCTCC
|
7081AACCTAATAG TGTATTCACA GAGACTTGGC AGCCAGAAAT ATCCTCCTTA CTCATGGTCG
|
7141GATCACAAAG ATTTGTGATT TTGGTCTAGC CAGAGACATC AAGAATGATT CTAATTATGT
|
7201GGTTAAAGGA AACGTGAGTA CCCATTCTCT GCTTGACAGT CCTGCAAAGG ATTTTTAGTT
|
7261TCAACTTTCG ATAAAAATTG TTTCCGTGAC TTTCATAATG TAAATCCTGT CTAGGGATAT
|
7321CACACATTTT AGCAGTCAAA TGTATTTCAG AGGTGATTGG GATCATCTGA GTTCATATAG
|
7381GTAAAAGGTT TTTGTGAGAT GGTACTCAAG TTATCACTCC ACATTTCAGC AACAGCAGCA
|
7441TCTATAAGAA TATCTTCTGT TCAATTTTGT TGAGCTTCTG AATTAACATT ATTGACTCTG
|
7501TTGTGCTTCT ATTACAGGCT CGACTACCTG TGAAGTGGAT GGCACCTGAA AGCATTTTCA
|
7561ACGTGTATAC ACGTTTGAAA GTGACGTCTG GTCCTATCGG ATTTTTCTTT GGGAGCTGTT
|
7621CTCTTTAGGT AAAATGATCC TTGCCAAAAG ACAACTTCAT TAGACTCAGA GCATCTTGAA
|
7681GTTTCATTGG TGTCCTGCTT CCTTGTGATT AACACTGCTT TGCAAACTGT GTCTCAGGAA
|
7741GCAGCCCCTA TCCTGGAATG CCGGTCGATT CTAAGTTCTA CAAGATGATC AAGGAAGGCT
|
7801TCCGGATGCT CAGCCTGAAC ACGCACCTGC TGAAATGTAA GAGCCAAAAA ATTTTTCCTT
|
7861TAGGTCACGT TTTCCCTTTT ATTTTTCTTT TTAGAGACAG AAACCCAGAT GTTGAGGGTT
|
7921TTCATAACAC AGTTTGAAAT GTCACTTCCA TTCTTTATGA CACACTGGTC AAATGTCATT
|
7981TCTCTAGTTT ATTTTCATAA TCTCTTGTCA CCAAAAATAC AGAAAGTTTC AGTAATATTT
|
8041CATACATGCA GTGTTTTATG TTATCTATAT GTCAGTCCAT ATGTCCAGTT GCATAGCCCT
|
8101CGAATTATTA CTGAAGTTGC TGGATGCCCA TACATTTGAA AACAACCTCA GGGCATTGAC
|
8161GAGGGATAGT AAATGGCCCT TGTCTTGCAG GTATCACATA ATGAAGACTT GCTGGGATGC
|
8221AGATCCCCTA AAAAGACCAA CATTCAAGCA AATTGTTCAG CTAATTGAGA AGCAGATTTC
|
8281AGAGACCACC AATCATGTGA GTATACCCTG CCCAGCCATA GAATCCCCCT TCTCCCAGTT
|
8341CCAGGTGTGT CCTCCTCCTC AGGCTTTCAG GGTGAGGACT AACCTCCCAA CCCCTTCTCT
|
8401CCTAATCTTA GGTTGCAAAT TGGGCTTCAC GTAGGGGAAG TAAAGCAATG GAAACTAGTT
|
8461CTTTTAAGAG TTCCATCAGT TAGTTGTGAT CTTGACACTG TAAGTATGCC TTTTGTTGCT
|
8521ATGTTCGTTG TAGGGACTGC TGTATTCACT ATGGGCTTGT TTTCTCCACA TTTACTCCAA
|
8581CTTAGCAAAC TGCAGCCCCA ACCGACACAA GCCCGTGGTA GACCATTCTG TGCGGATCAA
|
8641TTCTGTCGGC AGCACCGCTT CCTCCTCCCA GCCTCTGCTT GTGCACGACG ATGTCTGAGC
|
8701ACAATCAGTG TTTGGGTCAC CCCTCCAGGA ATCATCTCTT CTTTTGGCTT CCATGATGGT
|
8761TATTTTCTTT TCTTTCAACT TGCATCCAAC TCCAGGATAG TGGGCACCCC ACTGCAATCC
|
8821TGTCTTTCTG AGCACACTTT AGTGGCCGAT GATTTTTGTC ATCAGCCACC ATCCTATTGC
|
8881AAAGCTTCCA ACTGTATATA TTCCCAATAG CAACGTAGCT TCTACCATCA ACAGAAAACA
|
8941TTCTGATTTG GAAAAAGAGA GGCAGGTATG GACTGGGGGC CAGAGTCCTT TCCAAGGCTT
|
9001CTCCAATTCT GCCCAAAAAT ATGGTTGATA GTTTACCTGA ATAAATGGTA GTAATCACAG
|
9061TTGGCCTTCA GAACCATCCA TAGTAGTATG ATGATACAAG ATTAGAAGCT GAAAACCTAA
|
9121GTCCTTTATG TGGAAAACAG AACATCATTA GAACAAAGGA CAGAGTATGA ACACCTGGGC
|
9181TTAAGAAATC TAGTATTTCA TGCTGGGAAT CAGACATAGG CCATGAAAAA AATGATCCCC
|
9241AAGTCTGAAC AAAAGATCCT CTTCTGTCGA CCACTGCATG AGCTTTTATA CTACCGACCT
|
9301GGTPTTTAAA TAGACTTTGC TATTAGAGCA TTGAATTGGA GAGAAGGCCT CCCTAGCCAG
|
9361CACTTGTATA TACGCATGTA TAAATTGTCC GTGTTCATAC ATTTGAGGGG AAAACACCAT
|
9421AAGGTTTCGT TTCTGTATAC AACCCTGGCA TTATGTCCAC TGTGTATAGA AGTAGATTAA
|
9481GAGCCATATA AGTTTGAAGG AAACACTTAA TACCATTTTT TAAGGAAACA ATATAACCAC
|
9541AAAGCACAGT TTGAACAAAA TCTCCTCTTT TAGCTGATGA ACTTATTCTG TAGATTCTCT
|
9601GGAACAAGCC TATCAGCTTC AGAATGGCAT TGTACTCAAT GGATTTGATG CTGTTTGACA
|
9661AAGTTACTGA TTCACTGCAT GGCTCCCACA GGAGTGGGAA AACACTGCCA TCTTAGTTTG
|
9721GATTCTTATG TAGCAGGAAA TAAAGTATAG GTTTAGCCTC CTTCGCAGGC ATGTCCTGGA
|
9781CACCGGGCCA CTATCTATAT ATGTGTATGT ACGTTTGTAT GTGTGTAGAC AAATATTTGG
|
9841AGGGGTATTT TTGCCCTGAG TCCAAGAGGG TCCTTTAGTA CCTGAAAAGT AACTTGGCTT
|
9901TCATTATTAG TACTGCTCTT GTTTCTTTTC ACATAGCTGT CTAGAGTAGC TTACCAGAAG
|
9961CTTCCATAGT GGTGCAGAGG AAGTGGAAGG CATCAGTCCC TATGTATTTG CAGTTCACCT
|
10021GCACTTAAGG CACTCTGTTA TTTAGACTCA TCTTACTGTA CCTGTTCCTT AGACCTTCCA
|
10081TAATGCTACT GTCTCACTGA AACATTTAAA TTTTACCCTT TAGACTGTAG CCTGGATATT
|
10141ATTCTTGTAG TTTACCTCTT TAAAAACAAA ACAAAACAAA ACAAAAAACT CCCCTTCCTC
|
10201ACTGCCCAAT ATAAAAGGCA AATGTGTACA TGGCAGAGTT TGTGTGTTGT CTTGAAAGAT
|
10261TCAGGTATGT TGCCTTTATG GTTTCCCCCT TCTACATTTC TTAGACTACA TTTAGAGAAC
|
10321TGTGGCCGTT ATCTGGAAGT AACCATTTGC ACTGGAGTTC TATGCTCTCG CACCTTTCCA
|
10381AAGTTAACAG ATTTTGGGGT TGTGTTGTCA CCCAAGAGAT TGTTGTTTGC CATACTTTGT
|
10441CTGAAAAATT CCTTTGTGTT TCTATTGACT TCAATGATAG TAAGAAAAGT GGTTGTTAGT
|
10501TATAGATGTC TAGGTACTTC AGGGGCACTT CATTGAGAGT TTTGTCTTGC CATACTTTGT
|
10561CTGAAAAATT CCTTTGTGTT TCTATTGACT TCAATGATAG TAAGAAAAGT GGTTGTTAGT
|
10621TATAGATGTC TAGGTACTTC AGGGGCACTT CATTGAGAGT TTTGTCTTGG ATATTCTTGA
|
10681AAGTTTATAT TTTTATAATT TTTTCTTACA TCAGATGTTT CTTTGCAGTG GCTTAATGTT
|
10741TGAAATTATT TTGTGGCTTT TTTTGTAAAT ATTGAAATGT AGCAATAATC TCTTTTGAAT
|
10801ATTCCCAAGC CCATGAGTCC TTGAAAATAT TTTTTATATA TACAGTAACT TTATGTGTAA
|
10861ATACATAAGC GGCGTAAGTT TAAAGGATGT TGGTGTTCCA CGTGTTTTAT TCCTGTATGT
|
10921TGTCCAATTG TTGACAGTTC TGAAGAATTC TAATAAAATG TACATATATA AATCAA
|
GENBANK ID: M32110
VERSION M32110.1 GI:189421
RATPPSPISACHSTMGRKLDPTKEKRGPGRKARKQKGAETELVR
|
FLPAVSDENSKRLSSRARKRAAKRRLGSVEAPKTNKSPEAKPSPGKLPKGISAGAVQT
|
AGKKGPQSLFNAPRGKKRPAPGSDEEEEEEDSEEDGNVNHGDLWGSEDDADTVDDYGA
|
DSNSEDEEEGEALLPIEPAARKQKAREAAAGIQWSEEETEDEBEEKEVTPESGPPKVE
|
EADGGLQINVDEEPFVLPPAGEMEQDAQAPDLQRVHKRIQDIVGILRDPGAQREEGRS
|
RSEYLNRLKKQLAIYYSYGDFLLGKLMQLFPLSELVEFLBANEVPRPVTLRTNTLKTR
|
RRDLAQALINRGVNLDPLGKBSKTGLVVYDSSVPTGATPEYLAGHYMLQGASSMLPVM
|
ALAPQEHERILDMCCAFGGKTSYMAQLMKNTGVILANDANAERLKSVVGNLHRLGVTN
|
TIISHYDGRQFPKVVGGFDRVLLDAPCSGTGVISKDPAVKTNKDEKDILRCAHLQKEL
|
LLSAIDSVNATSKTGGYLVYCTCSITVEENEWVVDYALKKRNVRLVPTGLDFGQEGFT
|
RFRERRFHPSLRSTRRFYPHTHNMQGFFIAKFKKFSNSIPQSQTGNSETATPTNVDLP
|
QVIPKSENSSQPAKKAKGAGKTKQQLQKQQHPKKASFQKLNGISKGAQSELSTVPSVT
|
KTQASSSFQDSSQPAGKAEGIREPKVTGKLKQRSPKLQSSKKVAFLRQNAPPKGTDTQ
|
TPAVLSPSKTQATLKPKDHHQPLGRAKCVEKQQFAEQPFEKAAFQKQNDTPKGLSLPL
|
CLPSVPAAPHQQRGRNLSPGATASCCYLRWLKTRRVAHCHCHQVGTLASVRMPSLLCI
|
PMKFNTHFKTSGH
|
GenHank ID: J04111
VERSION J04111.1 GI:186624
MTAKMETTFYDDALNASFLPSESGPYGYSNPKTLKQSNTLNLAD
|
PVGSLKPHLRAKNSDLLTSPDVGLLKLASPELERLIIQSSNGHITTTPTPTQFLCPKN
|
VTDEQEGFAEGFVRALAELHSGNTLPSVTSAAQPVNGAGMVAPAVASVAGGSGSGGFS
|
ASLHSEPPVYANLSNFNFGALSSGGGAPSYGAAGLAFPAQPQQQQQPPHHLPQQNPVQ
|
HPRLQALKEEPQTVPEMPGETPPLSPIDMESQERIKAERKRNRNRIAASKCRKRKLER
|
IARLEEKVKTLKAQNSELASTANNLREQVAQLKQKVMNHVNSGCQLMLTQQLQTF
|
GENBANK ID: X59932
VERSION X59932.1 GI:30255
MSAIQAAWPSGTECIAKYNFHGTAEQDLPFCKGDVLTIVAVTKD
|
PNWYKAKNKVGREGIIPANYVQKREGVKAGTKLSLMPWFHGKITREQAERLLYPPETG
|
LFLVRESTNYFGDYTLCVSCDGKVEHYRIMYHASKLSIDEEVYFENLMQLVEHYTSDA
|
DGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK
|
VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD
|
YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG
|
LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL
|
KDVVPRVEKGYKMDAPDGCPPAVYEVNKNCWHLDAANRPSFLQLREQLEHIKTHELHL
|
GENBANK ID: L29220
VERSION L29220.1 GI:632969
MHHCIRYRSPEPDPYLSYRWKRRRSYSREHEGRLRYPSRREPPP
|
RRSRSRSHDRLFYQRRYRERRDSDTYRCEERSPSFGEDYYGPSRSRHRRRSRERGPYR
|
TRKHAHECHKRRTRSCSSASSMRLWGTWVKAFLARWWSAWTMPEGSLRLP
|
GENBANK ID: M91815.1
VERSION M91815.1 GI:180169
HOMO SAPIENS FETAL CDNA TO MRNA.
1CAGCTGACCC TGCTGGATCA CCTCGCCTTC AAGAAGATTC CTTATGAGGA GTTCTTCGGA
|
61CAAGGATGGA TGAAACTGGA AAAGAATGAA AGGACCCCTT ATATCATGAA AACCACTAAG
|
121CACTTCAATG ACATCAGTAA CTTGATTGCT TCAGAAATCA TCCGCAATGA GGACATCAAC
|
181GCCAGGGTGA GCGCCATCGG GAAGTGGGTG GCCGTAGCTG ACATATGCCG CTGCCTCCAC
|
241AACTACAATG CCGTACTGGA GATCACCTGC TCCATGAACC GCAGTGCAAT CTTCCGGCTC
|
301AAAAAGACGT GGCTCAAAGT CTCTAAGCAG ACTAAAGCTT TGATTGATAA GCTCCAAAAG
|
361CTTGTGTCAT CAGAGGGCAG ATTTAAGAAT CTCAGAGAAG CTCTGAAAAA TTGTGACCCA
|
421CCCTGTGTCC CTTACCTGGG GATGTACCTC ACCGACCTGG CCTTCATCGA GGAGGGGACG
|
481CCCAATTACA CGGAAGACGG CCTGGTCAAC TTCTCCAAGA TGAGGATGAT ATCCCATATT
|
541ATGCCAGAGA TTCGCCAGTT TCAACAAACT GCCTACAAAA TAGAGCACCA AGCAAAGGTA
|
601ACGCAATATT TACTGGACCA ATCTTTTGTA ATGGATGAAG AAAGCCTCTA CGAGTCTTCT
|
661CTCCGAATAG AACCAAAACT CCCCACCTGA AGCTGTGCCC AGACCCAGAC CAGCTGCTCC
|
721CGGGGACATG TGCTAGAIGA TACTGTACAT ATTCGTTTGG TTTCACTGGA TTTTCTTCTT
|
781CAGTATGTGC TTCTCCAAGA AATACAAATC GTCCTTGTTC TTAGATTCCT GTAG
|
GENBANK ID: M26708
VERSION M26708.1 GI:190695
MSDAAVDTSSEITTKDLKEKKEVVEEAENGRDAFANGNANEENG
|
EQEADNEVDEEEEEGGEEEEEEEEGDGEEEDGDEDEEAESATGKRAAEDDEDDDVDTK
|
KQKTDEDD
|
GENBANK ID: M81757
VERSION M81757.1 GI:337732
MPGVTVKDVNQQEFVRALAAFLEKSGKLKVPEWVDTVKLAIHKE
|
LAPYDENWFYTRAASTARHLYLRGGAGVGSNTKIYGGRQRNGVMPSHFSRGSRSVARR
|
VLQALEGLKMVEKDQDGGRKLTPQGQRDLDRIAGQVAAANEKH
|
GENBANK ID: V00568
DEFINITION HUMAN MRNA ENCODING THE C-NYC ONCOGENE.
VERSION V00568.1 GI:34815
MPLNV FTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPA
|
PSEDIWKKFELLPTPPLSFSRRSGLCSPSYVAVTPFSLRGDNDGGGGSFSTADQLEMV
|
TELLGGDMVNQSFICDPDDETFIKNIIIQDCNWSGFSAAAKLVSEKLASYQAARKDSG
|
SPNPARGHSVCSTSSLYLQDLSAAASECIDPSVVFPYPLNDSSSPRSCASQDSSAFSP
|
SSDSLLSSTESSPQGSPEPLVLHEETPPTTSSDSEEEQEDEEEIDVVSVEKRQAPGKR
|
SESGSPSAGGHSEPPHSPLVLKRCHVSTHQHNYAAPPSTRKDYPAAKRVKLDSVRVLR
|
QISNNRKCTSPRSSDTEENVKRRTHNVLERQRRNELKRSFFALRDQIPELENNEIAPK
|
VVILKKATAYILSVQAEEQKLISEEDLLRKRREQLKHNLEQLRNSCA
|
GENBANK ID: L29219.1
VERSION L29219.1 GI:632963
MRHSKRTYCPDWDDKDWDYGKWRSSSSHERRERENSSAQENKRC
|
KYNHSKMCDSHYLESRSINEEDYHSRRYIDEYRNDYTQGCEPGHRQRDHESRYQNHSS
|
KSSGRSGRSSYKSKHRIHHSTSHRRSHGKSHRRKRTRSVEDDEEGHLICQSGDVLSAR
|
YEIVDTLGEGAFGKVVECIDHKAGGREVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP
|
NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV
|
NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE
|
HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYIGFTVFPTHDSKEHLAMME
|
RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL
|
FDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI
|
GENBANK ID: U49399.1
VERSION U49399.1 GI:1418220
MLLEEVRAGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKT
|
ALQVMMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNV
|
PDGTGALPIHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG
|
HMVAPL
|
GENBANK ID: XM_039993.2
VERSION XM_039993.2 GI:16188964
MVSYWDTGVLLCALLSCLLLTGSSS0SKLKDPELSLKGTQHIMQ
|
AGQTLHLQCRGEAAHKWSLPEMVSKESERLSITKSACGRNGKQFCSTLTLNTAQANHT
|
GFYSCKYLAVPTSKKKETESAIYIFISDTGRPFVEMYSEIPEIIHMTEGRELVIPCRV
|
TSPNITVTLKKFPLDTLIPDGKRIIWDSRKGFIISNATYKEIGLLTCEATVN0HLYKT
|
NYLTHRQTNTIIDVQISTPRPVKLLRGHTLVLNCTATTPLNTRVQMTNSYPDEKNKRA
|
SVRRRIDQSNSHANIFYSVLTIDKMQNKDKGLYTCRVRSGPSFKSVNTSVHIYDKAFI
|
TVKHRKQQVLETVAGKRSYRLSMKVKAFPSPEVVWLKDGLPATEKSARYLTRGYSLII
|
KDVTEEDAGNYTILLSIKQSNVFKNLTATLIVNVKPQIYEKAVSSFPDPALYPLGSRQ
|
ILTCTAYGIPQPTIKNFNHPCNHNHSEARCDFCSNNEESFILDADSNMGNRIESITQR
|
MAIIEGKNKMASTLVVADSRISGIYICIASNKVQTVGRNISFYITDVPNGFHVNLEKN
|
PTEGEDLKLSCTVNKFLYRDVTWILLRTVNNRTMHYSISKQKMAITKEHSITLNLTIM
|
NVSLQDSGTYACRARNVYTGEEILQKKEITIRDQEAPYLLRNLSDHTVAIESSTTLDC
|
HANGVPEPQITWFKNNHKIQQEPGIILGPGSSTLFIERVTEEDEGVYHCKATNQKGSV
|
ESSAYLTVQGTSDKSNLELITLTCTCVAATLFWLLTLFIRKDAKRSSSEIKTDYLSII
|
MDPDEVPLDEQCERLPYDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCR
|
TVAVKMLKEGATASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKY
|
GNLSNYLKSKRDLFFLNKDAALHMEFKKEKNEPGLEQGKKPRLDSVTSSESFASSGFQ
|
EDKSLSDVEEEEDSD0FYKEPITMEDLISYSFQVARQNEFLSSRKCIHRDLAARNILL
|
SENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVL
|
LWEIFSLGGSFYPGVQNDEDFCSRLREGNRMRAPEYSTFEIYQIMLDCWHRDPKERPR
|
FAELVEKLGDLLQANVQQDGKDYIPINAILTGNSGFTYSTPAFSEDFFKESISAPKFN
|
SGSSDDVRYVNAFKFMSLERIKTFEELLPNATSMFDDYQGDSSTLLASPMLKRFTWTD
|
SKPKASLKIDLRVTSKSKESGLSDVSRPSFCHSSCGHVSEGKRRFTYDHAELERKIAC
|
CSPPPDYNSVVLYSTPPI
|
GENBANK ID: U61262.1
VERSION U61262.1 GI:1621606
CDS 137..4522
/CODON_START=1
1GGGCCGGGCC GGGCTGGGCT GGAGCAGCGG CGCCCGGGAG CCGAGCTTGC AGCGAGGGAC
|
61CGGCTGAGGC GCGCGGGAGG GAAGGAGGCA ACGGCTCCGC GGCGCTGTCG CGCTGCCGCT
|
121CACTCTCGGG GAAGAGATGG CGGCGGAGCG GGGAGCCCGG CGACTCCTCA GCACCCCCTC
|
181CTTCTGGCTC TACTGCCTGC TGCTGCTCGG GCGCCGGGCG CCGGGCGCCG CGGCGGCCAG
|
241GAGCGGCTCC GCGCCGCAGT CCCCAGGAGC CAGCATTCGA ACGTTCACTC CATTTTATTT
|
301TCTGGTGGAG CCGGTGGATA CACTCTCAGT TAGAGGCTCT TGTGTTATAT TAAACTGTTC
|
361AGCATATTCT GAGCCTTCTC CAAAAATTGA ATGGAAAAAA GATGGAACTT TTTTAAACTT
|
421AGTATCAGAT GATCGACGCC AGCTTCTCCC GGATGGATCT TTATTTATCA GCAATGTGGT
|
481GCATTCCAAA CACAATAAAC CTGATGAAGG TTATTATCAG TGTGTGGCCA CTGTTGAGAG
|
541TCTTGGAACT ATTATCAGTA GAACAGCGAA CCTCATAGTA GCAGGTCTTC CAAGATTTAC
|
601CAGCCAACCA GAACCTTCCT CAGTTTATGC TGGGAACGGA GCAATTCTGA ATTGTGAAGT
|
661TAATGCAGAT TTGGTCCCAT TTGTGAGGTG GGAACAGAAC AGACAACCCC TTCTTCTGGA
|
721TGATAGAGTT ATCAAACTTC CAAGTGGAAT GCTGGTTATC AGCAATGCAA CTGAAGGAGA
|
781TGGCGGGCTT TATCGCTGCG TAGTGGAAAG TGGTGGGCCA CCAAAGTATA GTCATGAAGT
|
841TGAATTGAAG GTTCTTCCAG ATCCTGAGGT GATATGAGAC TTGGTATTTT TGAAACAGCC
|
901TTCTCCCTTA GTCAGAGTCA TTGGTCACGA TGTAGTGTTG CCATGTGTTG CTTCAGGACT
|
961TCCTACTCCA ACCATTAAAT GGATGAAAAA TGAGGAGGCA CTTGACACAC AAAGCTCTGA
|
1021AAGATTGGTA TTGCTGGCAG GTGGTAGCCT GGAGATCAGT GATGTTACTG AGGATGATGC
|
1081TGGGACTTAT TTTTGTATAG CTGATAATGG AAATGAGACA ATTGAAGCTC AAGCAGAGCT
|
1141TACAGTGCAA GCTCAACCTG AATTCCTGAA GCAGCCTACT AATATATATG CTCACGAATC
|
1201TATGGATATT GTATTTGAAT GTGAAGTGAC TGGAAAACCA ACTCCAACTG TGAAGTGGGT
|
1261CAAAAATGGG GATATGGTTA TCCCAAGTGA TTATTTTAAG ATTGTAAAGG AACATAATCT
|
1321TCAAGTTTTG GGTCTGGTGA AATCAGATGA AGGGTTCTAT CAGTGCATTG CTGAAAATGA
|
1381TGTTGGAAAT GCACAAGCTG GAGCCCAACT GATAATCCTT GAACATGCAC CAGCCACAAC
|
1441GGGACCACTG CCTTCAGCTC CTCGGGATGT CGTGGCCTCC CTGGTCTCTA CCCGCTTCAT
|
1501CAAATTGACG TGGCGGACAC CTGCATCAGA TCCTCACGGA GACAACCTTA CCTACTCTGT
|
1561GTTCTACACC AAGGAAGGGA TTGCTAGGGA ACGTGTTGAG AATACCAGTC ACCCAGGAGA
|
1621GATGCAAGTA ACCATTCAAA ACCTAATGCC AGCGACCGTG TACATCTTTA GAGTTATGGC
|
1681TCAAAATAAG CATGGCTCAG GAGAGAGTTC AGCTCCACTG CGAGTAGAAA CACAACCTGA
|
1741GGTTCAGCTC CCTGGCCCAG CACCTAACCT TCGTGCATAT GCAGCTTCGC CTACCTCCAT
|
1801CACTGTTACG TGGGAAACAC CAGTGTCTGG CAATGGGGAA ATTCAGAATT ATAAGTTGTA
|
1861CTACATGGAA AAGGGGACTG ATAAAGAACA GGATGTTGAT GTTTCAAGTC ACTCTTACAC
|
1921CATTAATGGG TTGAAAAAAT ATACAGAGTA TAGTTTCCGA GTGGTGGCCT ACAATAAACA
|
1981TGGTCCTGGA GTTTCCACAC CAGATGTTGC TGTTCGAACA TTGTCAGATG TTCCCAGTGC
|
2041TGCTCCTCAG AATCTGTCCT TGGAAGTGAG AAATTCAAAG AGTATTATGA TTCACTGGCA
|
2101GCCACCTGCT CCAGCCACAC AAAATGGGCA GATTACTGGC TACAAGATTC GCTACCGAAA
|
2161GGCCTCCCGA AAGAGTGATG TCACTGAGAC CTTGGTAAGC GGGACACAGC TGTCTCAGCT
|
2221GATTGAAGGT CTTGATCGGG GGACTGAGTA TAATTTCCGA GTGGCTGCTC TAACAATCAA
|
2281TGGTACAGGC CCGGCAACTG ACTGGCTGTC TGCTGAAACT TTTGAAAGTG ACCTAGATGA
|
2341AACTCGTGTT CCTGAAGTGC CTAGCTCTCT TCACGTACGC CCGCTCGTTA CTAGCATCGT
|
2401AGTGAGCTGG ACTCCTCCAG AGAATCAGAA CATTGTGGTC AGAGGTTACG CCATTGGTTA
|
2461TGGCATTGGC AGCCCTCATG CCCAGACCAT CAAAGTGGAC TATAAACAGC GGTATTACAC
|
2521CATTGAAAAT CTGGATCCCA GCTCTCACTA TGTGATTACC CTGAAAGCAT TTAATAACGT
|
2581GGGTGAAGGC ATCCCCCTGT ATGAGAGTGC TGTGACCAGG CCTCACACAG ACACTTCTGA
|
2641AGTTGATTTA TTTGTTATTA ATGCTCCATA CACTCCAGTG CCAGATCCCA CTCCCATGAT
|
2701GCCACCACTG GGAGTTCAGG CTTCCATTCT GAGTCATGAC ACCATCAGGA TTACGTGGGC
|
2761AGACAACTCG CTGCCCAAGC ACCAGAAGAT TACAGACTCC CGATACTACA CCGTCCGATG
|
2821GAAAACCAAC ATCCCAGCAA ACACCAAGTA CAAGAATGCA AATGCAACCA CTTTGAGTTA
|
2881TTTGGTGACT GGTTTAAAGC CGAATACACT CTATGAATTC TCTGTGATGG TGACCAAAGG
|
2941TCGAAGATCA AGTACATGGA GTATGACAGC CCATGGGACC ACCTTTGAAT TAGTTCCGAC
|
3001TTCTCCACCC AAGGATGTGA CTGTTGTGAG TAAAGAGGGG AAACCTAAGA CCATAATTGT
|
3061GAATTGGCAG CCTCCCTCTG AAGCCAATGG CAAAATTACA GGTTACATCA TATATTACAG
|
3121TACAGATGTG AATGCAGAGA TACATGACTG GGTTATTGAG CCTGTTGTGG GAAACAGACT
|
3181GACTGACCAG ATACAAGAGT TAACTCTTGA CACACCATAC TACTTCAAAA TCCAGGCACG
|
3241GAACTCAAAG GGCATGGGAC CCATGTCTGA AGCTGTCCAA TTCAGAACAC CTAAAGCGGA
|
3301CTCCTCTGAT AAAATGCCTA ATGATCAAGC CTCAGGGTCT GGAGGGAAAG GAAGCCGGCT
|
3361GCCAGACCTA GGATCCGACT ACAAACCTCC AATGAGCGGC AGTAACAGCC CTCATGGGAG
|
3421CCCCACCTCT CCTCTGGACA GTAATATGCT GCTGGTCATA ATTGTTTCTG TTGGCGTCAT
|
3481CACCATCGTG GTGGTTGTGA TTATCGCTGT CTTTTGTACC CGTCGTACCA CCTCTCACCA
|
3541GAAAAAGAAA CGAGCTGCCT GCAAATCAGT GAATGGCTCT CATAAGTACA AAGGGAATTC
|
3601CAAAGATGTG AAACCTCCAG ATCTCTGGAT CCATCATGAG AGACTGGAGC TGAAACCCAT
|
3661TGATAAGTCT CCAGACCCAA ACCCCATCAT GACTGATACT CCAATTCCTC GCAACTCTCA
|
3721ACATATCACA CCAGTTGACA ACTCCATCCA CAGCAATATC CATCAAAGGC GAAATTCATA
|
3781CAGAGGGCAT GAGTCAGAGG ACAGCATGTC TACACTGGCT GGAAGGCGAG GAATGAGACC
|
3841AAAAATGATG ATGCCCTTTG ACTCCCAGCC ACCCCAGCCT GTGATTAGTG CCCATCCCAT
|
3901CCATTCCCTC GATAACCCTC ACCATCATTT CCACTCCAGC AGCCTCGCTT CTCCAGCTCG
|
3961CAGTCATCTC TACCACCCGG GCAGCCCATG GCCCATTGGC ACATCCATGT CCCTTTCAGA
|
4021CAGGGCCAAT TCCACAGAAT CCGTTCGAAA TACCCCCAGC ACTGACACCA TGCCAGCCTC
|
4081TTCCTCTCAA ACATGCTGCA CTGATCACCA GGACCCTGAA GGTGCTACCA GCTCCTCTTA
|
4141CTTGGCCAGC TCCCAAGAGG AAGATTCAGG CCAGACTCTT CCCACTGCCC ATGTTCGCCC
|
4201TTCCCACCCA TTGAAGAGCT TCGCCGTGCC AGCAATCCCG CCTCCAGGAC CTCCCACCTA
|
4261TGATCCTGCA TTGCCAAGCA CACCATTACT GTCCCAGCAA GCTCTGAACC ATCACATTCA
|
4321CTCAGTGAAG ACAGCCTCCA TCGGGACTCT AGGAAGCAGC CCCCCTCCTA TGCCAGTGGT
|
4381TGTTCCCAGT GCCCCTGAAC TGCAGGAGAC CACAAGGATG TTGGAAGACT CCGAGAGTAG
|
4441CTATGAACCA GATGAGCTGA CCAAAGAGAT GGCCCACCTG GAAGGACTAA TGAAGGACCT
|
4501AAACGCTATC ACAACAGCAT GACGACCTTC ACCAGGACCT GACTTCAAAC CTGAGTCTGG
|
4561AAGTCTTGGA ACTTAACCCT TGAAAACAAG GAATTGTACA GAGTACGAGA GGACAGCACT
|
4621TGAGAACACA GAATGAGCCA GCAGACTGGC CAGCGCCTCT GTGTAGGGCT GGCTCCAGGC
|
4681ATGGCCACCT GCCTTCCCCT GGTCAGCCTG GAAGAAGCCT GTGTCGAGGC AGCTTCCCTT
|
4741TGCCTGCTGA TATTCTGCAG GACTGGGCAC CATGGGCCAA AATTTTGTGT CCAGGGAAGA
|
4801GGCCAGAAGT GCAACCTGCA TTTCACTTTG TGGTCAGGCC GTGTCTTTGT GCTGTGACTG
|
4861CATCACCTTT ATGGAGTGTA GACATTGGCA TTTATGTACA ATTTTATTTG TGTCTTATTT
|
4921TATTTTACCT TCAAAAACAA AAACGCCATC CAAAACCAAG GAAGTCCTTG GTGTTCTCCA
|
4981CAAGTGGTTG ACATTTGACT GCTTGTTCCA ATTATGTATG GAAAGTCTTT GACACTGTGG
|
5041GTCGTTCCTG GGGTTGGCTT GTTTTTTGGT TTCATTTTTA TTTTTTAATT CTGAGTCATT
|
5101GCATCCTCTA CCAGCTGTTA ATCCATCACT CTGAGGGGGA GGAAATGTTG CATTGCTGTT
|
5161TGTAAGCTTT TTTTATTATT TTTTTATTAT AATTATTAAA GGCCTGACTC TTTCCTCTCA
|
5221TCACTGTGAG ATTACAGATC TATTTGAATT GAATGAAATG TAACATTGAA AAAAAAAAAA
|
5281AAAAAAAAAA AAAAAAA
|
GENBANK ID: M11730.1
VERSION M11730.1 GI:183986
PRODUCT=“HER2 MRNA”
CDS 151..3918
/CODON_START=1
1AATTCTCGAG CTCGTCGACC GGTCGACGAG CTCGAGGGTC GACGAGCTCG AGGGCGCGCG
|
61CCCGGCCCCC ACCCCTCGCA GCACCCCGCG CCCCGCGCCC TCCCAGCCGG GTCCAGCCGG
|
121AGCCATGGGG CCGGAGCCGC AGTGAGCACC ATGGAGCTGG CGGCCTTGTG CCGCTGGGGG
|
181CTCCTCCTCG CCCTCTTGCC CCCCGGAGCC GCGAGCACCC AAGTGTGCAC CGGCACAGAC
|
241ATGAAGCTGC GGCTCCCTGC CAGTCCCGAG ACCCACCTGG ACATGCTCCG CCACCTCTAC
|
301CAGGGCTGCC AGGTGGTGCA GGGAAACCTG GAACTCACCT ACCTGCCCAC CAATGCCAGC
|
361CTGTCCTTCC TGCAGGATAT CCAGGAGGTG CAGGGCTACG TGCTCATCGC TCACAACCAA
|
421GTGAGGCAGG TCCCACTGCA GAGGCTGCGG ATTGTGCGAG GCACCCAGCT CTTTGAGGAC
|
481AACTATGCCC TGGCCGTGCT AGACAATGGA GACCCGCTGA ACAATACCAC CCCTGTCACA
|
541GGGGCCTCCC CAGGAGGCCT GCGGGAGCTG CAGCTTCGAA GCCTCACAGA GATCTTGAAA
|
601GGAGGGGTCT TGATCCAGCG GAACCCCCAG CTCTGCTACC AGGACACCAT TTTGTGGAAG
|
661GACATCTTCC ACAAGAACAA CCAGCTGGCT CTCACACTGA TAGACACCAA CCGCTCTCGG
|
721GCCTGCCACC CCTGTTCTCC GATGTGTAAG GGCTCCCGCT GCTGGGGAGA GAGTTCTGAG
|
781GATTGTCAGA GCCTGACGCG CACTGTCTGT GCCGGTGGCT GTGCCCGCTG CAAGGGGCCA
|
841CTGCCCACTG ACTGCTGCCA TGAGCAGTGT GCTGCCGGCT GCACGGGCCC CAAGCACTCT
|
901GACTGCCTGG CCTGCCTCCA CTTCAACCAC AGTGGCATCT GTGAGCTGCA CTGCCCAGCC
|
961CTGGTCACCT ACAACACAGA CACGTTTGAG TCCATGCCCA ATCCCGAGGG CCGGTATACA
|
1021TTCGGCGCCA GCTGTGTGAC TGCCTGTCCC TACAACTACC TTTCTACGGA CGTGGGATCC
|
1081TGCACCCTCG TCTGCCCCCT GCACAACCAA GAGGTGACAG CAGAGGATGG AACACAGCGG
|
1141TGTGAGAAGT GCAGCAAGCC CTGTGCCCGA GTGTGCTATG GTCTGGGCAT GGAGCACTTG
|
1201CGAGAGGTGA GGGCAGTTAC CAGTGCCAAT ATCCAGGAGT TTGCTGGCTG CAAGAAGATC
|
1281TTTGGGAGCC TGGCATTTCT GCCGGAGAGC TTTGATGGGG ACCCAGCCTC CAACACTGCC
|
1321CCGCTCCAGC CAGAGCAGCT CCAAGTGTTT GAGACTCTGG AAGAGATCAC AGGTTACCTA
|
1381TACATCTCAG CATGGCCGGA CAGCCTGCCT GACCTCAGCG TCTTCCAGAA CCTGCAAGTA
|
1441ATCCGGGGAC GAATTCTGCA CAATGGCGCC TACTCGCTGA CCCTGCAAGG GCTGGGCATC
|
1501AGCTGGCTGG GGCTGCGCTC ACTGAGGGAA CTGGGCAGTG GACTGGCCCT CATCCACCAT
|
1561AACACCCACC TCTGCTTCGT GCACACGGTG CCCTGGGACC AGCTCTTTCG GAACCCGCAC
|
1621CAAGCTCTGC TCCACACTGC CAACCGGCCA GAGGACGAGT GTGTGGGCGA GGGCCTGGCC
|
1681TGCCACCAGC TGTGCGCCCG AGGGCACTGC TGGGGTCCAG GGCCCACCCA GTGTGTCAAC
|
1741TGCAGCCAGT TCCTTCGGGG CCAGGAGTGC GTGGAGGAAT GCCGACTACT GCAGGGGCTC
|
1801CCCAGGGAGT ATCTGAATGC CAGGCACTGT TTGCCCTGCC ACCCTGACTG TCAGCCCCAG
|
1861AATGGCTCAG TGACCTGTTT TGGACCGGAG GCTGACCAGT GTGTGGCCTC TCCCCACTAT
|
1921AAGGACCCTC CCTTCTGCGT GGCCCGCTGC CCCAGCGGTG TGAAACCTGA CCTCTCCTAC
|
1981ATGCCCATCT GGAAGTTTCC AGATGACGAG GGCGCATGCC AGCCTTGCCC CATCAACTGC
|
2041ACGCACTCCT GTGTGGACCT GGATGACAAG GGCTGCCCCG CCGAGCAGAG AGCCAGCCCT
|
2101CTGACGTCCA TCGTCTCTGC GGTGCTTGGC ATTCTGCTGG TCGTGGTCTT GGGGGTGGTC
|
2161TTTGGGATCC TCATCAAGCG ACGGCAGCAG AAGATCCCCA ACTACACCAT CCGGACACTG
|
2221CTGCAGCAAA CGGAGCTGGT GGAGCCCCTG ACACCTAGCG GAGCGATGCC CAACCAGGCG
|
2281CAGATGCGCA TCCTGAAAGA GACGGAGCTG ACGAAGGTGA AGGTGCTTGG ATCTGGCGCT
|
2341TTTGGCACAG TCTACAAGCG CATCTGGATC CCTGATCGGC ACAATGTGAA AATTCCAGTG
|
2401GCCATCAAAG TGTTGAGGGA AAACACATCC CCCAAAGCCA ACAAAGAAAT CTTACACGAA
|
2461GCATACGTGA TGGCTGGTGT GGGCTCCCCA TATGTCTCCC GCCTTCTGGG CATCTCCCTC
|
2521ACATCCACGG TGCAGCTGGT GACACAGCTT ATGCCCTATG GCTGCCTCTT ACACCATGTC
|
2581CGGGAAAACC GCGGACGCCT CGGCTCCCAG GACCTGCTGA ACTGGTGTAT GCAGATTGCC
|
2641AAGGGGATGA GCTACCTGGA GGATGTGCGC CTCCTACACA CGGACTTAGC CGCTCGGAAC
|
2701GTCCTGGTCA AGAGTCCCAA CCATGTCAAA ATTACAGACT TCGGGCTGGC TCGGCTGCTG
|
2761GACATTGACG AGACAGAGTA CCATGCAGAT GGGGGCAAGG TGCCCATCAA GTGGATGGCG
|
2821CTGGAGTCCA TTCTCCGCCG GCGGTTCACC CACCAGAGTG ATGTGTGGAG TTATGGTGTG
|
2881ACTGTGTGGG AGCTGATGAC TTTTGGGGCC AAACCTTACG ATGGGATCCC AGCCCGGGAG
|
2941ATCCCTGACC TGCTCGAAAA GGGGGAGCGG CTGCCCCAGC CCCCCATCTG CACCATTGAT
|
3001GTCTACATGA TCATGGTCAA ATGTTGGATG ATTGACTCTG AATGTCGGCC AAGATTCCGG
|
3061GAGTTGGTGT CTGAATTCTC CCGCATGGCC AGGGACCCCC AGCGCTTTGT GGTCATCCAG
|
3121AATGAGGACT TGGGCCCAGC CAGTCCCTTG GACAGCACCT TCTACCGCTC ACTGCTGGAG
|
3181GACGATGACA TGGGGGACCT GGTGGATGCT GAGGAGTATC TGGTACCCCA GCAGGGCTTC
|
3241TTCTGTCCAG ACCCTGCCCC GCGCGCTGGG GGCATGGTCC ACCACAGGCA CCGCAGCTCA
|
3301TCTACCAGGA GTGGCGGTGG GGACCTGACA CTAGGGCTGG AGCCCTCTGA AGAGGAGGCC
|
3361CCCAGGTCTC CACTGGCACC CTCCGAAGGG GCTGGCTCCG ATGTATTTGA TGGTGACCTG
|
3421GGAATGGGGG CAGCCAAGGG GCTGCAAAGC CTCCCCACAC ATGACGCCAG CCCTCTACAG
|
3481CGGTACAGTG AGGACCCCAC AGTACCCCTG CCCTCTGAGA CTGATGGCTA CGTTGCCCCC
|
3541CTGACCTGCA GCCCCCAGCC TGAATATGTG AACCAGCCAG ATGTTCGGCC CCAGCCCCCT
|
3601TCGCCCCGAG AGGGCCCTCT GCCTGCTGCC CGACCTGCTG GTGCCACTCT GGAAAGGGCC
|
3661AAGACTCTCT CCCCAGGGAA GAATGGGGTC GTCAAAGACG TTTTTGCCTT TGGGGGTGCC
|
3721GTGGAGAACC CCGAGTACTT GACACCCCAG GGAGGAGCTG CCCCTCAGCC CCACCCTCCT
|
3781CCTGCCTTCA GCCCAGCCTT CGACAACCTC TATTACTCGG ACCAGGACCC ACCAGAGCGG
|
3841GGGGCTCCAC CCAGCACCTT CAAAGGGACA CCTACGGCAG AGAACCCAGA GTACCTGGGT
|
3901CTGGACGTGC CAGTGTGAAC CAGAAGGCCA AGTCCGCAGA AGCCCTGATC TGTCCTCAGG
|
3961GAGCAGGGAA GGCCTGACTT CTGCTGGCAT CAAGAGGTGG GAGGGCCCTC CGACCACTTC
|
4021CAGGGGAACC TGCCATGCCA GGAACCTGTC CTAAGGAACC TTCCTTCCTG CTTGAGTTCC
|
4081CAGATGGCTG GAAGGGGTCC AGCCTCGTTG GAAGAGGAAC AGCACTGGGG AGTCTTTGTG
|
4141GATTCTGAGG CCCTGCCCAA TGAGACTCTA GGGTCCAGTG GATGCCACAG CCCAGCTTGG
|
4201CCCTTTCCTT CCAGATCCTG GCTACTGAAA GCCTTAGGGA AGCTGGCCTG AGAGGGGAAG
|
4261CGGCCCTAAG GGAGTGTCTA AGAACAAAAG CGACCCATTC AGAGACTGTC CCTGAAACCT
|
4321AGTACTGCCC CCCATGAGGA AGGAACAGCA ATGGTGTCAG TATCCAGGCT TTGTACAGAG
|
4381TGCTTTTCTG TTTAGTTTTT ACTTTTTTTG TTTTGTTTTT TTAAACACGA AATAAAGACC
|
4441CAGGGGAGAA TGGGTGTTGT ATGGGGAGGC AAGTGTGGGG GGTCCTTCTC CACACCCACT
|
4501TTGTCCATTT GCAAATATAT TTTGGAAAAC
|
GENBANK ID: X14798.1
SEQUENCE 1:
MKAAVDLKPTLTIIKTEKVDLELFPSPDMECADVPLLTPSSKEM
|
MSQALKATFSGFTKEQQRLGIFKDPRQWTETHVRDWVMWAVNEFSLKGVDFQKFCMNG
|
AALCALGKDCGLELAPDFVGDILWEHLEILQKEDVKPYQVNGVNPAYFESRYTSDYFI
|
SYGIEHAQCVPPSEFSEPSFITESYQTLHPISSEELLSLKYENDYPSVILRDPLQTDT
|
LQNDYFAIKQEVVTFDNNCMGRTSRGKLGGQDSFESIESYDSCDRLTQSWSSQSSFNS
|
LQRVPSYDSFDSEDYPAALPNHKPKGTFKDYVRDRADLNKDKPVIPAAALAGYTGSGP
|
IQLWQFLLELLTDKSCQSFISWTGDGWEFKLSDPDBVARRWGKRKNKPKMNYEKLSRG
|
LRYYYDKNIIHKTAGKRYVYRFVCDLQSLLGYTPEELHANLDVKPDADE
|
SEQUENCE 2;
MKAAVDLKPTLTIIKTEKVDLELFPSPDMECADVPLLTPSSKEM
|
MSQALKATFSGFTKEQQRLGIPKDFRQWTETHVRDWVNWAVNEFSLKGVDFQKFCMNG
|
AALCALGKDGFLELAPDFVGDILWEHLEILQKEDVKPYQVNGVNPAYPESRYTSDYFI
|
SYGIEHAQCVPPSEFSEPSFITESYQTLHPISSEELLSLKYENDYPSVILRDDLQTDT
|
LQNDYFAIKQEVVTPDNMCNGRTSRGSGPIQLWQFLLELLTDKSCQSFTSWTGDGWEF
|
KLSDPDEVARRNGKRRNKPKNNYEKLSRGLRYYYDKNIIHKTAGKRYVYRFVCDLQSL
|
LGYTPEELHAMLDVKPDADE
|
GENBANK ID: D49547
VERSION D49547.1 GI:710654
MGKDYYQTLGLARGASDEEIKRAYRRQALRYNFDKNKEFGAEEK
|
FKEIAEAYDVLSDPRKREIFDRYGEEGLKGSGPSGCSGGGANGTSFSYTFHGDPRAMF
|
AEFFGGRNPFDTFFGQRNGEEGNDIDDFFSGFPMGMGGFTNVNFGRSRSAQEPARKKQ
|
DPPVTNDLRVSLEEIYSGCTKKMKISHKRLNFDGKSIRNEDKILTIEVKKGWKEGTKI
|
TEPKEGDQTSNNIPADIVFVLKDKPHNIFKRDGSDVIYPARISLREALCGCTVNVPTL
|
DGRTIFVVFKDVIRPGMRRKVPGEGLPLPKTPEKRGDLIIEFEVIFPERIPQTSRTVL
|
EQVLPI
|
GENBANK ID: M11717
VERSION D49547.1 GI:710654
MGKDYYQTLGLARGASDEEIKRAYRRQALRYHPDKNKEPGAEEK
|
FKEIAEAYDVLSDPRKREIFDRYGEEGLKGSGPSCGSGGGANGTSFSYTFHGDPHAMF
|
AEFFGGRNPFDTFFGQRNGEEGNDIDDPFSGFPNGNGGFTNVNFGRSRSAQEPARKKQ
|
DPPVTHDLRVSLEEIYSGCTKKMKISHKRLNPDGKSIRNEDKILTIEVKKGWKEGTKI
|
TFPKEGDQTSNNIFADIVFVLKDKPHNIFKRDGSDVIYFARISLREALCGCTVNVPTL
|
DGRTIPVVFKDVIRPGNRRKVPGEGLFLFKTFEKRGDLIIEFEVIFPERIPQTSRTVL
|
EQVLPI
|
GENBANK ID: X76648
VERSION X76648.1 GI:531404
MAQSFVNCKIQFGKVVVFIKPTCPYCRRAQEILSQLPIKQGLLE
|
FVDITATNHTNEIQDYLQQLTGARTVFRVFIGKDCIGGCSDLVSLQQSGSLLTRLKQI
|
GALQ
|
GENBANK ID: NM_011587.1
VERSION NM_011587.1 GI:6755784
MVWWGSSLLLFTLFLASHVGASVDLTLLANLRITDPQRFFLTCV
|
SGEAGAGRSSDPPLLLSKDDRIVRTIFPGQPLYLARNGSHQVTLRGFSKPSDLVGVFS
|
CVGGAGARRTRVLYVHNSPGAHLFPDKVTHTVNKGDTAVLSAHVHKEKQTDVIWKNNG
|
SYFNTLDWQEADDGRFQLQLQNVQPPSSGIYSATYLSASFLGSAFFRLIVRGCGAGRW
|
GPGCVKDCFGCLHGGVCMDMDGSCVCPPGFTGTRQSQACRSGRFGQSCQSQCPGTAGC
|
RGLTFCLPDPYGCSCGSGWRGSQCQSACAPDHFGADCRLQCQCQNGGTCDRFSGCVCP
|
SGWHGVHCEKSDRIPQILSMATSVSFNIGTMPRINCAAAGNPFPVRGSMKLRKPDGTM
|
LLSTKVIVEPDRTTASFSVFSLTLGDSGFWECRVSTSGGQDSRRFKVNVKVPPVPLTA
|
PRLLAKQSRQLVVSPLVSFSGDGPISSVRLEYRPQDSTIAWSAIVVDPSSNVTLMNLK
|
PKTGYNVRVQLSRPGEGGEGGWGPSALMTTDCPEPLLQFWLSSWNVEGPDRLRVSWSL
|
PSVPLSGDGFLLRLMDGARGQSRRSNISFPQARTALLTGLTPGTHYQLDVRLYHCTLL
|
GPASPPAMVNLPPSGPPAPRELHAQALSDSEIQLMWQHPSAPSGPISKYIVSIQVAGG
|
SGDFQWMDVDRPESTSIIVRGLNASTRYLFRVRASVQGLGDWSNTVSSATLGNGLQSE
|
DPVRESRAASEGLDQQLVLAVVGSVSATCLTILAALLALVCIRRSCLHRRRTFTYQSG
|
SGEETILQFSSGTLTLTRRFKFQFSPLSYFVLEWEDITFSDLIGSGNFGQVIRAMIKK
|
DGLKMNAAIKNLKEYASENDMRDFAGELEVLCKLGBHFNIINLLGACSNRGYLYIAIE
|
YAPYGNLLDFLRKSRVLSTDPAFARSHGTASTLSSRQLLRFASDAANGMQYLSSKQFI
|
HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTNGRLPVRWMAISSLNYSVYTTKS
|
DVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEQPRNCDDEVYSLMRQCWRD
|
RRYERPPFAQIALQLGRMLSARKAYVNMSLFENFTYAGIDATASSA
|
GENBANK ID: NM_002867.1
VERSION NM_002867.1 GI:4506368
MASVTDGKMGVKDASDQNFDYMFKLLIIGNSSVGKTSFLLRYAD
|
DTFTPAFVSTVGIDFKVKTVYRMSKRVKLQIWDTAGQSRYRTITTAYYRGANGFILMY
|
DITNESSFNAVQDWATQIKTYSNDNAQVILVGNKCDMEEERVVPTSKGQLLASQLGFD
|
FFEASAKENISVRQAFSRLVDAICDKMSDSLDTDPSMLGSSKNTRLSDTPPLLQQNCS
|
C
|
GENBANK ID: 027361
NO VERSION DATA
LNENQRLAVERILSGDCRPLPYILEQPPGTQKTVTIIEAVLQVH
|
FALPDSRILVCAPSNSAADLVCLRLHESKVLQPATMVRVGHFTHVFVDEAGQASEPEC
|
LIPLGLMSDISGQIVLAQDPMQLGPVIKSRLAMAYGLNVSFLERLMSRPAYQRDENAF
|
GACGANNPLLVTKLVKNYRSHEALLMLPSRLFYHRELEVCADPTVVTSLLGWEKLPKK
|
GFPLIFHGVRQSEAREGKSPSWFNPAEAVQVLRYCCLLAHSISSQVSASDIGVITPYR
|
KQVEKIRILLRNVDLMDIKVGSVEEFQGQEYLVIIISTVRSNEDRFEDDRYFLGFLSN
|
SKRFNVAITRPKALLIVLGNPHVLVRDPCFGALLEYSITNGVYMGCDLPPALQSLQNC
|
GEGVADPSYPVVPESTGPEKHQEPS
|
GENBANK ID: NM_002752.1
VERSION NM_002752.1 GI:4506096
MSDSKCDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAF
|
DTVLGISVAVIKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQ
|
DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK
|
SDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL
|
VKGCVIFQGTDHIDQMNKVIEDLGTPSAEFMKKLQPTVRNYVENRPKYPGIKFEELFP
|
DWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPP
|
PQIYDAQLEEREHAIEEWKELIYKEVMDWEERSKNGVVKDQPSAQMQQ
|
GENBANK ID: M22262.1
VERSION M22382.1 GI:190126
MLRLPTVFRQMRPVSRVLAPHLTRAYAKDVKFGADARALMLQGV
|
DLLADAVAVTMGPKGRTVIIEQSWGSPKVTKDGVTVAKSIDLKDKYKNIGAKLVQDVA
|
NNTNEEAGDGTTTATVLARSIAKEGFEKISKGANPVEIRRGVMLAVDAVIAELKKQSK
|
PVTTPEEIAQVATISANGDKEIGNIISDAMKKVGRKGVITVKDGKTLNDELEIIEGMK
|
FDRGYISPYFINTSKGQKCEFQDAYVLLSEKKISSIQSIVPALEIANAHRKPLVIIAE
|
DVDGEALSTLVLNRLKVGLQVVAVKAPGF0DNRKNQLKDMAIATGGAVFGEEGLTLNL
|
EDVQPHDLGKVGEVIVTKDDAMLLKQKGDKAQIEKRIQEIIEQLDVTTSEYEKEKLNE
|
RLAKLSDGVAVLKVCGTSDVEVNEKKDRVTDALNATRAAVEEGIVLGGGCALLRCIPA
|
LDSLTPANEDQKIGIEIIKRTLKIPAMTIAKNAGVEGSLIVEKIMQSSSEVGYDAMAG
|
DFVNMVEKGIIDPTKVVRTALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGG
|
GMGGGMF
|
GENBANK ID: U09564.1
DEFINITION HUMAN SERINE KINASE MRNA, COMPLETE CDS.
VERSION U09564.1 GI:507212
MERKVLALQARKKRTKAKKDKAQRKSETQHRGSAPHSESDLPEQ
|
EEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQG
|
KKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH
|
ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDVLHTKCRIIHTDIKPEN
|
ILLSVNEQYIRRLAAEATENQRSGAPPPSGSAVSTAPQPKPADKMSKNKKKKLKKKQK
|
RQAELLEKRMQEIEEMEKESGPGQKRPNKQEESESPVERPLKENPPNKMTQEKLEESS
|
TIGQDQTLMERDTEGGAAEINCNGVIEVINYTQNSNNETLRHKEDLHNANDCDVQNLN
|
QESSFLSLPNGDSSTSQETDSCTPITSEVSDTMVCQSSSTVGQSFSEQHISQLQESIR
|
AEIPCEDEQEQEHNGPLDNKGKSTAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF
|
TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPNSGEEYTRDEDHI
|
ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKNITKLKPNGLFEVLVEKYEWSQEEAA
|
GFTDFLLPMLELIPEKRATAAECLRHPWLNS
|
GENBANK ID: M11507.1
VERSION M11507.1 GI:239515
MMDQARSAFSNLFGGEPLSYTRFSLARQVDGDNSHVEMKLAVDE
|
EENADNNTKANVTKPKRCSGSICYGTIAVIVFFLIGFMIGYLGYCKGVEPKTECERLA
|
GTESPVREEPGEDFPAARRLVWDDLKRKLSEKLDSTDFTSTIKLLNENSYVPREAGSQ
|
KDENLALYVENQFREFKLSKVWRDQHFVKIQVKDSAQNSVIIVDKNGRLVYLVENPGG
|
YVAYSKAATVTGKLVHANFGTKKDFEDLYTPVNGSIVIVRAGKITFAEKVANAESLNA
|
IGVLIYMDQTKFPIVNAELSFFGHAHLGTGDPYTPGFPSFNHTQFPPSRSSGLPNIFV
|
QTISRAAAEKLFGNMEGDCPSDWKTDSTCRMVTSESKNVKLTVSNVLKEIKILNIFGV
|
IKGFVEPDHYVVVGAQRDAWGPGAAKSGVGTALLLKLAQNFSDMVLKDGFQPSRSIIF
|
ASWSAGDFGSVGATENLEGYLSSLHLKAFTYINLDKAVLGTSNFKVSASPLLYTLIEK
|
TMQNVKHPVTGQFLYQDSNNASKVEKLTLDNAAFPFLAYSGIPAVSFCFCEDTDYPYL
|
GTTMDTYKELIERIPELNKVARAAAEVAGQFVIKLTHDVELNLDYERYNSQLLSFVRD
|
LNQYRADTKEMGLSLQWLYSARCDFFRATSRLTTDFGNAEKTDRFVMKKLNDRVMRVE
|
YHFLSFYVSPKESPFRHVFWGSGSHTLPALLENLKLRKQNNGAFNETLFRNQLALATW
|
TIQGAANALSGDVWDIDNEF
|
GENBANK ID: 055017.1
VERSION 055017.1 GI:1297296
MESYHKFDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSA
|
AEIMAVLFFHTMRYKSQDPRNPHNDIRFVLSKGHAAPILYAVWAEAGFLEAELLNLRK
|
ISSDLDGNPVFKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSE
|
GSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQNQNDIYQKRCEAFGWHAIIVDG
|
HSVEELCKAFCQAKHQFTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYS
|
QIQSKKKILATFPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDR
|
IIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNNVSIAVGCATRNRTVPFCSTFAAF
|
FTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSD
|
GVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGA
|
GVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKCRILTVEDHYYEG
|
GIGEAVSSAVVGEFGITVTNLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKA
|
GENEANK ID: X14034.
VERSION X14034.1 GI:35513
MSTTVNVDSLAEYEKSQIKRALELGTVNTVFSFRKSTFERRTVQ
|
VIMETRQVAWSKTADKIEGFLDINEIKEIRPGKNSKDFEPAKAVRQKEDCCFTILYGT
|
QFVLSTLSLAADSKEDAVNWLSGLKILHQEAMNASTPTIIESWLRKQIYSVDQTRRNS
|
ISLRELKTILPLINFKVSSAKFLKDKFVEIGAHKDELSFEQFHLFYKKLNFEQQKSIL
|
DEFKKDSSVFILGNTDRPDASAVYLHDFQRFLIHEQQENWAQDLNKVRERMTKFIDDT
|
MRETAEPFLFVDEFLTYLFSRENSTWDEKYDAVDNQDMNNPLSHYWISSSNNTYLTGD
|
QLRSESSPEAYIRCLRNGCRCIELDCWDGPDGKFVIYHGWTRTTKIKFDDVVQAIKDH
|
AFVTSSFPVILSIEEHCSVEQQRHMAKAFKEVFGDLLLTKPTEASADQLPSPSQLREK
|
IIIKNKKLGFPQDVDVNMEDKKDEHKQQGELYMWDSIDQKNTRHYCAIADAKLSFSDD
|
IEQTNEEEVFQDIFFTELNFGEKWFHKKVEKRTSAEKLLQEYCNETGGKDGTFLVRES
|
ETFPNDYTLSFWRSGRVQNCRIRSTNEGGTLKYYLTDNLRFRRNYALIQHYRETHLPC
|
AEFELRLTDFVFNPNPHESKPWYYDSLSRGEAEDMLNRIPRDGAFLIRKRECSDSYAI
|
TFRARGKVKHCRINRDGRHFVLGTSAYFESLVELVSYYEKHSLYRKNRLRYFVTPELL
|
ERYNTERDINSLYDVSRNYVDPSEINPSMPQRTVKALYDYKAKRSDELSFCRGALIHN
|
VSKEPGGNWKGDYGTRIQQYFFSNYVEDISTADFEELEKQIIEDNPLGSLCRGILDLN
|
TYNVVKAFQGKNQKSFVFILEPKEQ0DPPVEFATDRVEELFEWFQSIREITWKIDSKE
|
NNMKYWEKNQSIAIELSDLVVYCKFTSKTKDNLENPDFREIRSFVETKADSIIRQKPV
|
DLLKYNQKGLTRVYFKQQRVDSSNYDPFRLNLCGSQNVALNFQTADKYNQNNRALFSL
|
NGRTGYVLQFESNRTEKYDPNFFESQRKILMTLTVKVLGARHLPKLGRSIACPFVEVE
|
ICGAEYGNNKFKTTVVNDNGLSPIWAPTQEKVTFEIYDFNLAFLRFVVYEEDNFSDPN
|
FLAHATYPIKAVKSGPRSVFLKNGYSEDIELASLLVFCEMRPVLESEEELYSSCRQLR
|
RRQEELNNQLFLYDTHQNLRNANRDALVKEFSVNENHSSCTRRNATRG
|
GENBANK ID: M27691.1I
VERSION 1627691.1 GI:181038
NTMESGAENQQSCDAAVTEAENQQNTVQAQPQIATLAQVSMPAA
|
HATSSAPTVTLVQLPNGQTVQVHCVIQAAQPSVIQSPQVQTVQISTIAESEDSQESVD
|
SVTDSQKRREILSRRFSYRKILNDLSSDAFGVPRIEEEKSEEETSAFAITTVTVFTPI
|
YQTSSGQYIAITQGGAIQLANNGTDGVQGLQTLTNTNAAATQPGTTILQYAQTTDGQQ
|
ILVPSNQVVVQAASGDVQTYQIRTAPTSTIAPGVVMASSPALPTQPAEEAARKREVRL
|
MKNREAARECRRKKKEYVKCLENRVAVLENQNKTLIEELKALKDLYCHKSD
|
GENBANK ID: 1618391
VERSION 1618391.1 GI:339716
MERRWPLGLGLVLLLCAPLPPGARAKEVTTJIVIDTSKAQGELGWLL
|
DFPKDGWSEQQQILNGTPLYNYQDCPNQGRRDTDNWLRSNWIYRCEEASRVRVELQFT
|
VRDCKSFPGGAGFLGCKETFNLLYNESDQDVCIQLRRPLFQKVTTVAADQSFTIRDLA
|
SGSVKLNVERCSLGRLTRRGLYLAFHNPGACVALVSVRVFYQRCPETLNGLAQFPDTL
|
PGPAGLVEVACTCLPHARASPRFSCAPRNHCSPDGEWLVPVGRCHCEFGYEEGGSGEA
|
CVACPSGSYRNDMDTPHCLTCFQQSTAESEGATICTCESGHYRAFGEGPQVACTGPPS
|
APRNLSFSASGTQLSLRWEPPADTGGRQDVRYSVRCSQCQCTAQDGGPCQPCGVGVHF
|
SPGARALTTPAVEVNGLEFYANYTFNVEAQNGVSGLGSSGHASTSVSISMGNAESLSG
|
LSLRLVKKEPRQLELTWAGSRPRSPGANLTYELHVLNQDEERYQNVLEFRVLLTELQP
|
DTTYIVRVRMLTPLGPGPFSPDNEFRTSPFVSRGLTGGEIVAVIFGLLLGAALLLGIL
|
VFRSRRAQRQRQQRHVTAPPNWIERTSCAEALCGTSRHTRTLHREPWTLPCGWSNFPS
|
RELDFAWLNVDTVIGEGEFGEVYRGTLRLPSQDCKTVAIKTLKDTSPGCQWWNFLREA
|
TIMGQFSNFHILHLECVVTKRKPIMIITEFNENAALDAFLREREDQLVPGQLVAMLQG
|
IASGMNYLSNHNYVNRDLAARNILVNQNLCCKVSDFCLTRLLDDFDGTYETQGGKIPI
|
RWTAPEAIANRIFTTASDVWSFGIVNWEVLSFGDKPYGENSNQEVNKSIEDCYRLPPP
|
VDCPAPLYELMKNCWAYDRARRPNFQKLQAHLEQLLANPNSLRTIANFDPRVTLRLPS
|
LSGSDGIFVRTVSEWLESIRMKRYILHFHSAGLDTMECVLELTAEDLTQNGITLPGHQ
|
KRILCSIQGFKD
|
GENBANK ID: X54079.1
VERSION X54079.1 GI:32477
MTERRVPFSLLRGPSWDPERDWYPHSDLFDQAFGLPRLEEWSQ
|
WLGGSSWFGYVRPLPFAAIESPAVAAFAYSRALSRQLSSGVSEIRHTADRWRVSLDVN
|
HFAFDELTVKTKDGVVEITGKHEERQDEHGYISRCFTRKYTLFPGVDPTQVSSSLSFE
|
GTLTVEAPMPKLATQSNEITTPVTFESRAQLGGPEAAKSDETAAK
|
GENBANK ID: XM_012654.3
VERSION XM_012654.3 GI:14773503
MFGVTLWEMFSGGEEPWACVPPYLILQRLEDFARLPRPPLCSRA
|
LYSLALDCWAPHPSDRPSFSHLEGLLQEAGPSEACCVRDVTEFGALRNETGDPITVIE
|
GSSSFHSPDSTIWKGQNGRTFKVGSWPASAVTLADAGGLPATRPVHRGHPCFGRSTPR
|
KHRWRQKEGKSLGCAFSTGPEEEHAPGEDERNFQESGVSSVPRSSSHRGXVQAPLKXR
|
QARAXAPGTSRFASTPTFIL
|
GENBANK ID: XM_054457.2
VERSION XM_054457.2 GI:18590931
MASATDSRYGQKESSDQNFDYNFKILIIGNSSVGKTSFLFRYAD
|
DSFTPAFVSTVGIDFKVKTIYRNDKRIKLQIWDTAGQERYRTITTAYYRGANGFILMY
|
DITNEESFNAVGDWSTQIKTYSWDNAQVLLVGNKCDMEDERVVSSERGRQLADHLGFE
|
FFEASAKDNINVKQTFERLVDVICEKMSESLDTADPAVTGAKQGPQLSDQQVFPHQDC
|
AC
|
GENBANK ID: XM_038595.3
VERSION XM_038595.3 GI:18590923
MAPPSEETPLIPQRSCSLLSTEAGALEVLLPARGPGPPQRLSFS
|
FGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRI
|
RFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFADHRSDLVSGRLFVGLSLKEQG
|
ECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVR
|
RALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGD
|
GGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPG
|
LPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTG
|
GSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRFHSSL
|
RELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPFTSSLVQPQSQYQL
|
SQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCM
|
ESFLEAASLWSQVSYRHLVLLHGVCMAGDSTWVQEFVHLGAIDMYLRKRGHLVPASWK
|
LQVVKQLAYALNYLEDKGLFHGNVSARKVLLAREGADGSPPFIKLSDFGVSFAVLSLE
|
MLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYED
|
RQQLFAPKWTELALLIQQCMAYEFVQRPSFRAVIRDLNSLISSDYELLSDFTPGALAP
|
RDGLWNGAQLYACQDPTIFEERHLKYISGLGKGNFGSVELCRYDPLGDNTGALVAVKQ
|
LQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL
|
QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK
|
LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRGSDVWSFGVVLYELFTYCDKSCSP
|
SAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF
|
SALGFQLDMLWSGSRGCETHAFTAHFEGKHHSLSFS
|
GENBANK ID: NM_002755.2
VERSION NM_002755.2 GI:14589898
MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDE
|
QQRKRLEAFLTQKQKVGELKDDGFEKISELGAGNGGVVFKVSHKPSGLVMARKLTHLE
|
IKPAIRNQIIRELQVLHECNSFYIVGFYGAFYSDGEISICMEENDGGSLDQVLKKAGR
|
IPEQILGKVSIAVIKGLTYLREKNKIMNRDVKPSNILVNSRGEIKLCDFGVSGQLIDS
|
MANSFVGTRSYMSFERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPFDAKELELMFG
|
CQVEGDAAETPPRFRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPFPKLPSGVFSLEF
|
QDFVNKCLIKNPAERADLKQLMVRAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAG
|
V
|
GENBANK ID: NM_001744.1
VERSION NM_001744.1 GI:4502556
MLKVTVFSCSASSCSSVTASAAPGTASLVPDYWIDGSNRDALSD
|
FFEVESELGRGATSIVYRCKQKQTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNII
|
KLKEIFETFTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI
|
VHRDLKFENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY
|
GPEVDMWSVGIITYILLCCFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL
|
VRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAVKAVV
|
ASSRLCSASSSHGSIQESRKASRDPSPIQDGNEDMKAIPEGEKIQGDGAQAAVKGAQA
|
ELMKVQALEKVKGADINAEEAPKMVPKAVEDGIKVADLELEECLAEEKLKTVEEAAAP
|
REGQGSSAVGFEVPQQDVILPEY
|
GENBANK ID: XM_053461.2
VERSION XM_053461.2 GI:13553657
MASRGATRPNGPNTGNKICQFKLVLLGESAVGKSSLVLRFVKGQ
|
FHEFQESTGAAFLTQTVCLDDTTVKFEIWDTAGQERYEHSLAPMYYRGAQAAIVVYDI
|
TNEESFARAKNMVKELQRQASPNIVIALSGNKADLANKRAVDFQEAQSYADDNSLLFM
|
ETSAKTSMNVNEIFMAIAKKLPKNEPQNPGANSARGRGVDLTEPTQPTRNQCCSN
|
GENBANK ID: U33635.1
VERSION U33635.1 GI:1016701
MGAARGSPARPRRLPLLSVLLLPLLGGTQTAIVFIKQPSSQDAL
|
QGRRALLRCEVEAPGPVHVYWLLDGAPVQDTERRFAQGSSLSFAAVDPLQDSGTFQCV
|
ARDDVTGEEARSANASFNIKWIEAGPVVLKHPASEAEIQPQTQVKLRCHIDGMPRFTY
|
QWFRDGTPLSDGQSNHTVSSKERNLTLRPAGPEHSGLYSCCAHSAFSQACSSQNFTLS
|
IADESFARVVLAPQDVVVARYEEAMFHCQFSAQPPPSLQWLFEDETPITNRSRPPHLR
|
RATVFANGSLLLTQVRPRNAGIYRCIGQGQRGPPIILEATLHLAEIEDMPLFEPRVFT
|
AGSEERVTCLPPKGLFEPSVWWEHAGVRLFTHGRVYQKGHELVLANIAESDAGVYTCH
|
AANLAGQRRQDVNITVATVPSWLKKPQDSQLEECKPGYLDCLTQATPKFTVVWYRNQM
|
LISEDSRFEVFKNGTLRINSVEVYDGTWYRCMSSTPAGSIEAQAVLQVLEKLKFTPPP
|
QPQQCMGFDKEATVFCSATGREKPTIKWERADGSSLPEWVPDNAGTLHFARVTRDDAG
|
NYTCIASNGPQGQIRAHVQLTVAVFITFKVEPERITVYQGHTALLQCEAQGDPKPLIQ
|
WKGKDRILDPTKLGPRMHIFQNCSLVIHDVAPEDSGRYTCIAGNSCNIKHTEAPLYVV
|
DKPVPEESEGPGSPPPYKMIQTIGLSVGAAVAYIIAVLGLMFYCKKRCKAKRLQKQPE
|
GEEPEMECLNGGPLQNGQPSAEIQEEVALTSLGSGPAATNKRHSTSDKMHFPRSSLQP
|
ITTLGKSEFGEVFLAKAQGLEEGVAETLVLVKSLQSKDEQQQLDFRRELEMFGKLNHA
|
NVVRLLGLCREAEPHYMVLEYVDLEDLKQFLRISKSKDEKLKSQPLSIKQKVALCTQV
|
ALGMEHLSNNRFVNKDLAARNCLVSAQRQVKVSALGLSKDVYNSEYYHFRQANVALRW
|
MSPEAILEGDFSTKSDVNASGVLMWEVFTHGEMPHGGQADDEVLADLQAGKARLFQPE
|
GCPSKLYRLMQRCWALSPKDRPSESEIASALGDSTVDSKP
|
GENBANK ID: XM_004559.5
VERSION XM_004559.5 GI:17464405
MGPEALSSLLLLLLVASGDADMKGHFDPAKCRYALGMQDRTIPD
|
SDISASSSNSDSTAARHSRLESSSDGDGAWCPAGSVFPKEEEYLQVDLQRLHLVALGT
|
QGRHAGGLGKEFSRSYRLRYSRDGRRWMGWKDRWGQEVIS0NEDFEGVVLKDLGPPMV
|
ARLVRFYFRADRVMSVCLRVELYGCLWRDGLLSYTAPVGQTNYLSEAVYLNDSTYDGH
|
TVGGLQYGGLGQLADGVVGLDDFRKSQELRVWPGYDYVGWSNHSFSSGYVEMEFEFDR
|
LRAFQAMQVHCNNMHTLGARLPGGVECRFRRGFAMAWEGEPMRHNLGGNLGDPRARAV
|
SVPLGGRVARFLQCRFLFACPNLLFSEISFISDVVNNSSPALGGTFPPAPNNPPGPPP
|
TNFSSLELEPRGQQPVAKAEGSPTAILIGCINAIILLLLLIIALMLWRLHWRRLLSKA
|
ERRVLEEELTVHLSVPGDTILINNRPGPREPPPYQEPRPRGNFPHSAPCVPNGSALLL
|
SNPAYRLLLATYARPPRGPGFPTPAWAKPTNTQAYSGDYMEPEKPGAPLLFPPFQNSV
|
PEYAEADIVTLQCVTGGNTYAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEV
|
HLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKINSRLKDP
|
NIIRLLGVCVQDDPLCMITDYMENGDLNQELSAHQLEDKAAEGAPGDGQAAQGPTISY
|
PMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIAGFGMSRNLYAGDYYR
|
VQGRAVLPIRWMAWECILNGKFTTASDVWAFGVTLWEVLMLCRAQPEGQLTDEQVIEN
|
AGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV
|
GENBANK ID: M28212.1
VERSION M28212.1 GI:550071
/GENE=“RAB6”
CDS 71..697
/CODON_START=1
1AGCTGGCTGG AGCAGGATCG GTCCGGGACG GTCICTAGGC TGAGGCGGCG GCCGCTCCTC
|
61TAGTTCCACA ATGTCCACGC GGGGAGACTT CGCGAATCCG CTGACGAAAT TCAAGCTGGT
|
121GTTCCTGGGG GAGCAAAGCG TTGGAAAGAC ATCTTTGATC ACCAGATTCA TGTATGACAG
|
181TTTTGACAAC ACCTATCAGG CAACAATTGG CATTGACTTT TTATCAAAAA CTATGTACTT
|
241GGAGGATCGA ACAGTACGAT TGCAATTATG GGACACACCA GGTCAAGAGC GGTTCAGGAG
|
301CTTGATTCCT AGCTACATTC GTGACTCCAC TGTGGCAGTT GTTGTTTATG ATATCACAAA
|
361TGTTAACTCA TTCCAGCAAA CTACAAAGTG GATTGATGAT GTCAGAACAG AAAGAGGAAG
|
421TGATGTTATC ATCATGCTAG TAGGAAATAA AACAGATCTT GCTGACAAGA GGCAAGTGTC
|
481AATTGAGGAG GGAGAGAGGA AAGCCAAAGA GCTGAATGTT ATGTTTATTG AAACTAGTGC
|
541AAAAGCTGGA TACAATGTAA AGCAGCTCTT TCGACGTGTA GCAGCAGCTT TGCCGGGAAT
|
601GGAAAGCACA CAGGACAGAA GCAGAGAAGA TATGATTGAC ATAAAACTGG AAAAGCCTCA
|
661GGAGCAACCA GTCAGTGAAG GAGGCTGTTC CTGCTAATGT CCCTAGTCAT CTTCAACCTT
|
721CTTCAGAAGC TCACTGCTTT
|
GENBANK ID: M65066.1
VERSION M65066.1 GI:307376
/GENE=“PRKAR1B”
CDS <1..1144
/CODON_START=2
1GGCCTCCCCG CCCGCCTGCC CCTCGGAGGA GGACCAGAGC CTGAAGGGCT GTGAGCTGTA
|
61CGTGCAGCTG CACGGGATCC AGCAGGTCCT CAAAGACTGT ATCGTCCACC TCTGCATCTC
|
121CAAGCCCGAA CGCCCCATGA AGTTCCTCCG GGAGCACTTC GAGAAGCTGG AGAAGGAAGA
|
181AAACAGGCAG ATTTTGGCGC GGCAAAAGTC AAACTCACAG TCGGACTCCC ATGATGAGGA
|
241GGTGTCGCCC ACCCCCCCGA ACCCTGTGGT GAAGGCCCGC CGCCGGCGAG GAGGCGTGAG
|
301TGCCGAGGTG TACACCGAGG AGGACGCCGT GTCCTACGTC AGGAAGGTGA TTCCCAAGGA
|
361CTACAAAACC ATGACTGCGC TGGCCAAGGC CATCTCCAAG AACGTGCTCT TCGCTCACCT
|
421GGATGACAAC GAGAGGAGTG ACATATTCGA TGCCATGTTC CCTGTCACTC ACATCGCTGG
|
481GGAGACTGTT ATACAGCAAG GGAATGAAGG AGACAACTTC TATGTCGTTG ATCAAGGGGA
|
541AGTGGATGTG TACGTGAACG GAGAGTGGGT GACCAACATC AGCGAGGGAG GCAGCTTCGG
|
601GGAGCTGGCG CTCATCTACG GCACCCCCAG GGCTGCGACC GTGAAAGCCA AGACGGACCT
|
661CAAGCTCTGG GGGATCGACC CGGACAGCTA CCGGCGCATC CTTATGGGCA GCACGCTGAG
|
721GAAACGCAAG ATGTACGAGG AGTTCCTCAG CAAGGTCTCC ATCCTAGAGT CCCTGGAGAA
|
781GTGGGAGCGT CTGACCGTGG CGGATCGGCT GGAGCCCGTC CAGTTTGAAG ATGGAGAGAA
|
841AATTGTGGTC CAGGGAGAGC CTCGGGACCA CTTTTACATC ATCACGGAGG GCACCGCGTC
|
901CGTGCTGCAG CGCCGGTCCC CCAATGAGGA CTACCTCGAG GTGGGGCGCC TGGGACCCTC
|
961TGACTACTTC GCGGAGATTC CACTCCTCCT GAACCGGCCC CGGGCGGCCA CTGTCGTGGC
|
1021CCGGGGGCCC CTCAAGTGTG TGAAGCTGGA CCGGCCCCGC TTCGAGCGTG TGCTGGGGCC
|
1081CTGCTCTGAG ATCCTCAAGA GGAACATTCA GCGTTACAAC AGCTTCATCT CCCTCACCGT
|
1141CTGAGCACAC GTCCCGCCCT GCAGCCCCAG CTCCCCAGTG TGGTGGCCGT GCCTGCTCGT
|
1201CTGTGTCGGG GGCCCGGGAG CCGCTGTGTG AGGIGIGGCC CGGGTGGGGC TGGGTCCCGG
|
1261CAGCGTGAGG ACTGCCCCTT CCCCGGACTC ACTTTTTGGA ATAAATGATC ACCTTCTCCA
|
1321TTTCCAAATC AAAGGACAAG CGGACAAAAT GCATCCCAAG ATCAAGGAAG GGACAGCCCA
|
1381GCTTCCTCCC CACACGCCTC CCCGGCTGCC TCTGTGGGCT TCTCCTGGGG GGCCCACCCC
|
1441ACCCCTGCCA GTCTCCTGGA GATGCTTGAG GATCGGTCCT CCCCAGAAGC AGGCCAGGAC
|
1501GTTGCCCCTG GCGGCTGGTG ACCCTGTGAG GTCAGGTCCC CCAGATTGAG GTCTGAGTGT
|
1561GGGCAAGTGT GTCAAAAGGG GCTGCCCCCC AGGAGATGAG GCTGAGAGCA GGGAGTTGAG
|
1621GCCGAAGAAG TCAAGGCCCC TCCCGCAAAT GTGTACCCCT GCCCGCGCCA CTGCACCCCG
|
1681CCGCACCCCC ACCTCCCCGG GGGCCCTGCT GCGGATCGCG GACTGGGAGA GTCTCTGAGC
|
1741TATGAGATTG ATCTTGCCCC TAATTGGAGA GGAAGCCGGG CGCCAAGACA CACGGGGCTC
|
1801CTGCCTTGGG AGCCAGGGCC GCGGCCGCAG GTAGACCCCA GTAGGGGGGG CCGGGCTCGA
|
1861AGTTCCTTTG GGAGGGGCTG GCCGGACTCC AGCAGGCCCT CCTCACCTTT CTTAGAAAGT
|
1921CCACCCAGGG CAAGTTGATG TTGGGGGAAA GCAGAAGTCA AGCCAGCCGC GGCCCCACAC
|
1981GCCCCCACCC GCTCAACCGA CTTGTCCCTT AAATGTGTCT TGGATCCCGC AGTGATGACG
|
2041TGAGCCAGCC AGGCCCGAAA AGGTGAGGCC ACTGCAGAGA AGCTTCCCAG GGGATTCCTG
|
2101GTTCCCCCGA AACACAAGCG AGGTCATTGC AGTTCACCCG ATGTTGCTCC TGTCCCGTGC
|
2161GTCCCCGGGA GGCTGTCCTT GGTCCGCATG GCTCGTTGCA GCCCCTCCCC TGCTGGCGGT
|
2221TACGATGCGT GGGGTCCCCC TCCCCACCCA GCCCCGGCAC CGTCGCCGTG TCCCGCCTGT
|
2281GCCTGTGACG TCCCTGTGGA CCTGTGAGCC ATCCCCCCCT TATCTCTGCT CTGAATACTG
|
2341CATGAAGCAT TAAACGTGCA ATGAAG
|
GENBANK ID: U04897.1
VERSION U04897.1 GI:451563
CDS 102..1673
/CODON_START=1
1GTTTTTTTTT TTTTTTTGGT ACCATAGAGT TGCTCTGAAA ACAGAAGATA GAGGGAGTCT
|
61CGGAGCTCGC ATCTCCAGCG ATCTCTACAT TGGGAAAAAA CATGGAGTCA GCTCCGGCAG
|
121CCCCCGACCC CGCCGCCAGC GAGCCAGGCA GCAGCGGCGC GGACGCGGCC GCCGGCTCCA
|
181GGGAGACCCC GCTGAACCAG GAATCCGCCC GCAAGAGCGA GCCGCCTGCC CCGGTGCGCA
|
241GACAGAGCTA TTCCAGCACC ACCAGAGGTA TCTCAGTAAC GAAGAAGACA CATACATCTC
|
301AAATTGAAAT TATTCCATGC AAGATCTGTG GAGACAAATC ATCAGGAATC CATTATGGTG
|
361TCATTACATG TGAAGGCTGC AAGGGCTTTT TCAGGAGAAG TCAGCAAAGC AATGCCACCT
|
421ACTCCTGTCC TCGTCAGAAG AACTGTTTGA TTGATCGAAC CAGTAGAAAC CGCTGCCAAC
|
481ACTGTCGATT ACAGAAATGC CTTGCCCTAG GGATGTCTCG AGATGCTGTA AAATTTGGCC
|
541GAATGTCAAA AAAGCAGAGA GACAGCTTGT ATGCAGAAGT ACAGAAACAC CGGATGCAGC
|
601AGCAGCAGCG CGACCACCAG CAGCAGCCTG GAGAGGCTGA GCCGCTGACG CCCACCTACA
|
661ACATCTCGGC CAACGGGCTC ACGGAACTTC ACGACGACCT CAGTAACTAC ATTGACGGGC
|
721ACACCCCTGA GGGGAGTAAG GCACACTCCG CCGTCAGCAG CTTCTACCTG GACATACAGC
|
781CTTCCCCAGA CCAGTCAGGT CTTGATATCA ATGGAATCAA ACCAGAACCA ATATGTGACT
|
841ACACACCAGC ATCAGGCTTC TTTCCCTACT GTTCCTTCAC CAACGGCGAG ACTTCCCCAA
|
901CTGTGTCCAT GGCAGAATTA GAACACCTTG CACAGAATAT ATCTAAATCG CATCTGGAAA
|
961CCTGCCAATA CTTGAGAGAA GAGCTCCAGC AGATAACGTG GCAGACCTTT TTACAGGAAG
|
1021AAATTGAGAA CTATCAAAAC AAGCAGCGGG AGGTGATGTG GCAATTGTGT GCCATCAAAA
|
1081TTACAGAAGC TATACAGTAT GTGGTGGAGT TTGCCAAACG CATTGATGGA TTTATGGAAC
|
1141TGTGTCAAAA TGATCAAATT GTGCTTCTAA AAGCAGGTTC TCTAGAGGTG GTGTTTATCA
|
1201GAATGTGCCG TGCCTTTGAC TCTCAGAACA ACACCGTGTA CTTTGATGGG AAGTATGCCA
|
1261GCCCCGACGT CTTCAAATCC TTAGGTTGTG AAGACTTTAT TAGCTTTCTG TTTGAATTTG
|
1321GAAAGAGTTT ATCTTCTATG CACCTGACTG AAGATGAAAT TGCATTATTT TCTGCATTTG
|
1381TACTGATGTC AGCAGATCGC TCATGGCTGC AAGAAAAGGT AAAAATTGAA AAACTGCAAC
|
1441AGAAAATTCA GCTAGCTCTT CAACACGTCC TACAGAAGAA TCACCGAGAA GATGGAATAC
|
1501TAACAAAGTT AATATGCAAG GTGTCTACAT TAAGAGCCTT ATGTGGACCA CATACAGAAA
|
1561AGCTAATGGC ATTTAAAGCA ATATACCCAG ACATTGTGCG ACTTCATTTT CCTCCATTAT
|
1621ACAAGGAGTT GTTCACTTCA GAATTTGAGC CAGCAATGCA AATTGATGGG TAAATGTTAT
|
1681CACCTAAGCA CTTCTAGAAT GTCTGAAGTA CAAACATGAA AAACAAACAA AAAAATTAAC
|
1741CGAGACACTT TATATGGCCC TGCACAGACC TGGAGCGCCA CACACTGCAC ATCTTTTGGT
|
1801GATCGGGGTC AGGCAAAGGA GGGGAAACAA TGAAAACAAA TAAAGTTGAA CTTGTTTTTC
|
1861TCA
|
GENBANK ID: P53667
DBEST ID: 1741245
EST NAME: AN07C08.S1
ACTGGGCTCCCCGGTCTCCCATCGCAAGGACCTGGGTCGCTCTGAGTCCCTCCGCGTAGT
|
CTGCCGGCCACACCGCATCTTCCGGCCGTCGTATCTCATCCACGGTGAGGTGCTGGGCAA
|
GGGCTGCTTCGGCTATGCTATCAATGTGACATACTGTGAGACAGGTGATGTGATGGTGAT
|
GAAGGAGCTGATCCGGTTCGACGAGGAGACCCAGAGGACGTTCCTCAACGAGGTGAATGT
|
CATT
|
GENBANK ID: NM_002737.1
VERSION NM_002737.1 GI:4506066
CDS 28..2046
1GGAGCAAGAG GTGGTTGGGG GGGGACCATG GCTGACGTTT TCCCGGGCAA CGACTCCACG
|
61GCGTCTCAGC ACGTGGCCAA CCGCTTCGCC CCCAAACGCG CGCTGAGGCA GAAGAACGTG
|
121CACGAGGTGA AGGACCACAA ATTCATCGCG CGCTTCTTCA AGCAGCCCAC CTTCTCCAGC
|
181CACTGCACCG ACTTCATCTG GGGGTTTGGG AAACAAGGCT TCCAGTGCCA AGTTTGCTGT
|
241TTTGTGGTCC ACAAGAGCTG CCATGAATTT CTTACTTTTT CTTGTCCGGC TGCGGATAAG
|
301GGACCCGACA CTGATGACCC CAGGAGCAAC CACAAGTTCA AAATCCACAC TTACGCAAGC
|
361CCCACCTTCT GCGATCACTC TGGGTCACTG CTCTATGGAC TTATCCATCA AGCGATGAAA
|
421TCTGACACCT GCGATATGAA CGTTCACAAC CAATGCGTCA TCAATGTCCC CACCGTGTGC
|
481GCAATCGATC ACACTGAGAA GAGGGCGCGG ATTTACCTAA AGGCTGAGCT TGCTGATCAA
|
541AAGCTCCATG TCACAGTACG ACATGCAAAA AATCTAATCC CTATGGATCC AAACGGCCTT
|
601TCAGATCCTT ATGTGAAGCT GAAACTTATT CCTGATCCCA AGAATGAAAG CAACCAAAAA
|
661ACCAAAACCA TCCGCTCCAC ACTAAATCCG CAGTGCAATG ACTCCTTTAC ATTCAAATTG
|
721AAACCTTCAG ACAAAGACCG ACGACTGTCT GTACAAATCT GCGACTGCGA TCGAACAACA
|
781AGGAATCACT TCATGGGATC CCTTTCCTTT GGAGTTTCGC ACCTGATGAA GATCCCGGCC
|
841AGTGGATGGT ACAAGTTCCT TAACCAACAA GAACGTGAGT ACTACAACGT ACCCATTCCC
|
901GAACGGGACG AGGAAGGAAA CATCGAACTC ACGCAGAAAT TCGAGAAACC CAAACTTCCC
|
961CCTGCTGCCA ACAAAGTCAT CAGTCCCTCT GAAGACAGGA AACAACCTTC CAACAACCTT
|
1021GACCGAGTGA AACTCACGGA CTTCAATTTC CTCATGGTGT TGGGAAACGC CAGTTTTCCA
|
1081AAGGTCATGC TTGCC3ACAG GAAGGGCACA GAACAACTGT ATGCAATCAA AATCCTGAAG
|
1141AACGATGTGG TGATTCAGCA TGATGACGTG GAGTGCACCA TGGTAGAAAA GCGACTCTTC
|
1201GCCCTGCTTG ACAAACCCCC GTTCTTGACC CAGCTGCACT CCTCCTTCCA GACAGTGGAT
|
2261CGGCTCTACT TCGTCATGGA ATATGTCAAC GGTGGGGACC TCATGTACCA CATTCAGCAA
|
1321GTAGGA~AAT TTAAGGAACC ACAAGCAGTA TTCTATGCGC CAGAGATTTC CATCGGATTG
|
1381TTCTTTCTTC ATAAAAGAGG AATCATTTAT AGGGATCTCA ACTTACATAA CGTCATGTTG
|
1441GATTCAGAAG GACATATCAA AATTGCTGAC TTTGGGATGT GCAAGGAACA CATGATGGAT
|
1501GGAGTCACGA CCAGGACCTT CTGTGCGACT CCACATTATA TCGCCCCAGA GATAATCCCT
|
1561TATCAGCCGT ATGGAAAATC TGTGGACTGG TGGGCCTATC CCGTCCTGTT GTATGAAATG
|
1621CTTGCCGCGC AGCCTCCATT TGATGGTCAA GATGAAGACG AGCTATTTCA GTCTATCATG
|
1681GAGCACAACG TTTCCTATCC AAAATCCTTG TCCAAGCAGC CTGTTTCTAT CTGCAAAGGA
|
1741CTGATGACCA AACACCCAGC CAAGCGCCTG GGCTGTGGGC CTGAGGGGGA GAGGGACGTG
|
1801AGAGAGCATG CCTTCTTCCG GAGGATCGAC TGGGAAAAAC TGGAGAACAG GGAGATCGAG
|
1861CCACCATTCA AGCCCAAAGT GTGTGGCAAA GGACCACAGA ACTTTGACAA GTTCTTCACA
|
1921CGAGGACAGC CCGTCTTAAC ACCACCTGAT CAGCTGGTTA TTGCTAACAT AGACCAGTCT
|
1981GATTTTGAAG GGTTCTCGTA TGTCAACCCC CAGTTTGTGC ACCCCATCTT ACAGACTGCA
|
2041GTATGAAACT CACCAGCGAG AACAAACACC TCCCCAGCCC CCAGCCCTCC CCGCAGTGGA
|
2101AGTGAATCCT TAACCCTAAA ATTTTAAGGC CACGGCTTGT GTCTGATTCC ATATGGAGGC
|
2161CTGAAAATTG TAGGGTTATT AGTCCAAATG TGATCAACTG TTCAGGGTCT CTCTCTTACA
|
2221ACCAAGAACA TTATCTTAGT GGAAG
|
GENBANK ID: M16038.1
VERSION M16038.1 GI:187268
MGCIKSKGKDSLSDDGVDLKTQPVRNTERTIYVRDPTSNKQQRP
|
VPESQLLPGQRFQTKDPEEQGDIVVALYPYDGIHPDDLSFKKGEKMKVLEEHGEWWKA
|
KSLLTKKEGFIPSNYVAKLNTLETEEWFFKDITRKDAERQLLAPGNSAGAFLIRESET
|
LKGSFSLSVRDFDPVHGDVIKHYKIRSLDNGGYYISPRITFPCISDMIKHYQKQADGL
|
CRRLEKACISPKPQKPWDRDANEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKT
|
LKPGTNSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSD
|
EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI
|
EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNA
|
DVMTALSQGYRMPRVENCPDELYDIMKNCWKEKAEERPTFDYLQSVLDDFYTATEGQY
|
QQQP
|
GENBANK ID: 012128.1
VERSION 012128.1 GI:557287
CDS 218..7690
/GENE=“PTP1E”
/CODON_START=1
1CTGATTATGA AGTGCCTCAG AGCCAACCTA TTAAGCTTGG AGATCATCTC AACAGCATAC
|
61TGCTTGGAAT GTGTGAGGAT GTTAITTACG CTCGAGTTTC TGTICGGACT GTGCTGGATG
|
121CTTGCAGTGC CCACATTAGG AATAGCAATT GTGCACCCTC ATTTTCCTAC GTGAAACACT
|
181TGGTAAAACT GGTICTGGGA AATCTTTCTG GGGTAATATG CACGTGTCAC TAGCTGAGGC
|
241CCTGGAGGTT CGGGGTGGAC CACTTCAGGA GGAAGAAATA TGGGCTGTAT TAAATCAAAG
|
301TGCTGAAAGT CTCCAAGAAT TATTCAGAAA AGTAAGCCTA GCTGATCCTG CTGCCCTTGG
|
361CTTCATCATT TCTCCATGGT CTCTGCTGTT GCTGCCATCT GGTAGTGTGT CATTTACAGA
|
421TGAAAATATT TCCAATCAGG ATCTTCCAGC ATTCACTGCA CCAGAGGTTC TTCAAAATCA
|
481GTCACTAACT TCTCTCTCAG ATGTTGAAAA GATCCACATT TATTCTCTTG GAATGACACT
|
541GTATTGGGGG GGTGATTATG AAGTGCCTCA GAGCCAACCT ATTAAGCTTG GAGATCATCT
|
603CAACAGCATA CTGCTTGGAA TGTGTGAGGA TGTTATTTAC GCTCGAGTTT CTGTTCGGAC
|
661TGTGCTGGAT GCTTGCAGTG CCCACATTAG GAATAGCAAT TGTGCACCCT CATTTTCCTA
|
721CGTGAAACAC TTGGTAAAAC TGGTTCTGGG AAATCTTTCT GCGACAGATG AGCTTTCCTG
|
781TAACAGTGAA CAAAAGCCTG ATCGAAGCCA GGCTATTCGA GATCGATTGC GAGGAAAAGG
|
841ATTACCAACA GGAAGAAGCT CTAGTTCTGA TGTACTAGAC ATACAAAAGC CTCCACTCTC
|
901TCATCAGACC TTTCTTAACA AAGGGCTTAG TAAATCTATG GGATTTCTGT CCATCAAAGA
|
961TACACAAGAT GAGAATTATT TCAAGGACAT TTTATCAGAT AATTCTGGAC GTGAAGATTC
|
1021TGAAAATACA TTCTCCCCTT ACCAGTTCAA AACTAGTGGC CCAGAAAAAA AACCCATCCC
|
1081TGGCATTGAT GTGCTTTCTA AGAAGAAGAT CTGGGCTTCA TCCATGGACT TGCTTTGTAC
|
1141AGCTGACAGA GACTTCTCTT CAGGAGAGAC TGCCACATAT CGTCGTTGTC ACCCTGAGGC
|
1201AGTAACAGTG CGGACTTCAA CTACTCCTAG AAAAAAGGAG GCAAGATACT CAGATGGAAG
|
1261TATAGCCTTG GATATCTTTG GCCCTCAGAA AATGGATCCA ATATATCACA CTCGAGAATT
|
1321GCCCACCTCC TCAGCAATAT CAAGTGCTTT CGACCGAATC CGAGAGAGAC AAAAGAAACT
|
1381TCAGGTTCTG AGGGAAGCCA TGAATGTAGA AGAACCAGTT CGAAGATACA AAACTTATCA
|
1441TGGTGATGTC TTTAGTACCT CCAGTGAAAG TCCATCTATT ATTTCCTCTG AATCAGATTT
|
1501CAGACAAGTG AGAAGAAGTG AAGCCTCAAA GAGGTTTGAA TCCAGCAGTG GTCTCCCAGG
|
1561GGTAGATGAA ACCTTAAGTC AAGGCCAGTC ACAGAGACGG AGCAGACAAT ATGAAACACC
|
1621CTTTGAAGGC AACTTAATTA ATCAAGAGAT CATGCTAAAA CGGCAAGAGG AAGAACTGAT
|
1681GCAGCTACAA GCCAAAATGG CCCTTAGACA GTCTCGGTTG AGCCTATATC CAGGAGACAC
|
1741AATCAAAGCG TCCATGCTTG ACATCACCAG GGATCCGTTA AGAGAAATTG CCCTAGAAAC
|
1801AGCCATGACT CAAAGAAAAC TGAGGAATTT CTTTGGCCCT GAGTTTGTGA AAATGACAAT
|
1861TGAACCATTT ATATCTTTGG ATTTGCCACG GTCTATTCTT ACTAAGAAAG GGAAGAATGA
|
1921GGATAACCGA AGGAAAGTAA ACATAATGCT TCTGAACGGG CAAAGACTGG AACTGACCTG
|
1981TGATACCAAA ACTATATGTA AAGATGTGTT TGATATGGTT GTGGCACATA TTGGCTTAGT
|
2041AGAGCATCAT TTGTTTGCTT TAGCTACCCT CAAAGATAAT GAATATTTCT TTGTTGATCC
|
2101TGACTTAAAA TTAACCAAAG TGGCCCCAGA GGGATGGAAA GAAGAACCAA AGAAAAAGAC
|
2161CAAAGCCACT GTTAATTTTA CTTTGTTTTT CAGAATTAAA TTTTTTATGG ATGATGTTAG
|
2221TCTAATACAA CATACTCTGA CGTGTCATCA GTATTACCTT CAGCTTCGAA AAGATATTTT
|
2281GGAGGAAAGG ATGCACTGTG ATGATGAGAC TTCCTTATTG CTGGCATCCT TGGCTCTCCA
|
2341GGCTGAGTAT GGAGATTATC AACCAGAGGT TCATGGTGTG TCTTACTTTA GAATGGAGCA
|
2401CTATTTGCCC GCCAGAGTGA TGGAGAAACT TGATTTATCC TATATCAAAG AAGAGTTACC
|
2461CAAATTGCAT AATACCTATG TGGGAGCTTC TGAAAAAGAG ACAGAGTTAG AATTTTTAAA
|
2521GGTCTGCCAA AGACTGACAG AATATGGAGT TCATTTTCAC CGAGTGCACC CTGAGAAGAA
|
2581GTCACAAACA GGAATATTGC TTGGAGTCTG TTCTAAAGGT GTCCTTGTGT TTGAAGTTCA
|
2641CAATGGAGTG CGCACATTGG TCCTTCGCTT TCCATGGAGG GAAACCAAGA AAATATCTTT
|
2701TTCTAAAAAG AAAATCACAT TGCAAAATAC ATCAGATGGA ATAAAACATG GCTTCCAGAC
|
2761AGACAACAGT AAGATATGCC AGTACCTGCT GCACCTCTGC TCTTACCAGC ATAAGTTCCA
|
2821GCTACAGATG AGAGCAAGAC AGAGCAACCA AGATGCCCAA GATATTGAGA GAGCTTCGTT
|
2881TAGGAGCCTG AATCTCCAAG CAGAGTCTGT TAGAGGATTT AATATGGGAC GAGCAATCAG
|
2941CACTGGCAGT CTGGCCAGCA GCACCCTCAA CAAACTTGCT GTTCGACCTT TATCAGTTCA
|
3001AGCTGAGATT CTGAAGAGGC TATCCTGCTC AGAGCTGTCG CTTTACCAGC CATTGCAAAA
|
3061CAGTTCAAAA GAGAAGAATG ACAAAGCTTC ATGGGAGGAA AAGCCTAGAG AGATGAGTAA
|
3121ATCATACCAT GATCTCAGTC AGGCCTCTCT CTATCCACAT CGGAAAAATG TCATTGTTAA
|
3181CATGGAACCC CCACCACAAA CCGTTGCAGA GTTGGTGGGA AAACCTTCTC ACCAGATGTC
|
3241AAGATCTGAT GCAGAATCTT TGGCAGGAGT GACAAAACTT AATAATTCAA AGTCTGTTGC
|
3301GAGTTTAAAT AGAAGTCCTG AAAGGAGGAA ACATGAATCA GACTCCTCAT CCATTGAAGA
|
3361CCCTGGGCAA GCATATGTTC TAGGAATGAC TATGCATAGT TCTGGAAACT CTTCATCCCA
|
3421AGTACCCTTA AAAGAAAATG ATGTGCTACA CAAAAGATGG AGCATAGTAT CTTCACCAGA
|
3481AAGGGAGATC ACCTTAGTGA ACCTGAAAAA AGATGCAAAG TATGGCTTGG GATTTCAAAT
|
3541TATTGGTGGG GAGAAGATGG GAAGACTGGA CCTAGGCATA TTTATCAGTT CAGTTGCCCC
|
3601TGGAGGACCA GCTGACTTGG ATGGATGCTT GAAGCCAGGA GACCGTTTGA TATCTGTGAA
|
3661TAGTGTGAGT CTGGAGGGAG TCAGCCACCA TGCTGCAATT GAAATTTTGC AAAATGCACC
|
3721TGAAGATGTG ACACTTGTTA TCTCTCAGCC AAAAGAAAAG ATATCCAAAG TGCCTTCTAC
|
3781TCCTGTGCAT CTCACCAATG AGATGAAAAA CTACATGAAG AAATCTTCCT ACATGCAAGA
|
3841CAGTGCTATA GATTCTTCTT CCAAGGATCA CCACTGGTCA CGTGGTACCC TGAGGCACAT
|
3901CTCGGAGAAC TCCTTTGGGC CGTCTGGGGG CCTGCGGGAA GGAAGCCTGA GTTCTCAAGA
|
3961TTCCAGGACT GAGAGTGCCA GCTTGTCTCA AAGCCAGGTC AATGGTTTCT TTGCCAGCCA
|
4021TTTAGGTGAC CAAACCTGGC AGGAATCACA GCATGGCAGC CCTTCCCCAT CTGTAATATC
|
4081CAAAGCCACC GAGAAAGAGA CTTTCACTGA TAGTAACCAA AGCAAAACTA AAAAGCCAGG
|
4141CATTTCTGAT GTAACTGATT ACTCAGACCG TGGAGATTCA GACATGGATG AAGCCACTTA
|
4201CTCCAGCAGT CAGGATCATC AAACACCAAA ACAGGAATCT TCCTCTTCAG TGAATACATC
|
4261CAACAAGATG AATTTTAAAA CTTTTTCTTC ATCACCTCCT AAGCCTGGAG ATATCTTTGA
|
4321GGTTGAACTG GCTAAAAATG ATAACAGCTT GGGGATAAGT GTCACGGTAC TGTTTGACAA
|
4281GGGAGGTGTG AATACGAGTG TCAGACATGG TGGCATTTAT GTGAAAGCTG TTATTCCCCA
|
4441GGGAGCAGCA GAGTCTGATG GTAGAATTCA CAAAGGTGAT CCCGTCCTAC CTGTCAATGG
|
4501AGTTAGTCTA GAAGGAGCCA CCCATAAGCA AGCTCTGGAA ACACTCACAA ATACAGGACA
|
4561GGTGCTTCAT CTGTTATTAG AAAAGGGACA ATCTCCAACA TCTAAAGAAC ATGTCCCGGT
|
4621AACCCCACAG TGTACCCTTT CAGATCAGAA TGCCCAAGGT CAAGGCCCAG AAAAACTGAA
|
4681GAAAACAACT CAGGTCAAAG ACTACAGCTT TGTCACTGAA GAAAATACAT TTGAGGTAAA
|
4741ATTATTTAAA AATAGCTCAG GTCTAGGATT CAGTTTTTCT CGAGAAGATA ATCTTATACC
|
4801GGAGCAAATT AATGCCAGCA TAGTAAGGGT TAAAAAGCTC TTTCCTGGAC AGCCAGCAGC
|
4861AGAAAGTGGA AAAATTGATC TAGGAGATGT TATCTTGAAA GTGAATGGAG CCTCTTTGAA
|
4921AGGACTATGT CAGCAGGAAG TCATATCTGC TCTCAGGGGA ACTGCTGCAG AAGTATTCTT
|
4981GCTTCTCTGC AGACCTCCAC CTGGTGTGCT ACCGGAAATT GATACTGCGC TTTTGACCCC
|
5041ACTTCAGTCT CCAGCACAAG TACTTCCAAA CAGCAGTAAA GACTCTTCTC AGCCATCATG
|
5101TGTGGAGCAA AGCACCAGCT CAGATGAAAA TGAAATGTCA GACAAAAGCA AAAAACAGTG
|
5161CAAGTCCCCA TCCAGAAGAG ACAGTTACAG TGACAGCAGT GGGAGTGGAG AAGATGACTT
|
5221AGTGACAGCT CCAGCAAACA TATCAAATTC GACCTGGAGT TCAGCTTTGC ATCAGACTCT
|
5281AAGCAACATG GTATCACAGG CACAGAGTCA TCATGAAGCA CCCAAGAGTC AAGAAGATAC
|
5241CATTTGTACC ATGTTTTACT ATCCTCAGAA AATTCCCAAT AAACCAGAGT TTGAGGACAG
|
5401TAATCCTTCC CCTCTACCAC CGGATATGGC TCCTGGGCAG AGTTATCAAC CCCAATCAGA
|
5461ATCTGCTTCC TCTAGTTCGA TGGATAAGTA TCATATACAT CACATTTCTG AACCAACTAG
|
5521ACAAGAAAAC TGGACACCTT TGAAAAATGA CTTGGAAAAT CACCTTGAAG ACTTTGAACT
|
5581GGAAGTACAA CTCCTCATTA CCCTAATTAA ATCAGAAAAA GGAAGCCTGG GTTTTACAGT
|
5641AACCAAAGCC AATCAGAGAA TTGGTTGTTA TGTTCATGAT GTCATACAGG ATCCAGCCAA
|
5701AAGTGATGGA AGGCTAAAAC CTCGGGACCG GCTCATAAAG GTTAATGATA CAGATGTTAC
|
5761TAATATGACT CATACAGATG CAGTTAATCT GCTCCGGGCT GCATCCAAAA CAGTCAGATT
|
5821AGTTATTCGA CGAGTTCTAG AATTACCCAG AATACCAATG TTGCCTCATT TGCTACCGGA
|
5881CATAACACTA ACGTGCAACA AAGAGGAGTT GGGTTTTTCC TTATGTGGAG GTCATGACAG
|
5941CCTTTATCAA GTGGTATATA TTAGTGATAT TAATCCAAGG TCCGTCGCAG CCATTGAGGG
|
6001TAATCTCCAG CTATTAGATG TCATCCATTA TGTGAACGGA GTCAGCACAC AAGGAATGAC
|
6061CTTGGAGGAA GTTAACAGAG CATTAGACAT CTCACTTCCT TCATTGGTAT TGAAACCAAC
|
6121AAGAAATGAT CTTCCAGTGG TCCCCAGCTC AAAGAGGTCT GCTGTTTCAG CTCCAAAGTC
|
6181AACCAAAGGC AATGGTTCCT ACAGTGTGGG GTCTTCCAGC CAGCCTGCCC TCACTCCTAA
|
6241TGATTCATTC TCCACGGTTG CTGGGGAAGA AATAAATGAA ATATCGTACC CCAAAGGAAA
|
6301ATGTTCTACT TATCAGATAA AGGGATCACC AAACTTGACT CTGCCCAAAG AATCTTATAT
|
6261ACAAGAAGAT GACATTTATG ATGATTCCCA AGAAGCTGAA GTTATCCAGT CTCTGCTGGA
|
6421TGTTGTGGAT GAGGAAGCCC AGAATCTTTT AAACGAAAAT AATGCAGCAG GATACTCCTG
|
6481TGGTCCAGGT ACATTAAAGA TGAATGGGAA GTTATCAGAA GAGAGAACAG AAGATACAGA
|
6541CTGCGATGGT TCACCTTTAC CTGAGTATTT TACTGAGGCC ACCAAAATGA ATGGCTGTGA
|
6601AGAATATTGT GAAGAAAAAG TAAAAAGTGA AAGCTTAATT CAGAAGCCAC AAGAAAAGAA
|
6661GACTGATGAT GATGAAATAA CATGGGGAAA TGATGAGTTG CCAATAGAGA GAACAAACCA
|
6721TGAAGATTCT GATAAAGATC ATTCCTTTCT GACAAACGAT GAGCTCGCTG TACTCCCTGT
|
6781CGTCAAAGTG CTTCCCTCTG GTAAATACAC GGGTGCCAAC TTAAAATCAG TCATTCGAGT
|
6841CCTGCGGGGT TTGCTAGATC AAGGAATTCC TTCTAAGGAG CTGGAGAATC TTCAAGAATT
|
6801AAAACCTTTG GATCAGTGTC TAATTGGGCA AACTAAGGAA AACAGAAGGA AGAACAGATA
|
6961TAAAAATATA CTTCCCTATG ATGCTACAAG AGTGCCTCTT GGAGATGAAG GTGGCTATAT
|
7021CAATGCCAGC TTCATTAAGA TACCAGTTGG GAAAGAAGAG TTCGTTTACA TTGCCTGCCA
|
7081AGGACCACTG CCTACAACTG TTGGAGACTT CTGGCAGATG ATTTGGGAGC AAAAATCCAC
|
7141AGTGATAGCC ATGATGACTC AAGAAGTAGA AGGAGAAAAA ATCAAATGCC AGCGCTATTG
|
7201GCCCAACATC CTAGGCAAAA CAACAATGGT CAGCAACAGA CTTCGACTGG CTCTTGTGAG
|
7261AATGCAGCAG CTGAAGGGCT TTGTGGTGAG GGCAATGACC CTTGAAGATA TTCAGACCAG
|
7221AGAGGTGCGC CATATTTCTC ATCTGAATTT CACTGCCTGG CCAGACCATG ATACACCTTC
|
7381TCAACCAGAT GATCTGCTTA CTTTTATCTC CTACATGAGA CACATGCACA GATCAGGCCC
|
7441AATCATTACG CACTGCAGTG CTGGCATTGG ACGTTCAGGG ACCCTGATTT GCATAGATGT
|
7501GGTTCTGGGA TTAATCAGTC AGGATCTTGA TTTTGACATC TCTGATTTGG TGCGCTGCAT
|
7561GAGACTACAA AGACACGGAA TGGTTCAGAC AGAGGATCAA TATATTTTCT GCTATCAAGT
|
7621CATCCTTTAT GTCCTGACAC GTCTTCAAGC AGAAGAAGAG CAAAAACAGC AGCCTGAGGT
|
7681TCTGAAGTGA CATGAAAAGA GCCTCTGGAT GCATTTCCAT TTCTCTCCTT AACCTCCAGC
|
7741AGACTCCTGC TCTCTATCCA AAATAAGATC ACAGAGCAGC AAGTTCATAC AACATGCATG
|
7801TTCTCCTCTA TCTTAGAGGG GTATTCTTCT TGAAAATAAA AAATATTGAA ATGCTGTATT
|
7861TTTACAGCTA CTTTAACCTA TGATAATTAT TTACAAAATT TTAACACTAA CCAAACAATG
|
7821CAGATCTTAG GGATGATTAA AGGCAGCATT TGATGATAGC AGACATTGTT ACAAGGACAT
|
7981GGTGAGTCTA TTTTTAATGC ACCAATCTTG TTTATAGCAA AAATGTTTTC CAATATTTTA
|
8041ATAAAGTAGT TATTTTATAG GGGATACTTG AAACCAGTAT TTAAGCTTTA AATGACAGTA
|
8101ATATTGGCAT AGAAAAAAGT AGCAAATGTT TACTGTATCA ATTTCTAATG TTTACTATAT
|
8161AGAATTTCCT GTAATATATT TATATACTTT TTCATGAAAA TGGAGTTATC AGTTATCTGT
|
8221TTGTTACTGC ATCATCTGTT TGTAATCATT ATCTCACTTT GTAAATAAAA ACACACGTTA
|
8281AAACATG
|
GENEANK ID: NM_003326.1
VERSION NM_003336.1 GI:4507768
MSTPARRRLNRDFKRLQEDFPAGVSGAPSENNINVWNAVIFGPE
|
GTPFGDGTFKLTIEFTEEYPNKPPTVRFVSKMFHPNVYADGSICLDILQNRWSPTYDV
|
SSILTSIQSLLDEPNPNSPANSQAAQLYQENKREYEKRVSAIVEQSWRDC
|
GENBANK ID: S40706.1
VERSION S40706.1 GI:252001
MAAESLPFSSDTVSWELEAWYEDLQEVLSSDENCGTYVSPPGNE
|
SEESKIETTLDPASLAWLTEEEPEPAEVTSTSQSPHSPDSSQSSLAQEEEEEDQGRTR
|
KRKQSGHSPARAGKQRNKEKEQENERKVAQLAEENERLKQEIERLTREVEATRRALID
|
RMVNLHQA
|
GENBANK ID: M96995.1
VERSION M96995.1 GI:181975
MEAIAKYDEKATADDELSFKRGDILKVLNEECDQNNYKAELNGK
|
DGFIPKNYIEMKPHPWFFGKIPRAKAEENLSKQRHDGAFLIRESESAPGDFSLSVKFG
|
NDVQWFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTY
|
VQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACNGQTGMFPRNYVTPVNRNV
|
GENBANK ID: M21758.1
VERSION M21758.1 GI:183664
MAEKPKLHYFNARGRNESTRWLLAAAGVEFEEKFIKSAEDLDKL
|
RNDGYLNEQQVPNVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADL
|
GENILLLPVCPPEEKDAKLALIKEKIKNRYFPAEEKVLKSHGQDYLVGNKLSRADIHL
|
VELLYYVEELDSSLISSEPLLKALKTRISNLPTVKKFLQPGSPRKPPNDEKSLEEARK
|
IFRF
|
GENBANK ID: U32944.1
VERSION U32944.1 GI:1209060
MCDRKAVIKNADMSEENQQDSVECATQALEKYNIEKDIAARIKK
|
EFDKKYNPTWHCIVGRNFGSYVPMETKHFIYFYLGQVAILLFKSG
|
GENBANK ID: NM_021141.2
VERSION NM_021141.2 GI:12406650
MVRSGNKAAVVLCNDVGFTMSNSIPGIESPFEQAKKVITMFVQR
|
QVFAENKDEIALVLFGTDGTDNPLSGGDQYQNITVHRRLMLPDFDLLEDIESKIQPGS
|
QQADFLDALIVSMDVIQHETIGKKFEKRHIEIFTDLSSRFSKSQLDIIIHSLKKCDIS
|
LQFFLPFSLGKEDGSGDRGDGPFRLGGHGPSFPLKGITEQQKEGLEIVKMVMISLEGE
|
DGLDEIYSFSESLRKLCVFKKIERHSIHWPCRLTIGSNLSIRIAAYKSILQERVKKTW
|
TVVDAKTLKKEDIQKETVYCLNDDDETEVLKEDIIQGFRYQSDIVPFSKVDEEQMKYK
|
SEGKCFSVLGFCKSSQVQRRFFMGNQVLKVFAARDDEAAAVALSSLINALDDLDMVAI
|
VRYAYDKRANPQVGVAFPHIKMNYECLVYVQLPFNEDLRQYNFSSLKNSKKYAPTEAQ
|
LNAVDALIDSNSLAKKDEKTDTLEDLFPTTKIPNPRFQRLRQCLLMRALHPREPLPPI
|
QQHIWNNLNPPAEVTTKSQIPLSKIKTLEPLIEAKKKDQVTAQEIFQDNMEDGPTAKK
|
LKTEQGGAMESVSSLAEQSVTSVGSVNPAENFRVLVKQKKASEEEASNQLINHIEQFL
|
DTNETPYFNKSIDCIRAFREEAIKFSEEQRFNNFLKALQEKVEIKQLNHFNEIVVQDG
|
ITLITKEEASGSSVTAEEAKKFLAPKDKPSGDTAAVFEEGGDVDDLLDMI
|
GENBANK ID: NM_005053.1
VERSION NM_005053.1 GI:4826963
MAVTITLKTLQQQTFKIRNEPDETVKVLKEKIEAEKGRDAFPVA
|
DQKLIYAGKILSDDVPIRDYRIDEKNFVVVNVTKTKAGQGTSAPPEASPTAAPESSTS
|
FPPAPTSGMSHPPPAAREDKSPSEESAPTTSPESVSGSVPSSGSSGREEDAASTLVTG
|
SEYETNLTEIMSMGYERERVVAALRASYNNPHRAVEYLLTGIPGSPEPEMGSVQESQV
|
SEQPATEAAGENPLEFLRDQPQEQNNRQVIQQNPALLPALLQQLGQENPQLLQQISRH
|
QEQFIQMLNEPPGELADISDVEGEVGAIGEEAPQNNYIQVTPQEKEAIERLKALGEPE
|
SLVIQAYFACEKNENLAANFLLSQNFDDE
|
GENBANK ID: Z23115.1
VERSION Z23115.1 GI:510900
MSQSNEELVVDFLSYKLSQEKGYSWSQFSDVEENETEAPEGTESE
|
METPSAINGNPSWNLADSPAVNGATAHSSSLDAREVIPMAAVKQALREAGDEFELRYR
|
RAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFWSEGGALCVESVDKEMQ
|
VLVSRIAAWMATYLNDHLETWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGN
|
TVAGVVLLGSLFSRK
|
GENBANK ID: AB020979.1
VERSION AB02D979.1 GI:6518501
MDEADRRLLRRCRLRLVEELQVDQLWDALLSSELFRPHNIEDIQ
|
RAGSGSRRDQARQLIIDLETRGSQALPLFISCLEDTGQDMLASFLETNRQAAKLSKPT
|
LENLTPVVLRPEIRKPEVLRPETPRPVDIGSGGFGDVEQKDHGFEVASTSTEDESPGS
|
NPEPDATPFQEGLRTFDQLDAISSLPTPSDIFVSYSTFPGFVSWRDPKSGSWYVETLD
|
DIFEQWAHSEDLQSLLLRVANAVSVKGIYKQNPGCFNFLRKKLFFKTS
|
GENBANK ID: U21092.1
VERSION U21092.1 GI:726087
MESSKKNDSPGALQTNPPLKLHTDRSAGTPVFVPEQGGYKEKFV
|
KTVEDKYKCEKCHLVLCSPKQTECGHRTCESCMAALLSSSSPKCTACQESIVKDKVFK
|
DNCCKREILALQIYCRNESRGCAEQLTLGHLLVHLKNDCHFEELPCVRPDCKEKVLRK
|
DLRDHVEKACKYREATCSNCKSQVPMIALQKHEDTDCPCVVVSCPHKCSVQTLLRSEL
|
SAHLSECVNAPSTCSFKRYGCVFQGTNQQIKAHEASSAVQHVNLLKEWSNSLEKKVSL
|
LQNESVEKNKSIQSLHNQICSFEIEIERQKEMLRNNESKILHLQRVIDSQAEKLKELD
|
KEIRPFRQNMEEADSMKSSVESLQNRVTELESVDKSAGQVARNTGLLESQLSRHDQML
|
SVHDIRLADMDLRFQVLETASYNGVLIWKIRDYKRRKQEAVMGKTLSLYSQPFYTGYF
|
GYKMCARVYLNGDGMGKGTHLSLFFVIMRGEYDALLPWPFKQKVTLMLMDQGSSRRHL
|
GDAFKPDPNSSSFKKPTGEMNIASGCPVFVAQTVLENGTYIKDDTIFIKVIVDTSDLP
|
DP
|
GENBANK ID: NM_001459.1
VERSION NM_001459.1 GI:4503750
MTVLAPAWSPTTYLLLLLLLSSGLSGTQDCSFQHSPISSDFAVK
|
IRELSDYLLQDYPVTVASNLQDEELCGALWRLVLAQRWMERLKTVAGSKMQGLLERVN
|
TEIHFVTKCAFQPPPSCLRFVQTNISRLLQETSEQLVALKPWITRQNFSRCLELQCQP
|
DSSTLPPPNSPRPLEATAPTAPQPPLLLLLLLPVGLLLLAAAWCLHWQRTRRRTPRPG
|
EQVPPYPSPQDLLLVEH
|
GENBANK ID: X57500.1
VERSION M36089.1 GI:340396
MPEIRLRHVVSCSSQDSTHCAENLLKADTYRKWRAAKAGEKTIS
|
VVLQLEKEEQIHSVDIGNDGSAFVEVLVGSSAG0AGEQDYEVLLVTSSFMSPSESRSG
|
SNPNRVRMFGPDKLVRAAAEKRWDRVKIVCSQPYSKDSPFGLSFVRFHSPPDKDEAEA
|
PSQKVTVTKLGQFRVKEEDESANSLRPGALFFSRINKTSPYTASDPAGPSYAAATLQA
|
SSAASSASPVSRAIGSTSKPQESPKGKRKLDLNQEEKKTPSKPPAQLSPSVPKRPKLP
|
APTRTPATAPVPARAQGAVTGKPRGEGTEPRRPRAGPEELGKILQGVVVVLSGFQNPF
|
RSELRDKALELGAKYRPDWTRDSTHLICAFANTPKYSQVLGLGGRIVRKEWVLDCHRM
|
RRRLPSRRYLMAGPGSSSEEDEASHSGGSGDEAPKLPQKQPQTKTKPTQAAGPSSPQK
|
PPTPEETKAASPVLQEDIDIEGVQSEGQDNGAEDSGDTEDELRRVAEQKEHRLPPGQE
|
ENGEDPYA0STDENTDSEEHQEPPDLPVPELPDFFQGKHFFLYGEFPGDERRKLIRYV
|
TAFNGELEDYMSDRVQFVITAQEWDPSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPH
|
QLYGVVPQA
|
GENBANK ID: BAA02962.1
DEFINITION HUMAN MRNA FOR RECA-LIKE PROTEIN HSRAD51, COMPLETE CDS.
VERSION 013804.1 GI:397826
CDS 212..1231
/CODON_START=1
1GAATTCCGGT AAGGAGAGTG CGGCCCTTCC CGAGGCGTGC AGCTGGGAAC TGCAACTCAT
|
61CTGGGTTGTG CGCAGAAGGC TGGGGCAAGC GAGTAGAGAA GTGCACCGTA AGCCAGCGGG
|
121CTTGGGCGCC GTCCGGCCGG GTCGCGTGCA GCCCCGCGGG GTGAAGTCGG AGCGCGGGGC
|
181CTGCTGGAGA GAGGAGCGCT GCGACCGAGT AATGGCAATG CAGATGCAGC TTGAAGCGAA
|
241TGCAGATACT TCAGTCGAAG AAGAAAGCTT TGGCCCACAA CCCATTTGAC GGTTAGAGCA
|
301GTGTGGCATA AATGCCAACG ATGTGAAGAA ATTCGAAGAA GCTGGATTCC ATACTGTGGA
|
361GGCTGTTGCC TATGCGCCAA ACAAGCAGCT AATAAATATT AAGGGAATTA GTGAAGCCAA
|
421AGCTGATAAA ATTCTGGCTG AGGCAGCTAA ATTAGTTCCA ATGGGTTTCA CCACTGCAAC
|
481TGAAPTCCAC CAAACGCGGT CAGAGATCAT ACAGATTACT ACTGGCTCCA AAGAGCTTGA
|
541CAAACTACTT CAAGGTGGAA TTGAGACTGG ATCTATCACA GAAATGTTTG GAGAATTCCG
|
601AACTGGGAAG ACCCAGATCT GTCATACGCT AGCTGTCACC TGCCAGCTTC CCATTGACCG
|
661GGGTGGAGGT GAAGGAAACG CCATGTACAT TGACACTGAG GGTACCPTTA GGCCAGAACG
|
721GCTGCTGGCA GTGGCTGAGA GGTATGCTCT CTCTGGCAGT GATGTCCTGG ATAATGTAGC
|
781ATATGCTCGA GCGTTCAACA CAGACCACCA GACCCAGCTC CTTTATCAAG CATCAGCCAT
|
841GATGGTAGAA TCTAGGTATG CACTGCTTAT TGTAGACAGT GCCACCGCCC TTTACAGAAC
|
901AGACTACTGG GGTCGAGGTG AGCTTTCAGC CAGGCAGATG CACTTGGCCA GGTTTCTGCG
|
961GATCCTTCTG CGACTCGCTG ATGAGTTTGG TGTAGCAGTG GTAATCACTA ATCAGGTGGT
|
1021AGCTCAAGTG GATGGAGCAG CGATGTTTGC TGCTGATCCC AAAAAACCTA TTGGAGGAAA
|
1081TATCATCGCC CATGCATCAA CAACCAGATT GTATCTGAGG AAAGGAAGAG GGGAAACCAG
|
1141AATCTGCCAA ATCIACGACT CTCCCTGTCT TCCTGAAGCT GAAGCTATGT TCGCCATTAA
|
1201ICCAGAIGGA GTGGGAGATG CCAAAGACTG AATCATTGGG TTTTTCCTCT GTTAAAAACC
|
1261TTAAGTGCTG CAGCCTAATG AGAGTGCACT GCTCCCTGGG GTTCTCTACA GGCCTCTTCC
|
1321TGTTGTGACT GCCAGGATAA AGCTTCCGGG AAAACAGCTA TTATATCAGC TTTTCTGATG
|
1381GTATAAACAG GAGACAGGTC AGTAGTCACA AACTGATCTA AAATGGTTTA TTCCTTCTGT
|
1441AGTGTATTAA TCTCTGTGTG TTIICTTTGG TTTTGGAGGA GGGTATGAAG TATCTTTGAC
|
1501ATGGTGCCTT AGGAATGACT TGGGTTTAAC AAGCTGTCTA CTGGACAATC TTATGTTTCC
|
1561AAGAGAACTA AAGCTGGAGA GACCTGACCC TTCTCTCACT TCTAAATTAA TGGTAAAATA
|
1621AAAGTCCTCA GCTATGTAGC AAAGG
|
GENBANK ID: B56529
AGGAGGTGCAGGAGAACAGAAGTGTGCCCTGTGCTCTTCTGAGCAGAGAAGCACCATGAG
|
CTGGGGCAGGCAAACCCCACTGGGGCTGGCATGGCTCGCTGGGGCTGGCACGTGGAGGGA
|
AGTGCTGCCTCCCCAGGCCTCTGCTTTAATGATCAGCTTAGTCACTGGTGTGACTGTGCC
|
CTGGGCTATTGCCTGAGGTGAAACCTTTACCTGCTCCCTGGTCTATCTTGGTAGAATTGA
|
TCTATTTCAAAGGTATACAGCTAAGCAGATTCTTATTTCTGAGAATACCACCTGTGTGGC
|
ACCTCCTTTCCAGCTCCTCAGGGAATGTGAGACATGTGAGGAGCTGCCACACTCCTTGCC
|
AGTAGTCACAGGAAAGGGTGGTTAACAAGTTAAAGTAACCAAGAGGAATATGTGTGTTGA
|
GTCAGCTGATGGCGTTTGCAAGTGGAATGTCCTTCTTACC
|
GENBANK ID: CAA59230.1
DEFINITION H. SAPIENS MRNA FOR DNA LIGASE III.
VERSION X84740.1 GI:860962
CDS 334..3102
/CODON_START=1
1CCACGCGTCC GGCAGCCTGT ATGAGCAAGT GCCGAGGCCT ACGGTGAGCG CCGGAGCCGG
|
61AGAGGCAGCT ATATGTCTTT GGCTTTCAAG ATCTTCTTTC CACAAACCCT CCGTGCACTC
|
121AGCCGAAAAG AACTGTGCCT ATTCCGAAAA CATCACTGGC GTGATGTAAG ACAATTCAGC
|
181CAGTGGTCAG AAACAGATCT GCTTCATGGA CATCCCCTCT TCCTGAGAAG AAAGCCTGTT
|
241CTATCATTCC AGGGAAGCCA TCTAAGATCA CGTGCCACCT ACCTTGTTTT CTTGCCAGGG
|
301TTGCATGTGG GACTCTGCAG TGGCCCCTGT GAGATGGCTG AGCAACGGTT CTGTGTGGAC
|
361TATGCCAAGC GTGGCACAGC TGGCTGCAAA AAATGCAAGG AAAAGATTGT GAAGGGCGTA
|
421TGCCGAATTG GCAAAGTGGT GCCCAATCCC TTCTCAGAGT CTGGGGGTGA TATGAAAGAG
|
481TGGTACCACA TTAAATGCAT GTTTGAGAAA CTAGAGCGGG CCCGGGCCAC CACAAAAAAA
|
541ATCGAGGACC TCACAGAGCT GGAAGGCTGG GAAGAGCTGG AAGATAATGA GAAGGAACAG
|
601ATAACCCAGC ACATTGCAGA TCTGTCTTCT AAGGCAGCAG GTACACCAAA GAAGAAAGCT
|
661GTTGTCCAGG CTAAGTTGAC AACCACTGGC CAGGTGACTT CTCCAGTGAA AGGCGCCTCA
|
721TTTGTCACCA GTACCAATCC CCGGAAATTT TCTGGCTTTT CAGCCAAGCC CAACAACTCT
|
781GGGGAAGCCC CCTCGAGCCC CACCCCTAAG AGAAGTCTGT GTTCAAGCAA ATGTGACCCC
|
841AGGCATAAGG ACTGTCTGCT ACGGGAGTTT CGAAAGTTAT GCGCCATGGT GGCCGATAAT
|
901CCTAGCTACA ACACGAAGAC CCAGATCATC CAGGACTTCC TTCGGAAAGG CTCAGCAGGA
|
961GATGGTTTCC ACGGTGATGT GTACCTAACA GTGAAGCTGC TGCTGCCAGG AGTCATTAAG
|
1021ACTGTTTACA ACTTGAACGA TAAGCAGATT GTGAAGCTTT TCAGTCGCAT TTTTAACTGC
|
1081AACCCAGATG ATATGGCACG GGACCTAGAG CAGGGTGACG TGTCAGAGAC AATCAGAGTC
|
1141TTCTTTGAGC AGAGCAAGTC TTTCCCCCCA GCTGCCAAGA GCCTCCTTAC CATCCAGGAA
|
1201GTGGATGAGT TCCTTCTGCG GCTGTCCAAG CTCACCAAGG AGGATGACCA GCAACAGGCC
|
1261CTACAGGACA TTGCCTCCAG GTGTACAGCC AATGACCTTA AATGCATCAT CAGGTTGATC
|
1321AAACATCATC TGAAGATGAA CTCAGGTGCA AAACATGTGT TAGACGCCGT TGACCCCAAT
|
1381GCCTATGAAG CCTTCAAAGC CTCGCCCAAC CTGCAGGATG TGGTGGAGCG GGTCCTTCAC
|
1441AACGCGCAGG AGGTGGAGAA GGAGCCGGGC CAGAGACCAG CTCTGAGCGT CCAGGCCTCG
|
1501CTGATGACAC CTGTGCAGCC CATGTTGGCG GAGGCCTGCA AGTCCGTTGA GTATGCAATG
|
1561AAGAAATGTC CCAATGGCAT GTTCTCTGAG ATCAAGTACG ATGGAGAGCG AGTCCAGGTG
|
1621CATAAGAATG GAGACCACTT CAGCTACTTC AGCCGCAGTC TCAAGCCCGT CCTTCCTCAC
|
1681AAGGTGGCCC ACTTTAAGGA CTACATTCCC CAGGCTTPTC CTGGGGGCCA CAGCATGATC
|
1741TTGGATTCTG AAGTGCTTCT GATTGACAAC AAGACAGGCA AACCACTGCC CTTTGGGACT
|
1801CTGGGAGTAC ACAAGAAAGC AGCCTTCCAG GATGCTAATG TCTGCCTGTT TGTTTTTGAT
|
1861TGTATCTACT TTAATGATGT CAGCTTGATG GACAGACCTC TGTGTGAGCG GCGGAAGTTT
|
1921CTTCATGACA ACATGGTTGA AATTCCAAAC CGGATCATGT TCTCAGAAAT GAAGCGAGTC
|
1981ACAAAAGCTT TGGACTTGGC TGACATGATA ACCCGGGTGA TCCAGGAGGG ATTGGAGGGG
|
2041CTGGTGCTGA AGGATGTGAA GGGTACATAT GAGGCTGGGA AGCGGCACTG GCTGAAAGTG
|
2101AAGAAAGACT ATTTGAACGA GGGGGCCATG GCCGACACAG CTGACCTGGT GGTCCTTGGA
|
2161GCCTTCTATG GGCAAGGGAG CAAAGGCGGC ATGATGTCAA TCTTCCTCAT GGGCTGCTAC
|
2221GACCCTGGCA GCCAGAAGTG GTGCACAGTC ACCAAGTGTG CAGGAGGCCA TGATGATGCC
|
2281ACGCTTGCCC GCCTGCAGAA TGAACTAGAC ATGGTGAAGA TCAGCAAGGA CCCCAGCAAA
|
2341ATACCCAGCT GGTTGAAGGT CAACAAGATC TACTATGCTG ACTTCATCGT CCCAGACCCA
|
2401AAGAAAGCTG CCGTGTGGGA GATCACAGGG GCTGAATTCT CCAAATCGGA GGCTCATACA
|
2461GCTGACGGGA TCTCCATCCG ATTCCCTCGC TGCACCCGAA TCCGAGATGA TAAGGACTGG
|
2521AAATCTGCCA CTAACCTTCC CCAACTCAAG GAACTGTACC AGTTGTCCAA GGAGAAGGCA
|
2581GACTTCACTG TAGTGGCTGG AGATGAGGGG AGCTCCACTA CAGGGGGTAG CAGTGAAGAG
|
2641AATAAGGGTC CCTCAGGGTC TGCTGTGTCC CGCAAGGCCC CCAGCAAGCC CTCAGCCAGT
|
2701ACCAAGAAAG CAGAAGGGAA GCTGAGTAAC TCCAACAGCA AAGATGGCAA CATGCAGACT
|
2761GCAAAGCCTT CCGCTATGAA GGTGGGGGAG AAGCTGGCCA CAAAGTCTTC TCCAGTGAAA
|
2821GTAGGGGAGA AGCGGAAAGC TGCTGATGAG ACGCTGTGCC AAACAAAGGT ATTGCTGGAC
|
2881ATCTTCACTG GGGTGCGGCT TTACTTGCCA CCCTCCACAC CAGACTTCAG CCGTCTCAGA
|
2941CGCTACTTTG TGGCATTCGA CGGGGACCTG GTACAGGAAT TTGATATGAC TTCAGCCACG
|
3001CACGTGCTGG GTAGCAGGGA CAAGAACCCT GCGGCCCAGC AGGTCTCCCC AGAGTGGATT
|
3061TGGGCATGTA TCCGGAAACG GAGACTGGTA GCTCCCTGCT AGGTTTGCTG TCTTCCCTCT
|
3121CCCTCAGGCC ATACTCTCCT TTACCATACT ATTGGACTGG ACTCAGGCTG GAGGCAGATA
|
3181GACACAGTAT AGGGGGAATG GGCTTGCTTC TCCCAAACCC ACCAGTTCTC CACTGTCTCT
|
3241TCTGGACCAG GAATTAGTTG CTGTGGGTGC CACAGCTGAA GTCAGTTTGT CTTGCTGGTT
|
3301TAAATAGATC TTTCAGAGCT GGGTGCTGGG TTTGCCATCT TTTTGTTTTC TTTGAAAAGC
|
3361AGCTTAGTTA CCCTTTTTAT AAATAAAATA TCTTGCAGTT AAAAAAAAAA AAAAAAAAAA
|
3421AA
|
GENBANK ID: D26155.1
VERSION D26155.1 GI:505086
MSTPTDPGAMPHPGPSPGPGPSPGPILGFSPGPGPSPGSVESMM
|
GESPGPPSVSHPMPTNGSTDFPQEGMHQMHKPIDGIHDKGIVEDTHCGSNKGTGMRPP
|
HPGNGPPQSPMDQHSQGMSPHPSPLGAPEHVSSPMSGGGPTPPQYSPPSQPGALIPGD
|
PQAMSQPNRGPSPFSPVQLHQLRAQILAYKMLARGQFLPETLQLAVQGKRTLPGLQQQ
|
QQQQQGQQQQQQQQQQQQQPQQQPQQQPQTQQQQQPALVNYNRPSGPGPELSGPSTPQ
|
KLPVPAPGGRPSPAPPAAAQPFAAAVPGPSVPQFAPGQPSFVLQLQQKQSRISPIQKP
|
QGLDPVEILQEREYRLQARIAHRIQELENLFGSLPPDLRTKATVELKALRLLNFQRQL
|
REEVVACNRRDTTLETALNSKAYKRSKRQTLREARMTEKLEKQQKIEQERKRRQKHQE
|
YLNSILQHAKDFKEYNRSVAGKIQKLSKAVATWHANTEREQKKETERIEKERMRRLMA
|
EDEESYRKLIDQKKDRRLAYLLQQTGEYVANLTNLVWEHKQAQAAKEKKKRRRRKKKA
|
EENAEGGESALGPDGEPIDSSSQNSDLPVKVTNTETGKVLFGPEAPKASQLDANLEMN
|
PGYEVAPRSDSSESDSDYEEEDEEEESSRQETEEKILLDPNSEEVSEKDAKQIIETAK
|
QDVDDEYSMQYSARGSQSYYTVAHAISERVEKQSALLINGTLKHYQLQGLEWMVSLYN
|
NNLNGILADEMGLGKTIQTIALITYLMEHKRLNGPYLIIVFLSTLSNNTYEFDKWAPS
|
VVKISYKGTPAMRRSLVPQLRSGKFNVLLTTYEYIIKDKHILAKIRWKYMIVDEGNRM
|
KNHHCKLTQVLNTEYVAPRRILLTGTPLQNKLPELWALLNELLPTIFKSCSTFEQWFN
|
APFAMTGERVDLNEEETILIIRRLEKVLRPFLLRRLKKEVESQLPEKVEYVIKCDMSA
|
LQKILYRHMQAKGILLTDGSEKDKKGKGGAKTLMNTIMQLRKICNHPYNFQHIESSFA
|
EHLGYSNGVINGAELYRASGKFELLDRILPKLRATNHRVLLFCQMTSLNTIMEDYFAF
|
RNFLYLRLDGTTKSEDRAALLKKFNEPGSQYFIFLLSTRAGGLGLNLQAAHTVVIFDS
|
DWNPHQDLQAQDRARRIGQQNEVRVLRLCTVNSVEEKILAAAKYKLNV0QKVIQAGMF
|
DQKSSSHERRAFLQAILEHEEENEEEDEVPDDETLNQMIARREEEFDLFMRMDMDRRR
|
EDARNFKRKPRLNESDELPSWIIKDDAEVERLTCEEEEEKIFGRGSRQRRDVDYSDAL
|
TEKQWLRAIEDGNLEEMEEEVRLKKRKRRRNVDKDFAKEDVEKAKHRRGRPPAEKLSP
|
NPPKLTKQMNAIIDTVINYKDSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKE
|
RIRNHRYRSLGDLEKDVMLLCHNAQTFNLEGSQIYEDSIVLQSVFKSARQKIAKEEES
|
EDESNEEEEEEDEEESESEAKSVKKIKLNKKDDKCRDKGKGKKRPNRGKAKFVVSDF
|
DSDEEQDEREQSEGSGTDDE
|
GENBANK ID: M62829J
VERSION M62829.1 GI:182262
MAAAKAEMQLMSPLQISDPFGSFPHSPTMDNYPKLEEMMLLSNG
|
APQFLGAAGAFBGSGSNSSSSSSGGGGGGGGGSNSSSSSSTENPQADTGEQPYEHLTA
|
ESFFDISLNNEKVLVETSYFSQTTRLPFITYTGRFSLEPAPNSGNTLWPEFLFSLVSG
|
LVSNTNPPASSSSAPSFAASSASASQSPPLSCAVBSNDSSPIYSAAFTFPTPNTDIFP
|
EPQSQAFPGSAGTALQYPPPAYPAAKGGFQVFNIPDYLFPQQQGDLGLCTPDQKPFQG
|
LESRTQQPSLTPLSTIKAFATQSGSQDLKALNTSYQSQLIKPSRMRKYFNRPSKTPPH
|
ERPYACPVESCDRRFSRSDELTRHIRIHTGQKPFQCRICMRNFSRSDHLTTHIRTHTG
|
EKPFACDICGRKFARSDERKRETKIHLRQKDKKADKSVVASRATSSLSSYFSPVATSY
|
PSPVTTSYPSPATTSYPSPVPTSFSSPGSSTYPSPVHSGFPSPSVATTYSSVPPAFPA
|
QVSSFPSSAVTNSFSASTGLSDNTATFSFRTIEIC
|
GENBANK ID: U10421.1
VERSION U10421.1 GI:500756
MDNARMNSFLEYPILSSGGSGTCSARAYFSDBRITTFQSCAVSA
|
NSCGGDDRFLVGRGVQIGSPHHHHHHHHHHPQPATYQTSGNLGVSYSHESCQPSYGSQ
|
NFSAPYSPYALNQEADVSGGYPQCAPAVYSGNLSSPMVQHHHHHQGYAGGAVGSPQYI
|
HHSYGQEHQSLALATYNNSLSPLHASHQEACRSPASETSSPAQTFDWNKVKRNFPKTG
|
KVGEYGYLGQFNAVRTNFTTKQLTELEKEFHFNKYLTRARRVEIAASLQLNETQVKIW
|
FQNRRMKQKKREKEGLLPISPATPPGNDEKAEESSEKSSSSPCVPSPGSSTSDTLTTS
|
H
|
GENBANK ID: U08015.1
VERSION U08015.1 GI:500631
MPSTSFPVPSKFPLGPAAAVFGRGETLGPAPRAGGTMKSAEEEH
|
YGYASSNVSPALPLPTAHSTLPAPCHNLQTSTPGIIPPADHPSGYGAALDGGPAGYFL
|
SSGHTRPDGAFALESPRIEITSCLGLYHNNNQFFHDVEVEDVLPSSKRSPSTATLSLF
|
SLEAYRDPSCLSPASSLSSRSCNSEASSYESNYSYPYASPQTSPWQSPCVSPKTTDPE
|
EGFPRGLGACTLLGSPQHSFSTSPRASVTEESWLGARSSRPASPCNKRKYSLNGRQPP
|
YSPHHSPTPSPHGSPRVSVTDDSWLGNTTQYTSSAIVAAINALTTDSSLDLGDGVPVK
|
SRKTTLEQPPSVALKVEPVGEDLGSPPPPADFAPEDYSSFQEIRKGGFCDQYLAVPQN
|
PYQWAKPKPLSPTSYNSPTLPALDWQLPSHSGPYELRIEVQPKSHHRAHYETEGSRGA
|
VKASAGGHPIVQLHGYLENEPLMLQLFIGTADDRLLRPHAFYQVHRITGKTVSTTSHE
|
AILSNTKVLEIPLLPENSMRAVIDCAGILKLRNSDIELRKGETDICRKNTRVRLVFRV
|
HVPQPSGRTLSLQVASNPIECSQRSAQELPLVEKQSTDSYPVVGGKKMVLSGHNFLQD
|
SKVIFVEKAPDGHHVWENEAKTDRDLCKPNSLVVEIPPFRNQRITSPVHVSFYVCNGK
|
RKRSQYQRFTYLPANGNAIFLTVSREHERVGCFF
|
GENBANK ID: U08191.1
VERSION U08191.1 GI:476273
MTRVNAGRKGSLAALYDLAVLKKKVKEKEEKKKKKIRIIKSEAE
|
DLAEPLSSTEGVAPLSQAPSPLAIPAIKEEPLEDLKPCLGINEISSSFFSLLLEILLL
|
ESQASLFNLEERVLDWQSSPASSLNSWFSAAPNWAELVLPALQYLAGESRAVPSSFSP
|
FVEFKEKTQQWKLLGQSQDNEKELAALFQLNLETKDQAFCKQENEGSSDATTPVPRVR
|
TDYVVRPSTGEEKRVFQEQERYRYSQPHKAFTFRMHGFESVVGPVKGVFDKETSLNKA
|
REHSLLRSDRFAYVTILSLVRDAAARLPNGEGTRAEICELLKDSQFLAFDVTSTQVNT
|
VVSGALDRLHYEKDPCVKYDIGRKLWIYLER0RSEEEFERIHQAQAAAAKARKALQQK
|
PKPPSKVKSSSKESSIKVLSSGPSEQSQMSLSDSSNPFTPVTPVTPTTPALPAIPISP
|
PPVSAVNKSGFSTVSEPAKSSSGVLLVSSFTNPHLGTMLSPASSQTAPSSQAAARVVS
|
HSGSAGLSQVRVVAQPSLPAVPQQSGGPAQTLPQMPAGPQIRVFATATQTKVVPQTVM
|
ATVPVKAQTTAATVQRPGPGQTGLTVTSLPATASPVSKPATSSPGTSAPSASTAAVIQ
|
NVTGQNIIKQVAITGQLGVKPQTGNSIPLTATNFRIQGKDVLRLFPSSITTDAKGQTV
|
LRITPDNMATLAKSQVTTVKLTQDLFGTGGNTTGKGISATLHVTSNFVNAADSPAKAS
|
SASAPSSTPTGTTVVKVTPDLKPTEASSSAFRLNPALGVSVADQKGKSTVASSEARPA
|
ATIRIVQGLGVNPPKAGQTITVATHAKQGASVASGSGTVHTSAVSLPSNNAAVSKTVA
|
VASGAASTPISISTGAPTVRQVPVSTTVVSTSQACKLPTRITVPLSVISQPMKGKSVV
|
TAPIIKGNLGANLSGLGRNIILTTMPAGTKLIAGNKPVSFLTAQQLQQLQQQGQATQV
|
RIQTVPASISNREQLLAPPKQSPLLL
|
GENBANK ID: M55654
VERSION M55654.1 GI:339491
MDQNNSLPPYAQGLASPQGAMTPGIPIFSPMMPYGTGLTPQPIQ
|
NTNSLSILEEQQRQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQAVAAAAV
|
QQSTSQQATQGTSGQAPQLFHSQILTTAPLPGTTPLYPSPMTPNTPITPATPASESSG
|
IVPQLQNIVSTVNLGCKLDLKTIALRARNAEYNPKRFAAVINRIREPRTTALIFSSGK
|
MVCTGAKSEEQSRLAARKYARVVQKLGEPAKELDFKIQNNVGSCDVKFPIRLEGLVLT
|
HQQFSSYEPELFPGLIYRMIKPRIVLLIFVSQKVVLTGAKVRAEIYEAFENIYPILKG
|
FRKTT
|
GENBANK ID: NM_005568.1
VERSION NM_005568.1 GI:5031866
MVHCAGCKRPILDRFLLNVLDRAWHVKCVQCCECKCNLTEKCFS
|
REGKLYCKNDFFRCFGTKCAGCRQGISPSDLVRRARSKVFHLNCFTCNNCNKQLSTGE
|
ELYIIDENKFVCKEDYLSNSSVAKENSLRSATTGSDPSLSPDSQDPSQDDAKDSESAN
|
VSDKEAGSNEN0DQNLGAERRGPGTTIKAKQLETLKAAFAATPKPTREIREQLAQETG
|
LNMRVIQVNFQNRRSKERRMKQLSALAGHAFERSPRRMRPLVDRLEPGELIPNGFFSF
|
YGDYQSEYYGPGGNYDFFPQGPPSSQAQTPVDLPFVPSSGPSGTPLGGLEHPLPGHHP
|
SSEAQRFTDILAHPPGDSPSPEPSLPGPLHSNSAEVFGPSPPFSSLSVNGGASYGNHL
|
SHPPEMNEAAVW
|
GENBANK ID: X69111.1
VERSION X69111.1 GI:32294
MKALSPVRGCYEAVCCLSERSLAIARGRGKGPAAEEPLSLLDDM
|
NHCYSRLRELVPGVPRGTQLSQVEILQRVIDYILDLQVVLAEPAPGPPDGPHLPIQTA
|
ELAPELVISNDKRSFCH
|
GENBANK ID: NP_000507.1
VERSION NP_000507.1 GI:4504047
1MGCLGNSETE DQRNEEKAQR EANKKIEKQL QKDKQVYRAT HRLLLLGAGE SGKSTIVKQM
|
61RILHVNGFNG EGGEEDPQAA RSNSDGEKAT KVQDIKNNLK EAIETIVAAM SNLVPPVELA
|
121NPENQFRVDY ILSVMNVPDF DWPPEFYEHA KALWEDEGVR ACYERSNEYQ LIDCAQYFLD
|
181KIDVIEQADY VPSDQDLLRC RVLTSGIFET KFQVDKVNFH NFDVGGQRDE RRKWIQCFND
|
241VTAIIFVVAS SSYNMVIRED NQTNRLQEAL NLFKSIWNNR WLRTISVILF LNKQDLLAEK
|
301VLAGKSKIED YFPEFARYTT PEDATPEPGE DPRVTRAKYF IRDEFLEIST ASGDGRHYCY
|
361PHFTCAVDTE NIRRVFNDCR DIIQRMHLRQ YELL
|
GENBANK ID: AAA40889.1
VERSION AAA40889.1 GI:203357
1MEQYTANSNS STEQIVVQAG QIQQQQQGGV TAVQLQTEAQ VASASGQGVG TLQVVQGQPL
|
61NVQVSGGQLI TSTGQPINVQ AVPGGQGQTI MQVPVSGTQG LQQIQLVPPG QIQIQGGQAV
|
121QVQGQQGQTQ QIIIQQPQTA VTAGQTQTQQ QIAVQGQQVA QTAEGQTIVY QPVNADGTIL
|
181QQGMITIPAA SLAGAQIVQT GANTNTTSSG QGTVTVTLPV AGNVVNSGGM VMMVPGAGSV
|
241PAIQRIPLPG AEMLEEEPLY VNAKQYHRIL KRRQARAKLE AEGKIPKERR KYLHESRHRH
|
301AMARKRGEGG RFFSPKEKDS PHMQDPNQAD EEANTQIIRV S
|
GENBANK ID: B53771
VERSION B53771 GI:2136296
1MAWALKLPLA DEVIESGLVQ DFDASLSGIG QELGAGAYSM SDVLALPIFK QEESSLPPDN
|
61ENKILPFQYV LCAATSPAVK LHDETLTYLN QGQSYEIRML DNRELGELPE INGKLVKSIF
|
121RVVFHDRRLQ YTEHQQLEGW RWNRPGDRIL DIDIPMSVGI IDPRANPTQL NTVEFLWDPA
|
181KRTSVFIQVH CISTEFTMRK HGGEKGVPFR VQIDTFEENE NGEYTEHLHS ASCQIKVFKP
|
241KGADRKQKTD REKNEKRTPH EKEKYQPSYE TTILTECSPN PEITYVNNSP SPGFNSSHSS
|
301FSLGEGNGSP NHQPEPPPPV TDNLLPTTTP QEAQQWLHRN RFSTFTRLFT NFSGADLLKL
|
361TRDDVIQICG PADGIRLFNA LKGRNVRPRL TIYVCQESLQ LEEQQQQQQQ QQQKHEDGDS
|
421NGTFFVYHAI YLEELTAVEL TEKIAQLFSI SPCQISQIYK QGPTGIHVLI SDEMIQNFQE
|
481EACFILDTMK QETNQSYHII LK
|
GENBANK ID: M92299.1
VERSION M92299.2. GI:184292
MSSYFVNSFSGRYPNGPDYQLLNYGSGSSLSGSYRDPAANHTGS
|
YGYNYNGMDLSVNRSSASSSHEGAVGESSRAFPAPAQEPRFRQAASSCSLSSPESLPC
|
TNGDSHGAKPSASSPSDQATSASSSANFTEIDEASASSEPEEAASQLSSPSLARAQPE
|
PMATSTAAPEGQTPQIFPWMRKLHISHDNTCPDGKRARTAYTRYQTLELEKEFHFNRY
|
LTRRRRIEIAHALCLSERQIKIWFQNRRMKWKKDNKLKSMSLATAGSAEQP
|
GENBANK ID: M68891.1
VERSION M68891.1 GI:182995
MEVAPEQPGWMAHPAVLNANDPDSERPGLAHNYMEPAHVLPPDE
|
VDVFFNHLDSQGNPYYANPAEARAAVSYSPAHARLTGSQNCRPHLLHSPGLPWLDGGK
|
AALSAAAAHHHNPWTVSPFSKTPLHPSAAGGPGGPLSVYPGAGGGSGGGSGSSVASLT
|
PTAAHSGSHLFGFPPTPPKEVSPDPSTTGAASPASSSAGGSAARGEDKDGVKYQVSLT
|
ESMKMESGSPLRPGLATMGTQPATHHPIPTYPSYVPAAAHDYSSGLFHPGGFLGGPAS
|
SFTPKQRSKARSCSEGRECVNCGATATPLWRRDGTGHYLCNACGLYHKNNGQNRPLIK
|
PKRRLSAARRAGTCCANCQTTTTTLWRRNANGDPVCNACGLYYKLHNVNRPLTMKKEG
|
IQTRNRKMSNKSKKSKKGAECFEELSKCMQEKSSPFSAAALAGHMAPVGHLPPFSHSG
|
HILPTPTPIHPSSSLSFGNPEPSSMVTANG
|
GENBANK ID: XM_028606.2
VERSION XM_028606.2 GI:15304625
MDEMTAVVKIEKGVGGNNGGNGNGGGAFSQARSSSTGSSSSTGG
|
GGQESQPSHLALLAATCSRIESPNENSNNSQGPSQSGGTGELDLTATQLSQGPMAGRS
|
SLPPLGLPLPQRNRVAAVPMAAMAVSLPRIAQSLVGSMLCAAPNLQNQQVLTGLPGVM
|
PNIQYQVIPQFQTVDGQQLQFAATGAQVQQDGSGQIQIIPGANQQIITNRGSGGNIIA
|
AMPNLLQQAVPLQGLANNVLSGQTQYVTNVPVALNGNITLLPVNSVSAATLTPSSQAV
|
TISSSGSQESGSQPVTSGTTISSASLVSSQASSSSFFTNANSYSTTTTTSNNGIMNFT
|
TSGSSGTNSQGQIPQRVSGLQGSDALNIQQNQTSGGSLQAGQQKEGEQNQQTQQQQIL
|
IQPQLVQGGQALQALQAAPLSGQTFTTQAISQETLQNLQLQAVPNSGPIIIRTPTVGP
|
NGQVSNQTLQLQNLQVQNPQAQTITLAPMQGVSLGQTSSSNTTLTPIASAASIPAGTV
|
TVNAAQLSSMPGLQTINLSALGTSGIQVHPIQGLPLAIANAPGDHGAQLGLHGAGGDG
|
IHDDTAGGEEGENSPDAQPQAGRRTRREACTCPYCKDSEGRGSGDPGKKKQHICHIQG
|
CGKVYGKTSHLRANLRWHTGERPFNCTWSYCGKRFTRSDELQRHKRTNTGEKKFACPE
|
CPKRFNRSDHLSKHIKTHQNKKGGPGVALSVGTLPLDSGAGSEGSGTATPSALITTNM
|
VAMEAICPEGIARLANSGINVMQVADLQSINISGNGF
|
GENBANK ID: NP_009077.1
DEFINITION HOMO SAPIENS ZINC FINGER PROTEIN 161 (ZNF161), MRNA.
VERSION NB_007146.1 GI:6005967
CDS 42..1592
/CODON_START=4
1AGCGGGGGGA GTGGGGAGGA GGGGGGTCGG CCGCCGCAGC CATGGAGGCC AACTGGACCG
|
61CGTTCCTGTT CCAGGCCCAT GAAGCTTCCC ATCACCAACA GCAGGCAGCA CAGAACAGCT
|
121TGCTGCCCCT CCTGAGCTCT GCCGTGGAGC CCCCTGATCA GAAACCATTG CTTCCAATAC
|
181CAATAACTCA GAAACCTCAG GGTGCACCAG AAACATTAAA GGATGCCATT GGGATTAAAA
|
241AAGAAAAACC CAAAACTTCA TTTGTGTGCA CTTACTGCAG TAAAGCTTTC AGGGACAGCT
|
301ATCACCTGAG GCGCCACGAA TCGTGCCACA CAGGGATCAA GTTGGTGTCC CGGCCAAAGA
|
361AAACCCCCAC CACGGTGGTT CCCCTTATCT CTACCATCGC TGGGGACAGC AGCCGAACTT
|
421CGTTGGTCTC GACCATTGCA GGCATCTTGT CAACAGTCAC TACATCTTCC TCGGGCACCA
|
481ACCCCAGTAG CAGTGCCAGC ACCACAGCTA TGCCAGTGAC CCAGTCTGTC AAGAAACCCA
|
541GTAAGCCTGT CAAGAAGAAC CATGCTTGTG AGATGTGTGG GAAGGCCTTC CGAGATGTGT
|
601ACCATCTCAA TCGACACAAG CTCTCCCATT CAGATGAGAA ACCCTTTGAG TGTCCTATTT
|
661GTAATCAGCG CTTCAAGAGG AAGGACCGGA TGACTTACCA TGTGAGGTCT CATGAAGGAG
|
721GCATCACCAA ACCCTATACT TGCAGTGTTT GTGGGAAAGG CTTCTCAAGG CGTGACCACT
|
781TAAGCTGTCA TGTAAAACAT GTCCATTCAA CAGAAAGACC CTTCAAATGC CAAACGTGCA
|
841CTGCTGCCTT TGCCACCAAA GACAGACTGC GGACACACAT GGTGCGCCAT GAAGGCAAGG
|
901TATCATGTAA CATCTGTGGG AAGCTCCTGA GTGCAGCATA CATCACCAGC CACTTAAAGA
|
961CTCATGGGCA GAGCCAAAGT ATCAACTGTA ATACATGTAA ACAAGGCATC AGTAAAACAT
|
1021GCATGAGTGA AGAGACCACT AACCAAAAGC AGCAGCAGCA GCAGCAGCAG CAACAACAAC
|
1081AACAACAACA TGTGACAAGC TGGCCAGGGA AGCAAGTAGA AACACTCAGA CTGTGGGAAG
|
1141AAGCTGTTAA AGCAAGGAAG AAAGAAGCTG CTAACCTGTG CCAAACCTCC ACGGCTGCTA
|
1201CGACACCTGT GACTCTCACT ACTCCATTCA GTATAACATC CTCTGPGTCG TCTGAGACTA
|
1261TGTCAAACCC AGTCACAGTG GCAGCTGCAA TGAGCATGAG AAGTCCACPA AATGTTTCAA
|
1321GTGCAGTTAA CATAACCAGC CCAATGAACA TAGGGCATCC TGTAACTATA ACCAGTCCAT
|
1381TATCCATGAC CTCTCCTTTA ACACTCACTA CCCCAGTCAA CCTCCCCACC CCCGTCACTG
|
1441CCCCAGTGAA TATAGCACAC CCTGTCACCA TCACATCTCC AATGAATCTA CCCACACCTA
|
1501TGACATTAGC CGCCCCTCTC AATATAGCAA TGAGACCTGT AGACAGCATG CCTTTCTTGC
|
1561CCCAAGCTTT GCCTACATCA CCGCCTTGGT AAACAGTATT ATAAAATCAA AATATGGGTA
|
1621AAAGTAAATA TTTACCAGCA ACTTAACTTT TAGTTGATTA AAGCAAAAAG TAAACCATGA
|
1681AATTGGGAGA TTTTATTACA TTAGTTAATA AGAGTGTGGT AGCATTTTTC TCCAATTTGG
|
1741CTGGGATTAT TCAAAGTAGG GTGTGTATGT AACTTATCAC TGGACCACTT TAGTTTAATC
|
1801AGAAATTCCT TTTAGCTGAC AACATTGCTT AAACAGGATA GTAGTTGGCA AGATGAAATG
|
1861CCAGAATTAA AACCAATCAT AAGTAGAACC CACTTCAAAA TAAAAAAACA GCATTACTAT
|
1921TTCTAATCCC AAGGAATCAC TTTATTGTAA ACACTAGCAG AACTCTTCTC CCTATACAAG
|
1981GTGGATGGCT GATTTTAACC TGAAATTTTA AATCCACAGA TTGAGAGCTA GTGTAGAATT
|
2041GTCTGTGTTT ATTGTTTTTA TGAGTAAATA CATGCATTGT CATAATAAAA TGCATTTCAG
|
2101AGAATATGCA TTTTACCTTT GGGAATATGT TAATTTCAGG CAGCATTCCC TATGGGAAAG
|
2161GTGATACCAG CTCTGATATG CAAAGCATAT GATAATTTAT CATTCTAACT TCAACGTATA
|
2221ATAGGGATTG TGACCTGATA TTTGGAGATG TAAATATTGC TCAGCATATT AATCCCGATG
|
2281GAATATAGCA TTGTAGTTGA CTTTTT
|
GENBANK ID: AAA36598.1
DEFINITION HUMAN STEM CELL PROTEIN (SCL) MRNA, COMPLETE CDS.
VERSION M29038.1 GI:337958
CDS 81..725
/CODON_START=1
1AGTCAGAGTC ACTTTCTGTA AATGGTACTT AGGTAGGCGC GTCCGCCTCG GTTACAGCGG
|
61AGCTGCCCGG CGACGGCCGC ATGGTGCAGC TGAGTCCTCC CGCGCTGGCT GCCCCCGCCG
|
121CCCCCGGCCG CGCGCTGCTC TACAGCCTCA GCCAGCCGCT GGCCTCTCTC GGCAGCGGGT
|
181TCTTTGGGGA GCCGGATGCC TTCCCTATGT TCACCACCAA CAATCGAGTG AAGAGGAGAC
|
241CTTCCCCCTA TGAGATGGAG ATTACTGATG GTCCCCACAC CAAAGTTGTG CGGCGTATCT
|
301TCACCAACAG CCGGGAGCGA TGGCGGCAGC AGAATGTGAA CGGGGCCTTT GCCGAGCTCC
|
361GCAAGCTGAT CCCCACACAT CCCCCGGACA AGAAGCTCAG CAAGAATGAG ATCCTCCGCC
|
421TGGCCATGAA GTATATCAAC TTCTTGGCCA AGCTGCTCAA TGACCAGGAG GAGGAGGGCA
|
481CCCAGCGGGC CAAGACTGGC AAGGACCCTG TGGTGGGGGC TGGTGGGGGT GGAGGTGGGG
|
541GAGGGGGCGG CGCGCCCCCA GATGACCTCC TGCAAGACGT GCTTTCCCCC AACTCCAGCT
|
601GCGGCAGCTC CCTGGATGGG GCAGCCAGCC CGGACAGCTA CACGGAGGAG CCCGCGCCCA
|
661AGCACACGGC CCGCAGCCTC CATCCTGCCA TGCTGCCTGC CGCCGATGGA GCCGGCCCTC
|
721GGTGATGGGT CTGGGCCACC AGGATCAGCC AGGAGGGCGT TCTTAGGCTG CTGGGATGGT
|
781GGGCTTCAGG GCAGGTGGGG TGAGAATTGG GCGGCTCTGA AGCAAGGCGG TGGACTTGAA
|
841CTTTCCTGGA TGTCTGAACT TTGGGAAGCC TTTACTGACC CTGGGGCTGG CTTTTCTGTT
|
901TCCTGTACCA GTAGGAGAIC AGAAAAATGG AGCAAAGTGG TAGGTACTTT TTGTGAAGAC
|
961GGCACGGTCT TCCCTCTTCC CTCAGTCCCA AATCCTTCCC AAGTAAGAGG CTGGAGTTGT
|
1021CACTGCTTTT GGCCTGGAGT TTGGGATCCC TGTCTTTCCT AAGACCTGGG GTTGTCAGCT
|
1081CTCATCTGAG GCATCCAGCA GTCTCTGCCT TGCCTTTAGC CCCTCCCAAG CTGGCTGGGG
|
1141TGGCCTGTGT GGCCACTTCT GTCCATATTT ATAGGTACCC AATAGCTGCC CATTTCGTGA
|
1201GCCCCATCTT CACCCAGGCC TATGTTGATC CATCCAGCTT GCCAGATGCT GCAGAGTCAC
|
1261AAGCCTCGAG GTGCCTTCTT CAGGGCCTGG TTGAAGAAGA TGATCAGTGG ACAGTCTGCT
|
1321CTAGATGAGC TGGGCCGGAG GGTCAGGAAA CCCAGTCGCC CTTACTTCTT GCCCTGGGGA
|
1381TCAAAGTTCT GCTTTCTCCC CAATGAGACT TGCCTTCCTA AGCCTGTGGC TGTGGAGACC
|
1441ATGTCTGCAG CCCTGAGAAA GCCCTGTCGG GCTTTGTGTG AAGGCAGAGA AAGGGACAAT
|
1501GATACTAGAG TGATATGGAG CAAGAGATAT TTTGGGCATG TGGGCTTCAA CTCCTCGACA
|
1561TCACTGTTCA TGCTGGCGAG TGAATGCCAG TGTGCTGATG GGCGTACGCT GGTGCTGAGT
|
1621AGATGCGCAG CCCCATCTGT GCATTCTCCT GGATGCTTAG AGGGATTTCT TTGCTGTAAG
|
1681ATGTCTGTTT GCTGATGGTC TGGTCTATGT TCCGAATTGA GCACAAAACC TGTCCTATGA
|
1741ATGCTTTGCA TTTGGAATTT TTGCTTGACT TCAGTTATTG GTGGAATCTT TAGCGCTCAA
|
1801TAGGACCAGG ATCCAGCCTC ACTTCTAGGG TATGGGAAAT CCAATCAGAG ACCAGGCCCT
|
1861GGCTAAGACC CAAACATATG CACATTCACT TAGCAGAACC TTAAACACCC CTCAGTTGTG
|
1921CAGCTTTTGG TCATCAAGGG TGCGTCTGGG AGGTTGGTTT AATGCAATAG AAGTGCTCCC
|
1981CTCTGAAAGT TGTACATGAA ATTTTTGTAA ATCACATCCT TATCCTTCAT CTTTTAAAGA
|
2041AATAACCACT GCAAGTCCTT TTGTAAAGTG AAGAATCCTT TTGTAGAATG AACCACTGCC
|
2101CCTTCATTGA TTTCCTGTGT CAATCCAGAT GGTGGGATGT GGTTTTCTTA AGGTGAGGCC
|
2161TGTCTGTGAC CTGCATCTAA GCCCATGGGA CAAATTGCAC AGAAGTCCTG TATGTCTGTC
|
2221ATTGTACCCT TAAGTCACCC TAGCCCTCTC CCTCTAGGCT CTGCCTTCGA GGTCAGAGGA
|
2281GAGATAGCCT GTGGCCCTGT CCTGCCATGC AAGAACTCAT CACTGTGGCT GTCTGGAAAG
|
2341CCCCCCCTTA TAGTTTGGGC TTCAGCCTAG TGGCTTGTCC TGACCATGAT GGGGCCCTAA
|
2401TTCAGCCATG TACAGACAGA GAATATGTCT GCTCCTTTCC CCTTCCTTTT AAGTAAGGTC
|
2461CAATTCTCGA GCTTGGGGCA ACATTGTTCA CCTTTGTAGC ACTCAGGCTC TCCATTCAAT
|
2521TTCAGGCTCC CCAGATCATG TTTTGGTGAA AATTAGGGTT GGTTCCTTTC CAACGTTTGG
|
2581AAGATCCTGT GAGGAGCCCC ATCTGTCTAA AGATAGAGTC ATTGCTGTAG GATCTAAGGC
|
2641TGTTTGCTTC ACCGTGGATT CGCTTGAGTT AGGAATGAGA ACTACCGACA GTATGGATGG
|
2701GTGGATGGGT TTTATGAGAT GGATCACATA TTTTATTAAG AACTCAAACT TCTGGCTCCC
|
2761TCTTCTTTCA GACTTGCCAT GTGACTCTGG CTTGGCCTAT CTCCTAGGGC TATGGTGTGG
|
2821ACTGAATGGG ATCATGAAAG TAGACAGTTT TGAGAACGTA AAGAACTTTT TCTTTTCCCT
|
2881CAATCTCAAT CCTGCAGTGG GGTTTCGCAG CCTGAGTCCA CGACCTAGGC AGTAGGCCGG
|
2941TGTGCCTGAC TGCCCAGCAT TTGGGTAATT TAGATTGTAA ACCGCTTTGG CCTGAGTTAT
|
3001TGAGATTGTC CTCATTTCTC CAGATTATCT ATTTGTGTGT GTGTGTGTGT GTGTGTGAGA
|
3061GACGGTGTCT TGTTCTGTCA CTCAGGCTGG AGTACAGTGG TGCCATCATT GCTGTCTGCA
|
3121GCCTTGAACT CTGGGCTCAA GCAATCCTCT CACCTCAGCC TCCCGAGTAG GGAGGACCAC
|
3181AGGTGTGAGC CACCACACCT GGCTAATTTT TACTTTTTTT TTTTTTTGGT AGAGATGGAG
|
3241TCTTGCTATA TTGCCCAGGC TGGTCTTGAA GTCCTGGCTT CAGGCAATTC TCCTGCCTTT
|
3301GCCTCCAGAA GCACTGGGAT CACAGGTGTC AGCCATTGCA CCCAGCCCAG ATTGTCTTAA
|
3361TTTCTATCTT GTTCCAAGGC CAGGGACAGT AATAAGAATG GAAAAGAGAT ATGGGAACAC
|
3421TGGCAGACTG TGTAAAATGT AATGCAACTA CCCAAAACAA GCCTGGTAGG AAAGGGCAAG
|
3481TCTTTAGGTC TTTGTAAGAA CTAAAGAAGA TCTGTAATTT TTATTTTCAC CCTCTGTACC
|
3541CCATGACCTT ATCCTTCCTC TCCTTCCTTG TTACCCATGA AAAACTGGCA ACATTCCAAG
|
3601AATAGCATCT GTACAAAGGG GAAAGAACAT AAAGGTAAAA CAAAACAAAA CAACATTTTG
|
3661AGAACRAAGA TGACCATAAC CACTGAAGGG AATCACATCT TTTAAGACAA ATTCATATTC
|
3721TTTTATTTGT TATGGCAGAT GACAAGATGG TACAACCTTT ATTCTTTTCC AAAATAAAAC
|
3781AAAGGGCACA GCATCTGTAG TCAGCCGACA ACTCTTTCGG CCTTTTGGGG GTGGGTCTGG
|
3641CCGTACTTGT GATTTCGATG GTACGTGACC CTCTGCTGAA GACTTGCCCC CTGCCCGTGT
|
3901ACATAGTGCA TTGTTTCTGT GGGCGGGCCC AGCACTTTCC GTCAACGTTG TACTGTATGT
|
3961GATGAATTGC GTTGGTCTCT GCATTTTTCT GCAGAAGAGG AGTAACCGCT CCAGGTACCT
|
4021TGACCTTTGT ACAGGCCAGA GGCCAACACT GTGGGTGTGT GACTCTTTAG CAAAAAAAAC
|
4081CCATGTGGTG ATGATGTGTC TATATATGTG AGGATGTATC GGGAAGATTT CTAAATAAAA
|
4141GTTTTACAAA GGG
|
GENBANK ID: NP_006168
DEFINITION HOMO SAPIENS NEURAL RETINA LEUCINE ZIPPER (NRL), MRNA.
VERSION NM_006177.1 GI:5453801
CDS 118..831
/CODON_START=1
1CCAGGCCCTG CTCCATGGAG CCTTCAGTCT CCTGGGAAGC TGTGCCTGTC TGGCTCTGGC
|
61ACTGACCACA TCCTCTCGGC CATTTCTGAA GTGCACTCCT CCCAGCCCAG CTCCAGAATG
|
121GCCCTGCCCC CCAGCCCCCT GGCCATGGAA TATGTCAATG ACTTTGACTT GATGAAGTTT
|
181GAGGTAAAGC GGGAACCCTC TGAGGGCCGA CCTGGCCCCC CTACAGCCTC ACTGGGCTCC
|
241ACACCTTACA GCTCAGTGCC TCCTTCACCC ACCTTCAGTG AACCAGGCAT GGTGGGGGCA
|
301ACCGAGCGCA CCCGGCCAGG CCTGGAGGAG CTGTACTGGC TGGCTACCCT GGAGGAGGAG
|
361CTGGGGGCTG GGGAGGCATT GGGGCTGAGT CCTGAAGAGG CCATGGAGCT GCTGCAGGGT
|
421CAGGGCCCAG TCCCTGTTGA TGGGGCCGAT GGCTACTACC CAGGGAGCCC AGAGGAGACA
|
481GGAGCCCAGC ACGTCCAGCT GGCAGAGCGG TTTTCCGACG CGGCGCTGGT CTCGATGTCT
|
541GTGCGGGAGC TAAACCGGCA GCTGCGGGGC TGCGGGCGCG ACGAGGCGCT GCGGCTGAAG
|
601CAGAGGGGGC GCACGCTGAA GAACCGCGGC TACGCGCAGG CCTGTCGCTC CAAGCGGCTG
|
661CAGGAGGGGG GCGGGCTGGA GGCCGAGCGC GCCCGCCTGG CCGCCCAGCT GGACGCGCTG
|
721CGGGCCGAGG TGGCCCGCCT GGCCCGGGAG CGCGATCTCT ACAAGGCTCG CTGTGACCGG
|
781CTAACCTCGA GCGGCCCCGG GTCCGGGGAC CGCTGCCACG TCTTCCTCTG AGCCGTTCAG
|
841AGCACCTTGT GGTGTAGTGG GGGCTGGGTG GGGTGGCTCC GCCCAGGAGG CGGCTGCACG
|
901GTTCTCTGCA TCGTTACCAG AGCGCCTTCT GGTCCTAGCC ACGCCCTGTA TGACCGCGCA
|
961AATATCCCCA AAGCTTTTGG GTCCTCAAGT CATGCCCGAA TTTAGATGCT GGTCATTTTC
|
1021TGGAGAGGGG TCCCCTCCCC TTACGAACAC AAAAACCCAG CCCACATGAC TAGCACGCTG
|
1081AGCTCTGCAG GGACCAGTGC CAGGCACTGG GGGGTGGAAG TGTGGTGACA CAGTGAATGG
|
1141GAGGTGGAGG AGGGTTGCAG CTCCCACCTC AGTTTAGTTT TTAATTCAGG GTTTTCAACC
|
1201TGTAACACAT TAAAGCTGTA ATTAGCAATG AGGCTGTATT TTCATTCTGA AGCTTGTAAC
|
1261CTCCCCATTT TAGCACTACA GAATTTTCAA GATTTCAATA TCCAACAACT AGATAGATTA
|
1321GGACCTCTAT CGGAGATGCT TTTTCCCTGC CCAACCCTGT GGCCTTCAGG GCTCAGAGCA
|
1381GCAAAGGCCT GAAGAGTGAG CTCTGGGGGT TGTTGGTGTG GGTTGGGAGA GAGCTGTGTG
|
1441CAGAAGTCTG GAAACCTGGG TCCTAGTCCC AGCTCTTCCA TGGGATCCCC CTGTCACCCT
|
1501GAGCAAATCA GTTGCTTCCT GGACTTGTGT TACTTCATCT AATTCTCATG TGGATTGGAC
|
1561GACTTCTCCT CCCTTTCCAG TTCTGGCATC TCCCCAGTAT GGAAGTCCCG GTGGTCTCCC
|
1621CAAGAAGTCC CCAAGACAAT CTCGCCAAAG GCACCTCCTA TCCTCCTGCA GTTTCCCACC
|
1681TGCAGCCTAG GCAGGGCATG CACAGCCCAG GCGAGGAAGC CTGCCTTCTC TGTGAGCACA
|
1741TACGTGGGTC CTCCGCAGCT CCCTCCAGCC TGTCTGGGCC TCCAGACCTG CACAGGGTGC
|
1801TCCTGCCACC TCCCACCTCT CTGAGGGCTG AGGTGAGACT TCTCCTGGGA TGACAATTTG
|
1861CTGAGAGAGT GCAGCTTTTC TGAATTAAAC TTGAAGTCCA CGCAGAATTC TAATGCAATA
|
1921AGCTAAATGT T
|
GENBANK ID: AAA58399.1
VERSION M95809.1 GI:179568
/GENE=“BTF2”
CDS 55..1701
/CODON_START=1
1AGTTAGTTAC TTCCTGTCTA GAGTTGTAGC TTCCACCTGC ACCTTCTAGC CACCATGCCA
|
61ACCTCATCTG AAGAAGTTTT GCTGATTGTA AAGAAAGTGC GTCAAAAGAA GCAGGATGCA
|
121GCTCTGTACC TCATGGCAGA AAGAATTGCT TGGGCACCTG AAGGCAAAGA TAGATTTACA
|
181ATCAGCCATA TGTATGCAGA TATTAAATGC CAGAAAATTA GTCCAGAAGG AAAAGCTAAA
|
241ATTCAGCTTC AGCTGGTCCT ACATGCAGGG GACACAACTA ACTTCCATTT TTCCAATGAA
|
301ACCACACCAG TGAAAGAGCG AGATGCAGTA AAAGACCTTC TTCAGCAGCT GCTGCCCAAA
|
361TTCAAGAGGA AAGCAAATAA AGAACTGGAA GAGAAGAACA GAATGCTGCA AGAAGATCCT
|
421GTTTTGTTTC AGCTTTATAA AGACCTTGTT GTGAGTCAAG TGATCAGTGC TGAGGAATTC
|
481TGGGCCAATC GTTTAAATGT GAATGCAACA GATAGTTCTT CCACATCCAA TCATAAGCAG
|
541GATGTTGGCA TTTCTGCTGC ATTTCTGGCT GATGTCCGGC CCCAAACTGA TGGCTGTAAC
|
601GGTCTAAGAT ATAATTTAAC TTCTGATATC ATTGAGTCCA TATTTAGGAC CTATCCAGCA
|
661GTAAAAATGA AATATGCAGA AAATGTTCCC CACAACATGA CAGAGAAGGA ATTCTGGACA
|
721CGTTTTTTCC AGTCCCATTA TTTTCACAGG GATCGGCTGA ATACAGGGTC AAAGGATCTC
|
781TTTGCAGAAT GTGCCAAAAT AGATGAAAAA GGCCTAAAAA CAATGGTTTC ATTAGGAGTG
|
841AAAAACCCAC TACTAGATTT AACAGCTTTG GAAGATAAAC CATTAGATGA GGGCTATGGC
|
901ATTTCCTCTG TGCCATCTGC TTCCAATTCT AAATCCATAA AAGAGAATAG TAATGCTGCC
|
961ATCATCAAGA GATTTAACCA TCACAGTGCC ATGGTCCTGG CAGCTGGACT CAGAAAACAA
|
1021GAAGCACAAA ATGAACAAAC TAGTGAGCCC AGCAACATGG ATGGAAATTC CGGAGATGCA
|
1081GACTGCTTTC AGCCAGCAGT CAAAAGGGCG AAATTACAAG AGTCCATTGA ATATGAAGAC
|
1141TTGGGGAAAA ATAATTCTGT AAAAACGATT GCACTAAACC TCAAGAAGTC AGATAGGTAT
|
1201TATCATGGTC CAACTCCAAT CCAGTCACTA CAGTATGCAA CAAGTCAGGA CATTATTAAT
|
1261TCTTTTCAAA GTATTAGACA AGAAATGGAA GGTTATACAC CCAAGTTAAC TCAGGTTCTC
|
1321TCAAGTAGTG CTGCCAGTAG TACCATCACA GCACTGTCAC CTGGAGGGGC ACTTATGCAG
|
1381GGAGGAACAC AGCAAGCCAT AAACCAGATG GTGCCAAATG ATATTCAATC TGAATTGAAA
|
1441CACTTATATG TAGCTGTTGG AGAACTTCTA CGACATTTCT GGTCCTGCTT TCCTGTTAAT
|
1501ACGCCATTCC TAGAAGAAAA GGTAGTGAAA ATGAAAAGTA ATTTGGAACG ATTCCAAGTT
|
1561ACGAAGCTCT GTCCATTCCA AGAAAAGATT CGGAGACACT ATTTAAGCAC AAATTTGGTA
|
1621AGTCACATAG AAGAGATGCT CCAGACAGCC TACAACAAGC TCCACACATG GCAGTCACGG
|
1681CGTCTGATGA AGAAAACGTG AGGTGGCCAT GATGCTTACA GGTTTTGTGA GATTGAGAGA
|
1741ACTATGACCT GCAGCAACTC TGGAAACCTG GCCTGACAGA CAAGCAGATG ACCTCACAGG
|
1801AGTGATAAGA AACATCTGCT CCACGCCAAC TCCCAGAGCT GATGCTATTG TACTTGCACA
|
1861TTGGAGACTG AAAGGAAAGA AGGGACTAAA TGC
|
GENBANK ID: AAA65605.1
DEFINITION HUMAN OCTANER BINDING TRANSCRIPTION FACTOR 1 (OTF1) MRNA,
VERSION L20433.1 GI:418015
CDS 235..1497
/CODON_START=1
1GCGGGGCTAG AGCTGTCGGA GAAGCGGGAC CGCGAGGCCG GCGCGCGGCG CTCTGCGCGG
|
61TCAGAGGGAG CGCCTGGCAG CAGCAGGAGC AGCAGCAGCA GCCCGCGGCG GGGCCGCCGC
|
121CAGCCGCCGC GACCGCCGCG GCTGCAGCCT CCGAAGGGAG GCCGGGTGAG CCGGCGTACG
|
181CACTTTCCCG CGGACTTTCG GAGTGTTTGT GGATATACAT GCCAAGCCGC CACGATGATG
|
241TCCATGAACA GCAAGCAGCC TCACTTTGCC ATGCATCCCA CCCTCCCTGA GCACAAGTAC
|
301CCGTCGCTGC ACTCCAGCTC CGAGGCCATC CGGCGGGCCT GCCTGCCCAC GCCGCCGCTG
|
361CAGAGCAACC TCTTCGCCAG CCTGGACGAG ACGCTGCTGG CGCGGGCCGA GGCGCTGGCG
|
421GCCGTGGACA TCGCCGTGTC CCAGGGCAAG AGCCATCCTT TCAAGCCGGA CGCCACGTAC
|
481CACACGATGA ACAGCGTGCC GTGCACGTCC ACTTCCACGG TGCCTCTGGC GCACCACCAC
|
541CACCACCACC ACCACCACCA GGCGCTCGAA CCCGGCGATC TGCTGGACCA CATCTCCTCG
|
601CCGTCGCTCG CGCTCATGGC CGGCGCGGGC GGCGCGGGCG CGGCGGCCGG CGGCGGCGGC
|
661GCCCACGACG GCCCGGGGGG CGGTGGCGGC CCGGGCGGCG GCGGCGGCCC GGGCGGCGGC
|
721GGCCCCGGGG GAGGCCGCGC TGGCGGCCCG GGGGGCGGCG GCGGCGGCCC GGGCGGCGGG
|
781CTCCTGGGCG GCTCCGCGCA CCCTCACCCG CATATGCACA GCCTGGGCCA CCTGTCGCAC
|
841CCCGCGGCCG CCGCCGCCAT GAACATGCCG TCCGGGCTGC CGCACCCCGG GCTGGTGGCG
|
901GCGGCGGCGC ACCACGGCGC GGCAGCGGCA GCGGCGGCGG CGTCGGCCGG GCAGGTGGCA
|
961GCGGCATCGG CGGCGGCGGC CGTCGTGGCC GCAGCGGGCC TGGCGTCCAT CTGCGACTCG
|
1021GACACGGACC CGCGCCAGCT CCAGGCCTTC GCGGAGCGCT TCAAGCAGCG GCGCATCAAG
|
1081CTGGGCGTGA CGCAGGCCGA CGTGGGCTCG GCGCTGGCCA ACCTCAAGAT CCCGGGCGTG
|
1141CGCTCACTCA GCCAGAGCAC CATCTGCAGG TTCGAGTCGC TCACGCTCTC GCACAACAAC
|
1201ATGATCGCGC TCAAGCCCAT CCTGCAGGCG TGGCTCCAGG AGGCCGAGGG CCCCCAGCGC
|
1261GAGAAAATGA ACAAGCCTGA GCTCTTCAAC GGCGGCGAGA AGAAGCGCAA GCGGACTTCC
|
1321ATCGCCGCGC CCGAGAAGCG CTCCCTCGAG GCCTACTTCG CCGTGCAGCC CCGGCCCTCG
|
1381TCCGAGAAGA TCGCCGCCAT CGCCGAGAAA CTGGACCTCA AAAAGAACGT GGTGCGGGTG
|
1441TGGTTTTGCA ACCAGAGACA GAAGCAGAAG CGGATGAAAT TCTCTGCCAC TTACTGAGGG
|
1501GGCTGGGAGG TGTCGGGCGG GACAGAATGG GGAGCTGAGG AGGCATTTTT GGGGGGCTTT
|
1561CCTCTGCTTG CCTCCCCTCG GATTTGGAGT GTCCGTTATC CTGCCTGCAT TTGGGGAGTC
|
1621CCTTCTCGCT CTCTTTCCTC CACCCATTCT CTGATTTTCC TGCCTTTGCT GTCCCCTAGC
|
1681CTTGAGGACT GGGGTGCTGG GTGTGGGGAT TGGAGTATAG GGTAGGGGAG AAGGGGGGGA
|
1741GCATTCGGGG GAGTGGGGAG TGGGGGGAAG GAAAGCGGAG ACCGGACCAG GGGTTTTAAG
|
1801GAGCAGGATG GTTCTGGGGT TTGGGTGGGG GGAGACGCGG GAAGGGTAGG AAAATGGACT
|
1861GTTTCTGACC AGAGACACTT ACCTAAATAT CCTGGGGACC AAGGAACTAT GTACAAAAAC
|
1921AAACCTACCA ACCACCAAAA ACTAGACAAA TAAAGACAAA CTAAAACAAA ACAGAACAAA
|
1981AGCAAAGGAA AATGCTTTAG AAATTTTAAC TCCGGGGAGC CATAATCTGC AACTTCATTT
|
2041TCCCCCATAG AAGAGAAAAA AGACCACCAC CATTATTACG ACCTCCCCAA CCCTACACGC
|
2101ACGAACTGAG TCGAAAAACG AAAACCAAAC GAGCGAGAAG TTGAAGTTCT GGGTATCAAA
|
2161GCTAGTTGTT CTGTCTGCGT GTTTAATTTT TCCCTCTCTC ACCTCCACCC CATCCATATC
|
2221CTCTTTATTT CCTCCGTTCC AATGAGAGGC CTATGGCTGC TCTCCAATCC CGGGAAGTGA
|
2281GTGGGAGCAC AGCTGAAAAG AGAGGGTCAG GGGGAGGCTG GCTGCTTGCT TAGGTGGAAT
|
2341CCAACTTTTC CCGTGGCCCT GCCTATACTC TGGTGGCCTG GTCCTGTTGG GGTGGGGGTC
|
2401TTTGGAGAGA AGGGCATAGT CTTTGAGCTA CTAAAAAGCA GAATTCCGGA GCTTCGAGAT
|
2461ATCTTATTCT AGGAAAATGA AACAATTTTA ACAACAGTTT TTTTTCCTCT TATGTCGAAG
|
2521ATCTAGTTTT AGACAATTTC AAAATAAGCT TTTCCCACTC ATAGAACTTT AACTTGCCCT
|
2581TTCAGTTTTA TCTTTTTTTT AGAGAGAGGT TTAAACTACT GATTTTTCCT GTTGATTCAA
|
2641ATAGACTAAT GGGGTGAAAG TTATTAGGAG AGATACTGTC TCCTGTTTTC TCCACTGAAC
|
2701GAGACTCATC TTGCTCTTCT AGGTCCCGTT TCTTCCTCTC TTGGAGGACA TGAAATTATA
|
2761GAAATGTTGA GAAGTTCCTG CTTTCTTTTG CGGTAGGACT TGGCTGTGAG AAAATCACCT
|
2821AAATCCCAGA AAAGAGGAAG ACAGATTTAA AGTGCCCCCA CCCCCATTTG TTTCAAAGAG
|
2881GTCTGCATGT TGGGCGAAAA CAGAACAACT GTGTTTCCTT TTACTTGTTC TTATTATTCA
|
2941AGAGTCATTT ATTACAGGGG ATAAATGTTG GGTAGCAAGA ACTTTAATTT GCACTACCAG
|
3001TCTCCCAAAT AGAAAATCAT GTATAGTATT TCATAGTAAT AATCAGGTAC CTTACAAGCT
|
3061GCTGGTGGAT TTTAAAAAAT TAAGATAGTT GAAGGTGGTT AGGTAAAATG CCTGCTTTGT
|
3121GTACAAGATA CTCTTTGGAT CTCTCGTAGA GATGGTTTGT TACCATCCTT TAATCATAAC
|
3181TAAAACATTG AAAACAGAAC AAATGAGAAA AGAAAAAAAA CCTGCCGATT AACAAGACTG
|
3241AAATCATGCA TGATCTGAAA GGTGTGGAAA GAAACACAAT TAGGTCTCAC TCTGGTTAGG
|
3301CATTATTTAT TTAATTATGT TGTATATCAT TGTTTGCAGG GCAAACATTC TATGCATTTG
|
3361AAACTGAGCA CTAAACTGGG CTAGCTTTCT GGTAGACCGT TTTGTGGCTA GTGCGATTTC
|
3421ACAGTCTACT GCCTGTTTCC ACTGAAAACA TTTTTGTCAT ATTCTTGTAT TCAAAGAAAA
|
3481CAGGAAAAAA GTTATTGTAA ATATTTTATT TAATGCACAC ATTCACACAG TGGTAACAGA
|
3541CTGCCAGTGT TCATCCTGAA ATGTCTCACG GATTGATCTA CCTGTCTATG TATGTCTGCT
|
3601GAGCTTTCTC CTTGGTTATG TTTTTTCTCT TTTACCTTTC TCCTCCCTTA CTTCTATCAG
|
3661AACCAATTCT ATGCGCCAAA TACAACAGGG GGATGTGTCC CAGTACACTT ACAAAATAAA
|
3721ACATAACTGA AAGAAGAGCA GTTTTATGAT TTGGGTGCGT TTTTGTGTTT ATACTGGGCC
|
3781AGGTCCTGGT AGAACCTTTC AACAAACAAC CAAACAAAAA AAAA
|
GENBANK ID: AAA61146.1
DEFINITION HUMAN TRANSCRIPTION FACTOR (E2A) MRNA, COMPLETE CDS.
VERSION M31523.1 GI:339477
CDS 31..1995
/CODON_START=1
1GCCTGAGGTG CCCGCCCTGG CCCCAGGAGA ATGAACCAGC CGCAGAGGAT GGCGCCTGTG
|
61GGCACAGACA AGGAGCTCAG TGACCTCCTG GACTTCAGCA TGATGTTCCC GCTGCCTGTC
|
121ACCAACGGGA AGGGCCGGCC CGCCTCCCTG GCCGGGGCGC AGTTCGGAGG TTCAGGTCTT
|
181GAGGACCGGC CCAGCTCAGG CTCCTGGGGC AGCGGCGACC AGAGCAGCTC CTCCTTTGAC
|
241CCCAGCCGGA CCTTCAGCGA GGGCACCCAC TTCACTGAGT CGCACAGCAG CCTCTCTTCA
|
301TCCACATTCC TGGGACCGGG ACTCGGAGGC AAGAGCGGTG AGCGGGGCGC CTATGCCTCC
|
361TTCGGGAGAG ACGCAGGCGT GGGCGGCCTG ACTCAGGCTG GCTTCCTGTC AGGCGAGCTG
|
421GCCCTCAACA GCCCCGGGCC CCTGTCCCCT TCGGGCATGA AGGGGACCTC CCAGTACTAC
|
481CCCTCCTACT CCGGCAGCTC CCGGCGGAGA GCGGCAGACG GCACCCTAGA CACCCAGCCC
|
541AAGAAGGTCC GGAAGGTCCC GCCGGGTCTT CCATCCTCGG TGTACCCACC CAGCTCAGGT
|
601GAGGACTACG GCAGGGATGC CACCGCCTAC CCGTCCGCCA AGACCGCCAG CAGCACCTAT
|
661CCCGCCCCCT TCTACGTGGC AGATGGCAGC CTGCACCCCT CAGCCGAGCT CTGGAGTCCC
|
721CCGGGCCAGG CGGGCTTCGG GCCCATGCTG GGTGGGGGCT CATCCCCGCT GCCCCTCCCG
|
781CCCGGTAGCG GCCCGGTGGG CAGCAGTGGA AGCAGCAGCA CGTTTGGTGG CCTGCACCAG
|
841CACGAGCGTA TGGGCTACCA GCTGCATGGA GCAGAGGTGA ACGGTGGGCT CCCATCTGCA
|
901TCCTCCTTCT CCTCAGCCCC CGGAGGCACG TACGGCGGCG TCTCCAGCCA CACGCCGCCT
|
961GTCAGCGGGG CCGACAGCCT CCTGGGCTCC CGAGGGACCA CAGCTGGCAG CTCCGGGGAT
|
1021GCCCTCGGCA AAGCACTGGC CTCGATCTAC TCCCCGGATC ACTCAAGCAA TAACTTCTCG
|
1081TCCAGCCCTT CTACCCCCGT GGGCTCCCCC CAGGGCCTGG CAGGAACGTC ACAGTGGCCT
|
1141CGAGCAGGAG CCCCCGGTGC CTTATCGCCC AGCTACGACG GGGGTCTCCA CGGCCTGCAG
|
1201AGTAAGATAG AAGACCACCT GGACGAGGCC ATCCACGTGC TCCGCAGCCA CGCCGTGGGC
|
1261ACAGCCGGCG ACATGCACAC GCTGCTGCCT GGCCACGGGG CGCTGGCCTC AGGTTTCACC
|
1321GGCCCCATGT CGCTGGGTGG GCGGCACGCA GGCCTGGTTG GAGGCAGCCA CCCCGAGGAC
|
1381GGCCTCGCAG GCAGCACCAG CCTCATGCAC AACCACGCGG CCCTCCCCAG CCAGCCAGGC
|
1441ACCCTCCCTG ACCTGTCTCG GCCTCCCGAC TCCTACAGTG GGCTAGGGCG AGCAGGTGCC
|
1501ACGGCGGCCG CCAGCGAGAT CAAGCGGGAG GAGAAGGAGG ACGAGGAGAA CACGTCAGCG
|
1561GCTGACCACT CGGAGGAGGA GAAGAAGGAG CTGAAGGCCC CCCGGGCCCG GACCAGCCCA
|
1621GACGAGGACG AGGACGACCT TCTCCCCCCA GAGCAGAAGG CCGAGCGGGA GAAGGAGCGC
|
1681CGGGTGGCCA ATAACGCCCG GGAGCGGCTG CGGGTCCGTG ACATCAACGA GGCCTTTAAG
|
1741GAGCTGGGGC GCATGTGCCA ACTGCACCTC AACAGCGAGA AGCCCCAGAC CAAACTGCTC
|
1801ATCCTGCACC AGGCTGTCTC GGTCATCCTG AACTTGGAGC AGCAAGTGCG AGAGCGGAAC
|
1861CTGAATCCCA AAGCAGCCTG TTTGAAACGG CGAGAAGAGG AAAAGGTGTC AGGTGTGGTT
|
1921GGAGACCCCC AGATGGTGCT TTCAGCTCCC CACCCAGGCC TGAGCGAAGC CCACAACCCC
|
1981GCCGGCCACA TGTGAAAGGT ATGCCTCCGT GGGACGAGCC ACCCGCTTTC AGCCCTGTGC
|
2041TCTGGCCCCA GAAGCCGGAC TCGAGACCCC GGGCTTCATC CACATCCACA CCTCACACAC
|
2101CTGTTGTCAG CATCGAGCCA ACACCAACCT GACAAGGTTC GGAGTGATGG GGGCGGCCAA
|
2161GGTGACACTG GGTCCAGGAG CTCCCTGGGG CCCTGGCCTA CCACTCACTG GCCTCGCTCC
|
2221CCCTGTCCCC GAATCTCAGC CACCGTGTCA CTCTGTGACC TGTCCCATGG ATCCTGAAAC
|
2281TGCATCTTGG CCCTGTTGCC TGGGCTGACA GGAGCATTTT TTTTTTTTCC AGTAAACAAA
|
2341ACCTGAAAGC AAGCAACAAA ACATACACTT TGTCAGAGAA GAAAAAAATG CCTTAACTAT
|
2401AAAAAGCGGA GAAATGGAAA CATATCACTC AAGGGGGATG CTGTGGAAAC CTGGCTTATT
|
2461CTTCTAAAGC CACCAGCAAA TTGTGCCTAA GCGAAATATT TTTTTTAAGG AAAATAAAAA
|
2521CATTAGTTAC AAGATTTTTT TTTTCTTAAG GTAGATGAAA ATTAGCAAGG ATGCTGCCTT
|
2581TGGTCTCTGG TTTTTTTAAG CTTTTTTTGC ATATGTTTTG TAAGCAACAA ATTTTTTTGT
|
2641ATAAAAGTCC CGTGTCTCTC GCTATTTCTG CTGCTGTTCC TAGACTGAGC ATTGCATTTC
|
2701TTGATCAACC AGATGATTAA ACGTTGTATT AAAAAGACCC CGTGTAAACC TGAGCCCCCC
|
2761CCGTCCCCCC CCCCGGAAGC CACTGCACAC AGACAGACGG GGACAGGCGG CGGGTCTTTT
|
2821GTTTTTTTGA TGTTGGGGGT TCTCTTGGTT TTGTCATGTG GAAAGTGATG CGTGGGCGTT
|
2881CCCTGATGAA GGCACCTTGG GGCTTCCCTG CCGCATCCTC TCCCCTCAGG AAGGGGACTG
|
2941ACCTGGGCTT GGGGGAAGGG ACGTCAGCAA GGTGGCTCTG ACCCTCCCAG GTGACTCTGC
|
3001CAAGCAGCTG TGGCCCCAGC GGTACCCTAC ACAACGCCCT CCCCAGGCCC CCCTAAGCTG
|
3061CTCTCCCTTG GAACCTGCAC AGCTCTCTGA AATGGGGCAT TTTGTTGGGA CCAGTGACCC
|
3121CTGGCATGGG GACCACACCC TGGAGCCCGG TGCTGGGGAC CTCCTGGACA CCCTGTCCTT
|
3181CACTCCTTGC CCCAGGGACC CAGGCTCATG CTCTGAACTC TGGCTGAGAG GAGTCTGCTC
|
3241AGGAGCCAGC ACAGGACACC CCCCACCCCA CCCCACCATG TCCCCATTAC ACCAGAGGGC
|
3301CATCGTGACG TAGACAGGAT GCCAGGGGCC TGACCAGCCT CCCCAATGCT GGGGAGCATC
|
3361CCTGGCCTGG GGCCACACCT GCTGCCCTCC CTCTGTGTGG TCCAAGGGCA AGAGTGGCTG
|
3421GAGCCGGGGG ACTGTGCTGG TCTGAGCCCC ACGAAGGCCT TGGGCTGTGG CTCCGACCCT
|
3481GCTGCAGAAC CAGCAGGGTG TCCCCTCGGG CCCATCTGTG TCCCATGTCC CAGCACCCAG
|
3541GCCTCTCTCC AGGTCTCCTT TTCTGGTCTT TTGCCATGAG GGTAACCAGC TCTTCCCAGC
|
3601TGGCTGGGAC TGTCTTGGGT TTAAAACTGC AAGTCTCCTA CCCTGGGATC CCATCCAGTT
|
3661CCACACGAAC TAGGGCAGTG GTCACTGTGG CACCCAGGTG TGGGCCTGGC TAGCTGGGGG
|
3721CCTTCATGTG CCCTTCATGC CCCTCCCTGC ATTGAGGCCT TGTGGACCCC TGGGCTGGCT
|
3781GTGTTCATCC CCGCTGCAGG TCGGGCGTCT CCCCCCGTGC CACTCCTGAG ACTCCACCGT
|
3841TACCCCCAGG AGATCCTGGA CTGCCTGACT CCCCTCCCCA GACTGGCTTG GGAGCCTGGG
|
3901CCCCATGGTA GATGCAAGGG AAACCTCAAG GCCAGCTCAA TGCCTGGTAT CTGCCCCCAG
|
3961TCCAGGCCAG GCGGAGGGGA GGGGCTGTCC GGCTGCCTCT CCCTTCTCGG TGGCTTCCCC
|
4021TGCGCCCTGG GAGTTTGATC TCTTAAGGGA ACTTGCCTCT CCCTCTTGTT TTGCTCCTGC
|
4081CCTGCCCCTA GGTCTGGGTG GCAGTGGCCC CATAGCCTCT GGAACTGTGC GTTCTGCATA
|
4141GAATTCAAAC GAGATTCACC CAGCGCGAGG AGGAAGAAAC AGCAGTTCCT GGGAACCACA
|
4201ATTATGGGGG GTGGGGGGTG TGATCTGAGT GCCTCAAGAT GGTTTTCAAA AAATTTTTTT
|
4261TAAAGAAAAT AATTGTATAC GTGTCAACAC AGCTGGCTGG ATGATTGGGA CTTTAAAACG
|
4321ACCCTCTTTC AGGTGGATTC AGACACCTGT CCTGTATATA ACACCACTGT AGCAATAAAC
|
4381GTGACATTTT ATAAAG
|
GENBANK ID: NM_000416.1
VERSION NM_000416.1 GI:4557879
MALLFLLPLVMQGVSRAENGTADLGPSSVPTPTNVTIESYNMNP
|
IVYWEYQIMPQVFVFTVEVKNYCVKNSENIDACTNISHHYCNISDNVCDPSNSLWVRV
|
KARVCQKESAYAKSEEFAVCRDCKIGPPKLDIRKEEKQINIDIFHFSVFVNCDEQEVD
|
YDPETTCYIRVYNVYVRMNGSEIQYKILTQKEGDCDEIQCQLAIPVSSLNSQYCVSAE
|
GVLEVWCVTTEKSKEVCITIFNSSIKCSLWIPVVAALLLWLVLSLVFICFYIKKINPL
|
KEKSIILPKSLISVVRSATLETKPESKYVSLITSYQPFSLEKEVVCEEFLSPATVPGM
|
HTEDNPCKVEHTEELSSITEVVTTEENIPDVVPGSELTPIERESSSPLSSNQSEPGSI
|
ALNSYESRNCSESDHSRNGFDTDSSCLESHSSLSDSEFPPNNKCEIKTEGQELITVIK
|
APTSFGYDKFHVLVDLLVDDSGKESLIGYRPTEDSKEFS
|
GENBANK ID: M27492.1
VERSION M27492.1 GI:186289
MKVLLRLICFIALLISSLEADKCKEREEKIILVSSANEIDVRPC
|
PLNPNEHKGTITWYKDDSKTPVSTEQASRIMQHKEKLWFVFAKVEDSGHYYCVVRNSS
|
YCLRIKISAKEVENEPNLCYNAQAIFKQKLPVAGDGCLVCPYMEFFKNENNELPKLQW
|
YKDCKPLLLDNIHFSGVKDRLIVMNVAEKHRGNYTCHASYTYLGKQYPITRVIEFITL
|
EENKFTRPVIVSPANETNEVDLGSQIQLICNVTGQLSDIAYNKWNGSVIDEDDPVLGE
|
DYYSVENPANKRRSTLITVLNISEIESRFYKNPFTCFAKNTHGIDAAYIQLIYPVTNF
|
QKHMIGICVTLTVIIVCSVFIYKIFKIDIVLWYRDSCYDFLPIKASDGKTYDAYILYP
|
KTVCEGSTSDCDIWVFKVLPEVLEKQCGYKLFIYCRDDYVGEDIVEVINENVKKSRRL
|
IIILVRETSGFSWLGGSSEEQIANYNALVQDGIKVVLLELEKIQDYEKMPESIKFIKQ
|
KHGAIRWSCDFTQGFQSAKTRFWKNVRYHMFVQRRSPSSKHQLLSPATKEKLQREAHV
|
PLG
|
GENBANK ID: L34059
VERSION L34059.1 GI:506409
MTACAGVLLLLLSLSCALRANNEDLTTRETCKAGFSEDDYTALI
|
SQNILEGEKLLQVKFSSCVGTKGTQYETNSMDFKVGADGTVFATRELQVPSEQVAFTV
|
TAWDSQTAEKWDAVVRLLVAQTSSPHSGHKPDKGKKVVALDPSPPPKDTLLPWPQHQN
|
ANGLRRRKRDWVIFPINVFENSRGPFFQQLVRIRSDKDNDIPIRYSITGVGADQPPME
|
VFSINSMSGRNYVTRPMDREEHASYHLRAHAVDNNGNKVENPIDLYIYVIDMNDNHPE
|
FINQVYNCSVDEGSKFGTYVMTITANDADDSTTANGMVRYRTVTQTPQSPSQNNFTIN
|
SETGDIVTVAAGWDREKVQQYTVIVQATDNEGNLNYGLSNTATAIITVTDVNDNPSEF
|
TASTFAGEVPENSVETVVANLTVMDRDQPHSBNWNAVYRIISGDPSGHFSVRTDFVTN
|
EGMVTVVKAVDYELNRAFNLTVNVSNQAPLASGIQNSFQSTAGVTISINDINEAPYFP
|
SNHKLILEEGVPPGTVLTTFSIAVDRDRFMQQAVRYSKLSDPASWLHINATNGQITTV
|
AVLDRESLYTKNNVYEATFLAADNCIFPAS0TGTLQIYLIDINDNAFELLPKEAQICE
|
RPNLNAINITAADADVHPNIGPYVFELPFVFAAVRKNWTITRLNCDYAQLSLRILYLE
|
AGMYDVFIIVTDSGNPFLSNTSIIKVKVCPCDDNGDCTTIGAVAAAGLGTGAIVAILI
|
CILILLTMVLLFVMWMKRREKERHTKQLLIDPEDDVREKILKYDEEGGGEEDQDYDLS
|
QLQQPEAMGHVPSKAPCVRRVDERPVGFEFQYPIRPMVPHPGDIGDFINEGLRAADND
|
PTAPPYDSLLVFDYEGSGSTAGSVSSLNSSSSGDQDYDYLNDWGPRFKKLADMYGGGE
|
ED
|
GENSANK ID: M77640
VERSION M77640.1 GI:186053
MVVALRYVWPLLLCSPCLLIQIPEEYEGHHVNEPPVITEQSPRR
|
LVVFPTDDISLKCEASGKPEVQFRWTRDGVHFKPKEELGVTVYQSFHSQSFTITGNNS
|
NFAQRFQGIYRCFASNKLGTAMSHEIRLMAEGAFKWPKETVKPVEVEEGESVVLPCNP
|
PPSAEFLRIYWMNSKILIHKQDERVTMGQNGNLYFANVLTSDNHSDYICHAEFFGTRT
|
IIQKEPIDLRVKATNSNIDRKPRLLFPTNSSSHLVALQGQPLVLECIAEGFPTPTIKW
|
LRPSGPMFADRVTYQNENKTLQLLKVGEEDDGEYRCLAENSLGSAREAYYVTVEAAPY
|
WLHKPQSHLY0PGETARLDCQVQGRPQPEVTWRINGIFVEELAKDQKYRIQRGALILS
|
NVQPSDTNVTQCEARNRNGLLLANAYIYVVQLPAKILTADNQTYMAVQGSTAYLLCKA
|
FGAPVPSVQWLDEDGTTVLQDERFFPYANGTLGIRDLQANDTCRYFCLAANDQNNVTI
|
MANLKVKDATQITQCFRSTIEKKGSRVTFTCQASFDPSLGPSITWRGDGRDLQELGDS
|
DKYFIEDGRLVIHSLDYSDQGNYSCVASTELDVVESRAQLLVVGSFGPVFRLVLSDLH
|
LLTQSQVRVSWSFAEDHNAFIEKYDIEFEDKENAFEKWYSLGKVFGNQTSTTLKLSPY
|
VHYTFRVTAINKYGPGEPSPVSETVVTPEAAFEKNPVDVKGEGNETTNMVTTWKPLRW
|
MDNNAFQVQYRVQWRPQGTRGPWQEQIVSDPFLVVSNTSTFVPYEIKVQAVNSQGKGP
|
EPQVTIGYSGEDYFQAIPELEGIETLNSSAVLVKWRPVDLAQVKGELRGYNVTYWREG
|
SQRKHSKRHIHKDHVVVFANTTSVILSGLRPYSSYHLEVQAFNGRGSGPASEFTESTP
|
EGVFGHPEALHLECQSNTSLLLRWQPPLSHNGVLTGYVLSYHPLDEGGKGQLSFNLRD
|
PELRTHNLTDLSPELRYRFQLQATTKEGPGEAIVREGGTMALSGISDFGNISATAGEN
|
YSVVSWVFKEGQCNFRFEILFKALGEEKGGASLSPQYVSYNQSSYTQWDLQPDTDYEI
|
HLFKERIAFRHQNAVKTNGTGRVRLFFAGFATEGWFIGFVSAIILLLLVLLILCIKRS
|
KGGKYSVKDKEDTQVDSEARPNKDETFGEYRSLESDNEEKAFGSSQPSLNGDIKPLGS
|
DDSLADYGGSVQVQFNEDGSFIGQYSGKKEKEAAGGNDSSGATSPINPAVALE
|
GENBANK ID: M59911.1
VERSION M59911.1 GI:186496
MGPGPSRAPRAPRLMLCALALMVAAGGCWSAFNLDTRFLVVKE
|
AGNPGSLFGYSVALERQTERQQRYLLLAGAPRELAVPDGYTNRTGAVYLCFLTAHKDD
|
CERMNITVKNDPGEHIIEDNWLGVTVASQGPAGRVLVCAHRYTQVLWSGSEDQRRMVG
|
KCYVRGNDLELDSSDDWQTYHNENCNSNTDYLETGMCQLGTSGGFTQNTVYFGASGAY
|
NWKGNSYNIQRKEWDLSEYSYKDPEDQGNLYIGYTMQVGSFILHPKNITIVTGAPRHR
|
HMGAVFLLSQEAGGDLRRRQVLEGSQVGAYFGSAIALADLNNDGWQDLLVGAPYYFER
|
KEEVGGAIYVFMNQAGTSFPAHPSLLLHCPSGSAFGLSVASIGDINQDGFQDIAVGAP
|
FEGLGKVYIYHSSSKGLLRQPQQVIHGERLGLPGLATFGYSLSGQMDVDENFYPDLLV
|
GSLSDHIVLLRARPVINIVHKTLVPRPAVLDPALCTATSCVQVELCFAYNQSAGNPNY
|
RRNITLAYTLEADRDRRPPRLRFAGSESAVFHGFFSNPENRCQKLELLLMDNLRDKLR
|
PIIISMNYSLPLRNPDRPRLGLRSLDAYPILNQAQALENHTEVQFQKECGPDNKCESN
|
LQMRAAFVSEQQQKLSRLQYSRDVRKLLLSINVTNTRTSERSGEDAHEALLTLVVPPA
|
LLLSSVRPPGACQANETIFCELGNPFKRNQRNELLIAFEVTGVTLHTRDLQVQLQLST
|
SSHQDNLWPMTLTLLVDYTLQTSLSMVNHRLQSFFGGTVMGESGMKTVEDVGSPLKYE
|
FQVGPNGEGLVGLGTLVLGLEWPYEVSNGKWLLYPTETTVHGNGSWPCRPPGDLINPL
|
NLTLSDPGDRPSSPQRRRRQLDPGGGQGPPFVTLAAAKKAKSETVLTCATGRAHCVWL
|
ECPIPDAPVVTNVTVKARVWNSTFTEDYRDFDRVRVNGWATLFLRTSIPTINMENKTT
|
WFSVDIDSELVEELPAETELWLVLVAVGAGLLLLGLIILLLWKCGFFKRARTRALYEA
|
KRQKAEMKSQPSETERLTDDY
|
GENBANK ID: M81695.1
VERSION M81695.1 GI:487829
MTRTRAALLLFTALATSLGFNLDTEELTAFRVGSAGFGDSVVQY
|
ANSWVVVGAPQKITAANQTGGLYQCGYSTGACEPIGLQVPPEAVNMSLGLSLASTTSP
|
SQLLACGPTVHHECGRNNYLTGLCFLLGPTQLTQRLPVSRQECPRQEQDIVFLIDGSG
|
SISSRNFATNMNFVRAVISQFQRPSTQFSLNQFSNKFQTHFTFEEFRRTSNPLSLLAS
|
VHQLQGFTYTATAIQNVVHRLFHASYGARRDATKTLIVITDGKKEGDSLDYKDVTPMA
|
DAAGIIRYATGVGLAFQNRNSNKELNDTASKPSQEHIFKVEDFDALKDIQNQLKEKIF
|
AIEGTETTSSSSFELENAQEGFSAVFTPDGPVLGAVGSFTWSGGAFLYPPNNSPTFIN
|
MSQENVDNRDSYLGYSTELALWKGVQSLVLGAPRYQHTGKAVIFTQVSRQWRNKAEVT
|
GTQTGSYFGASLCSVDVDTDGSTDLVLTGAPHYYEQTRGGQVSVCPLPRGWRRWWCDA
|
VLYGEQGHPWGRFGAALTVLGDVNGDKLTDVVIGAPGEEENRGAVYLFHGVLGPSISP
|
SNSQRTAGSQLSSRLQYFGQALSGGQDLTQDGLVDLAVGARGQVLLLRTRPVLWVGVS
|
MQFIPAETPRSAFECREQVVSEQTLVQSNTCLYIDKRSKNLLGSRDLQSSVTLDLALD
|
PGELSPRATFQETKNRSLSRVRVLGLKAHCENFNLLLPSCVEGSVTPTTLRLNFTLVG
|
KPLLAFRNLRPMLAALAQRYFTASLPFEKNCGADHTCQDNLGISFSFPGLKSLLVGSN
|
LELNAEVNVWNDGEDSYGTTITFSHPAGLSYRYVAEGGKQGQLRSLHLTCDSAPVGSQ
|
GTWSTSCRTNHLTFRGGAQTTFLATFDVSPKAVLGDRLLLTANVSSENNTPRTSKTTF
|
QLELPVKYAVYTVVSSHEQFTKYLNFSESEEKESHVAMHRYQVNNLGQRDLPVSTNFW
|
VPVELNQEAVWMDVEVSHPQNPSLRCSSEKIAPPASDFLAHIQKNPVLDCSTAGCLRF
|
RCDVPSFSVQEELDFTLKGNLSFGWVRQTLQKKVSVVSVAETTFDTSVYSQLPGQEAF
|
MRAQTTTVLEKYKVHNPTPLTVGSSTGGLLLLALITAVLYKVGFFKRQYKEMMEEANG
|
QTAPENGTQTPSPPSEK
|
GENBANK ID: X51841.1
VERSION X51841.1 GI:33910
MAGPEPSPWARLLLAALTSVSLSGTLANRCKKAPVKSCTECVRV
|
DKDCAYCTDEMFRDRRCNTQAELLAAGCQRESIVVMESSFQTTEETQTDTTLRRSQNS
|
PQGLRVRLRPGFERHFELEVFEPLESPVDLYTLNDFSNSMSDDLDNLKKMGQNLARVL
|
SQLTSDYTIGFGKFVDKVSVPQTDMRPEKLKEFWPNSDPPFSFKNVISLTEDVDEFRN
|
KLQGERISGNLDAPEGGFDAILQTAVCTRDIGWRFDSTHLLVESTESAFHYEADGANV
|
LAGIMSRNDERCHLDTTGTYTQYRTQDYPSVPTLVRLLAKHNIIPIFAVTNYSYSYYE
|
KLHTYFPVSSLGVLQEDSSNIVELLEEAFNRIRSNLDIRALDSPRGLRTEVTSKMFQK
|
TRTGSPHIRRGEVGIYQVQLRALEHVDGTHVCQLPEDQKGNIHLKPSFSDGLKMDAGI
|
ICDVCTCELQKEVRSARCSFNGDFVCGQCVCSEGWSGQTCNCSTGSLSDIQFCLREGE
|
DKPCSGRGECQCCHCVCYGEGRYEGQFCEYDNFQCPRTSGFLCNDRGRCSMGQCVCEP
|
GWTGPSCDCPLSNATCIDSNGGICNGRGHCECGRCHCHQQSLYTSTICEINYSATHPG
|
LCEDLRSCVQCQAWGTCEKKGRTCEECNFKVKMVDELKRAEEVVVRCSFRDEDDDCTY
|
SYTMEGDGAPGPNSTVLVHKKKDCPPGSFNWLIPLLLLLLPLLALLLLLCWKYCACCK
|
ACLALLPCCNRGHMVGFKEDHYMLRENLMASDHLDTPMLRSGNLKGRDVVRWKVTNNM
|
QRPGFATHAASTNPTELVPYGLSLRLARLCTENLLKPDTRECAQLRQEVEENLNEVYR
|
QISGVHKLQQTKFRQQPNAGKKQDHTTVDTVLMAPRSAKPALLKLTEKQVEQRAFHDL
|
KVAPGYYTLTADQDARGNVEFQEGVELVDVRVFLFIRPEDDDEKQLLVEAIDVPAGTA
|
TLGRRLVNITIIKEQARDVVSFEQFEFSVSRGDQVARIPVTRRVLDCGKSQVSYRTQD
|
GTAQENRDYTPVEGELLFQPGEAWKELQVKLLELQEVDSLLRGRQVRRFHVQLSNPKF
|
GAHLGQPHSTTIIIRDEDELDRSFTSQMLSSQPPFHGDLGAPQNPNAKAAGSRKIHFN
|
WLPPSGKPMCYRVKYNIQGDSESEAHLLDSKVFSVELTNLYPYCDYEMKVCAYGAQGE
|
GEYSSLVSCRTHQEVPSEPGRLAFNVVSSTVTQLSWAEPAETNGEITAYEVCYGLVND
|
DNREIGPMKKVLVDNPKNRMLLIENLRESQFYRYTVKARNGAGWGPEREAIINLATQP
|
KRPMSIFIIPDIPIVDAQSGEDYDSFLMYSDDVLRSPSGSQRPSVSDDTEHLVNGRMD
|
FAFPGSTNSLHRNTTTSAAAYGTHLSPHVPHRVLSTSSTLTRDYNSLTRSEHSHSTTL
|
PRDYSTLTSVSSHDSRLTAGVFDTPTRLVFSALGPTSLRVSWQEPRCERPLQGYSVEY
|
QLLNGGELHRLNIFNPAQTSVVVEDLLPNHSYVFRVRAQSQEGWGREREGVITIESQV
|
HPQSPLCPLPGSAFTLSTPSAPGPLVFTALSPDSLQLSWERPRRFNGDIVGYLVTCEM
|
AQGGGPATAFRVDGDSPESRLTVPGLSENVPYKFKVQARTTEGFGPEREGIITIESQV
|
GGPFPQLGSRAGLFQHFLQSEYSSITTTHTSATEPFLVDGPTLGAQHLEACGSLTRHV
|
TQEFVSRTLTTSGTLSTHMDQQFFQT
|
GENBANK ID: XP_030326.1
VERSION XP_030326.1 GI:14763626
1MDKFWWHAAW GLCLVPLSLA QIDLNITCRF AGVFHVEKNG RYSISRTEAA DLCKAFNSTL
|
61PTMAQMEKAL SIGPETCRYG FIEGHVVIPR IHPNSICAAN NTGVYILTSN TSQYDTYCFN
|
121ASAPFEEDCT SVTDLPNAFD GPITITIVNR DGTRYVQKGE YRTNPEDIYP SNPTDDDVSS
|
181GSSSERSSTS GGYIFYTFST VHPIPDEDSE WITDSTDRIP ATTLNSTSAT ATETATKRQE
|
241TWDWPSWLPL PSESKNHLHT TTQMAGTSSN TISAGWEPNE ENEDERDRHL SFSGSGIDDD
|
301EDFISSTIST TPRAFDHTKQ NQDWTQWNPS HSNPEVLLQT TTRMTDVDRN GTTAYEGNWN
|
361PEAHPPLIHH EHHEEEETPH STSTIQATPS STTEETATQK EQWFGNRWHE GYRQTEKEDS
|
421HSTTGTAAAS AHTSHPMQGR TTPSFEDSSW TDFFNPISHP MGRGHQAGRR MDMDSSHSIT
|
481LQPTANPNTG LVEDLDRTGP LSMTTQQSNS QSFSTSHEGL EEDKDHPTTS TLTSSNRNDV
|
541TGGRRDPNHS EGSTTLLEGY TSHYPHTKES RTFIPVTSAK TGSPGVTAVT VGDSNSNVNR
|
601SLSGDQDTFH PSGGSHTTEG SESDGESHGS QEGGANTTSG PIRTEQIPEW LIILASLLAL
|
661ALILAVCIAV NSRRRCGQKK KLVINSGNGA VEDRKPSGLN GEASKSQEMV HLVNKESSET
|
721PDQFMTADET RNLQNVDMKI GV
|
GENBANK ID: NP_000826.1
VERSION NP_000826.1 GI:4504129
1MGGALGPALL LTSLPGAWAG LGPGQGEQGM TVAVVFSSSG PPQAQFRARL TPQSFLDLPL
|
61EIQPLTVGVN TTNPSSLLTQ ICGLLGAAHV HGIVPEDNVD TEAVAQILDF ISSQTHVPIL
|
121SISGGSAVVL TPKEPGSAFL QLGVSLEQQL QVLFKVLEEY DWSAFAVITS LHPGHALFLE
|
181GVRAVADASH VSWRLLDVVT LELGEGGPRA RTQRLLRQLD APVPVAYCSR EEAEVLFAEA
|
241AQAGLVGPGH VWLVPNLALG STDAPPATFP VGLISVVTES WRLSLRQKVR DGVAILALGA
|
301HSYWRQHGTL PAPAGDCRVH PGPVSPAREA FYRHLLNVTW EGRDPSFSPG GYLVQPTMVV
|
361IALNRHRLWE MVGRWEHGVL YMKYPVWPRY SASLQPVVDS RHLTVATLEE RPPVIVESPD
|
421PGTGGCVPNT VPCRRQSNHT FSSGDVAPYT KLCCKGFCID ILKKLARVVK FSYDLYLVTN
|
481GKHGKRVRGV WNGMIGEVYY KRADMAIGSL TINEERSEIV DPSVPFVETG ISVMVARSNG
|
541TVSPSAFLEP YSPAVWVMMF VMCLTVVAIT VFMFEYPSPV SYNQNLTRGK KSGGPAFTIG
|
601KSVWLLWALV FNNSVPIENP RGTTSKIMVL VWAFFAVIFL ASYTANLAAF MIQEQYIDTV
|
661SGLSDKKPQR PQDQYPPFRF GIVPNGSTER NIRSNYRDMH THMVKFNQRS VEDALTSLKM
|
721GKLDAFIYDA AVLNYMAGKD EGCKLVTIGS GKVPATTGYG IANQKDSHWK RAIDLALLQF
|
781LGDGETQKLE TVWLSGICQN EKNEVMSSKL DIDNMAGVFY MLLVAMGLAL LVFAWEHLVY
|
841WKLRHSVPNS SQLDPLLAFS RGIYSCPSGV QSLASPPRQA SPDLTASSAQ ASVLKNLQAA
|
901RDMVTTAGVS SSLDRATRTI ENWGGGRRAP PPSPCPTPRS GPSPCLPTPD PPPEPSETGW
|
961GPPDGGRAAL VRRAPQPPGR PPTPGPPLSD VSRVSRRPAW EARWPVRTGH CGRELSASER
|
1021PLSPARCHYS SFPRADRSGR PFLPLFPEPP ELEDLPLLGP EQLARREALL HAAWARGSRP
|
1081RHASLPSSVA EAFARPSSLP AGCTGPACAR PDGHSACRRL AQAQSMCLPI YREACQEGEQ
|
1141AGAPAWQHRQ HVCLHAHAHL PFCWGAVCPH LPPCASHGSW LSGAWGPLGH RGRTLGLGTG
|
1201YRDSGGLDEI SSVARGTQGF PGPCTWRRIS SLESEV
|
GENBANK ID: CAA43045.1
DEFINITION HUMAN CDW40 MRNA FOR NERVE GROWTH FACTOR RECEPTOR-RELATED
B-LYMPHOCYTE ACTIVATION MOLECULE.
VERSION X60592.1 GI:29850
CDS 48..881
/CODON_START=1
1GCCTCGCTCG GGCGCCCAGT GGTCCTGCCG CCTGGTCTCA CCTCGCCATG GTTCGTCTGC
|
61CTCTGCAGTG CGTCCTCTGG GGCTGCTTGC TGACCGCTGT CCATCCAGAA CCACCCACTG
|
121CATGCAGAGA AAAACAGTAC CTAATAAACA GTCAGTGCTG TTCTTTGTGC CAGCCAGGAC
|
181AGAAACTGGT GAGTGACTGC ACAGAGTTCA CTGAAACGGA ATGCCTTCCT TGCGGTGAAA
|
241GCGAATTCCT AGACACCTGG AACAGAGAGA CACACTGCCA CCAGCACAAA TACTGCGACC
|
301CCAACCTAGG GCTTCGGGTC CAGCAGAAGG GCACCTCAGA AACAGACACC ATCTGCACCT
|
361GTGAAGAAGG CTGGCACTGT ACGAGTGAGG CCTGTGAGAG CTGTGTCCTG CACCGCTCAT
|
421GCTCGCCCGG CTTTGGGGTC AAGCAGATTG CTACAGGGGT TTCTGATACC ATCTGCGAGC
|
481CCTGCCCAGT CGGCTTCTTC TCCAATGTGT CATCTGCTTT CGAAAAATGT CACCCTTGGA
|
541CAAGCTGTGA GACCAAAGAC CTGGTTGTGC AACAGGCAGG CACAAACAAG ACTGATGTTG
|
601TCTGTGGTCC CCAGGATCGG CTGAGAGCCC TGGTGGTGAT CCCCATCATC TTCGGGATCC
|
661TGTTTGCCAT CCTCTTGGTG CTGGTCTTTA TCAAAAAGGT GGCCAAGAAG CCAACCAATA
|
721AGGCCCCCCA CCCCAAGCAG GAACCCCAGG AGATCAATTT TCCCGACGAT CTTCCTGGCT
|
781CCAACACTGC TGCTCCAGTG CAGGAGACTT TACATGGATG CCAACCGGTC ACCCAGGAGG
|
841ATGGCAAAGA GAGTCGCATC TCAGTGCAGG AGAGACAGTG AGGCTGCACC CACCCAGGAG
|
901TGTGGCCACG TGGGCAAACA GGCAGTTGGC CAGAGAGCCT GGTGCTGCTG CTGCAGGGGT
|
961GCAGGCAGAA GCGGGGAGCT ATGCCCAGTC AGTGCCAGCC CCTC
|
GENBANK ID: AAB59544.1
DEFINITION HUMAN NERVE GROWTH FACTOR RECEPTOR MRNA, COMPLETE CDS.
VERSION M14764.1 GI:189204
CDS 114..1397
/CODON_START=1
1GCCGCGGCCA GCTCCGGCGG GCAGGGGGGG CGCTGGAGCG CAGCGCAGCG CAGCCCCATC
|
61AGTCCGCAAA GCGGACCGAG CTGGAAGTCG AGCGCTGCCG CGGGAGGCGG GCGATGGGGG
|
121CAGGTGCCAC CGGCCGCGCC ATGGACGGGC CGCGCCTGCT GCTGTTGCTG CTTCTGGGGG
|
181TGTCCCTTGG AGGTGCCAAG GAGGCATGCC CCACAGGCCT GTACACACAC AGCGGTGAGT
|
241GCTGCAAAGC CTGCAACCTG GGCGAGGGTG TGGCCCAGCC TTGTGGAGCC AACCAGACCG
|
301TGTGTGAGCC CTGCCTGGAC AGCGTGACGT TCTCCGACGT GGTGAGCGCG ACCGAGCCGT
|
361GCAAGCCGTG CACCGAGTGC GTGGGGCTCC AGAGCATGTC GGCGCCGTGC GTGGAGGCCG
|
421ACGACGCCGT GTGCCGCTGC GCCTACGGCT ACTACCAGGA TGAGACGACT GGGCGCTGCG
|
481AGGCGTGCCG CGTGTGCGAG GCGGGCTCGG GCCTCGTGTT CTCCTGCCAG GACAAGCAGA
|
541ACACCGTGTG CGAGGAGTGC CCCGACGGCA CGTATTCCGA CGAGGCCAAC CACGTGGACC
|
601CGTGCCTGCC CTGCACCGTG TGCGAGGACA CCGAGCGCCA GCTCCGCGAG TGCACACGCT
|
661GGGCCGACGC CGAGTGCGAG GAGATCCCTG GCCGTTGGAT TACACGGTCC ACACCCCCAG
|
721AGGGCTCGGA CAGCACAGCC CCCAGCACCC AGGAGCCTGA GGCACCTCCA GAACAAGACC
|
781TCATAGCCAG CACGGTGGCA GGTGTGGTGA CCACAGTGAT GGGCAGCTCC CAGCCCGTGG
|
841TGACCCGAGG CACCACCGAC AACCTCATCC CTGTCTATTG CTCCATCCTG GCTGCTGTGG
|
901TTGTGGGCCT TGTGGCCTAC ATAGCCTTCA AGAGGTGGAA CAGCTGCAAG CAGAACAAGC
|
961AAGGAGCCAA CAGCCGGCCA GTGAACCAGA CGCCCCCACC AGAGGGAGAA AAACTCCACA
|
1021GCGACAGTGG CATCTCCGTG GACAGCCAGA GCCTGCATGA CCAGCAGCCC CACACGCAGA
|
1081CAGCCTCGGG CCAGGCCCTC AAGGGTGACG GAGGCCTCTA CAGCAGCCTG CCCCCAGCCA
|
1141AGCGGGAGGA GGTGGAGAAG CTTCTCAACG GCTCTGCGGG GGACACCTGG CGGCACCTGG
|
1201CGGGCGAGCT GGGCTACCAG CCCGAGCACA TAGACTCCTT TACCCATGAG GCCTGCCCCG
|
1261TTCGCGCCCT GCTTGCAAGC TGGGCCACCC AGGACAGCGC CACACTGGAC GCCCTCCTGG
|
1321CCGCCCTGCG CCGCATCCAG CGAGCCGACC TCGTGGAGAG TCTGTGCAGT GAGTCCACTG
|
1381CCACATCCCC GGTGTGAGCC CAACCGGGGA GCCCCCGCCC CGCCCCACAT TCCGACAACC
|
1441GATGCTCCAG CCAACCCCTG TGGAGCCCGC ACCCCCACCC TTTGGGGGGG GCCCGCCTGG
|
1501CAGAACTGAG CTCCTCTGGG CAGGACCTCA GAGTCCAGGC CCCAAAACCA CAGCCCTGTC
|
1561AGTGCAGCCC GTGTGGCCCC TTCACTTCTG ACCACACTTC CTGTCCAGAG AGAGAAGTGC
|
1621CCCTGCTGCC TCCCCAACCC TGCCCCTGCC CCGTCACCAT CTCAGGCCAC CTGCCCCCTT
|
1681CTCCCACACT GCTAGGTGGG CCAGCCCCTC CCACCACAGC AGGTGTCATA TATGGCGGGC
|
1741CAACACCAGC GATGGTACTA GGGGCAAGTG ACAAGGCCCC AGAGACTGAG AGGGAGGAAT
|
1801CGAGGAACCA GAGCCATGGA CTCTACACTG TGAACTTGGG GAACAAGGGT GGCATCCCAG
|
1861TGGCCTCAAC CCTCCCTCAG CCCCTCTTGC CCCCCACCCC AGCCTAAGAT GAAGAGGATC
|
1921GGAGGCTTGT CAGAGCTGGG AGGGGTTTTC GAAGCTCAGC CCACCCCCCT CATTTTGGAT
|
1981ATAGGACAGT GAGGCCCAGG GAGAGGGCAT GATTCGCCCA AAGCCAGACA GCAACGGGGA
|
2041GGCCAAGTGC AGGCTGGCAC CGCCTTCTCT AAATGAGGGG CCTCAGGTTT GCCTGAGGGC
|
2101GAGGGGAGGG TGGCAGGTGA CCTTCTGGGA AATGGCTTGA AGCCAAGTCA GCTTTGCCTT
|
2181CCACGCTGTC TCCAGACCCC CACCCCTTCC CCACTGCCTG CCCACCCGTG GAGATGGGAT
|
2221GCTTGCCTAG GGCCTGGTCC ATGATGGAGT CAGGTTTGGG GTTCGTGGAA AGGGTGCTGC
|
2281TTCCCTCTGC CTGTCCCTCT CAGGCATGCC TCTGTGACAT CAGTGGCATG GCTCCAGTCT
|
2341GCTGCCCTCC ATCCCGACAT GGACCCGGAG CTAACACTGG CCCCTAGAAT CAGCCTAGGG
|
2401GTCAGGGACC AAGGACCCCT CACCTTGCAA CACACAGACA CACGCACACA CACACACAGG
|
2461AGGAGAAATC TCACTTTTCT CCATGAGTTT TTTCTCTTGG GCTGAGACTG GATACTGCCC
|
2521GGGGCAGCTG CCAGAGAAGC ATCGGAGGGA ATTGAGGTCT GCTCGGCCGT CTTCACTCGC
|
2581CCCCGGGTTT GGCGGGCCAA GGACTGCCGA CCGAGGCTGG AGCTGGCGTC TGTCTTCAAG
|
2841GGCTTACACG TGGAGGAATG CTCCCCCATC CTCCCCTTCC CTGCAAACAT GGGGTTGGCT
|
2701GGGCCCAGAA GGTTGCGATG AAGAAAAGCG GGCCAGTGTG GGAATGCGGC AAGAAGGAAT
|
2761TGACTTCGAC TGTGACCTGT GGGGATTTCT CCCAGCTCTA GACAACCCTG CAAAGGACTG
|
2821TTTTTTCCTG AGCTTGGCCA GAAGGGGGCC ATGAGGCCTC AGTGGACTTT CCACCCCCTC
|
2881CCTGGCCTGT TCTGTTTTGC CTGAAGTTGG AGTGAGTGTG GCTCCCCTCT ATTTAGCATG
|
2841ACAAGCCCCA GGCAGGCTGT GCGCTGACAA CCACCGCTCC CCAGCCCAGG GTTCCCCCAG
|
3001CCCTGTGGAA GGGACTAGGA GCACTGTAGT AAATGGCAAT TCTTTGACCT CAACCTGTGA
|
3061TGAGGGGAGG AAACTCACCT GCTGGCCCCT CACCTGGGCA CCTGGGGAGT GGGACAGAGT
|
3121CTGGGTGTAT TTATTTTCCT CCCCAGCAGG TGGGGAGGGG GTTTGGTGGC TTGCAAGTAT
|
3181GTTTTAGCAT GTGTTTGGTT CTGGGGCCCC TTTTTACTCC CCTTGAGCTG AGATGGAACC
|
3241CTTTTGGCCC CCAGCTGGGG GCCATGAGCT CCAGACCCCC AGCAACCCTC CTATCACCTC
|
3301CCCTCCTTGC CTCCTGTGTA ATCATTTCTT GGGCCCTCCT GAAACTTACA CACAAAACGT
|
3361TAAGTGATGA ACATTAAATA GCAAAG
|
GENEANK ID: NP_002502.1
VERSION NM_002511.1 GI:4505406
CDS 140..1312
/CODON_START=1
1GTGCTGTGAG GCTTGCCCGC GGACAGTAAA CTTGCAGGGG CGAGAGGGAG GGACATCGAT
|
61TAAACCTAAA TCGTGGGCGT TCAGTCCTCA GGGCACCGAG CGCGTGAAAA CTCCAGCGGA
|
121CTCTGCTGGA AAGGAGATCA TGCCCTCTAA GTCTCTTTCC AACCTCTCGG TGACCACCGG
|
181CGCGAATGAG AGCGGTTCCG TTCCCGAGGG GTGGGAAAGG GATTTCCTGC CGGCCTCGGA
|
241CGGGACCACC ACGGAGTTGG TGATCCGCTG TGTGATCCCG TCCCTCTACC TGCTCATCAT
|
301CACCGTGGGC TTGCTGGGCA ACATCATGCT GGTGAAGATC TTCATCACCA ACAGCGCCAT
|
361GAGGAGCGTC CCCAACATCT TCATCTCTAA CCTGGCGGCC GGGGACTTGC TGCTGCTGCT
|
421CACCTGCGTC CCGGTGGACG CCTCGCGCTA CTTCTTCGAC GAGTGGATGT TTGGCAAGGT
|
481GGGCTGCAAA CTGATCCCTG TCATCCAGCT CACTTCCGTG GGGGTTTCCG TGTTCACTCT
|
541CACTGCCCTC AGCGCCGACA GGTACAGAGC CATCGTTAAC CCCATCGACA TGCAGACGTC
|
601AGGGCCATTG CTGCGGACCT GTGTGAAGGC CATGGGTATC TGGGTGGTCT CCGTGTTGCT
|
661GGCAGTTCCC GAAGCGGTGT TTTCAGAAGT GGCTCGCATC AGTAGCTTGG ATAATAGCAG
|
721CTTCACAGCA TGTATCCCAT ACCCTCAAAC AGATGAATTA CATCCAAAGA TTCATTCAGT
|
781GCTCATTTTC TTGGTCTATT TCCTCATACC ACTTGCTATT ATTAGCATTT ATTATTATCA
|
841TATTGCAAAG ACCTTAATTA AAAGCGCACA CAATCTTCCT GGAGAATACA ATGAACATAC
|
901CAAAAAACAG ATGGAAACAC GGAAACGCCT GGCTAAAATT GTGCTTGTCT TTCTGGGCTG
|
981TTTCATCTTC TGTTGGTTTC CAAACCACAT CCTTTACATG TATCGGTCTT TCAACTATAA
|
1021TGAGATTGAT CCATCTCTAG GCCACATGAT TGTCACCTTA GTTGCCCGGG TTCTCAGTTT
|
1081TGGCAATTCT TGTGTCAACC CATTTGCTCT TTACCTACTC AGTGAAAGCT TCAGGAGGCA
|
1141TTTCAACAGC CAACTCTGCT GTGGGAGGAA GTCCTATCAA GAGAGAGGAA CCAGCTACCT
|
1201ACTCAGCTCT TCAGCGGTGC GTATGACATC TCTGAAAAGC AATGCTAAGA ACATGGTGAC
|
1261CAATTCTGTT TTACTAAATG GGCACAGCAT GAAGCAGGAA ATGGCAATCT GATTTTGGCC
|
1321ATTCAACTCA CTACCTGGAG AGAACTTAGT AA
|
GENBANK ID: Q00941
EST
DNA TYPE: CDNA
CGAAGGCGCGGCGGGCTCGGGGGCGGAGAACCTGACCTGCGAGATCCGAGCCGAGCGCTT
|
TCTTTTCTGCGCGTGGCGGGAGGGGCCAGCGGCGCCCGCGGACGTCCGGTACTCGCTGCG
|
AGTCCTTAACTCCACGGGTCACGACGTGGCGCGATGCATGGCCGACCCTGGGGATGACGT
|
CATGACACAGTGCATTGCGAACGACTTGTCACTGATGGGGAGTGAGGCCTACTTGGTCGT
|
GACCGGTCGCACCGGAGCGGGGCCAGTGCGGATCCTGGACGACTTGGTGGCTACGAAGGC
|
GCTCGACCGACTCGATCCCTCACCTGACGTCACCGAGTCCTGTAACTATTCCCACTGCAC
|
CGAGTCGTGGGCGCCGCCCTAGACCTGTGCATCCTATGAGGTGCGGGACTTGCAGTGTGA
|
GGTCCAGTGGCAGAGCACATATCCAGGAAGCTCACTCCAGAATGTGCTCATCCGCGAGGA
|
GAGGCGGTTTGCCTTTCGCACGCTGTTCCGCTCGAGGTTACATTGCTAAAGTGCGCACAG
|
GGTACACGAGGATGAGCACTGTGGCGAATGGTATAAGCGGCATCCTGTTATGGCTGAG
|
GENBANK ID: P05106
EST
DNA TYPE: CDNA
CGGCCGCTGCACAGCAGCCCATTGCTGGACATGCAGGTGTCAGTACGCGTGGTACAGTTG
|
CAGTAGTAGCCGGTCCAGTCGGAGTCACACAGGCAGTCCCCACAGCTGCACTGGCCATGG
|
CCTGAGCACATCTCCCCCTTGTAGCGGACACAGGAGAAGTCGTCACACTCGCAGTACTTG
|
CCCGTGATCTTGCCAAAGTCACTGCTGTGGCAGACACATTGACCACAGAGGCACTCGCCC
|
CGCTGGCTGCAGACGGGCTGACCCTCTCGGGGGCTGCACTCGTCCTGCTGGGAAGGGCGA
|
TAGTCCTCCTCTGAGCACTCACACTGGGATCCCAGCCAGCCAGGCCCACAACGGCATACC
|
CCACACTCAAAGGTCCCATTGCCATTGTTGCAGCGATGGCTATTAGGTTCAGCTTGGGCC
|
TGGCAGGCACAGTCACAATCAAAGGTGACCTGGACGATCAGGCTGTCCTTGAAGCCCACG
|
GGCTTTATGGTAAAGGACTTCTCCTTCTCCTGGGGACAGCCTCGCACCTTGGCCTCAATG
|
CTGAAGCTCACCGTGTCTCCAATCTTGAGTCCCATACAAGACTTGAGGCCAGGGATGACC
|
TCATTGGTGAGGCAGGT
|
EST GENBANK ACC: BF115658
DNA TYPE: CDNA
GCGGCCGCTGCACAGCAGCCCATTGCTGGACATGCAGGTGTCAGTACGCGTGGTACAGTT
|
GCAGTAGTAGCCGGTCCAGTCGGAGTCACACAGGCAGTCCCCACAGCTGCACTGGCCATG
|
GCCTGAGCACATCTCCCCCTTGTAGCGGACACAGGAGAAGTCGTCACACTCGCAGTACTT
|
GCCCGTGATCTTGCCAAAGTCACTGCTGTGGCAGACACATTGACCACAGAGGCACTCGCC
|
CCGCTGGCTGCAGACGGGCTGACCCTCCCGGGGGCTGCATTCGTCCTGCTGGGAAGGGCG
|
ATAGTCCTCCTCTGAGCACTCACACTGGGATCCCAGCCAGCCAGGCCCACAACGGCATAC
|
CCCACACTCAAAGGTCCCATTGCCATTGTTGCAGCGATGGCTATTAGGTTCAGCTTGGGC
|
CTGGCAGGCACAGTCACAATCAAAGGTGACCTGNACGATCAGGCTGTCCTTGAAGCCCAC
|
GGGCTNTATGGTAAAGGACTTCTCCTTCTCCTGGGGACAGCCTCGCACCTTGGCCTCAAT
|
GCTGAAGCTCACCGTGTCTCCAATCTTGAGTCCCATACAAGACTTGAGGCCAGGGATGAC
|
CTCATTGTTGAGGCATGTGGCATTGAAGGATAGAGANCACTCTTCAGGACGTCACGCACT
|
TTCAGCTCGACTTTAGAACGGAATTTCCATAAGCATCAACAATGAGCCTGAGGACATTGC
|
CTGAATCCATGGACAGAACCCCCACTGTGGTCCC
|
EST
GENBANK ACC: BFD62996
CGGCCGCTGCACAGCAGCCCATTGCTGGACATGCAGGTGTCAGTACGCGTGGTACAGTTG
|
CAGTAGTAGCCGGTCCAGTCGGAGTCACACAGGCAGTCCCCACAGCTGCACTGGCCATGG
|
CCTGAGCACATCTCCCCCTTGTAGCGGACACAGGAGAAGTCGTCACACTCGCAGTACTTG
|
CCCGTGATCTTGCCAAAGTCACTGCTGTGGCAGACACATTGACCACAGAGGCACTCGCCC
|
CGCTGGCTGCAGACGGGCTGACCCTCCCGGGGGCTGCATTCGTCCTGCTGGGAAGGGCGA
|
TAGTCCTCCTCTGAGCACTCACACTGGGATCCCAGCCAGCCAGGCCCACAACGGCATACC
|
CCACACTCAAAGGTCCCATTGCCATTGTTGCAGCGATGGCTATTATGTTCAGCTTGGGCC
|
TGGCAGGCACAGTCACAATCAAAGGTGACCTGGACGATCAGGCTGTCCTTGAAGCCCACG
|
GGCTTTATGGTAAAGGAATTCTCCTTTTCCTTGGGACAGACTCGCACCTTGGCCCTAATG
|
CTGAAGCTCACCGAGATCTTCAT
|
GENBANK ID: CAA52348.1
VERSION X74295.1 GI:437781
CDS <1..234
/CODON_START=1
1AAGATGGGAT TCTTCAAACG GGCGAAGCAC CCCGAGGCCA CCGTGCCCCA GTACCATGCG
|
61GTGAAGATTC CTCGGGAAGA CCGACAGCAG TTCAAGGAGG AGAAGACGGG CACCATCCTG
|
121AGGAACAACT GGGGCAGCCC CCCGCCGGAC GGCCCGGATG CACACGCCAT CCTCGCTGCT
|
181GACGGGCATC CCCAGCTGGG CCCCAATGGG CATCCAGGGC CAGGCACCGC CTAGGTTCCC
|
241ATGTCCCAGC CTGCGCTGTG GCTGCCCTCC ATCCCTTCCC CAGAGATGGC TCCTTGGGAT
|
301GAAGAGGGTA GAGTCGGCTG CTGGTGTCAC ATCAAGAATT TGGCAGGATC GGCTTCCTCA
|
361GGGGCACAGA CCTCTCCCAC CCACAAGAAC TGCTGCCACG CAACTTCCCC TTAGAGTGCT
|
421GTGAGATGAG AGTGGGTAAA TCAGGGACAG GGCCATGGGG TAGGGTGAGA AGGGCAGGGG
|
481TGTCCTGATG CAAAGGTGGG GAGAAGGATC CTAATCCCTT CCTCTCCCAT TCACCCTGTG
|
541TAACAGGACC CCAAGGACCT GCCTCCCCGG AAGTGCCTTA ACCTAGAGGG TCGGGGAGGA
|
601GGTTGTGTCA CTGACTCAAG GCTGCTCCTT CTCTAGTTTC CCCTCTCATC TGACCTTAGT
|
661TTGCTGCCAT CAGTCTAGTG GTTTCGTGGT TTCGTCTATT TATTAAAAAA TCGGAACCC
|
GENBANK ID: M57627
VERSION CAA51942.1 GI:580177
1MHSSAL
|
GENBANK ID: AAA52578.1
VERSION AAA52578.1 GI:183364
1MWLQSLLLLG TVACSISAPA RSPSPSTQPW EHVNAIQEAR RLLNLSRDTA AEMNETVEVI
|
61SEMFDLQEPT CLQTRLELYK QGLRGSLTKL KGPLTMMASH YKQRCPPTPE TSCATQIITF
|
121ESFKENLKDF LLVIPFDCWE PVQE
|
GENBANK ID: AAA58482.1
VERSION AAA58482.1 GI:182669
1METNFSIPLN ETEEVLPEPA GHTVLWIFSL LVHGVTFVFG VLGNGLVIMV AGFRMTRTVN
|
61TICYLNLALA DFSFSAILPF RNVSVANREK WPFASFLCKL VHVNIDINLF VSVYLITIIA
|
121LDRCICVLHP AWAQNHRTMS LAKRVMTGLW IFTIVLTLPN FIFNTTISTT NGDTYCIFNF
|
181AFWGDTAVER LNVFITNAKV FLILHFIIGF TVPMSIITVC YGIIAAKIHR NHMIKSSRPL
|
241RVFAAVVASF FICWFPYELI GILMAVWLKE NLLNGKYKII LVLINPTSSL AFFNSCLNPI
|
301LYVFMGRNFQ ERLIRSLPTS LERALTEVPD SAQTSNTHTT SASPPEETEL QAM
|
GENBANK ID: P17774
VERSION P17774 GI:121324
1MSESLVVCDV AEDLVEKLRK FRFRKETNNA ATINKIDMDK RLVVLDEELE GISPDELKDE
|
61LPERQPRFIV YSYKYQHDDG RVSYPLCFIF SSPVGCKPEQ QMMYAGSKNK LVQTAELTKV
|
121FEIRNTEDLT EEWLREKLGF FH
|
GENBANK ID: P51858
VERSION P51858 GI:1708157
1MSRSNRQKEY KCGDLVFAKM KGYPHWPARI DEMPEAAVKS TANKYQVFFF GTHETAFLGP
|
61KDLFPYEESK EKFGKPNKRK GFSEGLWEIE NNPTVKASGY QSSQKKSCVE EPEPEPEAAE
|
121GDGDKKGNAE GSSDEEGKLV IDEPAKEKNE KGALKRRAGD LLEDSPKRPK EAENPEGEEK
|
181EAATLEVERP LPNEVEKNST PSEPGSGRGP PQEEEEEEDE EEEATKEDAE APGIRDHESL
|
241
|
GENBANK ID: P10147
VERSION P10147 GI:127078
1MQVSTAALAV LLCTMALCNQ FSASLAADTP TACCFSYTSR QIPQNFIADY FETSSQCSKP
|
61GVIFLTKRSR QVCADPSEEW VQKYVSDLEL SA
|
GENBANK ID: P13500
VERSION P13500 GI:126842
1MKVSAALLCL LLIAATFIPQ GLAQPDAINA PVTCCYNFTN RKISVQRLAS YRRITSSKCP
|
61KEAVIFKTIV AKEICADPKQ KNVQDSMDHL DKQTQTPKT
|
GENBANK ID: NP_065391.1
VERSION NP_065391.1 GI:10092621
1MGVLLTQRTL LSLVLALLFP SMASMAAIGS CSKEYRVLLG QLQKQTDLMQ DTSRLLQPYI
|
61RIQGLDVFKL REHCRERPGA FPSEETLRGL GRRGFLQTLN ATLGCVLHRL ADLEQRLFKA
|
121QDLERSGLNI EDLEKLQMAR FNILGLRNNI YCMAQLLDNS DTAEPTKAGR DASQPPTPTP
|
181ASDAFQRKLE GCRFLHGYHR FMESVGRVFS KWGESFNRSR RHSPHQALRK GVRRTRPSRK
|
241GKRLMTRGQL PR
|
GENBANK ID: XP_013053.3
VERSION XP_013053.3 GI:14768277
1MERERETLQA WEERVGQELD RVVAFWNEHS HDQEEGGFFT CLGREGRVYD DLKYVWLQGR
|
61QVWMYCRLYR TFERFRHAQL LDAAKAGGEF LLRYARVAPP GKKCAFVLTR DGRPVKVQRT
|
121IFSECFYTMA MNELWRATGE VRYQTEAVEM MDQIVHWVQE DASGLGRPQL QGAPAAEPMA
|
181VPMNLLNLVE QLGEADEELA GKYAELGDWC ARRILQHVQR DGQAVLENVS EGGKELPGCL
|
241GRQQNPGHTL EAGWFLLRHC IRIGDPELRA HVIDKWLLLP FHSGWDPDHG GLFYFQDADN
|
301FCPTQLEWAN KLWWPHSEAM IAFLMGYSDS GDPVLLRLFY QVAEYTFRQF RDPEYGENFG
|
361YLSREGKVAL SIKGGPFKGC FHVPRCLAMC EEMLGALLSR PAPAPSPAPT PACRGAE
|
GENBANK ID: B31848
VERSION B31848 GI:87005
1MTCKNSQLER NIETIINTFH QYSVKLGEPD TLNQGEFKEL VRKDLQNFLK KENKNEKVIE
|
61HIMEDLDTNA DKQLSFEEFI MLMARLTWAS HENNEEGDEG PGHHHKPGLG ECTP
|
GENBANK ID: CAA38698.1
VERSION CAA38698.1 GI:35522
1MPVNRLFPCF LQLLAGLALP AVFFQQWALS AGNGSSEVEV VFFQEVWGRS YCRALERLVD
|
61VVSEYPSEVE HMFSFSCVSL LRCTGCCGDE NLHCVPVETA NVTMQLLKIR SGDRPSYVEL
|
121TFSQHVRCEC RPLREKMKPE RCGDAVPRR
|
GENBANK ID: AAA35789.1
VERSION AAA35789.1 GI:181971
1MNFLLSWVHW SLALLLYLHH AKWSQAAPNA EGGGQNHHEV VKFMDVYQRS YCHFIETLVD
|
61IFQEYPDEIE YIFKPSCVFL NRCGGCCNDE GLECVPTEES NITMQINRIK PHQGQHIGEM
|
121SFLQHNKCEC RPKKDRARQE NPCGPCSERR KHLFVQDPQT CKCSCKNTDS RCKARQLELN
|
181ERTCRCDKPR R
|
GENBANK ID: AAA66062.1
VERSION AAA66062.1 GI:536898
1MWKRWLALAL ALVAVAWVRA EEELRSKSKI CANVFCGAGR ECAVTEKGEF TCLCIEQCKP
|
61HKRFVCGSNG KTYLNHCELH RDACLTGSKI QVDYDGHCKE KKSVSPSASP VVCYQSNRDE
|
121LRRRIIQWLE AEIIFDGWFS KGSNYSEILD KYFKNFDNGD SRLDSSEFLK FVEQNETAIN
|
181ITTYPDQENN KLLRGLCVDA LIELSDENAD WKLSFQEFLK CLNPSFNPPE KKCALEDETY
|
241ADGAETEVDC NRCVCACGNW VCTANTCDGK NQKGAQTQTE EEMTRYVQEL QKHQETAEKT
|
301KRVSTKEI
|
GENBANK ID: AAA59872.1
VERSION AAA59872.1 GI:398038
1MGWLPLLLLL TQCLGVPGQR SPLNDFQVLR GTELQHLLHA VVPGPWDEDV ADAEECAGRC
|
61GPLMDCRAFH YNVSSHGCQL LFWTQRSPHT RLRRSGRCDL FQKKDYVRTC IMNNGVGYRG
|
121TMATTVGGLP CQAWSHKFPN DHKYTFTLRN GLEENFCRNP DGDPGGFWCY TTDPAVRFQS
|
181CGIKSCREAA CVWCNGEEYR GAVDRTESGR ECQRWQLQHP HQHPFEPGKF LDQGLDDNYC
|
241RNPDGSERPW CYTTDPQIER EFCDLFRCGS EAQFRQEATT VSCFRGKGEG YRGTANTTTA
|
301GVPCQRWDAQ IFHQHRFTPE KYACKDLREN FCRNPDGSEA PWCFTLRPGM RAAFCYQIRR
|
361CTDDVRPQDC YHGAGEQYRG TVSKTRKGVQ CQRWSAETPH KPQFTFTSEP HAQLEENFCR
|
421NPDGDSHGPW CYTMDPRTPF DYCALRRCAD DQPPSILDPP DQVQFENCGK RVDRLDQRRS
|
481KLRVVGGHPG NSFWTVSLRN RQGQHFCGGS LVKEQWILTA RQCFSSCHMP LTGYEVWLGT
|
541LFQNPQHGEP SLQRVPVAKM VCGPSGSQLV LLKLERSVTL NQRVALICLP PEWYVVFFGT
|
601KCEIAGWGET KGTGNDTVLN VAFLNVTSNQ ECNIKHRGRV RESENCTEGL LADVGACEGD
|
661YGGPLACFTH NCWVLEGIII PNRVCARSRW PAVFTRVSVF VDWIHKVMRL G
|
GENBANK ID: P01579
VERSION P01579 GI:124479
1MKYTSYILAF QLCIVLGSLG CYCQDPYVKE AENLKKYFNA GHSDVADNGT LFLGILKNWK
|
61EESDRKIMQS QIVSFYFKLF KNFKDDQSIQ KSVETIKEDM NVKFFNSNKK KRDDFEKLTN
|
121YSVTDLNVQR KAIHELIQVM AELSPAAKTC KRKRSQMLFR GRRASQ
|
GENBANK ID: XP_035842.1
DEFINITION HOMO SAPIENS SMALL INDUCIBLE CYTOKINE A5 (RANTES) (SCYAS),
MRNA.
CDS 22..297
/CODON_START=1
1ACAGCCTCTC CCACAGGTAC CATGAAGGTC TCCGCGGCAG CCCTCGCTGT CATCCTCATT
|
61GCTACTGCCC TCTGCGCTCC TGCATCTGCC TCCCCATATT CCTCGGACAC CACACCCTGC
|
121TGCTTTGCCT ACATTGCCCG CCCACTCCCC CGTGCCCACA TCAAGGAGTA TTTCTACACC
|
181AGTGGCAAGT GCTCCAACCC AGCAGTCGTC TTTGTCACCC GAAAGAACCG CCAAGTGTGT
|
241GCCAACCCAG AGAAGAAATG GGTTCGGGAG TACATCAACT CTTTGGAGAT GAGCTAGGAT
|
301GGAGAGTCCT TGAACCTGAA CTTACACAAA TTTGCCTGTT TCTGCTTGCT CTTCTCCTAG
|
361CTTGGGAGGC TTCCCCTCAC TATCCTACCC CACCCGCTCC TTGAAGGGCC CAGATTCTAC
|
421CACACAGCAG CAGTTACAAA AACCTTCCCC AGCCTGGACC TGGTGGCTCA CGCCTGTAAT
|
481CCCAGCACTT TGGGAGGGCA AGGTGGGTGG ATCACTTGAG GTCAGGAGTT CGAGACCAGC
|
541CTGGCCAACA TGATGAAACC CCATCTCTAC TAAAAATACA AAAAATTAGC CGGGCGTGGT
|
601AGCGGGCGCC TGTAGTCCCA GCTACTCGGG AGGCTGAGGC AGGAGAATGG CGTGAACCCG
|
661GGAGGCGGAG CTTGCAGTGA GCCGAGATCG CGCCACTGCA CTCCAGCCTG GGCGACAGAG
|
721CGAGACTCCG TCTCAAAAAA AAAAAAAAAA AAAAAAATAC AAAAATTAGC CGGGCGTGGT
|
781GGCCCACGCC TGTAATCCCA GCTACTCGGG AGGCTAAGGC AGGAAAATTG TTTGAACCCA
|
841GGAGGTGGAG GCTGCAGTGA GCTGAGATTG TGCCACTTCA CTCCAGCCTG GGTGACAAAG
|
901TGAGACTCCG TCACAACAAC AACAACAAAA AGCTTCCCCA ACTAAAGCCT AGAAGAGCTT
|
961CTGAGGCGCT GCTTTGTCAA AAGGAAGTCT CTAGGTTCTG AGCTCTGGCT TTGCCTTGGC
|
1021TTTGCCAGGG CTCTGTGACC AGGAAGGAAG TCAGCATGCC TGTAGAGGCA AGGAGGGGAG
|
1081GAACACTGCA CTCTTAAGCT TCCGCCGTCT CAACCCCTCA CAGGAGCTTA CTGGCAAACA
|
1141TGAAAAATCG G
|
GENBANK ID: CAA72079.1
DEFINITION H. SAPIENS MRNA FOR ESTROGEN SULFOTRANSFERASE.
CDS 63..947
/CODON_START=1
1GCCTTGAAGA GATATAAACT AGATCAATTT CTTTCACAGG ATCAACTAAA CAGTGTACCA
|
61CAATGAATTC TGAACTTGAC TATTATGAAA AGTTTGAAGA AGTCCATGGG ATTCTAATGT
|
121ATAAAGATTT TGTCAAATAT TGGGATAATG TGGAAGCGTT CCAGGCAAGA CCAGATGATC
|
181TTGTCATTGC CACCTACCCT AAATCTGGTA CAACCTGGGT TAGTGAAATT GTGTATATGA
|
241TCTATAAAGA GGGTGATGTG GAAAAGTGCA AAGAAGATGT AATTTTTAAT CGAATACCTT
|
301TCCTGGAATG CAGAAAAGAA AACCTCATGA ATGGAGTAAA ACAATTAGAT GAGATGAATT
|
361CTCCTAGAAT TGTGAAGACT CATTTGCCAC CTGAACTTCT TCCTGCCTCA TTTTGGGAAA
|
421AGGATTGTAA GATAATCTAT CTTTGCCGGA ATGCAAAGGA TGTGGCTGTT TCCTTTTATT
|
481ATTTCTTTCT AATGGTGGCT GGTCATCCAA ATCCTGGATC CTTTCCAGAG TTTGTGGAGA
|
541AATTCATGCA AGGACAGGTT CCTTATGGTT CCTGGTATAA ACATGTAAAA TCTTGGTGGG
|
601AAAAGGGAAA GAGTCCACGT GTACTATTTC TTTTCTACGA AGACCTGAAA GAGGATATCA
|
661GAAAAGAGGT GATAAAATTG ATACATTTCC TGGAAAGGAA GCCATCAGAG GAGCTTGTGG
|
721ACAGGATTAT ACATCATACT TCGTTCCAAG AGATGAAGAA CAATCCATCC ACAAATTACA
|
781CAACACTGCC AGACGAAATT ATGAACCAGA AATTGTCGCC CTTCATGAGA AAGGGAATTA
|
841CAGGAGACTG GAAAAATCAC TTTACAGTAG CCCTGAATGA AAAATTTGAT AAACATTATG
|
901AGCAGCAAAT GAAGGAATCT ACACTGAAGT TTCGAACTGA GATCTAAGAA GGTCTT
|
GENBANK ID: AAA63210.1
DEFINITION HUMAN KERATINOCYTE GROWTH FACTOR MRNA, COMPLETE CDS.
CDS 446..1030
/CODON_START=1
1ACGCGCTCAC ACACAGAGAG AAAATCCTTC TGCCTGTTGA TTTATGGAAA CAATTATGAT
|
61TCTGCTGGAG AACTTTTCAG CTGAGAAATA GTTTGTAGCT ACAGTAGAAA GGCTCAAGTT
|
121GCACCAGGCA GACAACAGAC ATGGAATTCT TATATATCCA GCTGTTAGCA ACAAAACAAA
|
181AGTCAAATAG CAAACAGCGT CACAGCAACT GAACTTACTA CGAACTGTTT TTATGAGGAT
|
241TTATCAACAG AGTTATTTAA GGAGGAATCC TGTGTTGTTA TCAGGAACTA AAAGGATAAG
|
301GCTAACAATT TGGAAAGAGC AAGTACTCTT TCTTAAATCA ATCTACAATT CACAGATAGG
|
361AAGAGGTCAA TGACCTAGGA GTAACAATCA ACTCAAGATT CATTTTCATT ATGTTATTCA
|
421TGAACACCCG GAGCACTACA CTATAATGCA CAAATGGATA CTGACATGGA TCCTGCCAAC
|
481TTTCCTCTAC AGATCATGCT TTCACATTAT CTGTCTAGTG GGTACTATAT CTTTAGCTTG
|
541CAATGACATG ACTCCAGAGC AAATGGCTAC AAATGTGAAC TGTTCCAGCC CTGAGCGACA
|
601CACAAGAAGT TATGATTACA TGGAAGGAGG GGATATAAGA GTGAGAAGAC TCTTCTGTCG
|
661AACACAGTGG TACCTGAGGA TCGATAAAAG AGGCAAAGTA AAAGGGACCC AAGACATGAA
|
721GAATAATTAC AATATCATGG AAATCAGGAC AGTGGCAGTT GGAATTGTGG CAATCAAAGG
|
781GGTGGAAAGT GAATTCTATC TTGCAATGAA CAAGGAAGGA AAACTCTATG CAAAGAAAGA
|
841ATGCAATGAA GATTGTAACT TCAAAGAACT AATTCTGGAA AACCATTACA ACACATATGC
|
901ATCAGCTAAA TGGACACACA ACGGAGGGCA AATGTTTCTT GCCTTAAATC AAAAGCCCAT
|
961TCCTGTAAGA GGAAAAAAAA CGAAGAAAGA ACAAAAAACA GCCCACTTTC TTCCTATGGC
|
1021AATAACTTAA TTGCATATGG TATATAAAGA ACCCAGTTCC AGCAGGGAGA TTTCTTTAAG
|
1081TGGACTGTTT TCTTTCTTCT CAAAATTTTC TTTCCATTTA TTTTTTAGTA ATCAAGAAAG
|
1141GCTGGAAAAA CTACTGAAAA ACTGATCAAG CTGGACTTGT GCATTTATGT TTGTTTTAAG
|
1201ACACTGCATT AAAGAAAGAT TTGAAAAGTA TACACAAAAA TCAGATTTAG TAACTAAAGG
|
1261TTGTAAAAAA TTGTAAAACT GGTTGTACAA TCATGATGTT AGTAACACTA ATTTTTTTCT
|
1321TAAATTAATT TACCCTTAAG AGTATGTTAG ATTTGATTAT CTGATAATGA TTATTTAAAT
|
1381ATTCCTATCT GCTTATAAAA TGGCTGCTAT AATAATAATA ATACAGATGT TGTTATATAA
|
1441CCTATATCAG ACCTACAGGC TTCTGGCAGG ATTTGTCAGA TAATCAACCC ACACTAACTA
|
1501TCGAAAATGA GCAGCATTTT AAATGCTTTC TAGTGAAAAA TTATAATCTA CTTAAACTCT
|
1561AATCAGAAAA AAAATTCTCA AAAAAACTAT TATGAAAGTC AATAAAATAG ATAATTTAAC
|
1621AAAAGTACAG GATTAGAACA TGCTTATACC TATAAATAAG AACAAAATTT CTAATCCTGC
|
1681TCAAGTGGAA AGGGTATTGC TAAAAGGATG TTTCCAAAAA TCTTGTATAT AAGATAGCAA
|
1741CAGTGATTGA TGATAATACT GTACTTCATC TTACTTGCCA CAAAATAACA TTTTATAAAT
|
1801CCTCAAAGTA AAATTGAGAA ATCTTTAACT TTTTTTCAAC TAACATAATC TATCTTTGTA
|
1861TAATTCATAT TTGGGAATAT GGCTTTTAAT AATGTTCTTC CCACAAATAA TCATGCTTTT
|
1921TTCCTATGGT TACAGCATTA AACTCTATTT TAAGTTGTTT TTGAACTTTA TTGTTTTGTT
|
1981ATTTAAGTTT ATGTTATTTA TAAAAAAAAA ACCTTAATAA GCTGTATCTG TTTCATATGC
|
2041TTTTAATTTT AAAGGAATAA CAAAACTGTC TGGCTCAACG GCAAGTTTCC CTCCCTTTTC
|
2101TGACTGACAC TAAGTCTACC ACACAGCACT TGGGCCAGCA AATCCTCGAA GCAGACAAAA
|
2161ATAAGAGCCT GAAGCAATGC TTACAATAGA TGTCTCACAC AGAACAATAC AAATATGTAA
|
2221AAACTCTTTC ACCACATATT CTTGCCAATT AATTGGATCA TATAAGTAAA ATCATTACAA
|
2281ATATAAGTAT TTACAGGATT TTAAAGTTAG AATATATTTG AATGCATGGG TAGAAAATAT
|
2341CATATTTTAA AACTATGTAT ATTTAAATTT AGTAATTTTC TAATCTCTAG AAATCTCTGC
|
2401TGTTCAAAAG GTGGCAGCAC TGAAAGTTGT TTTCCTGTTA GATGCCAAGA GCACAATGCC
|
2461CAAAATAGAA GATGCAGTTA AGAATAAGGG GCCCTGAATG TCATGAAGGC TTGAGGTCAG
|
2521CCTACAGATA ACAGGATTAT TACAAGGATG AATTTCCACT TCAAAAGTCT TTCATTGGCA
|
2581GATCTTGGTA GCACTTTATA TGTTCACCAA TGGGAGGTCA ATATTTATCT AATTTAAAAG
|
2641GTATGCTAAC CACTGTGCTT TTAATTTCAA AATATTTGTC ATTCAAGTCC CTTTACATAA
|
2701ATAGTATTTC GTAATACATT TATAGATGAG ACTTATATGA AAAGGCTAGG TCAACAAAAA
|
2761CAATAGATTC ATTTAATTTT CCTGTGGTTA ACCTATACGA CCAGGATGTA GAAAACTAGA
|
2821AAGAACTGCC CTTCCTCACA TATACTCTTG CGAGAGAGCA TGAATGCTAT TCTGAACTAT
|
2881CACCTGATTC AAGGACTTTG CTAGCTAGGT TTTGAGGTCA GGCTTCAGTA ACTGTAGTCT
|
2941TGTGAGCATA TTGAGGGCAG AGGAGGACTT AGTTTTTCAT ATGTGTTTCC TTAGTGCCTA
|
3001GCAGACTATC TGTTCATAAT CAGTTTTCAG TGTGAATTCA CTGAATGTTT ATAGACAAAA
|
3061GAAAATACAC ACTAAAACTA ATCTTCATTT TAAAAGGGTA AAACATGACT ATACAGAAAT
|
3121TTAAATAGAA ATAGTGTATA TACATATAAA ATACAAGCTA TGTTAGGACC AAATGCTCTT
|
3181TGTCTATGGA GTTATACTTC CATCAAATTA CATAGCAATG CTGAATTAGG CAAAACCAAC
|
3241ATTTAGTGGT AAATCCATTC CTGGTAGTAT AAGTCACCTA AAAAAGACTT CTAGAAATAT
|
3301GTACTTTAAT TATTTGTTTT TCTCCTATTT TTAAATTTAT TATGCAAATT TTAGAAAATA
|
3361AAATTTGCTC TAGTTACACA CCTTTAGAAT TCTAGAATAT TAAAACTGTA AGGGGCCTCC
|
3421ATCCCTCTTA CTCATTTGTA GTCTAGGAAA TTGAGATTTT GATACACCTA AGGTCACGCA
|
3481GCTGGCTAGA TATACACCTG TCACAAGAGT CTAGATCAGT TAGCACATGC TTTCTACTCT
|
3541TCGATTATTA GTATTATTAG CTAATGGTCT TTGGCATGTT TTTGTTTTTT ATTTCTGTTG
|
3601AGATATAGCC TTTACATTTG TACACAAATG TGACTATGTC TTGGCAATGC ACTTCATACA
|
3661CAATGACTAA TGTATACTGT GATGATTTGA CTCAAAAGGA GAAAAGAAAT TATGTAGTTT
|
3721TCAATTCTGA TTCCTATTCA CCTTTTGTTT ATGAATGGAA AGCTTTGTGC AAAATATACA
|
3781TATAAGCAGA CTAAGCCTTT TAAAAATGTT CTTTGAAAGA TAAAATTAAA TACATGAGTT
|
3841TCTAACAATT ACA
|
GENBANK ID: AAA62202.1
DEFINITION HUMAN ENDOTHELIAL-MONOCYTE ACTIVATING POLYPEPTIDE II MRNA,
COMPLETE
CDS.
VERSION U10117.1 GI:498909
MRNA 1..1057
CDS 50..988
/CODON_START=1
1GGAACCCGTG GTCCTCCGCT TCATGATTTT CTGCCGTCTC TTGGCAAAAA TGGCAAATAA
|
61TGATGCTGTT CTGAAGAGAC TGGAGCAGAA GGGTGCAGAC GCAGATCAAA TCATTGAATA
|
121TCTTAAGCAG CAAGTTTCTC TACTTAAGGA GAAAGCAATT TTGCAGGCAA CTTTGAGGGA
|
181AGAGAAGAAA CTTCGAGTTG AAAATGCTAA ACTGAAGAAA GAAATTGAAG AACTGAAACA
|
241AGAGCTAATT CAGGCAGAAA TTCAAAATGG AGTGAAGCAA ATAGCATTPC CATCTGGTAC
|
301TCCACTGCAC GCTAATTCTA TGGTTTCTGA AAATGTGATA CAGTCTACAG CAGTAACAAC
|
361CGTATCTTCT GGTACCAAAG AACAGATAAA AGGAGGAACA GGAGACGAAA AGAAAGCGAA
|
421AGAGAAAATT GAAAAGAAAG GAGAGAAGAA GGAGAAAAAA CAGCAATCAA TAGCTGGAAG
|
481TGCCGACTCT AAGCCAATAG ATGTTTCCCG TCTGGATCTT CGAATTGGTT GCATCATAAC
|
541TGCTAGAAAA CACCCTGATG CAGATTCTTT GTATGTCGAA GAAGTAGATG TCGGAGAAAT
|
601AGCCCCAAGG ACAGTTGTCA GTGGCCTGGT GAATCATGTT CCTCTTGAAC AGATGCAAAA
|
661TCGGATGGTG ATTTTACTTT GTAACCTGAA ACCTGCAAAG ATGAGGGGAG TATTATCTCA
|
721AGCAATGGTC ATGTGTGCTA GTTCACCAGA GAAAATTGAA ATCTTGGCTC CTCCAAATGG
|
781GTCTGTTCCT GGAGACAGAA TTACTTTTGA TGCTTTCCCA GGAGAGCCTG ACAAGGAGCT
|
841GAATCCTAAG AAGAAGATTT GGGAGCAGAT CCAGCCTGAT CTTCACACTA ATGATGAGTG
|
901TGTGGCTACA TACAAAGGAG TTCCCTTTGA GGTGAAAGGG AAGGGAGTAT GTAGGGCTCA
|
961AACCATGAGC AACAGTGGAA TCAAATAAAA TGCTTCCACT ACCAAAAGAC ATTAGAGAAA
|
1021ACCTTAAAAG TAATAAAGAG AAATATATTT GTCACTT
|
GENBANK ID: P17936
DEFINITION HUMAN ACIDIC FIBROELAST GROWTH FACTOR MRNA, 5′END, CLONE
LA64BDA-MJ36.
CDS 358..>478
/CODON_START=1
1TCCCCAAGGC TAGGAGGCCA ACCTACTAAC AGGTGGGTGG GTATGGTGTG TGGTTTCACT
|
61CAGTTCTTCT CATGGGGTTT CTCTGAGCTC CATTCATACC AGAAAGGGAG CAGGAGAGAG
|
121AGGACAAGTG GATCCAACAG CCTTCGCTCC AGGGGAATCA GGGCATCGCC TCCTTTTCTG
|
181GGAGGACACT CCCTTCTGAT GGTGAATGGG AACTCCCTTC CTCCTGCAGC AGCCTGCCTG
|
241CAGCTGTCCT GGTAGAACAG TGTGGACATT GCAGAAGCTG TCACTGCCCC AGAAAGAAAG
|
301CACCCCAGAG CCAAGGCAAA GAGTCTTGAA AGCGCCACAA GCAGCAGCTG CTGAGCCATG
|
361GCTGAAGGGG AAATCACCAC CTTCACAGCC CTGACCGAGA AGTTTAATCT GCCTCCAGGG
|
421AATTACAAGA AGCCCAAACT CCTCTACTGT AGCAACGGGG GCCACTTCCT GAGGATCC
|
GENBANK ID:
U76376. 1
VERSION U76376.1 GI:1923234
MCPCPLHRGRGPPAVCACSAGRLGLRSSAAQLTAARLKALGDEL
|
HQRTMWRRRARSRRAPAPGALPTYWPWLCAAAQVAALAAWLLGRRNL
|
GENBANK ID: Y00638
VERSION Y00638.1 GI:34280
MYLWLKLLAFGFAFLDTEVFVTGQSPTPSPTGLTTAKNPSVPLS
|
SDPLPTHTTAFSPASTFERENDFSETTTSLSPDNTSTQVSPDSLDNASAFNTTGVSSV
|
QTPHLPTHADSQTPSAGTDTQTFSGSAANAKLNFTPGSNAISDVPGERSTASTFPTDP
|
VSPLTTTLSLAHHSSAALPARTSNTTITANTSDAYLNASETTTLSPSGSAVISTTTIA
|
TTPSKPTCDEKYANITVDYLYNKETKLFTAKLNVNENVECGNNTCTNNEVHNLTECKN
|
ASVSISHNSCTAPDKTLILDVPPGVEKFQLHDCTQVEKADTTICLKWKNIETFTCDTQ
|
NITYRFQCGNNIFDNKEIKLENLEPEHEYKCDSEILYNNHKFTNASKIIKTDFGSPGE
|
PQIIFCRSEAAHQGVITWNPPQRSFHNFTLCYIKETEKDCLNLDKNLIKYDLQNLKPY
|
TKYVLSLHAYIIAKVQRNGSAAMCHFTTKSAPPSQVWNMTVSMTSDNSMHVKCRPPRD
|
RNGPHERYHLEVEAGNTLVRNESHKNCDFRVKDLQYSTDYTFKAYFHNGDYFGEPFIL
|
HHSTSYNSKALIAFLAFLIIVTSIALLVVLYKIYDLHKKRSCNLDEQQELVERDDEKQ
|
LMNVEPIHADILLETYKRKIADEGRPFLAEFQSIPRVFSKFPIKEARKPFNQNKNRYV
|
DILPYDYNRVELSEINGDAGSNYINASYIDGFKEPRKYIAAQGPRDETVDDFWRMIWE
|
QKATVIVNVTRCEEGNRNKCAEYWPSMEEGTRAFGDVVVKINQHKRCPDYIIQKLNIV
|
NKKEKATGREVTHIQFTSWPDHGVPEDPHLLLKLRRRVNAFSNFFSGPIVVHCSAGVG
|
RTGTYIGIDAMLEGLEAENKVDVYGYVVKLRRQRCLMVQVEAQYILIHQALVEYNQFG
|
ETEVNLSELHPYLHNNKKRDPPSEPSPLEAEFQRLPSYRSWRTQHIGNQEENKSKNRN
|
SNVIPYDYNRVPLKHELEMSKESEHDSDESSDDDSDSEEPSKYINASFIMSYWKPEVM
|
IAAQGPLKETIGDFWQMIFGRKVKVIVNLTELKHGDDEICAQYWGEGKQTYGDIEVDL
|
KDTDKSSTYTLRVFELRHSKRKDSRTVYQYQYTNWSVEDLPAEPKELISNIQVVKQKL
|
PQKNSSEGNKHHKSTPLLTHCRDGSQQTCIFCALLNLLESAETEEVVDIFQVVRALRK
|
ARLGMVSTFEQYQFLYDVIASTYPAQNQQVKKNNHQEDKIEFDNEVDKVKQDANCVNP
|
LGAPEKLPEAKEQAEGSEPTSGTEGPENSVNGPASPALNQGS
|
GENBANK ID: AF001383.1
VERSION AF001383.1 GI:2199534
MAEMGSKGVTAGKIASNVQKKLTRAQEKVLQKLDKADETKDEQF
|
EQCVQNFNKQLTECTRLQKDLRTYLASVKANHEASKKLNECLQEVYEPDWFGRDEANK
|
IAENNDLLNMDYHQKLVDQALLTMDTYLGQFPDIKSRIAKRQRKLVDYDSARHHYESL
|
QTAKKKDEAKIAKAEEELIKAQKVFEENNVDLQEELPSLWNSRVGFYVNTEQSIAGLE
|
ENFHKEMSKLNQNLNDVLVGLEKQNGSNTFTVKAQPSDNAPAKGNKSPSPEDGSPAAT
|
PEIRVNHEPEPAGGATPGATLFKSPSQLRKGPPVPPPFKHTPSKEVKQEQILSLFEDT
|
FVPEISVTTPSQPAEASEVAGGTQPAAGAQEPCETAASEAASSSLPAVVVETFPATVN
|
GTVEGGSGAGRLDLPPGFMFKVQAQEDYTATDTDELQLKAGDVVLVIPFQNFEEQDEG
|
WLMGVKESDWNQHKELEKCRGVFFENFTERVP
|
GENBANK ID: XM_038595.3
VERSION XM_038595.3 GI:18590923
MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSES
|
FGDHLAEDLCVQAAKASGILPVYRSLFALATEDLSCWFPPSHIESVEDASTQVLLYRI
|
REYEPNWEGLEKCNREGLRKDLASAILDLPVLEHLFAQERSDLVSGRLPVGLSLKEQG
|
ECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSPVTRRRIRRTVR
|
RALRRVAACQADRHSLMAKYIMDLERLDPAGAAETEHVGLPGALGGHDGLGLLRVAGD
|
GGIAWTQGEQEVLQPECDEFEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPG
|
LPEALSFVALVDGYFRLTTDSQHEFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTG
|
GSRPGSYVLRRSPQDEDSELLTVCVQNPLGPDYKGCLIRRSPTGTELLVGLSRPHSSL
|
RELLATCNDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQVQL
|
SQMTFEKIFADSLEWHENLGHGSETKIYRGCRHEVVDDEARKTEVLLKVMDAKHKNCM
|
ESFLEAASLMSQVSYRHLVLLHGVCNAGDSTNVQEFVHLGAIDNYLRKRCHLVPASWK
|
LQVVKQLAYALNYLEDKGLPNCNVSARKVLLAREGADGSPEFIELSDPCVSPAVLSLE
|
MLTDRIPWVAPECLREAQTLSLEADKNGFGATVWEVFSGVTNPISALDPAKKLQFYED
|
RQQLPAPKNTELALLIQQCNAYEPVQRPSERAVIRDLNSLISSDVELLSDPTPGALAP
|
RDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNEQSVELCRVDFLGDNTGALVAVKQ
|
LQHSGPDQQRDEQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVNEYLPSGCLRDEL
|
QRHRARLDASRLLLYSSQICKGNEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK
|
LLPLDKDYYVVREPGQSPIFWYAFESLSDNIESRQSDVWSFGVVLVELFTYCDKSCSP
|
SAEFLRMNGCERDVPALCRLLELLEEGQRLPAPPACPAEVEELMKLCWAPSPQDRPSF
|
SALDPQLDNLNSCSRGCETSAFTANPEGKHESLSFS
|
GENEANK ID: M32292.1
VERSION M32292.1 GI:181492
MENSLRCVWVPKLAEVLECASLLSAHLQVTCFQIKAETALRELS
|
EPSDAVTMRCGNVLLDCSAESDRGVFVIKWKKDGIHLALCMDERKQQLSNCSLLIQNI
|
LHSREHKPDEGLYQCEASLGDSGSIISRTAKVAVAGPLRELSQTESVTAENGDTVLLK
|
CEVIGEPMPTINNQKNQQDLTPIPGDSRVVVLPSGALQISRLQPGDIGIVRCSARNPA
|
SSRTGNEAEVRICSDPGLHRQLYFLQRPSNVVAIEGKDAVLECCVSGVPPPSFTWLRG
|
EEVIQLRSKKYSLLGGSNLLISNVTDDDSGMVTCVVTYKNENISASAELTVLVPPWFL
|
NHPSNLYAYESNDIEFECTVSCKPVPTVNWMKNCDVVIPSDYFQIVCCSNLRILGVVK
|
SDEGEYQCVAENEAGNAGTSAQLIVPKPAIPSSSVLPSAPRDVVPVLVSSREVRLSWR
|
PPAEAKCNIQTETVFFSREGDNRERALNTTQPGSLQLTVCNLKPEANVTFRVVAYNEW
|
GPGESSQPIKVATQPELQVPGPVENLQAVSTSPTSILITWEPPAVANGPVQCVRLFCT
|
EVSTGKEQNIEVDGLSYKLEGLKKFTEYSLRELAYNRYGPGVSTDDITVVTLSDVPSA
|
PPQNVSLEVVNSRSIKVSWLPPPSGTQNGEITGYKIRHRKTTRRGENETLEPNNLWYL
|
FTGLEKGSQYSFQVSANTVNCTCPPSNWYTAETPENDLDESQVPDQFSSLHVRPQTNC
|
IIMSWTPPLN
|
GENBANK ID: X06318
VERSION X06318.1 GI:35488
MADPAACFFPSEGEESTVRFARKGALRQKNVHEVKNHKETAREF
|
KQPTFCSHCTDFIWCFGKQGEQCQVCCFVVHKRCNEFVTFSCPGADKGPASDDPRSKH
|
KEKIHTYSSPTECDHCGSLLYGLIHQGMKCDTCMNNVHKRCVNNVPSLCCTDHTERRG
|
RIYIQAHIDRDVLIVLVRDAKNLVPNDPNGLSDPYVKLELIPDPKSESKQETETIKCS
|
LNPEWNETFRFQLKESDKDRRLSVETWDWDLTSRNDFMGSLSFGISELQKASVDGWFK
|
LLSQEEGEYFNVPVPPEGSEANEELRQKFERAKISQGTKVFEEKTTNTVSKFDNNGNR
|
DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKTLKKDVVTQDDDVECTMVEKR
|
VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLNYNIQQVGRFKEPHAVFYAAEI
|
AIGLFFLQSKGIIYRDLKLDNVNLDSEGHIRIADFCNCKENINDGVTTKTFCGTPDYI
|
APEIIAYQFYGKSVDWWAFGVLLYEMLAGQAFFEGEDEDELFQSIMEHNVAYFKSMSK
|
EAVAICKGLMTKHFGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQFPYKPKARDK
|
RDTSNFDKEFTRQPVELTFTDKLFIMNLDQNEFAGFSYTNPEFVINV
|
GENBANK ID: J04122.1
VERSION J04132.1 GI:623041
MKWKALFTAAILQAQLFITEAQSFGLLDPELCYLLDGILFIYGV
|
ILTALFLRVKFSRSAEPPAYQQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPRR
|
KNPQEGLYNELQKDKMAEAYSEIGNKGERRRGKGHDGLYQGLSTATKDTYDALHNQAL
|
PPR
|
GENBANK ID: 004313.1
VERSION 004313.1 GI:453368
MDALQLANSAFAVDLFKQLCEKEPLGNVLFSPICLSTSLSLAQV
|
GAKGDTANEIGQVLHFENVKDIPFGFQTVTSDVNKLSSFYSLKLIKRLYVDKSLNLST
|
EFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKIL
|
VVNAAYFVGKWNKKFPESETKECPFRLNKTDTKPVGMNNMEATFCMGNIDSINCKIIE
|
LPFQNKHLSMFILLPKDVEDESTGLEKIEKQLNSESLSQWTNPSTMANAKVKLSIPKF
|
KVEKMIDPKACLENLGLKHIFSEDTSDFSGNSETKGVALSNVINKVCLEITEDGGDSI
|
EVPGARILQHKDELNADHFFIYIIRHNKTRNIIFFGKFCSP
|
GENBANK ID: X68968.1
VERSION X68968.1 GI:452315
MDEPSPLAQFLELNQHSRFIIGSVSEDNSEGEISNLVKLDLLEE
|
KEGSLSPASVGSDTLSDLGISSLQDGLALHIRSSNSGLELVKQGRDRKKIDSQRDFTV
|
ASPAEFVTRFGGNKVIEKVLIANNGIAAVECMRSIRRWSYENFRNERAIRFVVMVTPE
|
DLKANAEYIKMADHYVPVFGGFNNNNYANVELILDIAKRIFVQAVWAGWGHASENPKL
|
PELLLKNGIAFNGPPSQANNALGDKIASSIVAQTAGIFTLFWSGSGLRVDWQENDFSK
|
RILNVFQELYEKGYVKDVDDGLQAAEEVGYPVNIKASEGGGGEGIRKVNNAGDFPNLF
|
RQVQAEVPGSPIFVMRLAKQSRHLEVQILADQYGNAISLFGRDCSVQRRHQKIIEEAP
|
ATIATFAVFEHMEQCAVKLAKMVGYVSAGTVEYLYSQDRSFYFLELNPRLQVEHFCTE
|
MVADVNLFAAQLQIAMGIFLYRIKDIRMMYGVSFWGDSFIDFEDSAHVFCPRGHVIAA
|
RITSENFDEGFKPSSGTVQELNFRSNKNVWGYFSVAAAGGLHEFADSQFGHCFSWGES
|
REEAISNNVVALKELSIRGDFRTTVEYLIKLLETESFQMNRIDTGWLDRLIAEKVQAE
|
RPDTMLGVVCGALHVADVSLRNSVSNFLHSLERGQVLEAHTLLNTVDVELIYEGVKYV
|
LKVTRQSPNSYVVINNGSCVEVDVHRLSDGGLLLSYDGSSYTTYNKEEVDRYRITIGN
|
KTCVFEKENDPSVMRSFSAGKLIQYIVEDGGHVLAGQCYAEIEVMKMVMTLTAVESGC
|
IHYVKRPGAALDPGCVLAKMQLDNPSKVQQAELHTGSLPRIQSTALRGEKLHRVFHYV
|
LDNLVNVMNGYCLFDFFSSSKVKDWVERLNKTLRDPSLPLLELQDIMTSVSGRIPPNV
|
EKSIKKEMAQYASNITSVLCQFPSQQIANILDSHAATLNRKSEREVFFNNTQSIVQLV
|
QRYRSGIRGHMKAVVMDLLRGYLRVETQFQNGHYDKCVFALREENKSDMNTVLNYIFS
|
HAQVTKKNLLVTMLIDQLCGRDPTLTDELLNILTELTQLSKTTNAKVALRARQVLIAS
|
HLPSYELRHNQVESIFLSAIDMYGHQFCIENLQKLILSEISIFDVLPNFFYNSNQVVR
|
MAALEVYVRRAYIAYELNSVQHRQLKDNTCVVEFQFNLPTSNPNRGNIPTLNRMSFSS
|
NLNHYGMTHVASVSDVLLDNSFTPPCQRMCGMVSFRTFEDFVRIFDEVNGCFSDSPPQ
|
SPTFPEAGHTSLYDEDKVPRDEPIHILNVAIKTDCDIEDDRLAANFREFTQQNKATLV
|
DHGIRELTFLVAQKDFRKQVNYEVDRRFHREFPKFFTFRARDKFEEDRIYRELEPALA
|
FQLELNRMRNFDLTAIPCANEKMHLYLGAAKVEVGTEVTDYRFFVRAIIRHSDLVTKE
|
ASFEYLQNEGERLLLEANDELEVAFNNTNVRTDCNHIFLNFVPTVIMDFSKIEESVRY
|
MVMRYGSRLWKLRVLQAEVKINIRQTTTGSAVPIRLFITNESGYYLDISLYKEVTDSR
|
SGNIMFHSFGNKQGFQHGNLINTPYVTEDLLQAKREGAQTLGTTYIYDFFEMFRQALF
|
KLWGSPDKYPKDILTYTELVLDSQGQLVENNRLFGGNEVGNVAFKMRFKTQEYFEGRD
|
VIVIGNDITFRIGSFGPGEDLLYLRASEMARAEAIFKIYVAANSGARIGMAEEIKHMF
|
HVAWVDPEDFHKGFKYLYLTPQDYTRISSLNSVHCKHIEEGGESRYMITDIIGKDDGL
|
GVENLRGSGMIAGESSLAYEEIVTISLVTCRAIGIGAYLVRLGQRVIQVENSHIILTG
|
ASALNKVLGREVYTSNNQLGGVQINNYNGVSEITVPDDFEGVYTILEWLSYMPKDNHS
|
PVPIITPTDPIDREIEFLFSRAPYDPRWNLAGRFHFTLKGTWQSGFFDHGSFKEIMAP
|
WAQTVVTGRARLGGIPVGVIAVETRTVEVAVPADPANLDSEAKIIQQAGQVWFPDSAY
|
KTAQAIKDFNREKLFLMIEANWRGFSGGNKDNYDQVLRFGAYTVDGLRQYKQPTLIYI
|
RPMRELRGGSWVVIDATINFLCIENYADKESRGGVLEFEGTVEIKFRKEDLIKSMRRI
|
DPAYKKLNEQLGEPDLSDKDRKDLEGRLKAREDLLLPIYHQVAVQFADFHDTPGEMLE
|
KGVISDILEWKTARTFLYWRLRRLLLEDQVKQEILQASGELSEVHIQSMLRRWFVETE
|
GAVRAYLWDNNQVVVQWLEQHWQAGDGPRSTIRENITYLKHDSVLKTIRGLVEENPEV
|
AVDCVIYLSQHISFAERAQVVHLLSTMDSPAST
|
GENBANK ID: L03840.1
VERSION L03840.1 GI:182570
MRLLLALLGVLLSVPGPPVLSLEASEEVELEPCLAPSLEQQEQE
|
LTVALGQPVRLCCGRAERGGHWYKEGSRLAPAGRVRGWRGRLEIASELFEDAGRYLCL
|
ARGSMIVLQNLTLITGDSLTSSNDDEGPKSNRDPSNRNSYPQQAPYNTHPQRMEKKLH
|
AVPAGNTVKFRCFAAGNPTPTIRWLKGGQAFHGENRIGGIRLRHQEWSLVMESVVPSD
|
RGTYTCLVENAVGSIRYNYLLDVLERSPHRPILQAGLPANTTAVVGSDVELLCKVYSD
|
AQPHIQWLKHIVINGSSFGADGFPYVQVLKTADINSSEVEVLYLRNVSAEDAGEYTCL
|
AGNSIGLSYQSAWLTVLPEEDPTWTAAAPEARYTDIILYASGSLALAVLLLLAGLYRG
|
QALNGRHPRPPATVQKLSRFPLARQFSLESGSSGKSSSSLVRGVRLSSSGPALLAGLV
|
SLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDN
|
ASDKDLADLVSEMEVMKLIGRHENIINLLGVCTQEGPLYVIVECAAKGNLREFLRARR
|
PPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGNQYLESRKCIHRDLAARNVLVTEDN
|
VMKIADFGLARGVHNIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEI
|
FTLGGSPYPGIPVEELFSLLREGHRMDRFFHCPFELYGLMRECWHAAPSQRPTFKQLV
|
EALDKVLLAVSEEYLDLRLTFGPYSPSGGDASSTCSSSDSVFSHDPLPLGSSSFPFGS
|
GVQT
|
GENBANK ID: AF043342.1
VERSION AF043342.1 GI:2905633
VRSSSRTPSDKPVANVVANPQAEGQLQWLNRRANALLANGVELR
|
DNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHITSRIAVSYQTKVNLLSAIKSPCQ
|
RETPRGAEAKPWYEPIYLCGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGITAL
|
GENBANK ID: NM_000735.2
VERSION NM_000735.2 GI:10800407
MDYYRKYAAIFLVTLSVFLNVLNSAPDVQDCPECTLQENPFFSQ
|
PGAPILQCMGCCFSRAYPTPLRSKKTNLVQKNVTSESTCCVAKSYNRVTVN0GFKVEN
|
HTACNCSTCYYNKS
|
GENBANK ID: M83533.1
VERSION M83533.1 GI:178541
LRKHNIETYLIKQPEDSLLSLPEDIVKESVSSSDRRNSGATFTE
|
GSWSPELPFDNIVGKQNTLAALTRNSINLLPNHLAQALHVQSGPEEINKRIEHTIDLR
|
SGDKLRRENIKPFSLNFKDSSLENKYSQMRDEVFKSNLVCAFIVLLFITAIQSLLPSS
|
RVMPMTIQFSILIMLHSALVLITTAEDYKCLPLILRKTCCWINETYLARNVIIFASIL
|
INFLGAILNILWCDFDKSIPLKNLTFNSSAVFTDICSYPEYFVFTGVLANVTCAVFLR
|
LNSVLKLAVLLIMIAIYALLTETVYA0LFLRYDNLNESGEDFLGTKEVSLLLMANFLL
|
AVFYHGQQLEYTARLDFLWRVQAKEEINEMKELREHNENMLRNILPSHVARNELEKDR
|
DNEELYSQSYDAVGVMFASIPGFADFYSQTEMNNQGVECLRLLNEIIADFDELLGEDR
|
FQDIEKIKTIGSTYNAVSGLSPEKQQCEDKWGHLCALADFSLALTESIQEINKHSFNN
|
FELRIGISNGSVVAGVIGAKKPQYDIMGKTVNLASRMDSTGVSGRIQVPEETYLILKD
|
QGFAFDYRGEIYVEGISEQEGKIKTYFLLGRVQPNPFILPPRRLPGQYSLAAVVLGLV
|
QSLNRQRQKQLLNENNNTGIIKGNYNRRTLLSPSGTEPGAQAEGTDKSDLP
|
GENBANK ID: M31767.1
VERSION M31767.1 GI:181615
MDKDCEMKRTTLDSPLGKLELSGCEQGLNEIKLLGKGTSAADAV
|
EVPAPAAVLGGPEPLMQCTAWLNAYFHQPEAIEEFPVPALHHPVFQQESFTRQVLWKL
|
LKVVKFGEVISYQQLAALAGNPKATRAVGGAMRGNPVPILIPCHRVVCSSGAVGNYSG
|
GLAVKENLLANEGNRLGKPGLGGSSGLAGAWLKGAGATSGSPPAGRN
|
GENBANK ID: X14723
VERSION X14723.1 GI:30250
MMKTLLLFVGLLLTWESGQVLGDQTVSDNELQEMSNQGSKYVNK
|
EIQNAVNGVKQTKTLIEKTNEERKTLLSNLEEAKKKKEDALNETRESETKLKELPGVC
|
NETMMALWEECKPCLKQTCMKFYARVCRSGSGLVGRQLEEFLNQSSFFYFWNNGDRID
|
SLLENDRQQTHMLDVMQDHFSRASSIIDELFQDRFFTREPQDTYHYLPFSLPHRRPHF
|
FFPKSRIVRSLNPFSPYEPLNFHAMFQPFLEMTHEAQQAMDIHFESPAFQNPPTEFIR
|
EGDDDRTVCREIRHNSTGCLRMKDQCDKCREILSVDCSTNNPSQAKLRRELDESLQVA
|
ERLTRKYNELLKSYQWKMLNTSSLLEQLNEQFNWVSRLANLTQGEDQYYLRVTTVASH
|
TSDSDVPSGVTEVVVKLFDSDPITVTVEVEVSRKNFKFMETVAEKALQEYRKKHREE
|
GENBANK ID: X04391.1
VERSION X04391.1 GI:37186
MPMGSLQPLATLYLLGNLVASCLGRLSWYDPDFQARLTRSNSKC
|
QGQLEVYLKDGWHMVCSQSWGRSSKQWEDESQASKVCQRLNCGVPLSLGPFLVTYTPQ
|
SSIICYGQLGSFSNCSESRNDMCESLGLTCLEPQKTTFFTTRPPPTTTPEPTAPPRLQ
|
LVAQSGGQHCAGVVEFYSGSLGGTISYEAQDKTQDLENFLCNNLQCGSFLKHLPETEA
|
GRAQDPGEFRENQPLPIQWKIQNSSCTSLEHCFRKIKPQKSGRVLALLCSGFQPKVQS
|
RLVGGSSICEGTVEVRQGAQWAALCDSSSARSSLRWEEVCREQQCGSVNSYRVLDAGD
|
PTSRGLFCFHQKLSQCEELWERNSYCKKVFVTCQDPNPAGLAAGTVASIILALVLLVV
|
LLVVCGPLAYKKLVKKFRGKKQRQWIGPTGNNQNNSFHRNETATVRSHAENPTASHVD
|
NEYSQFPRNSRLSAYFALEGVLNRSSNQPDNSSDSDYDLHGAQRL
|
GENBANK ID: S78187.1
VERSION S78187.1 GI:243485
MEVPQPEPAPGSALSPAGVCGGAQRPGHLPGLLLGSHGLLGSPV
|
RAAASSFVTTLTQTMHDLAGLGSRSRLTELSLSRRASESSLSSESSESSDAGLCMDSP
|
SPMDPHMAEQTFEQAIQAASRIIRNEQFAIRRFQSNPVRLLGHSPVLRNITNSQAPDG
|
RRKSEAGSGAASSSGEDKENDGFVFKMPWKPTHPSSTHALAEWASRREAFAQRPSSAP
|
DLMCLSPDRKNEVEELSPLALGRFSLTFAEGDTEEDDGFVDILESDLKDDDAVPPGME
|
SLISAPLVKTLEKEEEKDLVMYSKCQRLFRSFSNPCSVIRPILKRLERPQGRDTPVQN
|
KRRRSVTPPEEQQEAEEEKARVLRSKSLCHDEIENDLLSDHRELIGDYSKAFLLQTVD
|
GKHQDLKYISPETNVALLTGKFSNIVDKFVIVDCRYPYEYEGGHIKTAVNLPLERDAE
|
SFLLKSPIAPCSLDKRVILIFNCEFSSERGPRMCRFIRERDRAVNDYFSLYYPEMYIL
|
KGGYKEFFPQHPNFCEPQDYRPNNHEAFKDELKTFRLKTRSWAGERSRRELCDRLQDQ
|
GENBANK ID: Y00096.1
VERSION Y00096.1 GI:30455
MREAAFMYSTAVAIFLVILVAALQGSAPRESPLPYEIPLDPEGS
|
LELSWNVSYTQEAIHFQLLVRRLKAGVLFGMSDRQELENADLVVLWTDGDTAYFADAW
|
SDQKGQIHLDFQQDYQLLQVQRTPEGLTLLFKRPFGTCDPKDYLIEDGTVHLVYGILE
|
EPFRSLEAINGSGLQMGLQRVQLLKFNIFEPELFSDTCTNEVQAFNIQIESQETTYWC
|
YIKELPKGFSRHHIIKYEPIVTKGNEALVHHMEVFQCAPEMDSVPHFSGPCDSKMKPD
|
RLNYCRHVLAAWALGAKAFYYPEEAGLAFGGPGSSRVLRLEVHYHNPLVIEGRNDSSG
|
IRLYYTAKLRRFNAGINELGLVYIPVMAIFPRETAFILTGYCTDKCTQLALPPSGIHI
|
FASQLHTHLTGRKVVTVLVRDGREWEIVNQDNHYSFHFQEIRMLKKVVSVHFGDVLIT
|
SCTYNTEDRELATVGGFGILEEMCVNYVHYYPQTQLELCKTAVDAGFLQKYFHLINRF
|
NNEDVCTCFQASVSQQFTSVFWNSFNCDVLKALYSFAPISMHCNKSSAVRFQGEWNLQ
|
PLPKVISTLEEPTPQCPTSQGRSPAGPTVVSIGGGKG
|
GENBANK ID: XM_055551.3
VERSION XM_055551.3 GI:18557356
MKETQKSTYYITGESKEQVANSAFVERVRKQGFEVVYNTEPIDE
|
YCVQQLKEFDGKSLVSVTKEGLELPEDEEEKKKMEESKEKFENLCKLMKEILDKKVEK
|
VTISNRLVSSPCCIVTSTYGWTANMEQIMKAQALRDNSTMGYMNAKKHLEINPDHPIM
|
ETLRQKAEADKNDKAVKDLVVLLFETALLSSGFSLEDPQTHSNHIYHMIKLGLGTDED
|
EVAAEEPSDAVPDEIFFLEQDEDASRMEEVD
|
GENBANK ID: M84711.1
VERSION M84711.1 GI:182774
MAVGKNKRLTKGGKKGAKKKVVDPFSKKDWYDVKAPAMFNIRNI
|
GKTLVTRTQGTKIASDGLKCRVFEVSLADLQNDEVAFRKFKLITEDVQGKNCLTNFHG
|
MDLTRDKMCSMVKKWQTNIEAHVDVKTTDGYLLRLFCVGFTKKRNNQIRKTSYAQEQQ
|
VRQIRKKMMEIMTREVQTNDLKEVVNKLTPDSIGKDIEKACQSIYPLHDVFVRKVKML
|
KKPKFELGKLMELRGEGSSSGKATGDETGAKVERADGYEPPVQESV
|
GENBANK ID: X53505
VERSION X53505.1 GI:36145
MAEEGIAAGGVMDVNTALQEVLKTALIHDGLARGIREAAKALDK
|
RQAHLCVQASNCDEPMYVKLVEALLAEHQINLIKVDDNKKLGEWVGLCKIDREGNPRK
|
VVGCSCVVVKDYGKESQAKDVIEEYFKCKK
|
GENBANK ID: X06617
VERSION X06617.1 GI:26143
MADIQTERAYQKQPTIFQNKKRVLLGETGKEKLFRYYKNIGLGF
|
KTPKEAIEGTYIDKKCPFTGNVSIRGRILSGVVTKMKMQRTIVIRRDYLHYIRKYNRF
|
EKRHKNMSVHLSPCFRDVQIGDIVTVGECRFLSKTVRFNVLKVTKAAGTKKQFQKF
|
GENBANK: M55040.1
VERSION M55040.1 GI:177974
MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVR
|
GGRLRGIRLKTPGGPVSAFLGIPFAEPPNGPRRFLPPEPKQPWSGVVDATTFQSVCYQ
|
YVDTLYPGFEGTEMNNPNRELSEDCLYLNVWTPYPRPTSPTBVLVWIYGGGFYSGASS
|
LDVYDGRFLVQAERTVLVSNNYRVGAFGFLALPGSREAPGNVGLLDGRLALQWVQENV
|
AAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGNGEAR
|
RRATQLAHLVGCPBGGTGGNDTELVACLRTRPAQVLVNKEWHVLPQESVFRFSFVPVV
|
DGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLA
|
GVRVGVPQVSDLAAEAVVLHYTDWLHPEDFARLREALSDVVGDHNVVCPVAQLAGRLA
|
AQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIFLDPSRNYTAEEKIFAQRLM
|
RYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRF
|
LPKLLSATDTLDEAERQWKAEFHRWSSYMVHWKNQFDHYSKQDRCSDL
|
GENBANK ID: NM_000717.2
VERSION NM_000717.2 GI:9951925
MRMLLALLALSAARPSASAESHWCYEVQAESSNYPCLVPVKNGG
|
NCQKDRQSPINIVTTKAKVDKKLGRFFFSGYDKKQTWTVQNNGHSVMMLLENKASISG
|
GGLDAPYQAKQLHLHWSDLPYKGSEHSLDGEHFANEMNIVHEKEKGTSRNVKEAQDPE
|
DEIAVLAFLVEAGTQVNEGFQPLVEALSNIPKPEMSTTMAESSLLDLLFKEEKLRHYF
|
RYLGSLTTPTCDEKVVWTVFREPIQLRREQILAFSQKLYYDKEQTVSMKDNVRPLQQL
|
GQRTVIKSGAPGRPLPWALPALLGPMLACLLAGFLR
|
GENBANK ID: S70S87.1
VERSION S70587.1 GI:546848
MTALFLMSNLFGLACGQAMSFCIPTEYTMHIERRECAYCLTINT
|
TMCAGYCNTRDINGKLFLPKYALSQDVCTYRDFIYRTVEIPGCPLHVAPYFSYPVALS
|
CKCGKCNTDYSDCIHEAIKTNYCTKPQKSYLVGFSV
|
GENBANK ID: M34057
VERSION M34057.1 GI:339547
MDTKLMCLLFFFSLFPLLVSNHTGRIKVVFTPSICKVTCTKGSC
|
QNSCEKGNTTTLISENGHAADTLTATNFRVVICHLPCNNGGQCSSRDKCQCFFNFTGK
|
LCQIPVHGASVPKLYQNSQGFGKALGTHVIHSTHTLPLTVTSGQGVKVKFPPNIVNIH
|
VKHPPEASVQIHQVSRIDGPTGQKTKEAQPGQSQVSYQGLPVQKTQTIHSTYSHQQVI
|
PHVYPVAAKTQLGRCFQETIGSQCGKALPGLSKQEDCCGTVGTSWGFNKCQKCPKKPS
|
YHGYNQMMECLPGYKRVNNTFCQDINECQLQGVCFNGECLNTMGSYRCTCKIGFGPDP
|
TFSSCVPDPPVISEEKGPCYRLVSSGRQCMYPLSVHLTKQLCCCSVGKAGPHCEKCPL
|
PGTAAFKEICPGGMGYTVSGVHRRRPIHHHVGKGPVFVKPKNTQPVAKSTHPPPLPAK
|
EEPVEALTFSREHGARSAEPEVATAPPEKEIFSLDQEKTKLEPGQPQLSPGISAIHLH
|
PQFPVVIEKTSPFVPVEVAPEASTSSASQVIAPTQVTEINECTVNPDICGAGHCINLP
|
VRYTCICYEGYRFSEQQRKCVDIDECTQVQNLCSQGRCENTEGSFLCICPAGFMASEE
|
GTNCIDVDECLRPDVCGEGHCVNTVGAFRCEYCDSCYRMTQRGRCEDIDECLNPSTCP
|
DEQCVNSPGSYQCVPCTEGFRGWNGQCLDVDECLEFNVCANGDCSNLEGSYMCSCHKG
|
YTRTPDHKHCRDIDECQQCNLCVNGQCKNTECSFRCTCGQGYQLSAAKDQCEDIDECQ
|
NRHLCAHGQCRNTEGSFQCVCDQGYRASGLCDHCEDINECLEDKSVCQRGDCINTAGS
|
YDCTCPDGFQLDDNKTCQDINECEHPGLCGPQGECLNTEGSEHCVCQQGFSISADGRT
|
CEDIDECVNNTVCDSHGFCDNTAGSFRCLCYQGFQAPQDGQGCVDVNECELLSGVCGE
|
AFCENVEGSFLCVCADENQEYSPMTGQCRSRTSTDLDVDVDQPKEEKKECYYNLNDAS
|
LCDNVLAPNVTKQECCCTSGAGWGDNCEIFPCPVLCTAEFTEMCPKGKGFVPAGESSS
|
EAGGENYKDADECLLFGQEICKNGFCLNTRPGYECYCKQGTYYDFVKLQCFDNDECQD
|
PSSCIDGQCVNTEGSYNCFCTHPMVLDASEKRCIRFAESNEQIEETDVYQDLCWEHLS
|
DEYVCSRPLVGKQTTYTECCCLYGEAWGNQCALCPLKDSDDYAQLCNIPVTGRRQPYG
|
RDALVDFSEQYTFEADPYFIQDRFLNSFEELQAEECGILNGCENGRCVRVQEGYTCDC
|
LDGYHLDTAKNTCFDVNECDELNNRNSLCKNAKCINTDGSYKCLCLPGYVPSDKPNYC
|
TPLNTALNLEKDSDLE
|
GENBANK ID: AF257099.1
VERSION AF257099.1 GI:8037944
MSDAAVDTSSEITTEDLKEKKEVVEEAENGRDAFANGNANEENG
|
EPEADNEVDEEEEEGGEEEGDGEEEDGDEDEGAESATGKRAAEDDEDDDVDTQKQKTD
|
EDD
|
GENBANK ID: L06505.1
VERSION L06505.1 GI:186799
MPFKFDFNEIKVVYLRCTGGEVGATSALAPKIGPLGLSPKKVGD
|
DIAKATGDWKGLRITVKLTIQNRQAQIEVVPSASALIIKALKEPPRDRKKQKNIKHSG
|
NITFDEIVNIARQMRHRSLARELSGTIKEILGTAQSVGCNVDGRRHPHDIIDDINSGAV
|
ECPAS
|
GENBANK ID: X79234.1
VERSION X79234.1 GI:495125
MAQDQGEKENPMRELRIRKLCLNICVGESGGRLTRAAKVLEQLT
|
GQTPVFSKARYTVRSFGIRRNEKIAVECAVRGAKAEEILEKGLKVRELELRKNNFSDT
|
GNFGFGIQEHIDLGIEYDFSIGIYGLDFYVVLGRFGFSIADKKRRTGCIGAKHRISKE
|
EAMRWFQQKYDGIILPGK
|
GENBANK ID: X59932.1
VERSION X59932.1 GI:30255
MASIQAAWPSGTECIAKYNFHGTAEQDLPECKGDVLTIVAVIKD
|
PNWYKAKNKVGREGIIFANYVGKREGVKAGTKLSLNPWFHGKITREQAERLLYPPETG
|
LFLVRESTNYFGDYTLCVSCDGKVEHYRINYHASKLSIDEEVYFENLNQLVEHYTSDA
|
DGLCTRLIKFKVNEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVNLGDYRGNK
|
VAVKCIKNDATAQAFLAEASVNTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD
|
YLRSRGRSVLGGDCLLKFSLDVCEANEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG
|
LTKEASSTQDTGKLPVKWTAPEALREKKESTKSDVWSFGILLWEIYSFGRVPYPRIPL
|
KDVVFRVEKGYKNDAFDGCPFAVYEVNKNCWHLDAANRFSFLQLREQLEHIKTHELHL
|
GENBANK ID: AAA98616.1
VERSION AAA98616.1 GI:178428
1MQGPWVLLLL GLRLQLSLGI IPVEEENPDF WNRQAAEALG AAKKLQPAQT AAKNLIMFLG
|
61DGMGVSTVTA ARILKGQKKD KLGPETFLAM DRFPYVALSK TYSVDKHVPD SGATATAYLC
|
121GVKGNFQTIG LSAAARFNQC NTTRGNEVIS VVNRAKKAGK SVGVVTTTRV QHASPAGTYA
|
181HTVNRNWYSD ADVPASARQE GCQDIATQLI SNMDIDVILG GGRKYMFPMG TPDPEYFDDY
|
241SQGGTRLDGK NLVQEWLAKH QGARYVWNRT ELLQASLDPS VTHLMGLFEP GDMKYEIHRD
|
301STLDPSLMEM TEAALLLLSR NPRGFFLFVE GGRIDHGNHE SRAYRALTET IMFDDATERA
|
361GQLTSEEDTL SLVTADHSHV FSFGGYPLRG SSIFGLAPGK ARGRKAYTVL LYGNGRGYVL
|
421KDGARFDVTE SESGSPEYRQ QSAVFLDGET HAGEDVAVFA RGPQAHLVHG VQEQTFIAHV
|
481MAFAACLEPY TACDLAPPAG TTDAAHPGPS VVPALLPLLA GTLLLLGTAT AP
|
GENBANK ID: XM_041507.1
VERSION XM_041507.1 GI:14727457
MGCTVSAEDKAAAERSKMIDKNLREDGEKAAREVKLLLLGAGES
|
GKSTIVEQEKIIREDGVSEEECRQYRAVVYSNTIQSIEAIVKAMGNLQIDFADPSRAD
|
DARQLFALSCTAEEQGVLFDDLSGVIRRLWADHGVQACFCRSREYQLNDSAAYYLNDL
|
ERIAQSDYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKEFDVGGQRSERKKWIHCFEG
|
VIAIIFCVALSAYDLVLAEDEEMNRNNESMKLFDSICNNKWFTDTSIILFLNKKDLFE
|
EKITHSPLTICFPEVTGANKYDEAASYIQSKFEDLNKRKDTKEIVTHFTCATDTKNVQ
|
FVFDAVTDVIIKNNLKDCGLF
|
GENBANK ID: NM_001032.2
VERSION NM_001032.2 GI:13904868
MGHQQLYESHPRKFGQGSRSCRVCSNRHGLIRKVGLNMCRQCFR
|
QYAKDIGFIKLD
|
GENBANK ID: M22430.1
VERSION M22430.1 GI:190888
MKTLLLLAVIMIFGLLQAHGNLVNFHRNIKLTTGKEAALSVGFY
|
GCHCGVGGRGSPKDATDRCCVTNDCCYKRLEKRGCGTKFLSYKFSNSGSRITCAKQDS
|
CRSQLCECDKAAATCFARNKTTYNKKYQYYSNKHCRGSTPRC
|
GENBANK ID: X63527
VERSION X63527.1 GI:36127
MSNLRLQKRLASSVLRC0KKKVELDPNETNEIANANSRQQIRKL
|
IRDGLIIRKPVTVHSRARCRKNTLARRKGRHMGIGKRKGTANARMPEKVTENRRMRIL
|
RRLLRRYRESKKIDRHNYHSLYLKVK0NVFKNKRILNEHIHKLKADKARKKLLADQAE
|
ARRSKTKEARKRREERLQAKKEEIIKTLSKEEETKK
|
GENBANK ID: AF099644.1
VERSION AF099644.1 GI:4323527
MAQFAFESDLHSLLQLDAPIPNAPPARWGRKAKEAAGFAFSPMR
|
AANRSHSAGRTPGRTPGKSSSKVQTTPSKFGGDRVIFHRSAAQMEVASFLLSKENQFE
|
NSQTPTKKEHQKAWALNLNGFDVEEAKILRLSGKPQNAPEGYQNRLKVLYSQKATPGS
|
SRKICRVIPSLPDRILDAPEIRNDYYLNLVDWSSGNVLAVALDNSVVLWSASSGDILQ
|
LLQMEQPGEYISSVAWIKEGNYLAVGTSSAEVQLWDVQQQKRLRNMTSHSARVGSLSW
|
NSYILSSGSRSGHIHHHDVRVAEHHVATLSGHSGEVCGLRWAPDGRHLASGGNDNLVN
|
VWPSAPGEGGEVFLQTFTQHQGAVKAVAECPWQSNVLATGGGTSDRHIRIENVCSGAC
|
LSAVDAHSQVCSILWSPHYKELISGHGFAQNQLVIWKYPTMAKVAELKGHTSRVLSLT
|
MSPDGATVASAAADETLRLWRCFELDPARRREREKASAAKSSLIHQGIR
|
GENBANK ID: X51466
VERSION X51466.1 GI:31105
MVNFTVDQIRAIMDKKANIRNMSVIAHVDHGKSTLTDSLVCKAG
|
IIASARAGETRFTDTRKDEQERCITIKSTAISLFVELSENDLNFIKQSKDGAGFLINL
|
IDSPGMVDFSSEVTAALRVTDGALVVVDCVSGVCVQTETVLRQAIAERIKPVLMMNKM
|
DRALLELQLEPEELYQTFQRIVENVNVIISTYGEGESGPMGNIMIDPVLGTVGFGSGL
|
HGMAFTLKQFAEMYVAKFAAKGEGQLGPAERAKKVEDMMKKLWGDRYFDFANGKFSKS
|
ATSPEGKKLPRTFCQLILDPIFKVFDAIMNFKKEETAKLIEKLDIKLDSEDKDKEGKP
|
LLKAVMRRWLPAGDALLQMITIHLPSPVTAQKYRCELLYEGPPDDEAAMGIKSCDPKG
|
PLMMVISKNVPTSDKGRFYAFGRVFSGLVSTGLKVRIMGFNYTFGKKEDLYLKPIQRT
|
ILMMGRYVEPIEDVFCGNIVGLVGVDGFLVKTGTITTFEHAHNMRVMKFSVSPVVRVA
|
VEAKNPADLPKLVEGLKRLAKSDPMVQCIIEESGEHIIAGAGELHLEICLKDLEEDHA
|
CIPIKKSDPVVSYRETVSEESNVLCLSKSPNKHNRLYMKARPFPDGLAEDIDKGEVSA
|
RQELKQRARVLAEKVEWDVAEARKIMCFGPDGTGPNILTDITKGVQYLNEIKDSVVAG
|
FQWATKEGALCEENMRGVRFDVMDVTLMADAIHRGGGQIIPTARRCLYASVLTAQPRL
|
MEPIVLVEIQCPEQVVGGIVGVLNRKRGHVFEESQVAGTPMFVVKAYLPVNESFGFTA
|
DLRSNTGGQAFPQCVFDHWQILPGDPFDNSSRPSQVVAETRKRKGLKKGIPALDNFLD
|
GENBANK ID: M15661
VERSION M15661.1 GI:337577
MVNVPKTRRTFCKKCGKHQPHKVTQYKKGKDSLYAQGRRRYDRK
|
QSGYGGQTKPIFRKKAKTTKKIVLRLECVEPNCRSKRMLAIKRCKHFELGGDKKRKGQ
|
VIQF
|
GENEANK ID: J04823.1
VERSION J04823.1 GI:1311703
MSVLTFLLLRGLTGSARRLPVPRAKIHSLPPEGKLGINELAVGL
|
TSCFVTFLLPAGWILSHLETYRRPE
|
GENBANK ID: NM_001760.2
VERSION NM_001760.2 GI:16950657
MELLCCEGTRHAPRAGPDPRLLGDQRVLQSLLRLEERYVPRASY
|
FQCVQREIKPHMRKMLAYWMLEVCEEQRCEEEVFPLANNYLDRYLSCVPTRKAQLQLL
|
GAVCMLLASKLRETTPLTIEKLCIYTDHAVSFRQLRDWEVLVLGKLKWDLAAVIAHDF
|
LAFILHRLSLPRDRQALVKKHAQTFLALCATDYTFAMYPPSMIATGSIGAAVQGLGAC
|
SMSGDELTELLAGITGTEVDCLRACQEQIEAALRESLREASQTSSSPAPKABRGSSSQ
|
GPSQTSTPTDVTAIHL
|
GENBANK ID: NM_002625.1
DEFINITION HOMO SAPIENS 6-PHOSPHOFRUCTO-2-KINASEFRUCTOSE-2,6-BIPHOSPHA-
TASE 1
(PFKFB1), MRNA.
VERSION NM_002625.1 GI:4505744
CDS 80..1495
1GAATTCCGGA CAGGTAGTAA GATAGGAAGT GAGGCCAGGT ACCTTGTGGG CAGTGATGTC
|
61ATTCGGTGCG ACTCCTAAGA TGTCTCCAGA GATGGGAGAG CTCACCCAAA CCAGGTTGCA
|
121GAAGATCTGG ATTCCACACA GCAGCGGCAG CAGCAGGCTG CAACGGAGAA GGGGCTCATC
|
181CATACCCCAG TTTACCAATT CCCCCACAAT GGTGATCATG GTGGGTTTAC CAGCTCGAGG
|
241CAAGACCTAT ATCTCCACAA AGCTCACACG ATATCTCAAC TGGATAGGAA CACCAACTAA
|
301AGTGTTTAAT TTAGGCCAGT ATCGACGAGA GGCAGTGAGC TACAAGAACT ATGAATTCTT
|
361TCTTCCAGAC AACATGGAAG CCCTGCAAAT CAGGAAGCAG TGCGCCCTGG CAGCCCTGAA
|
421GGATGTTCAC AACTATCTCA GCCATGAGGA AGGTCATGTT GCGGTTTTTG ATGCCACCAA
|
481CACTACCAGA GPACGACGGT CACTGATCCT GCAGTTTGCA AAAGAACATG GTTACAAGGT
|
541GTTTTTCATT GAGTCCATTT GTAATGACCC TGGCATAATT GCAGAAAACA TCAGGCAAGT
|
601GAAACTTGGC AGCCCTGATT ATATAGACTG TGACCGGGAA AAGGTTCTGG AAGACTTTCT
|
661AAAGAGAATT GAGTGCTATG AGGTCAACTA CCAACCCTTG GATGAGGAAC TGGACAGCCA
|
721CCTGTCCTAC ATCAAGATCT TCGACGTGGG CACACGCTAC ATGGTGAACC GAGTGCAGGA
|
781TCACATCCAG AGCCGCACAG TCTACTACCT CATGAATATC CATGTCACAC CTCGCTCCAT
|
841CTACCTTTGC CGACATGGCG AGAGTGAACT CAACATCAGA GGCCGCATCG GAGGTGACTC
|
901TGGCCTCTCA GTTCGCGGCA AGCAGTATGC CTATGCCCTG GCCAACTTCA TTCAGTCCCA
|
961GGGCATCAGC TCCCTGAAGG TGTGGACCAG TCGCATGAAG AGGACCATCC AGACAGCTGA
|
1021GGCCCTGGGT GTCCCCTATG AGCAGTGGAA GGCCCTGAAT GAGATTGATG CGGGTGTCTG
|
1081TGAGGAGATG ACCTATGAAG AAATCCAGGA ACATTACCCT GAAGAATTTG CACTGCGAGA
|
1141CCAAGATAAA TATCGCTACC GCTATCCCAA GGGAGAGTCC TATGAGGATC TGGTTCAGCG
|
1201TCTGGAGCCA GTGATAATGG AGCTAGAACG ACAGGAGAAT GTACTGGTGA TCTGCCACCA
|
1261GGCTGTCATG CGGTGCCTCC TGGCCTATTT CCTGGATAAA AGTTCAGATG AGCTTCCATA
|
1321TCTCAAGTGC CCTCTGCACA CAGTGCTCAA ACTCACTCCT GTGGCTTATG GCTGCAAAGT
|
1381GGAATCCATC TACCTGAATG TGGAGGCCGT GAACACACAC CGGGAGAAGC CTGAGAATGT
|
1441GGACATCACC CGGGAACCTG AGGAAGCCCT GGATACTGTC CCAGCCCACT ACTGAGCGCT
|
1501TTCCAAGAAG TCAAACTGCC TGTGTCCTCA TCGCCTTCCA CCTTTAGGAA ATGCTATCTT
|
1561TGCTCTTCTC CTACTCTGCC TTGGCCTCAC TGAGGCACCC CACTTCCAGT GAAGAAGTCC
|
1621TCCGCAACTC CCAAACAAGC CTCGCTTGCT GGCCGCAACC AAGGAGCTAT CTAGCTCTGG
|
1681AGGAAACTTT CTTTCTTAAT TCCTATTCTC TGACGAATAA AGACTTACTG CCTACAAGAG
|
1741G
|
GENBANK ID: D00760
DEFINITION HUMAN MRNA FOR PROTEASOME SUBUNIT HC3.
VERSION D00760.1 GI:220023
CDS 1..705
/CODON_START=1
1ATGGCGGAGC GCGGGTACAG CTTTTCGCTG ACTACATTCA GCCCGTCTGG TAAACTTGTC
|
61CAGATTGAAT ATGCTTTGGC TGCTCTAGCT GGAGGAGCCC CGTCCGTGGG AATTAAAGCT
|
121GCAAATGCTG TGGTATTAGC AACTGAGAAA AAACAGAAAT CCATTCTGTA TGATGACCGA
|
181AGTGTACACA AAGTAGAACC AATTACCAAG CATATAGGTT TGGTGTACAG TGGCATGGGC
|
241CCCGATTACA GAGTGCTTGT GCACAGAGCT CGAAAACTAG CTCAACAATA CTATCTTGTG
|
301TACCAAGAAC CCATTCCTAC AGCTCAGCTG GTACAGAGAG TAGCTTCTGP CATGCAAGAA
|
361TATACTCAGT CAGGTGGTGT TCGTCCATTT GGAGTTTCTT TACTTATTTG TGGTTGGAAT
|
421GACGGACCAC CATATTTATT TCAGTCAGAT CCATCTGGAG CTTACTTTGC CTGGAAAGCT
|
481ACACCAATGG GAAAGAACTA TGTGAATCGG AAGACTTTCC TTGAGAAAAG ATATAATGAA
|
541GATCTGGAAC TTGAAGATGC CATTCATACA GCCATCTTAA CCCTAAAGGA AAGCTTTGAA
|
601GGGCAAATGA CAGAGGATAA CATAGAAGTT GGAATCTGCA ATGAAGCTGG ATTTAGGAGG
|
661CTTACTCCAA CTGAAGTTAA GGATTACTTG GCTGCCATAG CATAACAATG AAGTGACTGA
|
721AAAATCCAGA ATTTCAGATA ATCTATCTAC TTAAACATGT TTAAAGTATG TTTTGTTTTG
|
781CAGACTTTTT GCATACTTAT TTCTACATGG TTTAAATCGA CTGTTTTTAA AATGACACTT
|
841ATAAATCCTA ATAAACTGTT AAACCC
|
GENBANK ID: P10644
GENBANK ID: XM_043948.2
DEFINITION HOMO SAPIENS ALDOLASE A, FRUCTOSE-BISPHOSPHATE (ALDOA), MRNA.
VERSION XM_043948.2 GI:18585537
CDS 243..1349
/CODON_START=1
1AAAAACCAGG GCTCCAGAGA ATCAGAACAG CCACCATCAC CGCAGGGAGT CAAGGGAGGA
|
61GGGAGATTAG AGAAGGAGCC AGGGAGGGTG GCAGGGAGGC CACGTGATCC GAGTCCCCTC
|
121ACCCCTTTCC TTCCCACAGG TCCCTGGCCA AAGATTTATT TCTCTTGACA ACCAAGGGCC
|
181TCCGTCTGGA TTTCCAAGGA AGAATTTCCT CTGAAGCACC GGAACTTGCT ACTACCAGCA
|
241CCATGCCCTA CCAATATCCA GCACTGACCC CGGAGCAGAA GAAGGAGCTG TCTGACATCG
|
301CTCACCGCAT CGTGGCACCT GGCAAGGGCA TCCTGGCTGC AGATGAGTCC ACTGGGAGCA
|
361TTGCCAAGCG GCTGCAGTCC ATTGGCACCG AGAACACCGA GGAGAACCGG CGCTTCTACC
|
421GCCAGCTGCT GCTGACAGCT GACGACCGCG TGAACCCCTG CATTGGGGGT GTCATCCTCT
|
481TCCATGAGAC ACTCTACCAG AAGGCGGATG ATGGGCGTCC CTTCCCCCAA GTTATCAAAT
|
541CCAAGGGCGG TGTTGTGGGC ATGAAGGTAG ACAAGGGCGT GGTCCCCCTG GCAGGGACAA
|
601ATGGCGAGAC TACCACCCAA GGGTTGGATG GGCTGTCTGA GCGCTGTGCC CAGTACAAGA
|
661AGGACGGAGC TGACTTCGCC AAGTGGCGTT GTGTGCTGAA GATTGGGGAA CACACCCCCT
|
721CAGCCCTCGC CATCATGGAA AATGCCAATG TTCTGGCCCG TTATGCCAGT ATCTGCCAGC
|
781AGGTGGGCCT GCAGAATGGC ATTGTGCCCA TCGTGGAGCC TGAGATCCTC CCTGATGGGG
|
841ACCATGACTT GAAGCGCTGC CAGTATGTGA CCGAGAAGGT GCTGGCTGCT GTCTACAAGG
|
901CTCTGAGTGA CCACCACATC TACCTGGAAG GCACCTTGCT GAAGCCCAAC ATGGTCACCC
|
961CAGGCCATGC TTGCACTCAG AAGTTTTCTC ATGAGGAGAT TGCCATGGCG ACCGTCACAG
|
1021CGCTGCGCCG CACAGTGCCC CCCGCTGTCA CTGGGATCAC CTTCCTGTCT GGAGGCCAGA
|
1081GTGAGGAGGA GGCGTCCATC AACCTCAATG CCATTAACAA GTGCCCCCTG CTGAAGCCCT
|
1141GGGCCCTGAC CTTCTCCTAC GGCCGAGCCC TGCAGGCCTC TGCCCTGAAG GCCTGGGGCG
|
1201GGAAGAAGGA GAACCTGAAG GCTGCGCAGG AGGAGTATGT CAAGCGAGCC CTGGCCAACA
|
1261GCCTTGCCTG TCAAGGAAAG TACACTCCGA GCGGTCAGGC TGGGGCTGCT GCCAGCGAGT
|
1321CCCTCTTCGT CTCTAACCAC GCCTATTAAG CGGAGGTGTT CCCAGGCTGC CCCCAACACT
|
1381CCAGGCCCTG CCCCCTCCCA CTCTTGAAGA GGAGGCCGCC TCCTCGGGGC TCCAGGCTGG
|
1441CTTGCCCGCG CTCTTTCTTC CCTCGTGACA GTGGTGTGTG GTGTCGTCTG TGAATGCTAA
|
1501GTCCATCACC CTTTCCGGCA CACTGCCAAA TAAACAGCTA TTTAAGGGGG
|
GENBANK ID: NM_005175.1
DEFINITION HOMO SAPIENS ATP SYNTHASE, H+TRANSPORTING, MITOCHONDRIAL F0
COMPLEX, SUBUNIT C (SUBUNIT 9), ISOFORM 1 (ATP5G1), MRNA.
VERSION NM_005175.1 GI:4885080
CDS 120..530
/CODON_START=1
1GGGGAAGCTG AGGGCTGAGA CCAAGGGCTA AAGCTGGGAG GTGAGTCTGT CACCTTGAGC
|
61CGGGCGAGCG CTGTGGGCCA AGCAGGGGTT GCAGGGCAGT AGGAGTGCAG ACTGAAAAAA
|
121TGCAGACCGC CGGGGCATTA TTCATTTCTC CAGCTCTGAT CCGCTGTTGT ACCAGGGGTC
|
181TAATCAGGCC TGTGTCTGCC TCCTTCTTGA ATAGCCCAGT GAATTCATCT AAACAGCCTT
|
241CCTACAGCAA CTTCCCACTC CAGGTGGCCA GACGGGAGTT CCAGACCAGT GTTGTCTCCC
|
301GGGACATTGA CACAGCAGCC AAGTTTATTG GTGCTGGGGC AGCCACAGTT GGTGTGGCTG
|
361GTTCAGGGGC TGGCATTGGA ACCGTGTTTG GCAGCTTGAT CATTGGCTAT GCCAGGAACC
|
421CGTCTCTCAA GCAGCAGCTC TTCTCCTATG CCATTCTTGG CTTTGCCCTG TCTGAGGCCA
|
481TGGGGCTTTT CTGTTTGATG GTCGCCTTCC TCATCCTCTT CGCCATGTGA GGCTCCATGG
|
541GGGGTCACCG GCCTGTTGCT ACTGCAACTC CACACCATTC TTGGTGCTGC GGTGTGTTAA
|
601GCTTTACCAT TAAACACAAC GTTTCTCTAA A
|
GENBANK ID: M20496.1
DNA LINEAR
DEFINITION HUMAN CATHEPSIN L GENE, COMPLETE CDS.
VERSION M20496.1 GI:809235
CDS 134..1135
/CODON_START=1
1ACCTCCACGT GCCCTGTTTT TCTGGAGGCA CATCCTTGGC CTCTTCCACA GTCCTTGGGT
|
61AAATGCTTGG GAGAATAATT TAAATATTTT TATTGTACCA TGGTGGCCCT AATTTTTCAG
|
121GGGGCAGTAA GATATGAATC CTACACTCAT CCTTGCTGCC TTTTGCCTGG GAATTGCCTC
|
181AGCTACTCTA ACATTTGATC ACAGTTTAGA GGCACAGTGG ACCAAGTGCA AGGCGATGCA
|
241CAACAGATTA TACGGCATGA ATGAAGAAGG ATGGAGGAGA GCAGTGTGGG AGAAGAACAT
|
301GAAGATGATT GAACTGCACA ATCAGGAATA CAGGGAAGGG AAACACAGCT TCACAATGGC
|
361CATGAACGCC TTTGGAGACA TGACCAGTGA AGAATTCAGG CAGGTGATGA ATGGCTTTCA
|
421AAACCGTAAG CCCAGGAAGG GGAAAGTGTT CCAGGAACCT CTGTTTTATG AGGCCGCCAG
|
481ATCTGTGGAT TGGAGAGAGA AAGGCTACGT GACTCCTGTG AAGAATCAGG GTCAGTGTGG
|
541TTCTTGTTGG GCTTTTAGTG CTACTGGTGC TCTTGAAGGA CAGATGTTCC GGAAAACTGC
|
601GAGGCTTATC TCACTGAGTG AGCAGAATCT GGTAGACTGC TCTGGGCCTC AAGGCAATGA
|
661AGGCTGCAAT GGTGGCCTAA TGGATTATGC TTTCCAGTAT GTTCAGGATA ATGGAGGCCT
|
721GGACTCTGAG GAATCCTATC CATATGAGGC AACAGAAGAA TCCTGTAAGT ACAATCCCAA
|
781GTATTCTGTT GCTAATGACA CCGGCTTTGT GGACATCCCT AAGCAGGAGA AGGCCCTGAT
|
841GAAGGCAGTT GCAACTGTGG GGCCCATTTC TGTTGCTATT GATGCAGGTC ATGAGTCCTT
|
901CCTGTTCTAT AAAGAAGGCA TTTATTTTGA GCCAGACTGT AGCAGTGAAG ACATGGATCA
|
961TGGTGTGCTG GTGGTTGGCT ACGGATTTGA AAGCACAGAA TCAGATAACA ATAAATATTG
|
1021GCTGGTGAAG AACAGCTGGG GTGAAGAATG GGGCATGGGT GGCTACGTAA AGATGGCCAA
|
1081AGACCGGAGA AACCATTGTG GAATTGCCTC AGCAGCCAGC TACCCCACTG TGTGAGCTGT
|
1141GGACGGTGAT GAGGAAGGAC TTGACTGGGG ATGGCGCATG CATGGGAGGA ATTCTTCAGT
|
1201CTACCAGCCC CCGCTGTGTC GGATACACAC TCGAATCATT GAAGATCCGA GTGTGATTTG
|
1261AATTCTGTGA TATTTTCACA CTGGTAAATG TTACCTCTAT TTTAATTACT GCTATAAATA
|
1321GGTTTATATT ATTGATTCAC TTACTGACTT TGCATTTTCG TTTTTAAAAG GATGTATAAA
|
1381TTTTTACCTG TTTAAATAAA ATCG
|
GENBANK ID: XM_031596.3
DEFINITION HOMO SAPIENS ANNEXIN A4 (ANXA4), MRNA.
VERSION XM_031596.3 GI:18553329
CDS 48..770
/CODON_START=1
1GAAGAACTTC TGCTTGGGTG GCTGAACTCT GATCTTGACC TAGAGTCATG GCCATGGCAA
|
61CCAAAGGAGG TACTGTCAAA GCTGCTTCAG GATTCAATGC CATGGAAGAT GCCCAGACCC
|
121TGAGGAAGGC CATGAAAGGG CTCGGCACCG ATGAAGACGC CATTATTAGC GTCCTTGCCT
|
181ACCGCAACAC CGCCCAGCGC CAGGAGATCA GGACAGCCTA CAAGAGCACC ATCGGCAGGG
|
241ACTTGATAGA CGACCTGAAG TCAGAACTGA GTGGCAACTT CGAGCAGGTG ATTGTGGGGA
|
301TGATGACGCC CACGGTGCTG TATGACGTGC AAGAGCTGCG AAGGGCCATG AAGGGAGCCG
|
361GCACTGATGA GGGCTGCCTA ATTGAGATCC TGGCCTCCCG GACCCCTGAG GAGATCCGGC
|
421GCATAAGCCA AACCTACCAG CAGCAATATG GACGGAGCCT TGAAGATGAC ATTCGCTCTG
|
481ACACATCGTT CATGTTCCAG CGAGTGCTGG TGTCTCTGTC AGCTGGTGGG AGGGATGAAG
|
541GAAATTATCT GGACGATGCT CTCGTGAGAC AGGATGCCCA GGACCTGTAT GAGGCTGGAG
|
601AGAAGAAATG GGGGACAGAT GAGGTGAAAT TTCTAACTGT TCTCTGTTCC CGGAACCGAA
|
661ATCACCTGTT GCATGGTTTG ATGAATACAA AAGGATATCA CAGAAGGATA TTGAACAGAG
|
721TATTAAATCT GAAACATCTG GTAGCTTTGA AGATGCTCTG CTGGCTATAG TAAAGTGCAT
|
781GAGGAACAAA TCTGCATATT TTGCTGAAAA GCTCTATAAA TCGATGAAGG GCTTGGGCAC
|
841CGATGATAAC ACCCTCATCA GAGTGATGGT TTCTCGAGCA GAAATTGACA TGTTGGATAT
|
901CCGGGCACAC TTCAAGAGAC TCTATGGAAA GTCTCTGTAC TCGTTCATCA AGGGTGACAC
|
961ATCTGGAGAC TACAGGAAAG TACTGCTTGT TCTCTGTGGA GGAGATGATT AAAATAAAAA
|
1021TCCCAGAAGG ACAGGAGGAT TCTCAACACT TTGAATTTTT TTAACTTCAT TTTTCTACAC
|
1081TGCTATTATC ATTATCTCAG AATGCTTATT TCCAATTAAA ACCGCTACAG CTGCCTCCTA
|
1141GAATATAGAC TGTCTGTATT ATTATTGACG TATAATTAGT CATTATGATG CTTTAAAGCT
|
1201GTACTTGCAT TTCAAAGCTT ATAAGATATA AATGGAGATT TTAAAGTAGA AATAAATATG
|
1261TATTCCATGT TTTTAAAAGA TTACTTTCTA CTTTGTCTTT CACAGACATT GAATATATTA
|
1321AATTATTCCA TATTTTCTTT TCAGTGAAAA ATTTTTTAAA TGGAAGACTG TTCTAAAATC
|
1381ACTTTTTTCC CTAATCCAAT TTTTAGAGTG GCTAGTAGTT TCTTCATTTG AAATTGTAAG
|
1441CATCCGGTCA GTAAGAATGC CCATCCAGTT TTCTATATTT CATAGTCAAA GCCTTGAAAG
|
1501CATCTACAAA TCTCTTTTTT TAGGTTTTGT CCATAGCATC AGTTGATCCT TACTAAGTTT
|
1561TTCATGGGAG ACTTCCTTCA TCACATCTTA TGTTGAAATC ACTTTCTGTA GTCAAAGTAT
|
1621ACCAAAACCA ATTTATCTGA ACTAAATTCT AAAGTATGGT TATACAAACC ATATACATCT
|
1681GGTTACCAAA CATAAATGCT GAACATTCCA TATTATTATA GTTAATGTCT TAATCCAGCT
|
1741TGCAAGTGAA TGGAAAAAAA AATAAGCTTC AAACTAGGTA TTCTGGGAAT GATGTAATGC
|
1801TCTGAATTTA GTATGATATA AAGAAAACTT TTTTGTGCTA AAAATACTTT TTAAAATCAA
|
1861TTTTGTTGAT TGTAGTAATT TCTATTTGCA CTGTGCCTTT CAACTCCAGA AACATTCTGA
|
1921AGATGTACTT GGATTTAATT AAAAAGTTCA CTTTGT
|
GENBANK ID: M22865.1
DEFINITION HUMAN CYTOCHROME B5 MRNA, COMPLETE CDS.
VERSION M22865.1 GI:181226
53..457
CODON_START=1
1CAGCCAGCTC GACGGGGCTG TGTGTGCTGG GCCTGGCTCG CGGCGAACCG AGATGGCAGA
|
61GCAGTCGGAC GAGGCCGTGA ACTACTACAC CCTAGAGGAG ATTCAGAAGC ACAACCACAG
|
121CAAGAGCACC TGGCTGATCC TGCACCACAA GGTGTACGAT TTGACCAAAT TTCTGGAAGA
|
181GCATCCTGGT GGGGAAGAAG TTTTAAGGGA ACAAGCTGGA GGTGACGCTA CTGAGAACTT
|
241TGAGGATGTC GGGCACTCTA CAGATGCCAG GGAAATGTCC AAAACATTCA TCATTGGGGA
|
301GCTCCATCCA GATGACAGAC CAAAGTTAAA CAAGCCTCCG GAAACTCTTA TCACTACTAT
|
361TGATTCTAGT TCCAGTTGGT GGACCAACTG GGTGATCCCT CCCATCTCTG CAGTGGCCGT
|
421CGCCTTGATG TATCGCCTAT ACATGGCAGA GGACTGAACA CCTCCTCAGA AGTCAGCGCA
|
481GGCCGAGCCT GCTTTGGACA CGGGAGAAAA GAAGCCATTG CTAACTACTT CAACTGACAG
|
541AAACCTTCAC TTGAAAACAA TGATTTTAAT ATATCTCTTT CTTTTTCTTC CGACATTAGA
|
601AACAAAACAA AAAGAACTGT CCTTTCTGCG CTCAAATTTT TCGAGTGTGC CTTTTTATTC
|
661ATCTACTTTA TTTTGATGTT TCCTTAATGT GTAATTTACT TATTATAAGC ATCATCTTTT
|
721AAAAATATAT TTGGCTTTTA AAG
|
GENBANK ID: M14362.1
DEFINITION HUMAN T-CELL SURFACE ANTIGEN CD2 (T11) MRNA, COMPLETE CDS.
VERSION M14362.1 GI:179133
CDS 10..1065
/CODON_START=1
1ACCCCTAAGA TGAGCTTTCC ATGTAAATTT GTAGCCAGCT TCCTTCTGAT TTTCAATGTT
|
61TCTTCCAAAG GTGCAGTCTC CAAAGAGATT ACGAATGCCT TGGAAACCTG GGGTGCCTTG
|
121GGTCAGGACA TCAACTTGGA CATTCCTAGT TTTCAAATGA GTGATGATAT TGACGATATA
|
181AAATGGGAAA AAACTTCAGA CAAGAAAAAG ATTGCACAAT TCAGAAAAGA GAAAGAGACT
|
241TTCAAGGAAA AAGATACATA TAAGCTATTT AAAAATGGAA CTCTGAAAAT TAAGCATCTG
|
301AAGACCGATG ATCAGGATAT CTACAAGGTA TCAATATATG ATACAAAAGG AAAAAATGTG
|
361TTGGAAAAAA TATTTGATTT GAAGATTCAA GAGAGGGTCT CAAAACCAAA GATCTCCTGG
|
421ACTTGTATCA ACACAACCCT GACCTGTGAG GTAATGAATG GAACTGACCC CGAATTAAAC
|
481CTGTATCAAG ATGGGAAACA TCTAAAACTT TCTCAGAGGG TCATCACACA CAAGTGGACC
|
541ACCAGCCTGA GTGCAAAATT CAAGTGCACA GCAGGGAACA AAGTCAGCAA GGAATCCAGT
|
601GTCGAGCCTG TCAGCTGTCC AGAGAAAGGT CTGGACATCT ATCTCATCAT TGGCATATGT
|
661GGAGGAGGCA GCCTCTTGAT GGTCTTTGTG GCACTGCTCG TTTTCTATAT CACCAAAAGG
|
721AAAAAACAGA GGAGTCGGAG AAATGATGAG GAGCTGGAGA CAAGAGCCCA CAGAGTAGCT
|
781ACTGAAGAAA GGGGCCGGAA GCCCCACCAA ATTCCAGCTT CAACCCCTCA GAATCCAGCA
|
841ACTTCCCAAC ATCCTCCTCC ACCACCTGGT CATCGTTCCC AGGCACCTAG TCATCGTCCC
|
901CCGCCTCCTG GACACCGTGT TCAGCACCAG CCTCAGAAGA GGCCTCCTGC TCCGTCGGGC
|
961ACACAAGTTC ACCAGCAGAA AGGCCCGCCC CTCCCCAGAC CTCGAGTTCA GCCAAAACCT
|
1021CCCCATGGGG CAGCAGAAAA CTCATTGTCC CCTTCCTCTA ATTAAAAAAG ATAGAAACTG
|
1081TATTTTTCAA TAAAAAGCAC TGTGGATTTC TGCCCTCCTG ATGTGCATAT CCGTACTTCC
|
1141ATGAGGTGTT TTCTGTGTGC AGAACATTGT CACCTCCTGA GGCTGTGGGC CACAGCCACC
|
1201TCTGCATCTT CGAACTCAGC CATGTGGTCA ACATCTGGAG TTTTTGGTCT CCTCAGAGAG
|
1261CTCCATCACA CCAGTAAGGA GAAGCAATAT AAGTGTGATT GCAAGAATGG TAGAGGACCG
|
1321AGCACAGAAA TCTTAGAGAT TTCCTGTCCC CTCTCAGGTC ATGTGTAGAT GCGATAAATC
|
1381AAGTGATTGG TGTGCCTGGG TCTCACTACA AGCAGCCTAT CTGCTTAAGA GACTCTGGAG
|
1441TTTCTTATGT GCCCTGGTGG ACACTTGCCC ACCATCCTGT GAGTAAAAGT GAAATAAAAG
|
1501CTTTGACTAG
|
GENBANK ID: XM_087746.1
DEFINITION HOMO SAPIENS SIMILAR TO KIDNEY ANINOPEPTIDASE N; LEUCINE
ARYLANINOPEPTIDASE 1 (LOC153726), MRNA.
VERSION XM_087746.1 GI:18561749
CDS 262..639
/CODON_START=1
1GAGTTCCATG CCACCTCCCC GCCCTTTACA GACATGCTAT AAGGTCCCCA GCCCAGTCAC
|
61TCCGCAGTGC CTCTCTCTTC CTCCCCATGG ACTATACACA GGCCCTGCTT GTCCTGGAGG
|
121AAAGTTTGGA CGTCATTATA TAGAICAGGA GACTGAAGTA CTGAAAGGTT AAATGACTTG
|
181CCAAAGAATG AGATCTTTTT TTCTAACATT TTACATAATA TCCTCAGAGA AGATCACGCC
|
241CTGGTGACTA GAGCTGTGGC CATGAAGGTG GAAAATTTCA AAACAAGTGA AATACAGGAA
|
301CTCTTTGACA TATTTACTTA CAGCAAGGGA GCGTCTATGG CCCGGATGCT TTCTTGTTTC
|
361TTGAATGAGC ATTTATTTGT CAGTGCACTC AAGTCATATT TGAAGACATT TTCCTACTCA
|
421AACGCTGAGC AAGATGATCT ATGGAGGCAT TTTCAAATGG CCATAGATGA GCAGACTACA
|
481GTTATTTTGC CAGCAACAAT AAAAAACATA ATGGACAGGT GGACACACCA GAGTGGTTTT
|
541CCAGTGATCA CTTTAAATGT GTCTACTGGC GTCATGAAAC AGGAGCCATT TTATCTTGAA
|
601AACATTAAAA ATCGGACTCT TCTAACCAGC AATAAGTGAC ACATGGATTG TCCCTATTCT
|
661TTGGATAAAA AATGGAACTA CACAACCTTT AGTCTGGCTA GA
|
GENBANK ID: P31749
DEFINITION DICTYOSTELION DISCOIDEUM RAC-ALPHA SERINETHREONINE KINASE
HOMOLOG
MRNA, COMPLETE CDS.
VERSION PU15210.1 GI:1000068
CDS 1..1335
/CODON_START=1
1ATGTCAACAG CACCAATTAA ACATGAAGGT TTCCTCACTA AAGAAGGTGG TGGTTTCAAA
|
61AGTTGGAAAA AGAGATGGTT CATTCTCAAA GGTGGTGATT TAAGTTATTA TAAAACAAAA
|
121GGTGAACTTG TACCATTAGG AGTTATTCAT TTAAATACAT CAGGTCATAT TAAAAATTCT
|
181GATCGTAAGA AAAGAGTTAA TGGATTTGAA GTACAAACAC CATCACGTAC ATATTTCTTA
|
241TGTTCAGAGA CAGAGGAAGA ACGTGCAAAA TGGATAGAGA TATTAATTAA TGAAAGAGAA
|
301TTATTATTGA ATGGTGGTAA ACAACCAAAG AAATCGGAAA AGGTAGGAGT TGCAGATTTT
|
361GAATTATTGA ATTTAGTTGG TAAAGGTAGT TTTGGTAAAG TTATTCAAGT TAGAAAGAAA
|
421GATACTGGTG AAGTGTATGC AATGAAAGTT TTATCAAAGA AACATATCGT AGAGCATAAC
|
481GAAGTCGAAC ATACATTGAG TGAGCGTAAT ATTCTTCAAA AGATCAATCA CCCATTTTTG
|
541GTTAATCTCA ACTACAGTTT TCAAACAGAG GATAAGCTTT ACTTTATCTT GGATTATGTT
|
601AATGGTGGTG AGTTATTCTA TCATCTTCAA AAGGACAAAA AGTTTACAGA GGATCGTGTC
|
661CGTTATTATG GCGCAGAGAT CGTATTGGCA TTGGAACATT TACATTTGTC GGGTGTCATC
|
721TATAGAGATT TGAAACCAGA GAATTTACTA CTCACCAACG AGGGTCACAT TTGCATGACC
|
781GATTTCGGTC TTTGCAAAGA GGGTCTATTG ACACCAACCG ACAAAACTGG TACTTTCTGT
|
841GGTACTCCTG AATATTTAGC ACCCGAAGTA CTTCAAGGCA ATGGTTATGG TAAACAAGTG
|
901GATTGGTGGA GTTTTGGTTC TCTCCTCTAT GAAATGCTCA CTGGTTTACC ACCATTCTAC
|
961AATCAAGACG TCCAAGAGAT GTATCGTAAG ATCATGATGG AGAAATTATC TTTCCCACAT
|
1021TTCATTTCTC CAGATGCTCG TTCCCTCTTG GAACAACTCT TGGAAAGAGA TCCTGAAAAA
|
1081AGACTTGCCG ATCCAAATCT TATTAAAAGA CATCCTTTCT TCCGTTCCAT CGATTGGGAA
|
1141CAATTATTCC AAAAGAATAT TCCACCACCA TTCATTCCAA ATGTTAAAGG TTCTGCTGAT
|
1201ACCTCTCAAA TTGATCCAGT TTTCACTGAT GAAGCTCCTT CTTTAACTAT GGCTGGTGAA
|
1261TGTGCTTTAA ATCCGCAACA ACAAAAAGAT TTTGAAGGAT TTACATATGT CGCTGAATCT
|
1321GAACATTTAA GATAA
|
GENBANK ID: NM_000102.2
DEFINITION HOMO SAPIENS CYTOCEROME P450, SUBFANILY XVII (STEROID
17-ALPHA--HYDROXYLASE), ADRENAL HYPERPLASIA (CYP17), MRNA.
VERSION NM_000102.2 GI:13904854
CDS 61..1587
1GAGTTGCCAC AGCTCTTCTA CTCCACTGCT GTCTATCTTG CCTGCCGGCA CCCAGCCACC
|
61ATGTGGGAGC TCGTGGCTCT CTTGCTGCTT ACCCTAGCTT ATTTGTTTTG GCCCAAGAGA
|
121AGGTGCCCTG GTGCCAAGTA CCCCAAGAGC CTCCTGTCCC TGCCCCTGGT GGGCAGCCTG
|
181CCATTCCTCC CCAGACATGG CCATATGCAT AACAACTTCT TCAAGCTGCA GAAAAAATAT
|
241GGCCCCATCT ATTCTGTTCG TATGGGCACC AAGACTACAG TGATTGTCGG CCACCACCAG
|
301CTGGCCAAGG AGGTGCTTAT TAAGAAGGGC AAGGACTTCT CTGGGCGGCC TCAAATGGCA
|
361ACTCTAGACA TCGCGTCCAA CAACCGTAAG GGTATCGCCT TCGCTGACTC TGGCGCACAC
|
421TGGCAGCTGC ATCGAAGGCT GGCGATGGCC ACCTTTGCCC TGTTCAAGGA TGGCGATCAG
|
481AAGCTGGAGA AGATCATTTG TCAGGAAATC ACTACATTGT GTGATATGCT GGCCACCCAC
|
541AACGGACAGT CCATAGACAT CTCCTTTCCT GTCTTCGTGG CGGTAACCAA TGTCATCTCC
|
601TTGATCTGCT TCAATACCTC CTACAAGAAT GGCGACCCTG AGTTGAATGT CATACAGAAT
|
661TACAATGAAG GCATCATAGA CAACCTCAGC AAACACAGCC TGCTGGACCT AGTCCCCTGG
|
721TTGAAGATTT TCCCCAACAA AACCCTGGAA AAATTAAAGA GCCATGTTAA AATACGAAAT
|
781GATCTGCTGA ATAAAATACT TGAAAATTAC AAGGAGAAAT TCCGGAGTGA CTCTATCACC
|
841AACATGCTGG ACACACTGAT CCAAGCCAAG ATGAACTCAG ATAATGGCAA TGCTGGCCCA
|
901GATCAAGATT CAGAGGTGCT TTCAGATAAC CACATTCTCA CCACCATAGG GGACATCTTT
|
961GGGGCTGGCG TGGAGACCAC CACCTCTGTG GTTAAATGGA CCCTGGCCTT CCTGCTGCAC
|
1021AATCCTCAGG TGAAGAAGAA GCTCTACGAG GAGATTGACC AGAATGTGGG TTTCAGCCGC
|
1081ACACCAACTA TCAGTGACCG TAACCGTCTC CTCCTGCTGG AGGCCACCAT CGGAGAGGTG
|
1141CTTCGCCTCA GGCCCGTGGC CCCTATGCTC ATCCCCCACA AGGCCAACGT TGACTCCAGC
|
1201ATCGGTGAGT TTGCTGTGGA CAAGGGCACA GAAGTTATCA TCAATCTGTG GGCGCTGCAT
|
1261CACAATGAGA AGGAGTGGCA CCAGCCGGAT CAGTTCATGC CTGAGCGTTT CTTGAATCCA
|
1321GCGGGGACCC AGCTCATCTC ACCGTCAGTA AGCTATTTGC CCTTCGGAGC AGGACCTCGC
|
1381TCCTGTATAG GTGAGATCCT GGCCCGCCAG GAGCTCTTCC TCATCATGGC CTGGCTGCTG
|
1441CAGAGGTTCG ACCTGGAGGT GCCAGATGAT GGGCAGCTGC CCTCCCTGGA AGGCATCCCC
|
1501AAGGTGGTCT TTCTGATCGA CTCTTTCAAA GTGAAGATCA AGGTGCGCCA GGCCTGGAGG
|
1561GAAGCCCAGG CTGAGGGTAG CACCTAAAGG CTGTAACTCA CAGCCCCTGT CCACCCTATG
|
1621TGGCCCCACA ACACAGATTT AGAGATACAA CCCCCCACCC TTCTCCGCCA TTCTTCCCTA
|
1681CTCCCAACCC ACTCTGCCTT CTTTTTCAGC TTGTGGCAAT GCCAGTGATG TGCATAAACA
|
1741GTTTTTTTTT TTTCC
|
GENBANK ID: NM_001662
DEFINITION HOMO SAPIENS ADP-RIBOSYLATION FACTOR 5 (ARF5), MRNA.
VERSION NM_001662.2 GI:6995999
CDS 37..579
/CODON_START=1
1CCGCGTCGGT GCCCGCGCCC CTCCCCGGGC CCCGCCATGG GCCTCACCGT GTCCGCGCTC
|
61TTTTCGCGGA TCTTCGGGAA GAAGCAGATG CGGATTCTCA TGGTTGGCTT GGATGCGGCT
|
121GGCAAGACCA CAATCCTGTA CAAACTGAAG TTGGGGGAGA TTGTCACCAC CATCCCAACC
|
181ATAGGCTTCA ATGTAGAAAC AGTGGAATAT AAGAACATCT GTTTCACAGT CTGGGACGTG
|
241GGAGGCCAGG ACAAGATTCG GCCTCTGTGG CGGCACTACT TCCAGAACAC TCAGGGCCTC
|
301ATCTTTGTGG TGGACAGTAA TGACCGGGAG CGGGTCCAAG AATCTGCTGA TGAACTCCAG
|
361AAGATGCTGC AGGAGGACGA GCTGCGGGAT GCAGTGCTGC TGGTATTTGC CAACAAGCAG
|
421GACATGCCCA ACGCCATGCC CGTGAGCGAG CTGACTGACA AGCTGGGGCT ACAGCACTTA
|
481CGCAGCCGCA CGTGGTATGT CCAGGCCACC TGTGCCACCC AAGGCACAGG TCTGTACGAT
|
541GGTCTGGACT GGCTGTCCCA CGAGCTGTCA AAGCGCTAAC CAGCCAGGGG CAGGCCCCTG
|
601ATGCCCGGAA GCTCCTGCGT GCATCCCCGG GATGACCAGA CTCCCGGACT CCTCAGGCAG
|
661TGCCCTTTCC TCCCACTTTT CCTCCCCCAT AGCCACAGGC CTCTGCTCCT GCTCCTGCCT
|
721GCATGTTCTC TCTGTTGTTG GAGCCTGGAG CCTTGCTCTC TGGGCACAGA GGGGTCCACT
|
781CTCCTGCCTG CTGGGACCTA TGGAAGGGGC TTCCTGGCCA AGGCCCCCTC TTCCAGAGGA
|
841GGAGCAGGGA TCTGGGTTTC CTTTTTTTTT TCTGTTTTGG GTGTACTCTA GGGGCCAGGT
|
901TGGGAGGGGG AAGGTGAGGG CTTCGGGTGG TGCTATAATG TGGCACTGGA TCTTGAGTAA
|
961TAAATTTGCT GTGGTTTG
|
GENBANK 10: XM_048886.3
DEFINITION HOMO SAPIENS MICROSOMAL GLUTATHIONE 5-TRANSFERASE 1
(MGST1), MRNA.
VERSION XM_048886.3 GI:18580621
CDS 89..556
/CODON_START=1
1AGTCCCTGCA TTGCGCGCGA CCCGGCGGCG GGACAGGCTT GCTGCTTCCT CCTCCTCGGC
|
61CTCACCATTC CAGACCAAAA TTGAAAAAAT GGTTGACCTC ACCCAGGTAA TGGATGATGA
|
121AGTATTCATG GCTTTTGCAT CCTATGCAAC AATTATTCTT TCAAAAATGA TGCTTATGAG
|
181TACTGCAACT GCATTCTATA GATTGACAAG AAAGGTTTTT GCCAATCCAG AAGACTGTGT
|
241AGCATTTGGC AAAGGAGAAA ATGCCAAGAA GTATCTTCGA ACAGATGACA GAGTAGAACG
|
301TGTACGCAGA GCCCACCTGA ATGACCTTGA AAATATTATT CCATTTCTTG GAATTGGCCT
|
361CCTGTATTCC TTGAGTGGTC CCGACCCCTC TACAGCCATC CTGCACTTCA GACTATTTGT
|
421CGGAGCACGG ATCTACCACA CCATTGCATA TTTGACACCC CTTCCCCAGC CAAATAGAGC
|
481TTTGAGTTTT TTTGTTGGAT ATGGAGTTAC TCTTTCCATG GCTTACAGGT TGCTGAAAAG
|
541TAAATTGTAC CTGTAAAGAA AATCATACAA CTCAGCATCC AGTTGGCTTT TTAAGAATTC
|
601TGTACTTCCA ATTTATAATG AATACTTTCT TAGATTTTAG GTAGGAGGGG AGCAGAGGAA
|
661TTATGAACTG GGGTAAACCC ATTTTGAATA TTAGCATTGC CAATATCCTG TATTCTTGTT
|
721TTACATTTGG ATTAGAAATT TAACATAGTA ATTCTTAAGT CTTTTGTCTG ATTTTTAAAG
|
781TACTTTCTTA TAAATTTGGA TCATGTTATG ATTTGTAACA TTCACACAAC ACCTCACTTT
|
841TGAATCTATA AAAGAATTGC ACGTATGAGA AACCTATATT TCAATACTGC TGAAACAGAC
|
901ATGAAATAAA GAATTTAAAG AATG
|
GENBANK ID: X02162
DEFINITION HUMAN MRNA FOR AFOLIPOPROTEIN AI (APO AI)=.
VERSION X02162.1 GI:28771
CDS 87..890
/CODON_START=1
1GAATTCAAAA AAAAAAGAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAGAG AGACTGCGAG
|
61AAGGAGGTCC CCCACGGCCC TTCAGGATGA AAGCTGCGGT GCTGACCTTG GCCGTGCTCT
|
121TCCTGACGGG GAGCCAGGCT CGGCATTTCT GGCAGCAAGA TGAACCCCCC CAGAGCCCCT
|
181GGGATCGAGT GAAGGACCTG GCCACTGTGT ACGTGGATCT GCTCAAAGAC AGCGGCAGAG
|
241ACTATGTGTC CCAGTTTGAA GGCTCCGCCT TGGGAAAACA GCTAAACCTA AAGCTCCTTG
|
301ACAACTGCGA CAGCCTGACC TCCACCTTCA GCAAGCTGCG CGAACAGCTC GGCCCTGTGA
|
361CCCAGGAGTT CTGGGATAAC CTGGAAAAGG AGACAGAGGG CCTGAGGCAG GAGATGAGCA
|
421AGGATCTGGA GGAGGTGAAG GCCAAGGTGC AGCCCTACCT GGACGACTTC CAGAAGAAGT
|
481GGCAGGAGGA GATGGAGCTC TACCGCCAGA AGGTGGAGCC GCTGCGCGCA GAGCTCCAAG
|
541AGGGCGCGCG CCAGAAGCTG CACGAGCTGC AAGAGAAGCT GAGCCCACTG GGCGAGGAGA
|
601TGCGCGACCG CGCGCGCGCC CATCTGGACG CGCTGCGCAC GCATCTGGCC CCCTACAGCG
|
661ACGAGCTGCG CCAGCGCTTG GCCGCGCGCC TTGAGCCTCT CAAGGACAAC GGCGGCGCCA
|
721GACTGGCCGA GTACCACGCC AAGGCCACCG AGCATCTGAG CACGCTCAGC GAGAAGGCCA
|
781AGCCCGCGCT CGAGGACCTC CGCCAAGCCC TCCTGCCCGT GCTGGAGAGC TTCAAGGTCA
|
841GCTTCCTGAG CGCTCTCGAC GACTACACTA AGAAGCTCAA CACCCAGTGA GCCGCCCGCC
|
901GCCGCCCCCC TTCCCGGTGC TCAGAATAAA CGTTTCCAAA GTGGGAAAAA AAAAAAAAAG
|
961AATTC
|
GENBANK ID: XM_007441.1
DEFINITION HOMO SAPIENS PRESENILIN 1 (ALZHEIS2ER DISEASE 3) (PSEN1),
MRNA.
VERSION XM_007441.1 GI:11435041
CDS 249..1652
/CODON_START=1
1TGGGACAGGC AGCTCCGGGG TCCGCGGTTT CACATCGGAA ACAAAACAGC GGCTGGTCTG
|
61GAAGGAACCT GAGCTACGAG CCGCGGCGGC AGCGGGGCGG CGGGGAAGCG TATACCTAAT
|
121CTGGGAGCCT GCAAGTGACA ACAGCCTTTG CGGTCCTTAG ACAGGTTGGG CTGGAGGAGA
|
181ACACATGAAA GAAAGAACCT CAAGAGGCTT TGTTTTCTGT GAAACAGTAT TTCTATACAG
|
241TTGCTCCAAT GACAGAGTTA CCTGCACCGT TGTCCTACTT CCAGAATGCA CAGATGTCTG
|
301AGGACAACCA CCTGAGCAAT ACTGTACGTA GCCAGAATGA CAATAGAGAA CGGCAGGAGC
|
361ACAACGACAG ACGGAGCCTT GGCCACCCTG AGCCATTATC TAATGGACGA GCGCAGGGTA
|
421ACTCCCGGCA GGTGGTGGAG CAAGATGAGG AAGAAGATGA GGAGCTGACA TTGAAATATG
|
481GCGCCAAGCA TGTGATCATG CTCTTTGTCC CTGTGACTCT CTGCATGGTG GTGGTCGTGG
|
541CTACCATTAA GTCAGTCAGC TTTTATACCC GGAAGGATGG GCAGCTAATC TATACCCCAT
|
601TCACAGAAGA TACCGAGACT GTGGGCCAGA GAGCCCTGCA CTCAATTCTG AATGCTGCCA
|
661TCATGATCAG TGTCATTGTT GTCATGACTA TCCTCCTGGT GGTTCTGTAT AAATACAGGT
|
721GCTATAAGGT CATCCATGCC TGGCTTATTA TATCATCTCT ATTGTTGCTG TTCTTTTTTT
|
781CATTCATTTA CTTGGGGGAA GTGTTTAAAA CCTATAACGT TGCTGTGGAC TACATTACTG
|
841TTGCACTCCT GATCTGGAAT TTTGGTGTGG TGGGAATGAT TTCCATTCAC TGGAAAGGTC
|
901CACTTCGACT CCAGCAGGCA TATCTCATTA TGATTAGTGC CCTCATGGCC CTGGTGTTTA
|
961TCAAGTACCT CCCTGAATGG ACTGCGTGGC TCATCTTGGC TGTGATTTCA GTATATGATT
|
1021TAGTGGCTGT TTTGTGTCCG AAAGGTCCAC TTCGTATGCT GGTTGAAACA GCTCAGGAGA
|
1081GAAATGAAAC GCTTTTTCCA GCTCTCATTT ACTCCTCAAC AATGGTGTGG TTGGTGAATA
|
1141TGGCAGAAGG AGACCCGGAA GCTCAAAGGA GAGTATCCAA AAATTCCAAG TATAATGCAG
|
1201AAAGCACAGA AAGGGAGTCA CAAGACACTG TTGCAGAGAA TGATGATGGC GGGTTCAGTG
|
1261AGGAATGGGA AGCCCAGAGG GACAGTCATC TAGGGCCTCA TCGCTCTACA CCTGAGTCAC
|
1321GAGCTGCTGT CCAGGAACTT TCCAGCAGTA TCCTCGCTGG TGAAGACCCA GAGGAAAGGG
|
1381GAGTAAAACT TGGATTGGGA GATTTCATTT TCTACAGTGT TCTGGTTGGT AAAGCCTCAG
|
1441CAACAGCCAG TGGAGACTGG AACACAACCA TAGCCTGTTT CGTAGCCATA TTAATTGGTT
|
1501TGTGCCTTAC ATTATTACTC CTTGCCATTT TCAAGAAAGC ATTGCCAGCT CTTCCAATCT
|
1561CCATCACCTT TGGGCTTGTT TTCTACTTTG CCACAGATTA TCTTGTACAG CCTTTTATGG
|
1621ACCAATTAGC ATTCCATCAA TTTTATATCT AGCATATTTG CGGTTAGAAT CCCATGGATG
|
1681TTTCTTCTTT GACTATAACA AAATCTGGGG AGGACAAAGG TGATTTTCCT GTGTCCACAT
|
1741CTAACAAAGT CAAGATTCCC GGCTGGACTT TTGCAGCTTC CTTCCAAGTC TTCCTGACCA
|
1801CCTTGCACTA TTGGACTTTG GAAGGAGGTG CCTATAGAAA ACGATTTTGA ACATACTTCA
|
1861TCGCAGTGGA CTGTGTCCCT CGGTGCAGAA ACTACCAGAT TTGAGGGACG AGGTCAAGGA
|
1921GATATGATAG GCCCGGAAGT TGCTGTGCCC CATCAGCAGC TTGACGCGTG GTCACAGGAC
|
1981GATTTCACTG ACACTGCGAA CTCTCAGGAC TACCGTTACC AAGAGGTTAG GTGAAGTGGT
|
2041TTAAACCAAA CGGAACTCTT CATCTTAAAC TACACGTTGA AAATCAACCC AATAATTCTG
|
2101TATTAACTGA ATTCTGAACT TTTCAGGAGG TACTGTGAGC AAGAGCAGGC ACCAGCAGCA
|
2161GAATGGGGAA TCGACAGGTG GGCAGCGGTT CCAGCTTCCC TTTGATTTTT TGCTGCAGAC
|
2221TCATCCTTTT TAAATGAGAC TTGTTTTCCC CTCTCTTTGA GTCAAGTCAA ATATGTAGAT
|
2281TGCCTTTGGC AATTCTTCTT CTCAAGCACT GACACTCATT ACCGTCTGTG ATTGCCATTT
|
2341CTTCCCAAGG CCAGTCTGAA CCTGAGGTTG CTTTATCCTA AAAGTTTTAA CCTCAGGTTC
|
2401CAAATTCAGT AAATTTTGGA AACAGTACAG CTATTTCTCA TCAATTCTCT ATCATGTTGA
|
2461AGTCAAATTT GGATTTTCCA CCAAATTCTG AATTTCTAGA CATACTTGTA CGCTCACTTG
|
2521CCCCAGATGC CTCCTCTGTC CTCATTCTTC TCTCCCACAC AAGCAGTCTT TTTCTACAGC
|
2581CAGTAAGGCA GCTCTGTCGT GGTAGCAGAT GGTCCCATTA TTCTAGGGTC TTACTCTTTG
|
2641TATGATGAAA AGAATGTGTT ATGAATCGGT GCTGTCAGCC CTGCTGTCAG ACCTTCTTCC
|
2701ACAGCAAATG AGATGTATGC CCAAAGACGG TAGAATTAAA GAAGAGTAAA ATGGCTGTTG
|
2761AAGC
|
GENBANK ID: XM_087242.1
DEFINITION HOMO SAPIENS ARGINYL AMINOPEPTIDASE (AMINOPEPTIDASE B) -LIKE
1(RNPEPL1), MRNA.
VERSION XM_087242.1 GI:18600482
CDS 700..1764
/CODON_START=1
1GTGGACCCGT TCACCGACTA CGGCTCCTCC CTCACCGTCA CGCTGCCGCC CGAGCTGCAG
|
61GCGCACCAGC CCTTCCAGGT CATCCTGCGG TACACCTCGA CCGACGCCCC CGCCATCTGG
|
121TGGCTGGACC CAGAGCTGAC CTATGGCTGC GCCAAGCCCT TCGTCTTCAC CCAGGGCCAC
|
181TCCGTGTGCA ACCGCTCCTT CTTCCCGTGC TTCGACACAC CTGCCGTGAA GTGCACCTAC
|
241TCTGCCGTCG TCAAGGCGCC ATCGGGGGTG CAGGTGCTGA TGAGTGCCAC CCGGAGTGCA
|
301TACATGGAGG AAGAAGGCGT CTTCCACTTC CACATGGAGC ACCCCGTGCC CGCCTACCTC
|
361GTGGCCCTGG TGGCCGGAGA CCTCAAGCCG GCAGACATCG GGCCCAGGAG CCGCGTGTGG
|
421GCCGAGCCAT GCCTCCTGCC CACGGCCACC AGCAAGCTGT CGGGCGCAGT GGAGCAGTGG
|
481CTGAGTGCAG CTGAGCGGCT GTATGGGCCC TACATGTGGG GCAGGTACGA CATTGTCTTC
|
541CTGCCACCCT CCTTCCCCAT CGTGGCCATG GAGAACCCCT GCCTCACCTT CATCATCTCC
|
601TCCATCCTGG AGAGCGATGA GTTCCTGGTC ATCGATGTCA TCCACGAGGT GGCCCACAGT
|
661TGGTTCGGCA ACGCTGTCAC CAACGCCACG TGGGAAGAGA TGTGGCTGAG CGAGGGCCTG
|
721GCCACCTATG CCCAGCGCCG TATCACCACC GAGACCTACG GTGCTGCCTT CACCTGCCTG
|
781GAGACTGCCT TCCGCCTGGA CGCCCTGCAC CGGCAGATGA AGCTTCTGGG AGAGGACAGG
|
841CCGGTCAGCA AACTGCAGGT CAAGCTGGAG CCAGGAGTGA ATCCCAGCCA CCTGATGAAC
|
901CTGTTCACCT ACGAGAAGGG CTACTGCTTC GTGTACTACC TGTCCCAGCT CTGCGGAGAC
|
961CCACAGCGCT TTGATGACTT TCTCCGAGCC TATGTGGAGA AGTACAAGTT CACCAGCGTG
|
1021GTGGCCCAGG ACCTGCTGGA CTCCTTCCTG AGCTTCTTCC CGGAGCTGAA GGAGCAGAGC
|
1081GTGGACTGCC GGGCAGGGCT GGAATTCGAG CGCTGGCTCA ATGCCACAGG CCCGCCGCTG
|
1141GCTGAGCCGG ACCTGTCTCA GGGATCCAGC CTGACCCGGC CCGTGGAGGC CCTTTTCCAG
|
1201CTGTGGACCG CAGAACCTCT GGACCAGGCA GCTGCCTCGG CCAGCGCCAT TGACATCTCC
|
1261AAGTGGAGGA CCTTCCAGAC AGCACTCTTC CTGGACCGGC TCCTGGATGG GTCCCCGCTG
|
1321CCGCAGGAGG TGGTGATGAG CCTGTCCAAG TGCTACTCCT CCCTGCTGGA CTCGATGAAC
|
1381GCTGAGATCC GCATCCGCTG GCTGCAGATT GAGGTCCGCA ACGACTACTA TCCTGACCTC
|
1441CACAGGGTGC GGCGCTTCCT GGAGAGCCAG ATGTCACGCA TGTACACCAT CCCGCTGTAC
|
1501GAGGACCTCT GCACCGGTGC CCTCAAGTCC TTCGCGCTGG AGGTCTTCTA CCAGACGCAG
|
1561GGCCGGCTGC ACCCCAACCT GCGCAGAGCC ATCCAGCAGA TCCTGTCCCA GGGCCTGGGC
|
1621TCCAGCACAG AGCCCGCCTC AGAGCCCAGC ACGGAGCTGG GCAAGGCTGA AGCAGACACA
|
1681GACTCGGACG CACAGGCCCT GCTGCTTGGG GACGAGGCCC CCAGCAGTGC CATCTCTCTC
|
1741AGGGACGTCA ATGTGTCTGC CTAGCCCTGT TGGCGGGCTG ACCCTCGACC TCCCAGACAC
|
1801CACAATTGTG CCTTCTGTGG GCCAGGCCTG CCATGACTGC GTCTCGGCTC TGGCCATGAG
|
1861CTCTGCCCAG GCCCACAAGC CCCTCCCCTG GGCTCTCCCA GGCAGGGAGA ATGGGGAGAG
|
1921GGACCTCCTT GTGTCTGGCA GAGACCTGTG GACCTGGCCT CCCCACTCCC AGCTCTCTTG
|
1981CACTGCAGGC CCTGGGGCCA GCCCGCACAC ACCATGCCTC CTGTCTCAAC ACTGACAGCT
|
2041GTGCCTAGCC CCGGATGCCA GCACCTGCCA GGTGCCGCCC CGGGGCAAGG GCCCCAGCAG
|
2101CCCTATGGTG ACCGCCACAC TGTGCCTTAA TGTCTGCCGG GGGCCCAGGC TGTGCTGTCC
|
2161CTGCAGCACG CCTCCTTGCA GGGATCTGAG CCACCCTCCC CGCACAGCCC TGCACCCCGC
|
2221CCCTAGGGTT GGCAGCCTCA GTTGGCCCCT GGCAGAGGAA CAAGGACACA GACATTCCCT
|
2281CAGTGTGGGG GGCAGGGGAC ACAGGGAGAG GATGGTTGTC CCTGGGGAGG GCCCTCTGGC
|
2341CCCAGGCAAC CTTAGCCCCT CAGAACAGGG AGTCCCAGGA CCCAGGGAGA GTGTGGGGAC
|
2401AGGACAGCCT GTCTCTTGTA GCTTCCTGGG GTGGGAGGCA CAGGGGCAAA GCAATACCCC
|
2461AGGGAAAGTG GGAGGTGGTG CTGGTGCTCT CTCCAGGCCC ACCATGCTGG GAGAGGCGGC
|
2521CAGAGCCTGG GGCCTCCAGC CTGGGACTGC TGTGATGGGG TATCACGGTG ATGGTCCCAT
|
2581TAAACTTCCA CTCTGCAAAC CTG
|
GENBANK ID: S90469
DEFINITION CYTOCHROME P450 REDUCTASE [HUMAN, PLACENTA, MRNA PARTIAL, 2403
NT].
VERSION S90469.1 GI:247306
CDS 1..2031
CODO_START=1
1GGAGACTCCC ACGTGGACAC CAGCTCCACC GTGTCCGAGG CGGTCGCCGA AGAAGTATCT
|
61CTTTTCAGCA TGACGCACAT GATTCTGTTT TCGCTCATCG TGGGTCTCCT AACCTACTGG
|
121TTCCTCTTCA GAAAGAAAAA AGAAGAAGTC CCCGACTTCA CCAAAATTCA GACATTGACC
|
181TCCTCTGTCA GAGAGAGGAG CTTTGTGGAA AAGATGAAGA AAACGGGGAG GAACATCATC
|
241GTGTTCTACG GCTCCCAGAC GGGGACTGCA GAGGAGTTTG CCAACCGCCT GTCCAAGGAC
|
301GCCCACCGCT ACGGGATGCG AGGCATGTCA GCGGACCCTG AGGAGTATGA GCTGCCGGAC
|
361CTGAGCAGCC TGCCAGAGAT CGACAACGCC CTGGTGGTTT TCTGCATGGC CACGTACGCT
|
421GAGGGAGACC CCACCGACAA TGCCCAGGAC TTCTACGACT GGCTGCAGGA GACAGACGTG
|
481GATCTCTCTG GGGTCAAGTT CGCGGTGTTT GGTCTTGGGA ACAAGACCTA CGAGCACTTC
|
541AATGCCATGG GCAAGTACGT GGACAAGCGG CTGGAGCAGC TCGGCGCCCA GCGCATCTTT
|
601GAGCTGGGGT TGGGCGACGA CGATGGGAAC TTGGAGGAGG ACTTCATCAC CTGGCGAGAG
|
661CAGTTCTGGC CGGCCGTGTG TGAACACTTT GGGGTGGAAG CCACTGGCGA GGAGTCCAGC
|
721ATTCGCCAGT ACGAGCTTGT GGTCCACACC GACATAGATG CGGCCAAGGT GTACATGGGG
|
781GAGATGGGCC GGCTGAAGAG CTACGAGAAC CAGAAGCCCC CCTTTGATGC CAAGAATCCG
|
841TTCCTGGCTG CAGTCACCAC CAACCGGAAG CTGAACCAGG GAACCGAGCG CCACCTCATG
|
901CACCTGGAAT TGGACATCTC GGACTCCAAA ATCAGGTATG AATCTGGGGA CCACGTGGCT
|
961GTGTACCCAG CCAACGACTC TGCTCTCGTC AACCAGCTGG GCAAAATCCT GGGTGCCGAC
|
1021CTGGACGTCG TCATGTCCCT GAACAACCTG GATGAGGAGT CCAACAAGAA GCACCCATTC
|
1081CCGTGCCCTA CGTCCTACCG CACGGCCCTC ACCTACTACC TGGACATGAC CAACCCGCCG
|
1141CGTACCAACG TGCTGTACGA GCTGGCGCAG TACGCCTCGG ACCGCTGGGA GCAGGAGCTG
|
1201CTGCGCAAGA TGGCCTCCTC CTCCGGCGAG GGCAAGGAGC TGTACCTGAG CTGGGTGGTG
|
1261GAGGGCGGGA GGCACATCCT GGCCATCCTG CAGGACTGCC CGTCCCTGCG GCCCCCCATC
|
1321GACCACCTGT GTGAGCTGCT GCCGCGCCTG CAGGCCCGCT ACTACTCCAT CGCCTCATCC
|
1381TCCAAGGTCC ACCCCAACTC TGTGCACATC TGTGCGGTGG TTGTGGAGTA CGAGACCAAG
|
1441GCCGGCCGCA TCAACAAGGG CGTGGCCACC AACTGGCTGC GGGCCAAGGA GCCTGTCGGG
|
1501GAGAACGGCG GCCGTGCGCT GGTGCCCATG TTCGTGCGCA AGTCCCAGTT ACGCCTGCCC
|
1561TTCAAGGCCA CCACGCCTGT CATCATGGTG GGCCCCGGCA CCGGGTGGCA CCCTTTCATA
|
1621GGCTTCATCC AGGAGCGGGC CTGGCTGCGA CAGCAGGGCA AGGAGGTGGG GGAGACGCTG
|
1681CTGTACTACG GCTGCCGCCG CTCGGATGAG GACTACCTGT ACGGGGAGGA GCTGGCGCAG
|
1741TTCCACAGGG ACGGTGCGCT CACCCAGCTC AACGTGGCCT TCTCCCGGGA GCAGTCCCAC
|
1801AAGGTCTACG TCCAGCACCT GCTAAAGCAA GACCGAGAGC ACCTGTGGAA GTTGATCGAA
|
1861GGCGGTGCCC ACATCTACGT CTGTGGGGAT GCACGGAACA TGGCCAGGGA TGTGCAGAAC
|
1921ACCTTCTACG ACATCGTGGC TGAGCTCGGG GCCATGGAGC ACGCGCAGGC GGTGGACTAC
|
1981ATCAAGAAAC TGATGACCAA GGGCCGCTAC TCCCTGGACG TGTGGAGCTA GGGGCCTGCC
|
2041TGCCCCACCC ACCGCACAGA CTCCGGCCTG TAATCAGCTC TCCTGGCTCC CTCCCGTAGT
|
2101CTCCTGGGTG TGTTTGGCTT GGCCTTGGCA TGGGCGCAGG CCCAGTGACA AAGACTCCTC
|
2161TGGGCCTGGG GTGCATCCTC CTCAGCCCCC AGGCCAGGTG AGGTCCACCG GCCCCTGGCA
|
2221GCACAGCCCA GGGCCTGCAT GGGGGCACCG GGCTCCATGC CTCTGGAGCC TCTGGCCCTC
|
2281GGTGGCTGCA CAGAAGGGCT CTTTCTCTCT GCTGAGCTGG CCCAGCCCCT CCACGTGATT
|
2341TCCAGTGAGT GTAAATAATT TTAAATAACC TCTGGCCCTT GGAATAAAGT TCTGTTTTCT
|
2401GTA
|
GENBANK ID: NM_006254.1
DEFINITION HOMO SAPIENS PROTEIN KINASE C, DELTA (PRKCD), MRNA.
VERSION NM_006254.1 GI:5453969
CDS 59..2089
/CODON_START=1
1TGCCGCCGCG ACCCTTGGCG CCTGCCCCTG CAACGGGAGC CCCACTGCAG GCCCCACCAT
|
61GGCGCCGTTC CTGCGCATCG CCTTCAACTC CTATGAGCTG GGCTCCCTGC AGGCCGAGGA
|
121CGAGGCGAAC CAGCCCTTCT GTGCCGTGAA GATGAAGGAG GCGCTCAGCA CAGAGCGTGG
|
181GAAAACACTG GTGCAGAAGA AGCCGACCAT GTATCCTGAG TGGAAGTCGA CGTTCGATGC
|
241CCACATCTAT GAGGGGCGCG TCATCCAGAT TGTGCTAATG CGGGCAGCAG AGGAGCCAGT
|
301GTCTGAGGTG ACCGTGGGTG TGTCGGTGCT GGCCGAGCGC TGCAAGAAGA ACAATGGCAA
|
361GGCTGAGTTC TGGCTGGACC TGCAGCCTCA GGCCAAGGTG TTGATGTCTG TTCAGTATTT
|
421CCTGGAGGAC GTGGATTGCA AACAATCTAT GCGCAGTGAG GACGAGGCCA AGTTCCCAAC
|
481GATGAACCGC CGCGGAGCCA TCAAACAGGC CAAAATCCAC TACATCAAGA ACCATGAGTT
|
541TATCGCCACC TTCTTTGGGC AACCCACCTT CTGTTCTGTG TGCAAAGACT TTGTCTGGGG
|
601CCTCAACAAG CAAGGCTACA AATGCAGGCA ATGTAACGCT GCCATCCACA AGAAATGCAT
|
661CGACAAGATC ATCCGCAGAT CCACTGGCAC CGCCGCCAAC AGGCGGGACA CTATATTCCA
|
721GAAAGAACGC TTCAACATCC ACATGCCGCA CCGCTTCAAG GTTCACAACT ACATGAGCCC
|
781CACCTTCTGT GACCACTGCG GCAGCCTGCT CTGGGGACTG GTGAAGCAGG GATTAAAGTG
|
841TGAAGACTGC GGCATGAATG TGCACCATAA ATGCCGGGAG AAGGTGGCCA ACCTCTGCGG
|
901CATCAACCAG AAGCTTTTGG CTGAGGCCTT GAACCAAGTC ACGCAGAGAG CCTCCCGGAG
|
961ATCAGACTCA GCCTCCTCAG AGCCTGTTGG GATATATCAG GGTTTCGAGA AGAAGACCGG
|
1021AGTTGCTGGG GAGGACATGC AAGACAACAG TGGGACCTAC GGCAAGATCT GGGAGGGCAG
|
1081CAGCAAGTGC AACATCAACA ACTTCATCTT CCACAAGGTC CTGGGCAAAG GCAGCTTCGG
|
1141GAAGGTGCTG CTTGGAGAGC TGAAGGGCAG AGGAGACTAC TCTGCCATCA AGGCCCTCAA
|
1201GAAGGATGTG GTCCTGATCG ACGACGACGT GGAGTGCACC ATGGTTGAGA AGCGGGTGCT
|
1261GACACTTGCC GCAGAGAATC CCTTTCTCAC CCACCTCATC TGCACCTTCC AGACCAAGGA
|
1321CCACCTGTTC TTTGTGATGG AGTTCCTCAA CGGGGGGGAC CTGATGTACC ACATCCAGGA
|
1381CAAAGGCCGC TTTGAACTCT ACCGTGCCAC GTTTTATGCC GCTGAGATAA TGTGTGGACT
|
1441GCAGTTTCTA CACAGCAAGG GCATCATTTA CAGGGACCTC AAACTGGACA ATGTGCTGTT
|
1501GGACCGGGAT GGCCACATCA AGATTGCCGA CTTTGGGATG TGCAAAGAGA ACATATTCGG
|
1561GGAGAGCCGG GCCAGCACCT TCTGCGGCAC CCCTGACTAT ATCGCCCCTG AGATCCTACA
|
1621GGGCCTGAAG TACACATTCT CTGTGGACTG GTGGTCTTTC GGGGTCCTTC TGTACGAGAT
|
1681GCTCATTGGC CAGTCCCCCT TCCATGGTGA TGATGAGGAT GAACTCTTCG AGTCCATCCG
|
1741TGTGGACACG CCACATTATC CCCGCTGGAT CACCAAGGAG TCCAAGGACA TCCTGGAGAA
|
1801GCTCTTTGAA AGGGAACCAA CCAAGAGGCT GGGAATGACG GGAAACATCA AAATCCACCC
|
1861CTTCTTCAAG ACCATAAACT GGACTCTGCT GGAAAAGCGG AGGTTGGAGC CACCCTTCAG
|
1921GCCCAAAGTG AAGTCACCCA GAGACTACAG TAACTTTGAC CAGGAGTTCC TGAACGAGAA
|
1981GGCGCGCCTC TCCTACAGCG ACAAGAACCT CATCGACTCC ATGGACCAGT CTGCATTCGC
|
2041TGGCTTCTCC TTTGTGAACC CCAAATTCGA GCACCTCCTG GAAGATTGAG GTTCCTGGAC
|
2101AGAT
|
GENBANK ID: X61971.1
DEFINITION H. SAPIENS MRNA FOR MACROPAIN SUBUNIT DELTA.
VERSION X61971.1 GI:296733
CDS <1..543
/CODON_START=1
1ATCGCCAATC GAGTGACTGA CAAGCTGACA CCTATTCACG ACCGCATTTT CTGCTGTCGC
|
61TCAGGCTCAG CTGCTGATAC CCAGGCAGTA GCTGATGCTG TCACCTACCA GCTCGGTTTC
|
121CACAGCATTG AACTGAATGA GCCTCCACTG GTCCACACAG CAGCCAGCCT CTTTAAGGAG
|
181ATGTGTTACC GATACCGGGA AGACCTGATG GCGGGAATCA TCATCGCAGG CTGGGACCCT
|
241CAAGAAGGAG GGCAGGTCTA CTCAGTGCCT ATGGGGGGTA TGATGGTAAG GCAGTCCTTT
|
301GCCATTGGAG GCTCCGGGAG CTCCTACATC TATGGCTATG TTGATGCTAC CTACCGGGAA
|
361GGCATGACCA AGGAAGAGTG TCTGCAATTC ACGGCCAATG CTCTCGCTTT GGCCATGGAG
|
421CGGGATGGCT CCAGTGGAGG AGTGATCCGC CTGGCAGCCA TTGCAGAGTC AGGGGTAGAG
|
481CGGCAAGTAC TTTTGGGAGA CCAGATACCC AAATTCGCCG TTGCCACTTT ACCACCCGCC
|
541TGAATCCTGG GATTCTAGTA TGCAATAAGA GATGCCCTGT ACTGATGCAA AATTTAATAA
|
601AGTTTGTCAC AGAGAAAAAA AAAA
|
GENBANK ID: AH005909.1
GENBANK ID: XM_088424.1
DEFINITION HOMO SAPIENS RETINOID X RECEPTOR, ALPHA (RXRA), MRNA.
VERSION XM_088424.1 GI:18571706
CDS 519..1016
/CODON_START=1
1AAGCAGAACC TGGCCTCCCT GGCCACAGCA GCCTTACCCA CCGCTCTACG TGTCCCGGGC
|
61ACTTCCCGCA GCCTTCCCGT CCCTTTCTCA TCGGCCTTGT AGTTGTACAG TGCTGTTGGT
|
121TTGAAAAGGT GATGTGTGGG GAGTGCGGCT CATCACTGAG TAGAGAGGTA GAATTTCTAT
|
181TTAACCAGAC CTGTAGTAGT ATTACCAATC CAGTTCAATT AAGGTGATTT TTTGTAATTA
|
241TTATTATTTT GGTGGGACAA TCTTTAATTT TCTAAAGATA GCACTAACAT CAGCTCATTA
|
301GCCACCTGTG CCTGTCCCCG CCTTGGCCCG GCTGGATGAA GCGGCTTCCC CGCAGGGCCC
|
361CCACTTCCCA GTGGCTGCTT CCTGGGGACC CAGGGCACCC CGGCACCTTC AGGCACGCTC
|
421CTCAGCTGGT CACCTCCCGG CTTTGCCGTT CAGATGGGGC TCCTGAGGCT CAGGAGTGAA
|
481GATGCCACAG AGCCGGGCTC CCCTAGGCTG CGTCGGGCAT GCTTGGAAGC TGGCCTGCCA
|
541GGACCTTCCA CCCTGGGGCC TGTGTCAGCC GCCGGCCCTC CGCACCCTGG AAGCACACGG
|
601CCTCTGGGAA GGACAGCCCT GACCTTCGGT TTTCCGAGCA CGGTGTTTCC CAAGAATTCT
|
661GGGCTTGCCG CCTGGTGGCA GTGCTGGAGA TGACCCCGAG CCCCTCCCCG TGGGGCACCC
|
721AGGAGGGCCC TGCCGAAATG TGCAGCCTGT GGGTAGTCGG CTGGTGTCCC TGTCGTGGAG
|
781CTGGGGTGCG TGATCTGGTG CTCGTCCACG CAGGTGTGTG GTGTAAACAT GTATGTGCTG
|
841TACAGACAGA CGCGTGTGGA GAGAGCCGCA CACCAGCGCC ACCCAGGAAA GGCGGAGCGG
|
901TTACCAGTGT TTTGTGTTTA TTTTTAATCA AGACGTTTCC CCTGTTTTCC TATAAATTTG
|
961CTTCGTGTAA GCAAGTACAT AAGGACCCTC CTTTGGTGAA ATCCGGGTTC GAATGAATAT
|
1021CTCAAGGCAG GAGATGCATC TATTTTAAGA TGCTTTGGAG CAGACAGCTT TAGCCGTTCC
|
1081CAATCCTTAG CAATGCCTTA GCTGGGACGC ATAGCTAATA CTTTAGAGAG GATGACAGAT
|
1141CCATAAAGAG AGTAAAGATA AGAGAAAATG TCTAAAGCAT CTGGAAAGGT AAAAAAAAAA
|
1201AATCTATTTT TGTACAAATG TAATTTTATC CCTCATGTAT ACTTGGATAT GGCGGGGGGA
|
1261GGGGTCGGAC TGTTTCGTTT CTGCTTCTAG AGATTGAGGT GAAAGCTTCG TCCGAGAAAC
|
1321GCCAGGACAG ACGATGGCAG AGGAGAGGGC TCCTGTGACG GGGGCCAGGG TTGGGAGGAA
|
1381ACCGCCGCAA TGGGGGTGTC TTCCCTCGGG GGAGGAGGGT GGGCCTGAGG CTTTCAAGGG
|
1441TTTTCTTCCC TTTCGAGTAA TTTTTAAAGC CTTGCTCTGT TGTGTCCTGT TGCCGGCTCT
|
1501GGCCTTCCTG TGACTGACTG TGAAGTGGCT TCTCCGTACG ATTGTCTCTG AAACATCGTG
|
1561GCCGCAGGTG CCAGGGTTTG ATGGACAGTA GCATTAGAAT TGTGGAAAAG GAACACGCAA
|
1621AGGGAGAAGT GTGAGAGGAG AAACAAAATA TGAGCGTTTA AAATACATCG CCATTCAG
|
GENBANK ID: U41745.1
DEFINITION HUMAN PDGF ASSOCIATED PROTEIN MRNA, COMPLETE CDS.
VERSION U41745.1 GI:1136583
CDS 22..567
/CODON_START=1
1GAATTCCGCG GCGGCGCCTC AATGCCTAAA GGAGGAAGAA AGGGAGGCCA CAAAGGCCGG
|
61GCGAGGCAGT ATACAAGCCC TGAGGAGATC GACGCGCAGC TGCAGGCTGA GAAGCAGAAG
|
121GCCAGGGAAG AAGAGGAGCA AAAAGAAGGT GGAGATGGGG CTGCAGGTGA CCCCAAAAAG
|
181GAGAAGAAAT CTCTAGACTC AGATGAGAGT GAGGATGAAG AAGATGACTA CCAGCAAAAG
|
241CGCAAAGGCG TTGAAGGGCT CATCGACATC GAGAACCCCA ACCGGGTGGC ACAGACAACC
|
301AAAAAGGTCA CACAACTGGA TCTGGACGGG CCAAAGGAGC TTTCGAGGAG AGAACGAGAA
|
361GAGATTGAGA AGCAGAAGGC AAAAGAGCGT TACATGAAAA TGCACTTGGC CGGGAAGACA
|
421GAGCAAGCCA AGGCTGACCT GGCCCGGCTG GCCATCATCC GGAAACAGCG GGAGGAGGCT
|
481GCCCGGAAGA AGGAAGAGGA AAGGAAAGCA AAAGACGATG CCACATTGTC AGGAAAACGA
|
541ATGCAGTCAC TCTCCCTGAA TAAGTAACTG CGACCCGTGG GAGGAGATGC CGGGGACCTG
|
601GGCCGCGCTG CCAGGACCTC TGCTGTGTCT CGCCCACCCT GTGCCCTGGC GCCGCTGCAA
|
661CAGCCCCTCA TGGCCAGGAG CCCCCCATGC CTGGGCCTCC TCTTCATCTT GGCACAGAAA
|
721TTGTTTGGGG GATGGGGGGG GGACTGGGGG AGGGGTAGCT GCTATCTTTG AGACAGAAAG
|
781ATGCAGGACA GCATTTCATA TGTAACCATT TGAATGTTTT TGCTGTTTTT AGAATTC
|
GENBANK ID: AH002617.1
GENBANK ID: XM_034862.1
DEFINITION HOMO SAPIENS INTERFERON REGULATORY FACTOR 1 (IRF1), MRNA.
VERSION XM_034862.1 GI:14726087
CDS 197..1174
/CODON_START=1
1CGAGCCCCGC CGAACCGAGG CCACCCGGAG CCGTGCCCAG TCCACGCCGG CCGTGCCCGG
|
61CGGCCTTAAG AACCCGGCAA CCTCTGCCTT CTTCCCTCTT CCACTCGGAG TCGCGCTCCG
|
121CGCGCCCTCA CTGCAGCCCC TGCGTCGCCG GGACCCTCGC GCGCGACCGC CGAATCGCTC
|
181CTGCAGCAGA GCCAACATGC CCATCACTCG GATGCGCATG AGACCCTGGC TAGAGATGCA
|
241GATTAATTCC AACCAAATCC CGGGGCTCAT CTGGATTAAT AAAGAGGAGA TGATCTTCCA
|
301GATCCCATGG AAGCATGCTG CCAAGCATGG CTGGGACATC AACAAGGATG CCTGTTTGTT
|
361CCGGAGCTGG GCCATTCACA CAGGCCGATA CAAAGCAGGG GAAAAGGAGC CAGATCCCAA
|
421GACGTGGAAG GCCAACTTTC GCTGTGCCAT GAACTCCCTG CCAGATATCG AGGAGGTGAA
|
481AGACCAGAGC AGGAACAAGG GCAGCTCAGC TGTGCGAGTG TACCGGATGC TTCCACCTCT
|
541CACCAAGAAC CAGAGAAAAG AAAGAAAGTC GAAGTCCAGC CGAGATGCTA AGAGCAAGGC
|
601CAAGAGGAAG TCATGTGGGG ATTCCAGCCC TGATACCTTC TCTGATGGAC TCAGCAGCTC
|
661CACTCTGCCT GATGACCACA GCAGCTACAC AGTTCCAGGC TACATGCAGG ACTTGGAGGT
|
721GGAGCAGGCC CTGACTCCAG CACTGTCGCC ATGTGCTGTC AGCAGCACTC TCCCCGACTG
|
781GCACATCCCA GTGGAAGTTG TGCCGGACAG CACCAGTGAT CTGTACAACT TCCAGGTGTC
|
841ACCCATGCCC TCCACCTCTG AAGCTACAAC AGATGAGGAT GAGGAAGGGA AATTACCTGA
|
901GGACATCATG AAGCTCTTGG AGCAGTCGGA GTGGCAGCCA ACAAACGTGG ATGGGAAGGG
|
961GTACCTACTC AATGAACCTG GAGTCCAGCC CACCTCTGTC TATGGAGACT TTAGCTGTAA
|
1021GGAGGAGCCA GAAATTGACA GCCCAGGGGG GGATATTGGG CTGAGTCTAC AGCGTGTCTT
|
1081CACAGATCTG AAGAACATGG ATGCCACCTG GCTGGACAGC CTGCTGACCC CAGTCCGGTT
|
1141GCCCTCCATC CAGGCCATTC CCTGTGCACC GTAGCAGGGC CCCTGGGCCC CTCTTATTCC
|
1201TCTAGGCAAG CAGCACCTGG CATCATGGTG GATATCGTGC ACAGAAGCTG GACTTCTCTG
|
1261GGCCCCTCAA CAGCCAAGTG TGACCCCACT CCCAAGTGGG GATGGGGCCT CCCTCCTTGG
|
1321GTCATTGACC TCTCAGGGCC TGGCAGGCCA GTGTCTGCGT TTTTCTTGTC GTCTAAAGCT
|
1381GGCCCTGCCT CCTGGCAAGA TGAGGTTCTG AGACCAGTGT ATCAGGTCAG GCACTTGGAC
|
1441AGGAGTCAGT GTCTGGCTTT TTCCTCTGAG CCCAGCTGCC TGGAGAGGGT CTCGCTGTCA
|
1501CTGGGTGGCT CCTAGGGGAA CAGACCAGTG ACCCCAGAAA AGCATAACAC CAATCCCAGG
|
1561GCTGGCTCTG CACTAAGAGA AAATTGCACT AAATCAATCT CGTTCCCAAA GAACTACCCC
|
1621CTTTTCAGCT CAGCCCTGGG GACTGTTCCA AAGCCAGTGA AATGTGAAGG AAAGTGCGGT
|
1681CCTTCGGGGC GATGCTGGCT CAGCCTCAGA GGAGCTCTAC CCTGCTCCCT GCTTTGGCTG
|
1741AGGGGCTTGG GAAAAAAACT TGGCACTTTT TCGTGTGGAT CTTGCCACAT TTCTGATCAG
|
1801AGGTGTACAC TAACATTTCC CCCGAGCTCT TGGCCTTTCC ATTTATTTAT ACAGTGCCTT
|
1861GCTCGGCGCC CACCACCCCC TCAAGCCCCA GCAGCCCTCA ACAGGGCCAG GGAGGGAAGT
|
1921GTGAGCGCCT TGGTATGACT TAAAATTGGA AATGTCATCT AACCATTAAG TCATGTGTGA
|
1981ACACATAGGA CGTGTGTATA TATGTACATT TGTCTTTTTA TAAAAAGTAA ATTGTT
|
GENBANK ID: AJ310549.1
DEFINITION HOMO SAPIENS MRNA FOR CLP-36 PROTEIN.
VERSION AJ310549.1 GI:13160404
CDS 1..990
/CODON_START=1
1ATGACCACCC ACCAGATAGA CCTCCAGGGC CCGGGGCCGT GGGGCTTCCG CCTCGTGGGC
|
61GGCAAGGACT TCGAGCAGCC TCTCGCCATT TCCCGGGTCA CTCCTGGAAG CAAGGCGGCT
|
121CTAGCTAATT TATGTATTGG AGATGTAATC ACAGCCATTG ATGGGGAAAA TACTAGCAAT
|
181ATGACACACT TGGAAGCTCA GAACAGAATC AAAGGCTGCA CAGACAACTT GACTCTCACT
|
241GTAGCCAGAT CTGAACATAA ACTGTGGTCT CCTCTGGTGA CGGAGGAAGG GAAGCGTCAT
|
301CCATACAAGA TGAATTTAGC CTCTGAACCC CAGGAGGTCC TGCACATAGG AAGCGCCCAC
|
361AACCGAAGTG CCATGCCCTT TACCGCCTCG CCTGCCTCCA GCACTACTGC CAGGGTCATC
|
421ACAAACCAGT ACAACAACCC AGCTGGCCTC TACTCTTCTG AAAATATCTC CAACTTCAAC
|
481AATGCCCTGG AGTCAAAGAC TGCTGCCAGC GGGGTGGAGG CGAACAGCAG ACCCTTAGAC
|
541CATGCTCAGC CTCCAAGCAG CCTTGTCATC GACAAAGAAT CTGAAGTTTA CAAGATGCTT
|
601CAGGAGAAAC AGGAGTTGAA TGAGCCCCCG AAACAGTCCA CGTCTTTCTT GGTTTTGCAG
|
661GAAATCCTGG AGTCTGAAGA AAAAGGGGAT CCCAACAAGC CCTCAGGATT CAGAAGTGTT
|
721AAAGCTCCTG TCACTAAAGT GGCTGCGTCG ATTGGAAATG CTCAGAAGTT GCCTATGTGT
|
781GACAAATGTG GCACTGGGAT TGTTGGTGTG TTTGTGAAGC TGCGGGACCG TCACCGCCAC
|
841CCTGAGTGTT ATGTGTGCAC TGACTGTGGC ACCAACCTGA AACAGAAGGG CCATTTCTTT
|
901GTGGAGGATC AAATCTACTG TGAGAAGCAT GCCCGGGAGC GAGTCACACC ACCTGAGGGT
|
961TATGAAGTGG TCACTGTGTT CCCCAAGTGA GCCAGCAGAT CTGACCACTG TTCTCCAGCA
|
1021GGCCTCTGCT GCAGCTTTTT CTCTCAGTGT TCTGGCCCTC TCCTCTCTTG AAAGTTCTCT
|
1081GCTTACTTTG GTT
|
GENBANK ID: XM_016642.3
DEFINITION HOMO SAPIENS ADENYLATE KINASE 3 (AK3), MRNA.
VERSION XM_016642.3 GI:16163712
CDS 145..816
/CODON_START=1
1CCTTCCCCCT GTAGGGCCGG CCGGCGAGTC CCAGTGAGAG CGGAGGGTGC CAGAGGTAGG
|
61GGGCCGAGAA ACAAAGTTCC CGGGGCTCCC TCCGGGGCCG CGGTCGGGGC TGCGCGTTTG
|
121ACCGCCCCCC TCCTCGCGAA GGCAATGGCT TCCAAACTCC TGCGCGCGGT CATCCTCGGG
|
181CCGCCCGGCT CGGGCAAGGG CACCGTGTGC CAGAGGATCG CCCAGAACTT TGGTCTCCAG
|
241CATCTCTCCA GCGGCCACTT CTTGCGGGAG AACATCAAGG CCAGCACCGA AGTTGGTGAG
|
301GTGGCAAAGC AGTATATAGA GAAAAGTCTT TTGGTTCCAG ACCATGTGAT CACACGCCTA
|
361ATGATGTCCG AGTTGGAGAA TAGGCGTGGC CAGCACTGGC TCCTTGATGG TTTTCCTAGG
|
421ACATTAGGAC AAGCCGAGGC CCTGGACAAA ATCTGTGAAG TGGATCTAGT GATCAGTTTG
|
481AATATTCCAT TTGAAACACT TAAAGATCGT CTCAGCCGCC GTTGGATTCA CCCTCCTAGC
|
541GGAAGGGTAT ATAACCTGGA CTTCAATCCA CCTCATGTAC ATGGTATTGA TGACGTCACT
|
601GGTGAACCAT TAGTCCAGCA GGAGGAIGAT AAACCCGAAG CAGTTGCTGC CAGGCTAAGA
|
661CAGTACAAAG ACGCGGCAAA GCCAGTCATT GAATTATACA AGAGCCGAGG AGTGCTCCAC
|
721CAATTTTCCG GAACGGAGAC GAACAAAATC TGGCCCTACG TTTACACACT TTTCTCAAAC
|
781AAGATCACAC CTATTCAGTC CAAAGAAGCA TATTGACCCT GCCCAATGGA AGAACCAGGA
|
841AGATGTGGTC ATTCATTCAA TAGTGTGTGT AGTATTGGTG CTGTGTCCAA ATTAGAAGCT
|
901AGCTGAGGTA GCTTGCAGCA TCTTTTCTAG TTGAAATGGT GAACTGATAG CAAAACAAAT
|
961GAGTAGAAAG AGTTCATGAA GAGGCCCTCC TCTGCCTTTC AAAAGGGTGG TCACCTACAC
|
1021ATGTTTAAGG TGTCTCTGCA CATGTCTCAA GCCCATCACA AGAAAGCAAG TACAGTGTGG
|
1081ATTTCAAATG GTGTGTAACT TCAGCTCCAG CTGGTTTTTG ACAGCTGTTG CTGTGGTAAT
|
1141ATTTTTTACA TGTGATGGTG ATAGTCTCTG GTTCTCCCCA TCCCCACAAA GGCTGTTGAA
|
1201CCACACCACC AGGAAGCCTG AGAATGAATC CTGAGGGCTC TACCGCAGGC TTTGTCCCAG
|
1261GCTTTCTGGT GTGTGCCCTC CTGGTAACAG TGAAATTGAA GCTACTTACT CATAGTGGTT
|
1321GTTTCTCTGG TCTTGAGTGA CTGTGTCCAC AGTTCATTTT TTTCCGGTAG GAATAACTCC
|
1381TTTTCTACAT CCACACTCCA TAGAGTCTCT CCTTTTCAGA TATCCTGGGA TGAAAGAATT
|
1441TGGCTTTTTT TTTTTTTTTT TTTTTGACAT CTGTTTTCAC TCTTAGGCTT TTAAACAATA
|
1501GTTATTGCTC TTATCCCTCT CAGATTCTAA TAACTGAGAG TGATGGGGCT ATATTGAATC
|
1561TCTGTATGCA CTGAGAACTG AGCTATGAAG AGGATCTTAT TAAACTGCTG GTCTGACTTT
|
1621ATGGATTGAC ACTGTTCCTT TCTTTTATTG TG
|
GENBANK ID: Z35307.1
DEFINITION H. SAPIENS MRNA FOR ENDOTHELIN-CONVERTING-ENZYME 1.
VERSION Z35307.1 GI:535181
CDS 38..2299
/CODON_START=1
1CGCCCCCCCG GTGTCCGCCC TGCTGTCGGC GCTGGGGATG TCGACGTACA AGCGGGCCAC
|
61GCTGGACGAG GAGGACCTGG TGGACTCGCT CTCCGAGGGC GACGCATACC CCAACGGCCT
|
121GCAGGTGAAC TTCCACAGCC CCCGGAGTGG CCAGAGGTGC TGGGCTGCAC GGACCCAGGT
|
181GGAGAAGCGG CTGGTGGTGT TGGTGGTACT TCTGGCGGCA GGACTGGTGG CCTGCTTGGC
|
241AGCACTGGGC ATCCAGTACC AGACAAGATC CCCCTCTGTG TGCCTGAGCG AAGCTTGTGT
|
301CTCAGTGACC AGCTCCATCT TGAGCTCCAT GGACCGCACA GTGGACCCCT GCCATGACTT
|
361CTTCAGCTAC GCCTGTGGGG GCTGGATCAA GGCCAACCCA GTCCCTGATG GCCACTCACG
|
421CTGGGGGACC TTCAGCAACC TCTGGGAACA CAACCAAGCA ATCATCAAGC ACCTCCTCGA
|
481AAACTCCACG GCCAGCGTGA GCGAGGCAGA GAGAAAGGCG CAAGTATACT ACCGTGCGTG
|
541CATGAACGAG ACCAGGATCG AGGAGCTCAG GGCCAAACCT CTAATGGAGT TGATTGAGAG
|
601GCTCGGGGGC TGGAACATCA CAGGTCCCTG GGCCAAGGAC AACTTCCAGG ACACCCTGCA
|
661GGTGGTCACC GCCCACTACC GCACCTCACC CTTCTTCTCT GTCTATGTCA GTGCCGATTC
|
721CAAGAACTCC AACAGCAACG TGATCCAGGT GGACCAGTCT GGCCTGGGCT TGCGCTGGAG
|
781AGACTATTAC CTGAACAAAA CTGAAAACGA GAAGGTGCTG ACCGGATATC TGAACTACAT
|
841GGTCCAGCTG GGGAAGCTGC TGGGCGGCGG GGACGAGGAG GCCATCCGGC GCCAGATGCA
|
901GCAGATCTTG GACTTTGAGA CGGCACTGGC CAACATCACC ATCCCACAGG AGAAGCGCCG
|
961TGATGAGGAG CTCATCTACC ACAAAGTGAC GGCAGCCGAG CTGCAGACCT TGGCACCCGC
|
1021CATCAACTGG TTGCCTTTTC TCAACACCAT CTTCTACCCC GTGGAGATCA ATGAATCCGA
|
1081GCCTATTGTG GTCTATGACA AGGAATACCT TGAGCAGATC TCCACTCTCA TCAACACCAC
|
1141CGACAGATGC CTGCTCAACA ACTACATGAT CTGGAACCTG GTGCGGAAAA CAAGCTCCTT
|
1201CCTTGACCAG CGCTTTCAGG ACGCCGATGA GAAGTTCATG GAAGTCATGT ACGGGACCAA
|
1261GAAGACCTGT CTTCCTCGCT GGAAGTTTTG CGTGAGTGAC ACAGAAAACA ACCTGGGCTT
|
1321TGCGTTGGGC CCCATGTTTG TCAAAGCAAC CTTCGCCGAG GACAGCAAGA GCATAGCCAC
|
1381CGAGATCATC CTGGAGATTA AGAAGGCATT TGAGGAAAGC CTGAGCACCC TGAAGTGGAT
|
1441GGATGAGGAA ACCCGAAAAT CAGCCAAGGA AAAGGCCGAT GCCATCTACA ACATGATAGG
|
1501ATACCCCAAC TTCATCATGG ATCCCAAGGA GCTGGACAAA GTGTTTAATG ACTACACTGC
|
1561AGTTCCAGAC CTCTACTTTG AAAATGCCAT GCGGTTTTTC AACTTCTCAT GGAGGGTCAC
|
1621TGCCGATCAG CTCAGGAAAG CCCCCAACAG AGATCAGTGG AGCATGACCC CGCCCATGGT
|
1681GAACGCCTAC TACTCGCCCA CCAAGAATGA GATTGTGTTT CCGGCCGGGA TCCTGCAGGC
|
1741ACCATTCTAC ACACGCTCCT CACCCAAGGC CTTAAACTTT GGTGGCATAG GTGTCGTCGT
|
1801GGGCCATGAG CTGACTCATG CTTTTGATGA TCAAGGACGG GAGTATGACA AGGACGGGAA
|
1861CCTCCGGCCA TGGTGGAAGA ACTCATCCGT GGAGGCCTTC AAGCGTCAGA CCGAGTGCAT
|
1921GGTAGAGCAG TACAGCAACT ACAGCGTGAA CGGGGAGCCG GTGAACGGGC GGCACACCCT
|
1981GGGGGAGAAC ATCGCCGACA ACGGGGGTCT CAAGGCGGCC TATCGGGCTT ACCAGAACTG
|
2041GGTGAAGAAG AACGGGGCTG AGCACTCGCT CCCCACCCTG GGCCTCACCA ATAACCAGCT
|
2101CTTCTTCCTG GGCTTTGCAC AGGTCTGGTG CTCCGTCCGC ACACCTGAGA GCTCCCACGA
|
2161AGGCCTCATC ACCGATCCCC ACAGCCCCTC TCGCTTCCGG GTCATCGGCT CCCTCTCCAA
|
2221TTCCAAGGAG TTCTCAGAAC ACTTCCGCTG CCCACCTGGC TCACCCATGA ACCCGCCTCA
|
2281CAAGTGCGAA GTCTGGTAAG GACGAAGCGG AGAGAGCCAA GACGGAGGAG GGGAAGGGGC
|
2341TGAGGACGAG ACCCCCATCC AGCCTCCAGG GCATTGCTCA GCCCGCTTGG CCACCCGGGG
|
2401CCCTGCTTCC TCACACTGGC GGGTTTTCAG CCGGAACCGA GCCCATGGTG TTGGCTCTCA
|
2461ACGTGACCCG CAGTCTGATC CCCTGTGAAG AGCCGGACAT CCCAGGCACA CGTGTGCGCC
|
2521ACCTTCAGCA GGCATTCGGG TGCTGGGCTG GTGGCTCATC AGGCCTGGGC CCCACACTGA
|
2581CAAGCGCCAG ATACGCCACA AATACCACTG TGTCAAATGC TTTCAAGATA TATTTTTGGG
|
2641GAAACTATTT TTTAAACACT GTGGAATACA CTGGAAATCT TCAGGGAAAA ACACATTTAA
|
2701ACACTTTTTT TTTTAAGCCC
|
GENBANK ID: J02683
DEFINITION HUMAN ADPATP CARRIER PROTEIN MRNA, COMPLETE CDS.
VERSION J02683.1 GI:179246
CDS 70..966
/CODON_START=1
1CCGCAGCGCC GTAGTCAAAC CGAACCCGGC CCAGTCCCGT CCTGCAGCAG TCTGCCTCCT
|
61TCTTTCAACA TGACAGATGC CGCATTGTCC TTCGCCAAGG ACTTCCTGGC AGGTGGAGTG
|
121GCCGCAGCCA TCTCCAAGAC GGCGGTAGCG CCCATCGAGC CGGTCAAGCT GCTGCTGCAG
|
181GTGCAGCATG CCAGCAAGCA GATCACTGCA GATAAGCAAT ACAAAGGCAT TATAGACTGC
|
241GTGGTCCGTA TTCCCAAGGA GCACCAAGTT CTGTCCTTCT GGCGCGGTAA CCTGGCCAAT
|
301GTCATCAGAT ACTTCCCCAC CCACGCTCTT AACTTCGCCT TCAAAGATAA ATACAAGCAG
|
361ATCTTCCTCG GTGGTGTGGA CAAGAGAACC CAGTTTTGGC GCTACTTTGC AGGGAATCTG
|
421GCATCGGGTG CTGCCGCAGG GGCCACATGC CTGTGTTTTC TGTACCCTCT TGATTTTGCC
|
481CGTACCCGTC TAGCAGCTGA TGTGGGTAAA GCTGGAGCTG AAAGGGAATT CCGAGGCCTC
|
541GGTGACTGCC TGGTTAAGAT CTACAAATCT GATGGGATTA AGGGCCTGTA CCAAGGCTTT
|
601AACGTGTCTG TGCAGGGTAT TATCATCTAC CGAGCCGCCT ACTTCGGTAT CTATGACACT
|
661GCAAAGGGAA TGCTTCCGGA TCCCAAGAAC ACTCACATCG TCATCAGCTG GATGATCGCA
|
721CAGACTGTCA CTGCTGTTGC CGGGTTGACT TCCTATCCAT TTGACACCGT TCGCCGCCGC
|
781ATGATGATGC AGTCAGGGCG CAAAGGAACT GACATCATGT ACACAGGCAC GCTTGACTGC
|
841TGGCGGAAGA TTGCTCGTGA TGAAGGAGGC AAAGCTTTTT TCAAGGGTGC ATGGTCCAAT
|
901GTTCTCAGAG GCATGGGTGG TGCTTTTGTG CTTGTCTTGT ATGATGAAAT CAAGAAGTAC
|
961ACATAAGTTA TTTCCTAGGA TTTTTCCCCC TGTGAACAGG CATGTTGTAT TCTATAACAC
|
1021AATCTTGAGC ATTGTTGACA GACTCCTGGC TGTCAGTTTC TCAGTGGCAA CTACTTTACT
|
1081GGTTGAAAAT GGGAAGCAAT AATATTCATC TGACCAGTTT TCTCTTAAAG CCATTTCCAT
|
1141GCATGATGAT GATGGGACTC AATTGTATTT TTTATTTCAG TCACTCCTGA CTAAATAACA
|
1201ATTTGGAGAA ATAAAAATAG TCTAAAAT
|
GENBANK ID: M22760.1
DEFINITION HOMO SAPIENS NUCLEAR-ENCODED MITOCHONDRIAL CYTOCHROME C OXI-
DASE VA
SUBUNIT MRNA, COMPLETE CDS.
VERSION M22760.1 GI:695359
20..472
/CODON_START=1
1GGGCGCCGCC ATCGCCGTCA TGCTGGGCGC CGCTCTCCGC CGCTGCGCTG TGGCCGCAAC
|
61CACCCGGGCC GACCCTCGAG GCCTCCTGCA CTCCGCCCGG ACCCCCGGCC CCGCCGTGGC
|
121TATCCAGTCA GTTCGCTGCT ATTCCCATGG GTCACAGGAG ACAGATGAGG AGTTTGATGC
|
181TCGCTGGGTA ACATACTTCA ACAAGCCAGA TATAGATGCC TGGGAATTGC GTAAAGGGAT
|
241AAACACACTT GTTACCTATG ATATGGTTCC AGAGCCCAAA ATCATTGATG CTGCTTTGCG
|
301GGCATGCAGA CGGTTAAATG ATTTTGCTAG TCTAGTTCGA ATCCTAGAGG TTGTTAAGGA
|
361CAAAGCAGGA CCTCATAAGG AAATCTACCC CTATGTCATC CAGGAACTTA GACCAACTTT
|
421AAATGAACTG GGAATCTCCA CTCCGGAGGA ACTGGGCCTT GACAAAGTGT AAACCGCATG
|
481GATGGGCTTC CCCAAGGATT TATTGACATT GCTACTTGAG TGTGAACAGT TACCTGGAAA
|
541TACTGATGAT AACATATTAC CTTATTTTGA ACAAGTTTCC CTTTATTGAG TACCAAGCCA
|
601TGTAATGGTA ACTTGGACTT TAATAAAAGG GAAATGAGTT TGAACTG
|
GENBANK ID: 5118079
DNA LINEAR
DEFINITION HUMAN, INTESTINAL FATTY ACID BINDING PROTEIN GENE, COMPLETE
CDS, AND AN ALU REPETITIVE ELEMENT.
VERSION M18079.1 GI:182351
1GTAATATCTT GGGCAAGCCC TAGAGCTTCT TTCCTGACCC TTAGTTAATA AGATGTTATC
|
61TGGTCACATT CAGTCACAAT AATAGACTCA TTTTAGTAAT AAACATCTTA AGACTAGTAA
|
121TTAAAACTCT TTACTTCACA CCAAGTTTCC TCCCCAAGCT TGGCCTGTTC CTGGCTGGCA
|
181GCCTGAAGTA GGGAAAGGAG AGATATGGTG ACCTTTTCTT TGTACCTTTC TAGCTACCCT
|
241CTATACCCTG ACCCCACATA CATAATTGAG CTGTGGCTTC TGACTCTACT GGGTTTGGGG
|
301ATGAGAGGCA GTGAGAGTAA AATGAAGGAG TGGTTTTAAT TAATGGCACA GCTAAAACTG
|
361GATTTTGTTC TCTCTGCACA TGGCAGATGT TTAAAGCTCA TTCTTTCTTT TATGCAAGTT
|
421TTTACACCAT CCAGCCTCAT TTGTACCTCT TGAATTTTTG CTCAGTGGCC TATCACCATT
|
481CAGGATCAAG ACAAAAATCA ATGAGCACTT ATTGTGTGTC ATGCACCCTA CAAAGTGCCA
|
541GGATATTTAT CCAAACTCCT GGCAATGCTA AACACAATGC AAAAAGACAT ATTAGAAAAC
|
601GAATCTTATT AACTTTAGCT TTTCAACTGT ATTTCATCAT AAAGTCTTAC TTTACAAGAT
|
661AATTGCTGTT GTGAAAAAGG GAAAGGTCAT GGTCTCATTT CCCAGATGTT ATTTGATATA
|
721TGCTATAAAT TATATTACCT CCAACATAGT CTGCACTTTG AACTTAGAAA AACAATCTTC
|
781AGACGGCATG CATTCTAATT CTTGAAATAA GTATGCCCAC AAACTGTAGT TTAAGACAGA
|
841ATAGGTATGC TTCTCATGTT TTAATTCAGT TGAATTTCAG AAGATCTCAG GAATGTACAG
|
901AACGAGAATT AAGAATTAAT AAGAATAAGA ATTAATTAAT TGCTTGACAT AGAGTAGTTA
|
961GGTGATTTCC TGAACTTTAA GCTTCCACAT CACACTATGA AGTTGGTTCA AGATAAGAAA
|
1021TATAATAAAT TCTCGCCCAA GGACAGACCT GAATCTCTAG CTGCCTAGAG GCTGACTCAA
|
1081CTGAAATCAT GGCGTTTGAC AGCACTTCCA AGGTAGACCG GAGTGAAAAC TATGACAAGT
|
1141TCATGGAAAA AATGGGTAAA GACTTTATTT CTTTGTGCCT CATTCTTTGC TTTCTTACAA
|
1201ACATTTTTCT TTCTAACTCC TAAATCTCTA GGAGATTACA GATAGCTTAC AGATAGCTCC
|
1261TGATGTGGTA GAGACGGATC CAGAAGATGT TCAGAGGAGG GAAACCATAT TTTCCCTTCT
|
1321TACATTAGGA AGAATCCACT ATCTCACTAA TGCAAGAAAA GATTCTTTGA GTGCTGTTCT
|
1381CTGAAACACA CCAAAAAGAT CCAGAAATGT TTCCTTCACT CTTTAACTGA AAAATGACTT
|
1441TTTTTCTTGT TTACAGTAAG AAAATGGCAG CGTGTAATGA TAACTTCCAG ATCTGAAAAT
|
1501GTTAAATTCT ACGAGATGGA AAAACAAAGA CCATATAACA AAGTAATGGA AAAAGTTCTC
|
1561TTAAAATTTA TAGCTCTGAA TAAGTTAGAT TTAATTCTGA TTTCTTCTAA CTTAAAAAAG
|
1621TTTTGGAATA ATCTTGAGAA GCTGTGTAGT TTTCTCCAGG GCGTTTAATT TAACTGATTT
|
1681ATAATTTGAT ACCAATACTC TGGCAGCCCA TATACTATAC AAGATAGGCA AACAAATTTG
|
1741TGTCATTCCC CTAAAAGAAA AATCTGCATC AATTATAGCT TACAGTTTAG GAACTCTAAG
|
1801TTTAAATTTA TAAAAGTTGT AGATTCTTAT AGTGATTTTG GCTTAATATT TGCTAATTTT
|
1861CTCATTTTTG TGTCAGAAAG AAATGCCACA AGAAGCAAAT AGAACTATAA AGTTCAAAAT
|
1921GTTAAAGCCA CTAAGAAAAA CAAAGGGGCA TTTAAGAAAA AAGAATACTG TATATGTGGA
|
1981ATTAAAGATG TGCTTCCTTA TAAATATATG AATATACATT TTAATCCTTC ATTTAATATT
|
2041TCTAGAATTT GATTTACTTA ACACTGAAAT GAACAGTTTG TTAATCTTAT TAAGGTTGCT
|
2101CAGCTCTAAG ATTCTATAAT TCTGTACTCT ACTTAATTTT TCTCAAGTTA TGGAAAAACA
|
2161ACTTTAATCA GTTCTCTTGA TCGGATTGAA CCTGAACTTC TATAGAAGCA ATCTGAATGT
|
2221TCTTGTGCAA AGGCAATGCT ACCGAGTTTT CTTCCCACCC TCAAAATAAA CAAACAAAAC
|
2281ATAACTTGGA AAAATAAACA CTTCCTATGG GATTTGACTT TATTTTCTCC ATTGTCTTAC
|
2341CTTTTACAGG TGTTAATATA GTGAAAAGGA AGCTTGCAGC TCATGACAAT TTGAAGCTGA
|
2401CAATTACACA AGAAGGAAAT AAATTCACAG TCAAAGAATC AAGCGCTTTT CGAAACATTG
|
2461AAGTTGTTTT TGAACTTGGT GTCACCTTTA ATTACAACCT AGCAGACGGA ACTGAACTCA
|
2521GGGTAAGAAT TTTTTTTTTT ATGAGCAATG CATTCTTGAT TTTTCTACCC AATATTAAAA
|
2581TGATTTCTGC TCTATTTCAT TGGATGGTTT AATTAATGCA GGTCTCCTTC ACTAACTGAA
|
2641GAAGCCAATG AAGTTTGTCT ACATTATATA TTACACAAAT TGGCAGGGTA TTTAAATATG
|
2701CTTTTATTTT TATACGCATC TGTGAAGAAT CTGAATTGAA CAGTAAGAAT TAGAAAACTA
|
2761TCTTTTGAAT GACTGAATAT AGACCTATTC ATAAAGAAAT TTAAAACTGT GTTTTTAAAC
|
2821AGTACAGCAA AACAAGCCTT TAGAGTTAAT ATGTAACTTA ACTGTAACAT GTTGAAATAA
|
2881TAAAAGAAAT GAATAGATGA ACAAATGACT GAGTTACCAA ATGGAAAGAT TTGATGTATT
|
2941GTAGGTCATT GGCAGTGTAC CTTTTCATGT TTAAGATAAC ACATTTTAGG AAGTCATCAT
|
3001TTTCAACAAA TTTTTTAAAA ACTTTTTTTA GCCTCAACAT TTTTCTATTT AAATTACATG
|
3061TTTGTAATGA CAATTTAACT ACTGAATGTT TTATCGTAAG TTATCTCTTT CCTTAATTAG
|
3121TACCACAATC ACACAAATTA AAACAAGCAC AGGTTATTAA CATCTCCGTG AAACTAATTT
|
3181TAACCATGAC TATATTTCTG GACACGTAAC ATGAAAGATT CAGAAAGAAG TGCTGCTCAT
|
3241CTGCCTTAAA ATTCAGCGTA TGCAAATTAT TGAAGAGAAC AAGCATAATG GTTATCAACA
|
3301CATACTCTGT AGCCCAATGG CCTAGGTTCA ATCCTCACTC TGTGACTTTA GGTGAATCAC
|
3361TGTGCCATTT TACAGTCTCC TCTTCTGCAA ACTAGAGATA GTAGTATCAG TTTCATAGGG
|
3421TCACCATGAA GATTAAATGA AAAAGTGTGT CTACAGAACT CAGAACAGTG CCTGACATGT
|
3481GTAAGACCCT AATAAATGCC ATTATTATTA TTATTATTAT TATTATTATT ATTATTATTA
|
3541TGTAGGGGAC CTGGAGCCTT GAGGGAAATA AACTTATTGG AAAATTCAAA GGGACAGACA
|
3601ATGGAAACGA ACTGAATACT GTCCGAGAAA TTATAGGTGA TGAACTAGTC CAGGTGAGTT
|
3661GTCAAATTTA TAGCTATTTT CAAAAGGCAA AAATTACTAC AAAACAATAA TTTTTGTCAC
|
3721TGCTGAGCCA GATCTTCAGT AAACTGACTA CTTCTTTTCT CATAAATCTT ACTGATTTTA
|
3781AAAATATTGT ATAGCTATTT TCTGATGCCT ATTTACTAAA GACAACTTAT ATATGTCAAA
|
3841TAATCAATGC CTATTTTAAC TGAAAATATA AATGACTACA AACCAACATG TGTTTTAAAA
|
3901TGGCTGTATC CCATATCTGT ATAAATCTTG CTATCAAGTA CAAGAAAAAA TTGTATAAAC
|
3961TCATACTCAT ATAATATATA TGAATATATA ATATAAAAAT AGTATAAACT CATATACTAT
|
4021AAAACTATAA TACTACTTTT TCTTAACTTA GATGTAAACC TTAAAGATAA ATTCTTCTGT
|
4081TTGTTAACAC CTTTCAGACT TATGTGTATG AAGGAGTAGA AGCCAAAAGG ATCTTTAAAA
|
4141AGGATTGAGC ATTATTCTTG GCGCACAGTC CAAAATACAA ATTGGACAGA AGATCTATAT
|
4201TGTACCAGAA CTGTTTATTT CACCCCATCA AGTATAAGGT TACTGATTGA TTGGTCCTTT
|
4261TATAAACATT GGTATATTTC CATTCATGCC AAAGCAAAAG AAGTAAAAGC TAATTAGGAT
|
4321TTAATTTGTT TTATATTCTC TAAGATATAT ATTTACTAAA AGAATTTGTG ACATTTTAAA
|
4381AAACAAAAAT AAATATTGCA TCCATGTTGC TTTATATGTA GCCTTGCCTT TTAAAAGAAA
|
4441AAGTATGTGA ATATGAATTG ACAGATTGTT TTCGTAGAGA GAGGGTCTTA CTCTTTCACT
|
4501CAGGCTGGAA TGCAGTGGAG AGATCATAGC TCACTGTAAC CTCAAACTCC TGGACTCATG
|
4561CAATCTTCCT GCCTCAGGCT TCTGAGTAGC TAGGACTATG GGTACATTCC ACAGTGCCCA
|
4621GCTAATTTTT GTTTTGTTTT CTTTTTATTT TTTTTAGAGA TGGGGTCTTG CTATATTGCC
|
4681CAGGCTGGTC TTGAACCCCT GGCCTCAAGC AATCCTCCTG CCTCAGCCTC TCAAGTTGTT
|
4741TTTTTCTTTA CATTTGATAA ACTAAAAGCA TAGGCTGCAT ATGAGTCTTT AACATCTTGA
|
4801ACTGGTTGTG AATAATTTTC TGGCACTGGT TGTAAGTAAT ATCTATTATT ATAAAAATAA
|
4861TATATGCTCA ACCAGAAAAC TTAGAAATAA GAAACACAAA TGTAAAATAA GTATTTCCAT
|
4921AACTCATAAT CCAGAGATAA TTGCCATTCT GATTTTGATA GATATCCTCT CAGCTCTCTT
|
4981CCCTGGGGGC AGATATTTCC CAATACATAC CACTTTGAAT AGGATGATAG GAAATAAATG
|
5041ATGTACTACA TTAAATTAAA TTATTGTATT ACATTTTTGT ACACATCAGT CATTCCCAGG
|
5101CTTGGCTGAA AATCAGGATC ATCTGAGAAA CTTAAACAAT TTCTGCATTC TTAATCTCCA
|
5161CTGTTATTCT ATTATATCAG AATCGCTAAT AGAACCAAGA ATTC
|
GENBANK ID: X16277
DNA LINEAR
DEFINITION HUMAN GENE FOR ORNITHINE DECARBOXYLASE ODC (EC 4.1.1.17).
VERSION X16277.1 GI:35137
MRNA JOIN(795..1001,3858..3967,4073..4191,4475..4648,
4855..5027,5286..5420,5551..5632,5809..5892,6948..7110,
7193..7305,7399..7613,8254..8740)
1GGATCCGGGT CCCCTCACGC TCCTGGCTGA GTCCCTGGCT TCACAGGGGA AACTACCTCC
|
61GCAGGCCAGG ACCCATCTAG TTACACGATA CCTCGATGTT ACAAAGACGA GGCTTCCAGC
|
121GCGGGGGCGT GGAGGCGGCT GCCAGCCCTG CCCGCAGCGT GCTGGCGACC CCCGGGACGC
|
181CCCTTCCCTC CCGCGCCTCT GCTCCCTAGC TGGTGGGAGC AGAGCGCACC GGGATCACTT
|
241CCAGGTCCCT TGCACCGGAG GAATGGGCGG CAGCAGGGTC CGGAGTCGGC CCGGCGGGGC
|
301CCACGTGGCC AGCACATCGG TCCTCCGCTC GCGATTTCCC TTTTCCGCTC TCGGGCACGA
|
361GGTACTGAAC GCCAGGTGGA AGCACAGCTG TGCAGGTACA GGCTCTGCCG TTCAGCTGCC
|
421GCGGGCCGGG GCCGGGGCCT GCGGCGTCGT GCGCGTGCGC GGACCAGTTC CAGGCGGGCG
|
481AGACCGCCGC AGGGCGGGGC GGGGCGAGGC GGCCGCAGGG CGGGGAGGGC GGGGAGAGGC
|
541GGCCGCAGGG CGGGGAGGGC GGGGCGCGAA GCCGGGGGCG GGGGCCACGC GTGGGGCAGG
|
601CGGTGCTCGG CTCGGCTGAC GTCGGCCCGC CGGCGCCCCA CCAGCTCCGC GCGGGCCCGG
|
661GTTGGCCACC GCCGGGCCCC CGCCCCTCCC CCGGCCGTGT CCCGGCCGGA ACCGATCGTG
|
721GCTGGTTTGA GCTGGTGCGT CTCCATGGCG ACCCGCCGGT GCTATAAGTA GGGACCGGGG
|
781TGCCGTGGGG CTTTGTCAGT CCCTCCTGTA GCCGCCGCCG CCGCCGCCCG CCGCCCCTCT
|
841GGCACCAGGT CGGGCGCCAC CTCGGGCCGG CGTCTCCGGC GGGCGGGAGC CAGGCGCTGA
|
901CGGGCGCGGC GGGGGCGGCC GAGCGCTCCT GCGGCTGCGA CTCAGGCTCC GGCGTCTGCG
|
961CTTCCCCATG GGGCTGGCCT GCGGCGCCTG GGCGCTCTGA GGTGAGGGAC TCCCCGGCCG
|
1021CGGAGGAAGG GAGGGAGCGA GGGCGGGAGC CGGGGCGGGC TGCGGGCCCC GGGCCCCGGG
|
1081CACGTGTGCG GCGCGCCTCG CCGGCCTGCA GAGACACGTG GTCGCCGAGC GGGCCACGAC
|
1141CTTGAGGCGC CGCTTCCTCC CGGCCCGGGG TTCTCCCGCG GCTGGATAAG GGTGATCCGG
|
1201GCGCCTCGTT CTGCCCCCGT CTTCACAGCT CGGGGCTGGA GGGGCCTAGG GGAGACCCAC
|
1261CCGGAGACCC TGCGGCCCCG CGCCGGCCTC TTTCCCAACC CTTCGGCGGC CGCGCGCTGG
|
1321CCGGGGAGCC GTTGGGGAGG CCCTGGCGGC CGCGCAGCAG GTGCAGGGGC GCAGAGCCTG
|
1381GGCTCGCCTT GGTACAGACG AGCGGCCCCG GCCTTGGCGC CTTCAGTTTC CTTCCAGTTT
|
1441TTATTTTCGC TGTGTCTACA GAGCAGATGA CACCAATTTG GAAACCCGCG AGAGTGGGTA
|
1501GAGCTAAGAT AGTCTTGCTG TAGTAGCTGT GATATTAGAT GCTCGGCCAT GACTTAGAGG
|
1561TGTTTATTTA AGGACTGTGA ATGACTCGGT GATTTCGGAA AAGCTTGGCT TAGATGAACG
|
1621GACATACACA GGGGAGACAG CCCTAAGGTT TGCAGAAAAG GCTGATTGTG CTGTTTGCGA
|
1681AGTCGAAATA ATTGGTGAAA GTGTAGAAGG CAGAACCTCT CAGGAATGTC TGOGGAGGAC
|
1741AAAGAATGTG TTGGCTGACT TTGTTTAAAC ATAAAATTGG GCAGACTTTA ATTGATTTGT
|
1801GAAATTTTTT TCAAAGTTTG TTTGAATTAG CCCCTATCTC TTCTAACATT ATCCTCTTGT
|
1861GCTAATTGAT TGACCATTTT AAATAACTTA GGTGTTACAG AAAGACCGAA AGGTGTTCTT
|
1921CAGTAAAATA TATTCAAGTA AGTTACTTAA GTAACGCCTT AAAAGATACA GAAAAGCAAA
|
1981AAAGTATTGG CGTATTAAAA AGAAATCAAA ACTTTCCAAG TTTAGGCCTG AACATTGCCT
|
2041TAAAAATATT TAATAAGGCC TCAAATGACC CAGTCCGAGA CTGCATGAGC CTATTTATTA
|
2101TTAAATTGTA AATATTCTTC ATATAAACAA AAATATATAA CCATGTCTGT AACAAAAATG
|
2161GTTTTGCTAG CGTTGTTACT CTCTTCCCTT CTCCGAGGGG TGATTTAGGC AACTTCGGAG
|
2221GTTGACAATG CCAAGCAGTC ACAATAGATA GAGCTTTAAA GCAAATTCTA TGCATGGGTT
|
2281TGGATTTATG ACAGGCCCGT CACCCTGGGC CTGTCATAGT ACCCCATGCC AGAGCAAACT
|
2341GTGTCCCCGA ACCATTGCCT GGCCTCTGTG CCCGTAGGCT GCTGGCACTG AAGTGGGTTG
|
2401CACAGTGGAA AAGAAGAAAG CTCTACCTGG CAGAAATTTT TAAAGGTTAA AATAAATAAT
|
2461TTTAAGAAAG CTGGTTCACA AGGTGCCACA TTTGATGAAA GCAAAATACA GTGGCTTTTA
|
2521TTGTTACTAG AGTGATGTTC TTGCTTGTTT TTCTTTTTTG GTGAAGTTAG CCCCAAATTA
|
2581TTCTCATAGC TAAGCAAATA CGAGAGTGAC TGTAAGGACA GTTGGCATTC CCGGAATTGC
|
2641TAAACTTGGT AGGCAACGCT GGTTTAAGAA TACTGAGTTC TAGCCGGGCG TGGTGGCTCA
|
2701CGCCTGTAAT CCCAACACTT TGGGAGGCTG AGGCAGGCGG ATCACCTGAG GTCGGGAGTT
|
2761GGAGACCAGC CTGACTAACA TGGAGAAACG CCATCTCCAC TAAAAATATA AAATTAGCCA
|
2821GGCCCCGGGT GTGGTGGCAC ATGCCGGTAA TCCCAGCTAC TCGGGAGACT GAGGCAGGAG
|
2881AATCGCTTGA ACCCAGGAGG CGGAGGTTGA GGTGAGCCGA GATCATGCCA TTGCACTCCA
|
2941GCCTGGGCAA CAAGAGTAAA ACTCTGTCTC AAAAAAAAAA AAAAAAAAAT ACTGAATTCT
|
3001GATCAGGTAA CAGCAACTGT AATACAATGT GATAAGTTGA CTTGAAGATT ACAGTTTTTA
|
3061AGAAGTATAT ACCCAGCTAA TACATGAAAA TTAACTCCTA AAATCTCAAA TGCTCCAGAC
|
3121ATTTCCATGA TGCCTGTTGG TCAGTAAAAA TCATTCTAAG ACTTAGTGGA AGTAGGAAAT
|
3181GTTTGTATGG CTGTGTATAA AGGCTATAAT GTAATCCCAG CACTTTGGAA GACCGAGGCG
|
3241GGACGATCAC CTGGGGTCAG GAGTTTGACA CCCACCTGGA CAACGTGGTG AAATCCTGTC
|
3301TCTACTAAAA ACACAAAAAT TAGCCGGGCA TGGTGCCAGG CGCCTGTAAT CCCAGCTGCT
|
3361GGGGAGGCTG AGGCAGGAGA ATCGCTTGAA CCCGGGAGGC AGAGGTTGCA CTGAGCCAAG
|
3421ATTGCACCGC TCCACTCCAG CCTGGGTGAC AACCTGAGAC TCTGTCTCAA AAAAAATAAA
|
3481AAAGTCTATA ATGCTATTTT AAGTTTCTAA GGAACTGAAA CTGCTCTGAA ATAAATCAGA
|
3541CCATTATAAG ACTTTTTTCC ATATCAGTGA GCTAAGTGCA GATAAGCTTC TGAAACTTCC
|
3601ATGCTAGATT TTTTTGGTAC AAATATTTGA AATGCTTAGT GTCCTGCCTT GGAAAAACCT
|
3661GGTATTTTTT GTTGTCTCCT TATACTGCCA AGGTTTATGC AATCATGTAC CTTATGCCAA
|
3721GTAATAATTA GGATGACCAG GCCAGTGAGT GGTTCATATC CCGGGCATGA TTAGCTCTGC
|
3781GTGTGCTCAG CCAGTGCCCC ATCTTCAACT CGATGTGTTC CTAACGTAGA CACCAAATTC
|
3841CCTATTTTAT TTCTCAGATT GTCACTGCTG TTCCAAGGCC ACACGCAGAG GGATTTGCAA
|
3901TTCCTGGAGA GTTGCCTTTG TGAGAAGCTG CAAATATTTC TTTCAAITCC ATCTCTTAGT
|
3961TTTCCATGTA AGTATTCAGT TTACATTTAT GTTGCAGGTT AATCTTAAGA ATTGTATTGC
|
4021TAAGGCTTCT AAGTGAATTT CTCCACTCTA TTTGCATTTT GTTGCATTTC AGAGGAACAT
|
4081CAAGAAATCA TGAACAACTT TGGTAATGAA GAGTTTGACT GCCACTTCCT CGATCAAGGT
|
4141TTTACTGCCA AGCACATTCT GGACCAGAAA ATTAATGAAG TTTCTTCTTC TGTAAGTATA
|
4201TGAGGCCCAT CCTGGCAGTG CAGCTGAGAG TCCCAGGCAA GTGGAAAACT TTGGCAAGGT
|
4261CTAAGGAAGA GCAATGAGGC TTACATGTCT TGTTATGGAA TGTAGAAATT AATTCACTGG
|
4321TGGTAAATTA ATAGTGATAA TGCTGATACT CATATCAGTC GCTAGACTCA AAAGAGCAGG
|
4381ATTCATTGTG ACTGATGGGA ATGAAGGTCG CTGGCTATTG GTGTGGTGTG TGGTGAGGCT
|
4441GCTAGTGAGT CACCTGTGAC CACTCTTGTT TCAGGATGAT AAGGATGCCT TCTATGTGGC
|
4501AGACCTGGGA GACATTCTAA AGAAACATCT GAGGTCGTTA AAAGCTCTCC CTCGTGTCAC
|
4561CCCCTTTTAT GCACTCAAAT GTAATGATAG CAAAGCCATC CTGAAGACCC TTGCTGCTAC
|
4621CGGGACAGGA TTTGACTGTG CTAGCAAGGT AAGCGATAGC AGCAGGCCTC AAAAGCGTTG
|
4681TATAAAATGC GCCTGGTATT CCCCACGAGG CACATACAAG TTGTGTTTTT TGGGCAATAA
|
4741ATGCTCACTA AAGGCAAATG GGCCGGGGGG GTACATGACA ACTTCCCATG CTTTTCTGTT
|
4801TATTCCACGT GTTAAGCCAC ATATGGATAG CATGACACCA CTCTTCTTTT TCAGACTGAA
|
4861ATACAGTTGG TGCAGAGTCT GGCGGTGCCT CCAGAGAGGA TTATCTATGC AAATCCTTGT
|
4921AAACAAGTAT CTCAAATTAA GTATCCTGCT AATAATGGAG TCCAGATGAT GACTTTTCAT
|
4981AGTCAAGTTG AGTTGATGAA AGTTGCCAGA GCACATCCCA AAGCAAAGTG AGTTATTCCC
|
5041CCATCTGAGG GCAAGATCGG GAGCATAAGA TATCTGGATT CTTATCAAAC AAACTTAAAT
|
5101TTCTGATTAT TATATTTCTA TACTTTAGTA GAAAGTAGTT GAAACCCCCA TTGAGTCATG
|
5161AAGCCTGGGA CTCAAACTAC AGAATATATC AGCGACAGTA TTTAGAACAG GATTGTTTTT
|
5221ATTTTAATTG TGGCTATAAG TGAACATCTA TCATGAGACA TTTGCTGCAC TTTCCTTGCT
|
5281TGTAGGTTGG TTTTGCGGAT TGCCACTGAT GATTCCAAAG CAGTCTGTCG TCTCAGTGTG
|
5341AAATTCGGTG CCACCCTCAG AACCAGCAGG CTCCTTTTGG AACGGGCGAA AGAGCTAAAT
|
5401ATCGATGTTG TTGGTGTCAG GTGAGATTTT GGTGGGATAG CTAGAGGTCA AGACATTGAA
|
5461CAGTTTGAGT TTTACAGGCT TTCTCCTAGT GTTTGCTATT A
TTTAAGAA ATACTAAGAC
|
5521ACAGTGTCTC GTCTCTTTAT TTTACCCCAC CTTCCATCTA GGAACCGGCT GTACCGATCC
|
5581TGAGACCTTC CTGCAGGCAA TCTCTGATGC CCGCTGTGTT TTTGACATGC GGGTGAGTAT
|
5641ACGTGACCCT GTTAGGCAAG GGCGGGACAC AACTGACAAT AACTAGTCTT AATTCTAGAG
|
5701TTAACTTTTT A2GGCAGTTG GTTCTCTATT ACATGGGTTT CAGCCTATCT GCTGCATACA
|
5761TTTTTGTTAT TACCTGTGGA TCTGGCTGAC TTATTTTCTT CATTCTAGGC TCAGGTTGGT
|
5821TTCAGCATGT ATCTCCTTGA TATTGGCGGT GGCTTTCCTG CATCTGAGGA TGTGAAACTT
|
5881AAATTTCAAG AGGTAATTTA GAACAAAACT GTAATACTCA GTAGCCGTTC TAATAAATTC
|
5941CTTTTTGGAA TATTTCAAAA TTTAAGTGTC TTAACTAATA CCACAATGGG CTGAAGTGTC
|
6001TTGGTGTGAT ATTTTGAGTG ATTTCTTTGT GCTGTCTGAC ATTACACTTG ATACCATTTG
|
6061GTTTTCTAAA GTGTGAATCA GCTTTCCCAG AAGTCTTGGA TAAATGGTTA CATTGGAAAT
|
6121CATGGCTCAC ACCTGTAATC CACCACTTGG GCAGGCCAAG GTGCTAGGAT CACTTGAGCC
|
6181CAGGAGTTTG AGACCAGCCT GGGCAACACA GTGAGACCCG ATCTCTACAA AAAAAATTTT
|
6241AAAATTAGCC TGGTGTGGTG GCCGGCACCT GTAATCCCAG CTACTTGGAA GGCTGAGGTG
|
6301CGAGGATCAC TTGAGCCCAG GAGGTTGAGG CTGCAGTGAG CCATGATCAT GCCACTGCAC
|
6361TCAGCCTGGG CTACAGAGTG AGACCCTGTC TCAAAAAAAA AAAAGAAAAA GCATGTTGCT
|
6421GTGGGCTTCC TAGAGAATAT GCTGACTGTA GCACATCATC ACCCCAAATG TGCTTTCCTA
|
6481GACCTATGCT TCCTCTCCTT AAAATACTTG AAATCTTTAG TCACTTACCA AGTTAACCCA
|
6541TTATATTGGT GCTTGAATTT ATAAAATACA TCCACATGGT TTGTTAAAAT CATGACGTAG
|
6601GCAGAATAGG ATTTTTATCC TGTTGGCATC TATTTGTTAA AATGTTTTCA CATCTTGATC
|
6661CCTTCCTAGG TAGTAGTTAG TTGCGTACTG TTCTTTGATA AAAATCATAC CCATAACATC
|
6721CTAAAGGACA TAGGGTGCCT GGAGGGGAAT GAAAACGAGC CACGTGGGAT ATGTAGCCTG
|
6781GTTTTCAGGG AGATGTTGAT GTTTTTTTGC TTTTGTTACT TTAATGATAA ACCTGTCTGT
|
6841TGATGCCTGG TCTCATGATG TCATGTCACA AGGCCCTGTG ATGTTACTCC CCCATGTGAA
|
6901TTTCCCACAA TGAAGGCTGC TCTTTCTTTT CTGTTTCACT CTCTTAGATC ACCGGCGTAA
|
6961TCAACCCAGC GTTGGACAAA TACTTTCCGT CAGACTCTGG AGTGAGAATC ATAGCTGAGC
|
7021CCGGCAGATA CTATGTTGCA TCAGCTTTCA CGCTTGCAGT TAATATCATT GCCAAGAAAA
|
7081TTGTATTAAA GGAACAGACG GCCTCTGATG GTATGTATAA AGGACGAATC ACTTCATGTA
|
7141TAACTGAAAG CTGATGCAAA AAGTCATTAA GATTGTTGAT CTGCCTTTCT AGACGAACAT
|
7201GACTCGAGTG AGCAGACCTT TATGTATTAT GTGAATGATG GCGTCTATGG ATCATTTAAT
|
7261TGCATACTCT ATGACCACGC ACATGTAAAG CCCCTTCTGC AAAAGGTAAT TTCTGAGCAT
|
7321ACTGTATAAA ACAATTAAGA GGACTGGTCA CAACACCTGT AATTAACTAC TACTTCCTCT
|
7381CTCCGTCTCT TTATATAGAG ACCTAAACCA GATGAGAAGT ATTATTCATC CAGCATATGG
|
7441GGACCAACAT GTGATGCCCT CGATCGGATT GTTGAGCGCT CTGACCTGCC TCAAATGCAT
|
7501GTGGGTGATT GGATGCTCTE TGAAAACATG GGCGCTTACA CTGTTGCTGC TGCCTCTACG
|
7561TTCAATGGCT TGCAGAGGGC GACCATGTAC TATGTGATGT CAGGGCCTGC GTGGTAAGTA
|
7621AGCCATGCAT GTTGATGGTG CTGCCAAGAA TAGGCACCTT CTTGGATGTC TGCTTCTTGT
|
7681CTAGACGAAT AAGAAATTGT CTTGCCTAAG ATTAAATATA TATGGATATT TTTCCTAAGA
|
7741AAAGTTTTAG AAAAGACTGA TGAGTGTATT TCTATGTAAT TGCAATATAT TTAAGTTCAT
|
7801GCCATGTGTC TTGTGGTTTC CTTATTACCA AAACGGTGAC TGAAGAAACG CTTGCTTTAG
|
7861AAATACATTG AATTGGCCAG GTGTGCTGGC TCACACCTGA AATCACAACA CATTGGGAGG
|
7921CCAAGGCAGA AGGATCACTT GAGCCCAGGA GTTCGAGCCT GGGCAACATA GTGAGACCCT
|
7981GTCTCTACAA AAAATTAAAA AATTAGTTGG CCATGGTAGT GGGCGCCTGT AGTCCCAGCT
|
8041GCTTGGCTAA GGTGAGAGGT TTGCTTGAGC CTGGGAGGTT GAGGCTGCGG TGAGCTATGA
|
8101TAGCACCATT GTATTCCAGC CTGAGTAACA GAGAAAGACC CTGTCTCAGA AAAAAAAAAA
|
8161ATACATTGAA TTGTTTCCTG ATGGGAAGTA AATACTCTCA TGCCCAGTTA GGAGTGAGTC
|
8221AGGGTTTTTA ATATGCCACT TTTTCTTTCT CAGGCAACTC ATGCAGCAAT TCCAGAACCC
|
8281CGACTTCCCA CCCGAAGTAG AGGAACAGGA TGCCAGCACC CTGCCTGTGT CTTGTGCCTG
|
8341GGAGAGTGGG ATGAAACGCC ACAGAGCAGC CTGTGCTTCG GCTAGTATTA ATGTGTAGAT
|
8401AGCACTCTGG TAGCTGTTAA CTGCAAGTTT AGCTTGAATT AAGGGATTTG GGGGGACCAT
|
8461GTAACTTAAT TACTGCTAGT TTTGAAATGT CTTTGTAAGA GTAGGGTCGC CATGATGCAG
|
8521CCATATGGAA GACTAGGATA TGGGTCACAC TTATCTGTGT TCCTATGGAA ACTATTTGAA
|
8581TATTTGTTTT ATATGGATTT TTATTCACTC TTCAGACACG CTACTCAAGA GTGCCCCTCA
|
8641GCTGCTGAAC AAGCATTTGT AGCTTGTACA ATGGCAGAAT GGGCCAAAAG CTTAGTGTTG
|
8701TGACCTGTTT TTAAAATAAA GTATCTTGAA ATAATTAGGC ATTGGGACGT TTTTATGGTG
|
8761TGTTCATTCC AGACAGTTCA CGAATCCCGT ATAGCTCGCT CTGATTCTCA GAGAACAATG
|
8821AGTGGGTCCA CCCACACACA GGTAGGAGGA CAGGTGAGAC GGAAGCCCCA TCCTCCCATG
|
8881TGGACGGTGC ACATCTGCTC AGCCCACCCC ACATGTCCAG AGTTGGCTGC AAACTCCTTG
|
8941TCCAGAGCCT CTGGTGGTGG GACCTACTTA AGTCTGACGG ACCTGTCCTG TCCAGGCCAG
|
9001TGCCCAGGGA AGGTGTGGGA GGCCCTTTGA GCCTGGCCTG CAG
|
GENBANK ID: X57522
DEFINITION H. SAPIENS RING4 CDNA.
VERSION X57522.1 GI:36060
CDS 31..2457
/CODON_START=1
1GCGGCCGCTT TCGATTTCGC TTTCCCCTAA ATGGCTGAGC TTCTCGCCAG CGCAGGATCA
|
61GCCTGTTCCT GGGACTTTCC GAGAGCCCCG CCCTCGTTCC CTCCCCCAGC CGCCAGTAGG
|
121GGAGGACTCG GCGGTACCCG GAGCTTCAGG CCCCACCGGG GCGCGGAGAG TCCCAGACCC
|
181GGCCGGGACC GGGACGGCGT CCGAGTGCCA ATGGCTAGCT CTAGGTGTCC CGCTCCCCGC
|
241GGGTGCCGCT GCCTCCCCGG AGCTTCTCTC GCATGGCTGG GGACAGTACT GCTACTTCTC
|
301GCCGACTGGG TGCTGCTCCG GACCGCGCTG CCCCGCATAT TCTCCCTGCT GGTGCCCACC
|
361GCGCTGCCAC TGCTCCGGGT CTGGGCGGTG GGCCTGAGCC GCTGGGCCGT GCTCTGGCTG
|
421GGGGCCTGCG GGGTCCTCAG GGCAACGGTT GGCTCCAAGA GCGAAAACGC AGGTGCCCAG
|
481GGCTGGCTGG CTGCTTTGAA GCCATTAGCT GCGGCACTGG GCTTGGCCCT GCCGGGACTT
|
541GCCTTGTTCC GAGAGCTGAT CTCATGGGGA GCCCCCGGGT CCGCGGATAG CACCAGGCTA
|
601CTGCACTGGG GAAGTCACCC TACCGCCTTC GTTGTCAGTT ATGCAGCGGC ACTGCCCGCA
|
661GCAGCCCTGT GGCACAAACT CGGGAGCCTC TGGGTGCCCG GCGGTCAGGG CGGCTCTGGA
|
721AACCCTGTGC GTCGGCTTCT AGGCTGCCTG GGCTCGGAGA CGCGCCGCCT CTCGCTGTTC
|
781CTGGTCCTGG TGGTCCTCTC CTCTCTTGGG GAGATGGCCA TTCCATTCTT TACGGGCCGC
|
841CTCACTGACT GGATTCTACA AGATGGCTCA GCCGATACCT TCACTCGAAA CTTAACTCTC
|
901ATGTCCATTC TCACCATAGC CAGTGCAGTG CTGGAGTTCG TGGGTGACGG GATCTATAAC
|
961AACACCATGG GCCACGTGCA CAGCCACTTG CAGGGAGAGG TGTTTGGGGC TGTCCTGCGC
|
1021CAGGAGACGG AGTTTTTCCA ACAGAACCAG ACAGGTAACA TCATGTCTCG GGTAACAGAG
|
1081GACACGTCCA CCCTGAGTGA TTCTCTGAGT GAGAATCTGA GCTTATTTCT GTGGTACCTG
|
1141GTGCGAGGCC TATGTCTCTT GGGGATCATG CTCTGGGGAT CAGTGTCCCT CACCATGGTC
|
1201ACCCTGATCA CCCTGCCTCT GCTTTTCCTT CTGCCCAAGA AGGTGGGAAA ATGGTACCAG
|
1261TTGCTGGAAG TGCAGGTGCG GGAATCTCTG GCAAAGTCCA GCCAGGTGGC CATTGAGGCT
|
1321CTGTCGGCCA TGCCTACAGT TCGAAGCTTT GCCAACGAGG AGGGCGAAGC CCAGAAGTTT
|
1381AGGGAAAAGC TGCAAGAAAT AAAGACACTC AACCAGAAGG AGGCTGTGGC CTATGCAGTC
|
1441AACTCCTGGA CCACTAGTAT TTCAGGTATG CTGCTGAAAG TGGGAATCCT CTACATTGGT
|
1501GGGCAGCTGG TGACCAGTGG GGCTGTAAGC ACTCCGAACC TTCTCACATT TCTTCTCTAC
|
1561CAGATCCAGT TCACCCAGGC TGTGGAGGTA CTGCTCTCCA TCTACCCCAG AGTACAGAAG
|
1621GCTGTGGGCT CCTCAGAGAA AATATTTGAG TACCTGGACC GCACCCCTCG CTGCCCACCC
|
1681AGTGGTCTGT TGACTCCCTT ACACTTGGAG GGCCTTGTCC AGTTCCAAGA TGTCTCCTTT
|
1741GCCTACCCAA ACCGCCCAGA TGTCTTAGTG CTACAGGGGC TCACATTCAC CCTACGCCCT
|
1801GGCGAGGTGA CGGCGCTGGT GCGACCCAAT GGGTCTGGGA AGAGCACAGT CGCTGCCCTG
|
1861CTGCACAATC TGTACCAGCC CACCGGGCGA CAGCTGCTGT TGGATGGGAA GCCCCTTCCC
|
1921CAATATGAGC ACCGCTACCT GCACAGGCAG GTGGCTGCAG TGGGACAAGA GCCACAGGTA
|
1981TTTGGAAGAA GTCTTCAAGA AAATATTGCC TATGGCCTGA CCCAGAAGCC AACTATGGAG
|
2041GAAATCACAG CTGCTGCAGT AAACTCTGGG GCCCATACTT TCATCTCTGG ACTCCCTCAG
|
2101GGCTATGACA CAGAGGTAGA CGAGGCTGGG AGCCAGCTGT CAGGGGCTCA GCGACAGGCA
|
2161GTGGCGTTGG CCCGAGCATT GATCCGGAAA CCCTGTGTAC TTATCCTGGA TGATGCCACC
|
2221AGTGCCCTGG ATGCAAACAG CCAGTTACAG GTGGAGCAGC TCCTGTACGA AAGCCCTGAG
|
2281CGGTACTCCC GCTCAGTGCT TCTCATCACC CAGCACCTCA GCCTGGTGGA GCAGGCTGAC
|
2341CACATCCTCT TTCTGGAAGG AGGCGCTATC CGGGAGCGGG GAACCCACCA GCAGCTCATG
|
2401GAGAAAAAGG GGTGCTACTG GGCCATGGTG CAGGCTCCTG CAGATGCTCC AGAATCAAAG
|
2461CCTTCTCAGA CCTGCGCACT CCATCTCCCT CCCTTTTCTT CTCTCTGTGG TGGAGAACCA
|
2521CAGCTGCAGA GTAGCAGCTC CCTCCAGGAT GAGTTACTTG AAATTTGCCT TGAGTGTGTT
|
2581ACCTCCTTTC CAAGCTCCTC GTGATAATGC AGACTTCCTG GAGTACAAAC ACAGGATTTG
|
2641TAATTCCTAC TGTAACGGAG TTTAGAGCCA GGGCTGATGC TTTGGTGTGG CCAGCACTCT
|
2701GAAACTGAGA AATGTTCAGA ATGTACGGAA AGATGATCAC CTATTTTCAA CATAACTGAA
|
2761GGCATATGCT GGCCCATAAA CACCCTGTAG GTTCTTGATA TTTATAATAA AATTGGTGTT
|
2821TTGT
|
GENBANK ID: D00017.1
DEFINITION HOMO SAPIENS MRNA FOR LIPOCORTIN II, COMPLETE CDS.
VERSION D00017.1 GI:219909
CDS 50..1069
/CODON_START=1
1CATTTGGGGA CGCTCTCAGC TCTCGGCGCA CGGCCCAGCT TCCTTCAAAA TGTCTACTGT
|
61TCACGAAATC CTGTGCAAGC TCAGCTTGGA GGGTGATCAC TCTACACCCC CAAGTGCATA
|
121TGCGTCTGTC AAAGCCTATA CTAACTTTGA TGCTGCGCGG GATGCTTTGA ACATTGAAAC
|
181AGCCATCAAC ACCAAACGTG TGGATGAGGT CACCATTGTC AACATTTTGA CCAACCGCAG
|
241CAATGCACAG AGACAGGATA TTGCCTTCGC CTACCAGAGA AGGACCAAAA AGGAACTTGC
|
301ATCAGCACTG AAGTCAGCCT TATCTGGCCA CCTGGAGACG GTGATTTTGG GCCTATTGAA
|
361GACACCTGCT CAGTATGACG CTTCTGAGCT AAAAGCTTCC ATGAAGGGGC TGGGAACCGA
|
421CGAGGACTCT CTCATTGAGA TCATCTGCTC CAGAACCAAC CAGGAGCTGC AGGAAATTAA
|
481CAGAGTCTAC AAGGAAATGT ACAAGACTGA TCTGGAGAAG GACATTATTT CGGACACATC
|
541TGGTGACTTC CGCAAGCTGA TGGTTGCCCT GGCAAAGGGT AGAAGAGCAG AGCATGGCTC
|
601TGTCATTGAT TATGAACTGA TTGACCAAGA TGCTCGGGAT CTCTATGACG CTGGAGTGAA
|
661GAGGAAAGGA ACTGATGTTC CCAAGTGGAT CAGCATCATG ACCGAGGGGA GCGTGCCCCA
|
721CCTCCAGAAA GTATTTGATA GGTACAAGAG TTACAGCCCT TATGACATGT TGGAAAGCAT
|
781CAGGAAAGAG GTTAAAGGAG ACCTGGAAAA TGCTTTCCTG AACCTGGTTC AGTGCATTCA
|
841GAACAAGCCC CTGTATTTTG CTGATCGGCT GTATGACTCC ATGAAGGGCA AGGGGACGCG
|
901AGATAAGGTC CTGATCAGAA TCATGGTCTC CCGCAGTGAA GTGGACATGT TGAAAATTAG
|
961GTCTGAATTC AAGAGAPAGT ACGGCAAGTC CCTGTACTAT TATATGCAGG AAGACACTAA
|
1021GGGCGACTAC CAGAAAGCGC TGCTGTACCT GTGTGGTGGA GATGACTGAA GCCCGACACG
|
1081GCCTGAGCGT CCAGAAATGG TGCTCACCAT GCTTCCAGCT AACAGGTCTA GAAAACCAGC
|
1141TTGCGAATAA CAGTCCCCGT GGCCATCCCT GTGAGGGTGA CGTTAGCATT ACCCCCAACC
|
1201TCATTTTAGT TGCCTAAGCA TTGCCTGGCC TTCCTGTCTA GTCTCTCCTG TAAGCCAAAG
|
1261AAATGAACAT TCCAAGGAGT TGGAAGTGAA GTCTATGATG TGAAACACTT TGCCTCCTGT
|
1321GTACTGTGTC ATAAACAGAT GAATAAACTG AATTTGTACT TT
|
GENBANK ID: M10277.1
DNA LINEAR
DEFINITION HUMAN CYTOPLASMIC BETA-ACTIN GENE, COMPLETE CDS.
VERSION M10277.1 GI:177967
1GCCCAGCACC CCAAGGCGGC CAACGCCAAA ACTCTCCCTC CTCCTCTTCC TCAATCTCGC
|
61TCTCGCTCTT TTTTTTTTTC GCAAAAGGAG GGGAGAGGGG GTAAAAAAAT GCTGCACTGT
|
121GCGGCGAAGC CGGTGAGTGA GCGGCGCGGG GCCAATCAGC GTGCGCCGTT CCGAAAGTTG
|
181CCTTTTATGG CTCGAGCGGC CGCGGCGGCG CCCTATAAAA CCCAGCGGCG CGACGCGCCA
|
241CCACCGCCGA GACCGCGTCC GCCCGCGAGC ACAGAGCCTC GCCTTTGCCG ATCCGCCGCC
|
301CGTCCACACC CGCCGCCAGG TAAGCCCGGC CAGCCGACCG GGGCATGCGG CCGCGGCCCT
|
361TCGCCCGTGC AGAGCCGCCG TCTGGGCCGC AGCGGGGGGC GCATGGGGCG GAACCGGACC
|
421GCCGTGGGGG GCGCGGGAGA AGCCCCTGGG CCTCCGGAGA TGGGGGACAC CCCACGCCAG
|
481TTCGCAGGCG CGAGCCCGCG CTCGGGCGGG CGCGCTCCGG GCGTGCCGCT CTCGGGGCGG
|
541GGGCAACCGG CGGCGTCTTT GTCTGAGCCG GCCTCTTGCC AATGGGGATC GCACCCTGGG
|
601CGCGGCGTAG CCCCCGTCAG GCCCGGTGGG GGCTCGGGCG CCATGCGCGT GCGCGCTGGT
|
661CCTTTGGGCG CTAACTGCCT GCGCGCTGGG AATTGCCGCT AATTGCCCGT GCGCGCTGCG
|
721ACTCAATGCC GCTAATCGCG CGTCCGTTCT GGGGCCCGGG CCCTTGCGCC ACTTCCTGCC
|
781CGAGCCGCTG GCGCCCGAGG GTGTGGCCGC TGCGTGCGCG CCCGCGACCC GGTCGCTGTT
|
841TCAACCGGGC GGAGGCCGGG CTCCCGCCCC GTTCGGAGGG GGTTGGGGCC TGGCTTCCTG
|
901CCGCCCGCCG CGGGCACGCC TCCGACCAGT GTTTGCCTTT TATGGTAATA ACGCGGCCGG
|
961CCCCCCTTCC TTTGTCCCCA ATCTCGCCGC GCGCCGGCGC CCCCTGGCGG CCTAAGGACT
|
1021CGGCGCGCCG GAAGTGGCCA GGGCGGGGGC GACTTCGGCT CACAGCGCGC CCGGCTATTC
|
1081TCGCAGCTCA CCATGGATGA TGATATCGCC GCGCTCGTCG TCGACAACGG CTCCGGCATG
|
1141TGCAAGGCCG GCTTCCCGGG CCACGATGCC CCCCGGGCCG TCTTCCCCTC CATCGTGGGG
|
1201CGCCCCAGGC ACCAGGTAGG GGAGCTGGCT GGGTGGGGCA GCCCCGGGAG CCGGCGGGAG
|
1261GCAAGGGCGC TTTCTCTGCA CAGGAGGCTG CCGGTTTCCG GGGTGGGCTG CGCCCGTGCT
|
1321CAGGGCTTCT TGTCCTTTCC TTCCCAGGGC GTGATGGTGG GCATGGGTCA GAAGGATTCC
|
1381TATGTGGGCG ACGAGGCCCA GAGCAAGAGA GGCATCCTCA CCCTGAAGTA CCCCATCGAG
|
1441CACGCCATGG TCACCAACTG GGACGACATG GAGAAAATCT GGCACCACAC CTTCTACAAT
|
1501GAGCTGCGTG TGGCTCCCGA GGAGCACCCC GTGCTGCTGA CCGAGGCCCC CCTGAACCCC
|
1561AAGGCCAACC GCGAGAAGAT GACCCAGGTG AGTGGCCCGC TACCTCTTCT GGTGGCCGCC
|
1621TCCCTCCTTC CTGGCCTCCC GGAGCTGCGC CCTTTCTCAC TGGTTCTCTC TTCTGCCGTT
|
1681TTCCGTAGGA CTCTCTTCTC TGACCTGAGT CTCCTTTGGA ACTCTGCAGG TTCTATTTGC
|
1741TTTTTCCCAG ATGAGCTCTT TTTCTGGTGT TTGTCTCTCT GACTAGGTGT CTGAGACAGT
|
1801GTTGTGGGTG TAGGTACTAA CACTGGCTCG TGTGACAAGG CCATGAGGCT GGTGTAAAGC
|
1861GGCCTTGGAG TGTGTATTAA GTAGGCGCAC AGTAGGTCTG AACAGACTCC CCATCCCAAG
|
1921ACCCCAGCAC ACTTAGCCGT GTTCTTTGCA CTTTCTGCAT GTCCCCCGTC TGGCCTGGCT
|
1981GTCCCCAGTG GCTTCCCCAG TGTGACATGG TGCATCTCTG CCTTACAGAT CATGTTTGAG
|
2041ACCTTCAACA CCCCAGCCAT GTACGTTGCT ATCCAGGCTG TGCTATCCCT GTACGCCTCT
|
2101GGCCGTACCA CTGGCATCGT GATGGACTCC GGTGACGGGG TCACCCACAC TGTGCCCATC
|
2161TACGAGGGGT ATGCCCTCCC CCATGCCATC CTGCGTCTGG ACCTGGCTGG CCGGGACCTG
|
2221ACTGACTACC TCATGAAGAT CCTCACCGAG CGCGGCTACA GCTTCACCAC CACGGCCGAG
|
2281CGGGAAATCG TGCGTGACAT TAAGGAGAAG CTGTGCTACG TCGCCCTGGA CTTCGAGCAA
|
2341GAGATGGCCA CGGCTGCTTC CAGCTCCTCC CTGGAGAAGA GCTACGAGCT GCCTGACGGC
|
2401CAGGTCATCA CCATTGGCAA TGAGCGGTTC CGCTGCCCTG AGGCACTCTT CCAGCCTTCC
|
2461TTCCTGGGTG AGTGGAGACT GTCTCCCGGC TCTGCCTGAC ATGAGGGTTA CCCCTCGGGG
|
2521CTGTGCTGTG GAAGCTAAGT CCTGCCCTCA TTTCCCTCTC AGGCATGGAG TCCTGTGGCA
|
2581TCCACGAAAC TACCTTCAAC TCCATCATGA AGTGTGACGT GGACATCCGC AAAGACCTGT
|
2641ACGCCAACAC AGTGCTGTCT GGCGGCACCA CCATGTACCC TGGCATTGCC GACAGGATGC
|
2701AGAAGGAGAT CACTGCCCTG GCACCCAGCA CAATGAAGAT CAAGGTGGGT GTCTTTCCTG
|
2761CCTGAGCTGA CCTGGGCAGG TCAGCTGTGG GGTCCTGTGG TGTGTGGGGA GCTGTCACAT
|
2821CCAGGGTCCT CACTGCCTGT CCCCTTCCCT CCTCAGATCA TTGCTCCTCC TGAGCGCAAG
|
2881TACTCCGTGT GGATCGGCGG CTCCATCCTG GCCTCGCTGT CCACCTTCCA GCAGATGTGG
|
2941ATCAGCAAGC AGGAGTATGA CGAGTCCGGC CCCTCCATCG TCCACCGCAA ATGCTTCTAG
|
3001GCGGACTATG ACTTAGTTGC GTTACACCCT TTCTTGACAA AACCTAACTT GCGCAGAAAA
|
3061CAAGATGAGA TTGGCATGGC TTTATTTGTT TTTTTTGTTT TGTTTTGGTT TTTTTTTTTT
|
3121TTTTGGCTTG ACTCAGGATT TAAAAACTGG AACGGTGAAG GTGACAGCAG TCGGTTGGAG
|
3181CGAGCATCCC CCAAAGTTCA CAATGTGGCC GAGGACTTTG ATTGCATTGT TGTTTTTTTA
|
3241ATAGTCATTC CAAATATGAG ATGCATTGTT ACAGGAAGTC CCTTGCCATC CTAAAAGCCA
|
3301CCCCACTTCT CTCTAAGGAG AATGGCCCAG TCCTCTCCCA AGTCCACACA GGGGAGGTGA
|
3361TAGCATTGCT TTCGTGTAAA TTATGTAATG CAAAATTTTT TTAATCTTCG CCTTAATACT
|
3421TTTTTATTTT GTTTTATTTT GAATGATGAG CCTTCGTGCC CCCCCTTCCC CCTTTTTGTC
|
3481CCCCAACTTG AGATGTATGA AGGCTTTTGG TCTCCCTGGG AGTGGGTGGA GGCAGCCAGG
|
3541GCTTACCTGT ACACTGACTT GAGACCAGTT GAATAAAAGT GCACACCTTA AAAATGAGGC
|
3601CAAGTGTGAC TTTGTGGTGT GGCTGGGTTG GGGGCAGCAG AGGGTG
|
GENBANK ID: XM_042788.1
DEFINITION HOMO SAPIENS ALDOLASE B, FRUCTOSE-BISPHOSPHATE (ALDOB), MRNA.
VERSION XM_042788.1 GI:14738248
CDS 126..1220
/CODON_START=1
1AAAAACATGA TGAGAAGTCT ATAAAAATTG TGTGCTACCA AAGATCTGTC TTATTTGGCA
|
61GCTGCTGCCT CACCCACAGC TTTTGATATC TAGGAGGACT CTTCTCTCCC AAACTACCTG
|
121TCACCATGGC CCACCGATTT CCAGCCCTCA CCCAGGAGCA GAAGAAGGAG CTCTCAGAAA
|
181TTGCCCAGAG CATTGTTGCC AATGGAAAGG GGATCCTGGC TGCAGATGAA TCTGTAGGTA
|
241CCATGGGGAA CCGCCTGCAG AGGATCAAGG TGGAAAACAC TGAAGAGAAC CGCCGGCAGT
|
301TCCGAGAAAT CCTCTTCTCT GTGGACACTT CCATCAACCA GAGCATCGGG GGTGTCATCC
|
361TTTTCCACGA GACCCTCTAC CAGAAAGACA GCCAGGGAAA GCTGTTCACA AACATCCTCA
|
421AGGAAAAGGG GATCGTGGAG CGAATCAAGT TAGACCAAGG AGGTGCTCCT CTTGCAGGAA
|
481CAAACAAAGA AACCACCATT CAAGGGCTTG ATGGCCTCTC AGAGCGCTGT GCTCACTACA
|
541AGAAAGATGG TGTTGACTTT GGGAAGTGGC GTGCTGTGCT GAGGATTGCC GACCAGTGTC
|
601CATCCAGCCT CGCTATCCAG CAAAACGCCA ACGCCCTGGC TCGCTACGCC AGCATCTGTC
|
661AGCAGAATGG ACTGGTACCT ATTGTTGAAC CAGAGGTAAT TCCTGATGGA GACCATGACC
|
721TGGAACACTG CCAGTATGTT ACTGAGAAGG TCCTGGCTGC TGTCTACAAG GCCCTGAATG
|
781ACCATCATGT TTACCTGGAG GGCACCCTGC TAAAGCCCAA CATGGTGACT GCTGGACATG
|
841CCTGCACCAA GAAGTATACT CCAGAACAAG TAGGTATGGC CACCGTAACA GCTCTCCACC
|
901GTACTGTTCC TGCAGCTGTT CCTGGCATCT GCTTTTTGTC TGGTGGCATG AGTGAAGAGG
|
961ATGCCACTCT CAACCTCAAT GCTATCAACC TTTGCCCTCT ACCAAAGCCC TGGAAACTAA
|
1021GTTTCTCTTA TGGACGGGCC CTGCAGGCCA GTGCACTGGC TGCCTGGGGT GGCAAGGCTG
|
1081CAAACAAGGA GGCAACCCAG GAGGCTTTTA TGAAGCGGGC CATGGCTAAC TGCCAGGCGG
|
1141CCAAAGGACA GTATGTTCAC ACGGGTTCTT CTGGCGCTGC TTCCACCCAG TCCCTCTTCA
|
1201CAGGCTGCTA TACCTACTAC GGTCCAATGC CCGCCAGCCT ACCTCCAGTG CTTCTACTAG
|
1261GAGGGCTGAA AGGGAGCAAC TTTTCCTCCA ATCCTGGAAA TTCGACACAA TTAGATTTGA
|
1321ACTGCTGGAA ATACAACACA TGTTAAATCT TAAGTACAAG GCGGAAAAAA TAAATCAGTT
|
1381ATTGAAACAT AAAAATGAAT ACCAAGGACC TGATCAAATT TCACACAGCA GTTTCCTTGC
|
1441AACACTTTCA GCTCCCCATG CTCCAGAATA CCCACCCAAG AAAATAATAG GCTTTAAAAC
|
1501AATATCGGCT CCTCATCCAA AGAACAACTG CTGATTGAAA CACCTCATTA GCTGAGTGTA
|
1561GAGAAGTGCA TCTTATGAAA CAGTCTTAGC AGTGGTAGGT TGGGAAGGAG ATAGCTCCAA
|
1621CCAAAAAAGA AATAAATATT CTATAAACCT TC
|
GENBANK ID: NM_005317.2
DEFINITION HOMO SAPIENS GRANZYME N (LYMPHOCYTE MET-ASE 1) (GZMM), MRNA.
VERSION NM_005317.2 GI:7108347
CDS 46..819
/CODON_START=1
1GGCTCGGGGC CGGGGCCAGC ACCCACACTG GGTCTCCACA GCGGCATGGA GGCCTGCGTG
|
61TCTTCACTGC TGGTGCTGGC CCTGGGGGCC CTGTCAGTAG GCAGCTCCTT TGGGACCCAG
|
121ATCATCGGGG GCCGGGAGGT GATCCCCCAC TCGCGCCCGT ACATGGCCTC ACTGCAGAGA
|
181AATGGCTCCC ACCTGTGCGG GGGTGTCCTG GTGCACCCAA AGTGGGTGCT GACGGCTGCC
|
241CACTGCCTGG CCCAGCGGAT GGCCCAGCTG AGGCTGGTGC TGGGGCTCCA CACGCTGGAC
|
301AGCCCCGGTC TCACCTTCCA CATCAAGGCA GCCATCCAGC ACCGTGGCTA CAAGCCCGTC
|
361CCTGCCCTGG AGAACGACCT CGCGCTGCTT CAGCTGGACG GGAAAGTGAA GCCCAGCCGG
|
421ACCATCCGGC CGTTGGCCCT GCCCAGTAAG CGCCAGGTGG TGGCAGCAGG GACTCGGTGC
|
481AGGATGCCGG GCTGGGGGCT GACCGACCAG GGCGGGCGCC TGTCCCGGGT GCTGCGGGAG
|
541CTGGACCTCC AAGTGCTGGA CACCCGCATG TGTAACAACA GCCGCTTCTG GAACGGCAGC
|
601CTCTCCCCCA GCATGGTCTG CCTGGCGGGC GACTCCAAGG ACCAGGCTCC CTGCAAGGGT
|
661GACTCGGGCG GGCCCCTGGT GTGTGGCAAA GGCCGGGTGT TGGCCGGAGT CCTGTCCTTC
|
721AGCTCCAGGG TCTGCACTGA CATCTTCAAG CCTCCCGTGG CCACCGCTGT GGCGCCTTAC
|
781GTGTCCTGGA TCAGGAAGGT CACCGGCCGA TCGGCCTGAT GCCCTGGGGT GATGGGGACC
|
841CCCTCGCTGT CTCCACAGGA CCCTTCCCCT CCAGGGGTGC AGTGGGGTGG GTGAGGACGG
|
901GTGGGAGGGA CAGGGAGGGA CCAATAAATC ATAATGAAGA AACGCTC
|
GENBANK ID: XM_003595.2
DEFINITION HOMO SAPIENS GLOTAMYL AMINOPEPTIDASE (ANINOPEPTIDASE A)
(ENPEP) ,MRNA.
VERSION XM_003595.2 GI:13647140
CDS 1401..2957
/CODON_START=1
1TCCAATTTAA AAAGGAAGTC TGCTGACGTT AGTTAGTTAA ATTTAACATC TTTTTATGTG
|
61TAACACTTGA CTTTGGAAGC AAAAATGAAC TTTGCGGAGA GAGAGGGCTC TAAGAGATAC
|
121TGCATTCAAA CGAAACATGT GGCCATTCTC TGTGCGGTGG TGGTGGGTGT AGGATTAATA
|
181GTGGGACTTG CCGTGGGCTT GACCAGATGG TGTGACTCCA GCGGGGACGG CGGGCCGGGC
|
241ACTGCGCCAG CTCCTTCCCA CCTGCCTTCT TCCACGGCCA GCCCCTCAGG TCCTCCTGCC
|
301CAGGACCAGG ACATCTGCCC GGCCAGTGAG GATGAGAGCG GACAGTGGAA AAACTTTCGA
|
361CTGCCGGACT TCGTCAACCC AGTCCACTAC GACCTGCACG TGAAGCCCCT GTTGGAGGAG
|
421GACACGTACA CGGGCACCGT GAGGATGTGC ATCAACCTGA GCGCTGCCAC CCGGTACCTG
|
481TGGCTGCACC TCCGGGAGAC CAGGATGACG CGGCTCCCGG AGCTGAAGAG GCCCTCTGGG
|
541GACCAGGTGC AAGTCCGGAG GTGTTTCGAG TACAAAAAGC AGGAGTACGT GGTGGTCGAG
|
601GCGGAGGAAG AGCTTACCCC CAGCAGTGGA GATGGCCTGT ATCTCCTGAC CATGGAGTTC
|
661GCCGGCTGGC TGAACGGCTC CCTCGAGGGA TTTTATAGAA CCACCTACAC GGAGAACGGA
|
721CAAGTCAACA GCATAGTGGC CACCGATCAT GAACCAACAG ATCCCAGGAA ATCTTTTCCT
|
781TGTTTTGATG AGCCCAACAA AAAGGCAACT TATACAATAT CTATCACCCA TCCCAAAGAA
|
841TACGGACCAC TTTCAAATAT GCCAGTGGCG AAACAACAGT CAGTGGATGA TAAATGGACT
|
901CGAACAACTT TTGAGAAGTC TGTCCCCATG AGCACGTACC TGGTGTGCTT TGCTGTACAT
|
961CAATTTGACT CTGTAAAGAG AATATCAAAT AGTGGAAAAC CTCTTACAAT TTATGTCCAC
|
1021CCAGAGCAAA AGCACACAGC CGAATATGCT GCAAACATAA CTAAAAGTGT GTTTGATTAT
|
1081TTTGAAGAAT ACTTTGCTAT GAATTATTCT CTTCCTAAAT TAGATAAAAT CGCTATTCCA
|
1141GATTTTGGCA CTGGTGCCAT GGAGAACTGG CGACTCATCA CGTACAGAGA AACGAACCTG
|
1201CTTTATGACC CTAAGGAATC AGCCTCATCA AACCAACAGA GGGTGGCCAC TGTGGTTGCC
|
1261CATGAACTTG TGCATCAGTG GTTTCGAAAT ATTGTGACCA TGGACTGGTG GGAAGACTTG
|
1321TGCCTAAATG AAGGATTTGC TTCTTTCTTT GAGTTTCTGG GAGTAAACCA TGCAGAAACA
|
1381GACTGGCAAA TGGTGACCAA ATGTTACTTG AAGATGTATT ACCTGTTCAA GAGGATGATT
|
1441CTTTGATGTC TTCCCATCCA ATTATTGTGA CTGTGACAAC CCCTGATGAA ATAACATCTC
|
1501TTTTTGATGG AATATCCTAT AGCAAGGGAT CTTCTATTTT GAGAATGCTT GAAGACTGGA
|
1561TAAAACCAGA GAATTTTCAA AAAGGATGTC AGATGTACTT GGAAAAATAC CAATTCAAGA
|
1621ATGCAAAAAC TTCTGATTTT TGGGCAGCAC TGGAAGAGGC AAGTAGGCTA CCAGTGAAAG
|
1681AAGTAATGGA CACCTGCACC AGACAGATGG CTTATCCTGT GCTTAACGTG AACGGTGTCA
|
1741AGAACATCAC ACAGAAACGC TTTTTGTTGC ACCCAAGAGC TAACCCTTCT CAGCCCCCTT
|
1801CAGATCTTCG TTATACATGG AATATCCCAG TTAAATGGAC TGAAGATAAT ATAACAAGCA
|
1861GTCTGTTATT TAATAGGTCA GAAAAAGAAG GAATGACTTT GAACTCCTCT AATCCTAGTG
|
1921GAAATGCTTT TCTCAAAATA AACCCACATC ATATTGGGTT TTATCGTGTA AATTATGAAG
|
1981TAGCAACTTG GGACTCGATA CCTACAGCGC TCTCCTTGAA CCACAAGACA TTTTCTTCAG
|
2041CAGATCGTCC AAGTCTTATT GATGATGCTT TTGCCTTGGC AAGAGCTCAA CTTCTACATT
|
2101ATAAGGTGGC TTTGAACTTG ACCAAGTATC TCAAAACGGA AGAGAATTTT TTACCATGGC
|
2161AGAGAGTAAT TTCAGCTGTA ACCTACATCA TTAGCATGTT TGAAGATGAT AAAGAGCTAT
|
2221ATCCTATGAT TGAGGAATAC TTCCAAGGTC AAGTGAAGCC TATTGCAGAT TCTCTGGGAT
|
2281GGAATGATGC TGGAGACCAT GTCACAAAGT TACTCCGTTC CTCCGTGTTA GGGTTTGCGT
|
2341GCAAGATGGG AGACAGAGAA GCCTTGAACA ATGCTTCCTC GTTATTTGAG CAGTGGCTAA
|
2401ATGCCACTGT AAGCCTTCCC GTAAATCTCA GGCTTCTGGT GTATCGGTAT GGGATGCAGA
|
2461ACTCTGGCAA TGAGATTTCA TGGAACTACA CTCTTGAGCA ATACCAGAAA ACTTCATTAG
|
2521CTCAAGAAAA AGAAAAACTG CTGTATGGAT TAGCATCAGT GAAGAACGTT ACTCTTTTGT
|
2581CAAGGTATTT GGATTTGCTC AAGGACACGA ACCTTATTAA AACTCAGGAT GTGTTTACAG
|
2641TCATTCGATA TATCTCATAT AACAGCTATG GGAAGAACAT GGCCTGGAAT TGGATACAAC
|
2701TCAACTGGCA CTATCTAGTC AACAGATATA CACTCAATAA CAGAAACGTT GGCCGAATTG
|
2761TCACAATAGC AGAGCCATTC AACACTGAAC TGCAACTGTG GCAGATGGAG AGCTTTTTTG
|
2821CAAAATATCC ACAAGCTGGA GCAGGAGAAA AACCTAGGGA ACAAGTGCTG GAAACAGTGA
|
2881AAAACAATAT AGAGTGGCTA AAACAACATA GAAACACCAT CAGAGAATGG TTTTTTAATT
|
2941TACTTGAGAG TGGTTAATGT ATTCAAATGT TAGAGTTTAA TTTTGTGAAT CTATTGTTTC
|
GENBANK ID: U34683.1
DEFINITION HUMAN GLUTATHIONE SYNTHETASE MRNA, COMPLETE CDS.
VERSION 034683.1 GI:1236349
CDS 41..1465
/CODON_START=1
1GGGAGAACCG TTCGCGGAGG AAAGGCGAAC TAGTGTTGGG ATGGCCACCA ACTGGGGGAG
|
61CCTCTTGCAG GATAAACAGC AGCTAGAGGA GCTGGCACGG CAGGCCGTGG ACCGGGCCCT
|
121GGCTGAGGGA GTATTGCTGA GGACCTCACA GGAGCCCACT TCCTCGGAGG TGGTGAGCTA
|
181TGCCCCATTC ACGCTCTTCC CCTCACTGGT CCCCAGTGCC CTGCTGGAGC AAGCCTATGC
|
241TGTGCAGATG GACTTCAACC TGCTAGTGGA TGCTGTCAGC CAGAACGCTG CCTTCCTGGA
|
301GCAAACTCTT TCCAGCACCA TCAAACAGGA TGACTTTACC GCTCGTCTCT TTGACATCCA
|
361CAAGCAAGTC CTAAAAGAGG GCATTGCCCA GACTGTGTTC CTGGGCCTGA ATCGCTCAGA
|
421CTACATGTTC CAGCGCAGCG CAGATGGCTC CCCAGCCCTG AAACAGATCG AAATCAACAC
|
481CATCTCTGCC AGCTTTGGGG GCCTGGCCTC CCGGACCCCA GCTGTGCACC GACATGTTCT
|
541CAGTGTCCTG AGTAAGACCA AAGAAGCTGG CAAGATCCTC TCTAATAATC CCAGCAAGGG
|
601ACTGGCCCTG GGAATTGCCA AAGCCTGGGA GCTCTACGGC TCACCCAATG CTCTGGTGCT
|
661ACTGATTGCT CAAGAGAAGG AAAGAAACAT ATTTGACCAG CGTGCCATAG AGAATGAGCT
|
721ACTGGCCAGG AACATCCATG TGATCCGACG AACATTTGAA GATATCTCTG AAAAGGGGTC
|
781TCTGGACCAA GACCGAAGGC TGTTTGTGGA TGGCCAGGAA ATTGCTGTGG TTTACTTCCG
|
841GGATGGCTAC ATGCCTCGTC AGTACAGTCT ACAGAATTGG GAAGCACGTC TACTGCTGGA
|
901GAGGTCACAT GCTGCCAAGT GCCCAGACAT TGCCACCCAG CTGGCTGGGA CTAAGAAGGT
|
961GCAGCAGGAG CTAAGCAGGC CGGGCATGCT GGAGATGTTG CTCCCTGGCC AGCCTGAGGC
|
1021TGTGGCCCGC CTCCGCGCCA CCTTTGCTGG CCTCTACTCA CTGGATGTGG GTGAAGAAGG
|
1081GGACCAGGCC ATCGCCGAGG CCCTTGCTGC CCCTAGCCGG TTTGTGCTAA AGCCCCAGAG
|
1141AGAGGGTGGA GGTAACAACC TATATGGGGA GGAAATGGTA CAGGCCCTGA AACAGCTGAA
|
1201GCACACTGAG GAGAGGGCCT CCTACATCCT CATGGAGAAG ATCGAACCTG AGCCTTTTGA
|
1261GAATTGCCTG CTACGGCCTG GCAGCCCTGC CCGAGTGGTC CAGTGCATTT CAGAGCTGGG
|
1321CATCTTTGGG GTCTATGTCA GGCAGGAAAA GACACTCGTG ATGAACAAGC ACGTGGGGCA
|
1381TCTACTTCGA ACCAAAGCCA TCGAGCATGC AGATGCTGGT GTGGCACCGG GAGTGGCAGT
|
1441CCTGGACAAC CCATACCCTG TGTGAGGGCA CAACCAGGCC ACGGGACCTT CTATCCTCTG
|
1501TATTTGTCAT TCCTCTCCTA GCCCTCCTGA GGGGTATCCT CCTAAAGACC TCCAAAGTTT
|
1561TTATGGAAGG GTAAATACTG CTACCTTCCC CCAGCTTTCC ATCTGACGAC CAGAAAACTT
|
1621GTGTCTCCCT TACATGACAT CTAGACGCCC CCAAATCCTT CAGATGTGGG TATAGCTCAG
|
1681GCTAAGCTGC TCTGAGGTAA AGGTCCATGA ACCCTGCCCC ACTCCTGTCA GCCCCTCATC
|
1741AGCCTTTTCA CCAGGTTCCA GTCCCTGACT TGGGATAGCA CTCAGTGCTA CCACCAGGGC
|
1801GAGTGGAGGG GCATAGCCTT TCCCTAATTC TGCCTTAAAT AAAACTGCAT TGCTGT
|
GENBANK ID: AF035429.1
DNA LINEAR
DEFINITION HOMO SAPIENS CYTOCHEOME OXIDASE SUBUNIT I (001) AND SUBUNIT II
(CCII) PSEUDOGENES, COMPLETE SEQUENCE.
VERSION AF035429.1 GI:2665724
1AATATGAAAA TCACCTCGGA GCTGGTAAAA AGAGGCTTAA CCCCTGTCTT TAGATTTACA
|
61GTCCAATGCT TCACTCAGCC ATTTTACCTC ACCCCCACTG ATGTTCGCCG ACCGTTGACT
|
121ATTCTCTACA AACCACAAAG ACATTGGAAC ACTATACCTA TTATTCGGCG CATGAGCTGG
|
181AGTCCTACGC ACAGCTCTAA GCCTCCTTAT TCGAGCCGAA CTGGGCCAGC CAGGCAACCT
|
241TCTAGGTAAC GACCACATCT ACAACGTTAT CGTCACAGCC CATGCATTTG TAATAATCTT
|
301CTTCATAGTA ATACCCATCA TAATCGGAGG CTTTGGCAAC TGACTAGTTC CCCTAATAAT
|
361CGGTCCCCCC GATATGGCGT TTCCCCGCAT AAACAACATA AGCTTCTCAC TCTTACCCCC
|
421CTCTCTCCTA CTCCTGCTTG CATCTCCTAT AGTGGAGGCC GGCGCAGGAA CAGGTTGAAC
|
481AGTCTACCCT CCCTTGGCAG GGAACTACTC CCACCCTGGA GGCTGCGTAG ACCTAACCAT
|
541CTTCTCCTTA CACCTAGCAG GTATCTCCTC TATCTTAGGA GCCATCAATT TCATCACAAC
|
601AATTATTAAT ATAAAACCCC CTGCCATAAC CCAATACCAA ACGCCCCTTT TCGTCTGATC
|
661CGTCCTAATC ACAGCAGTCT TACTTCTCCT ATCTCTCCCA GTCCTAGCCG CTGGCATCAC
|
721TATACTACTA ACAGACCGTA ACCTCAACAC CACCTTCTTC GACCCAGCCG GAGGAGGAGA
|
781CCCCATTCTA TACCAACACC TATTCTGATT TTTCGGTCAC CCTGAAGTTT ATATTGTGAT
|
841CCTACCAGGC TTCGGAATAA TCTCCCATAT TGTAACTTAC TACTCCGGAA AAAAAGAACC
|
801ATTTGGATAC ATAGGTATGG TCTGAGCTAT GATATCAATT GGCTTCCTAG GGTTTATCGT
|
961GTGAGCACAC CATATATTTA CAGTAGGAAT AGACGTAGAC ACACGAGCAT ATTTCACCTC
|
1021CGCTACCATA ATCATCGCTA TCCCCACCGG CGTCAAAGTA TTTAGCTGAC TCGCCACACT
|
1081CCACGGAAGC AATATGAAAT GATCTGCTGC AGTGCTCTGA GCCCTAGGAT TTATTTTTCT
|
1141TTTGACCGTA GGTGGGCTGA CTGGCATTGT ATTAGCAAAC TCATCACTAG ACATCGTACT
|
1201ACACGACACG TACTACGTTG TAGCCCACTT CCACTATGTC CTATCAATAG GAGCTGTATT
|
1261TGCCATCATA GGAGGCTTCA TTCACTGATT TCCCCTATTC TCAGGCTACA CCCTAGACCA
|
1321AACCTACGCC AAAATCCATT TCGCTATCAT ATTCATCGGC GTAAATCTAA CTTTCTTCCC
|
1381ACAACACTTT CTCGGCCTAT CCGGAATGCC CCGACGTTAC TCGGACTATC CCGATGCATA
|
1441CACCACATGA AATATCCTAT CATCTGTAGG CTCATTCATT TCTCTAACAG CAGTAATATT
|
1501AATAATTTTC ATAATTTGAG AAGCCTTCGC TTCGAAGCGA AAAGTCCTAA TAGTAGAAGA
|
1561ACCCTCCATA AACCTGGAGT GACTATATGG ATGCCCCCCA CGCTACCACA CATTCGAAGA
|
1621ACCCGTATAC ATAAAATCTA GACAAAAAAG GAAGGAATCG AACCCCCCAA AGCTGGTTTC
|
1681AAGCCAACCC CATGGCCTCC ATGACTTTTT CAAAAAGATA TTAGAAAAAC CATTTCATAA
|
1741CTTTGTCAAA GTTAAATTAT AGGCTAAATC CTATATATCT TAATGGCACA TGCAGCGCAA
|
1801GTAGGTCTAC AAAACGCTAC TTCCCCTATC ATAGAAGAGC TTATCATCTT TCATGATCAC
|
1861GCCCTCATAA TCATTTTCCT TATCTGCTTC CTAGTCCTGT ACGCCCTTTT CCTAACACTC
|
1921ACAACAAAAC TAACTAATAC TAACATCTCA GACGCTCAGG AAATAGAAAC CGTCTGAACT
|
1981ATCCTGCCCG CCATCATCCT AGTCCTTATC GGGCTGCCAT CCCTACGCAT CCTTTACATA
|
2041ACAGACGAGG TCAACGATCC CTCCTTTACC ATCAAATCAA TTGGCCATCA ATGGTACTGA
|
2101ACCTACGAAT ACACGGACTA CGGCGGACTA ATCTTCAACT CCTACATACT TCCCCCATTA
|
2161TTCCTAGAAC CAGGCGACCT GCGACTCCTT GACGTTGACA ATCGAGTAGT ACTCCCGGTT
|
2221GAAGCCCCCA TTCGTATAAT AATTACATCA CAAGACGTCT TACACTCATG AGCTGTCCCC
|
2281ACATTAGGCT TAAAAACAGA TGCAATTCCC GGACGTCTAA ACCAAACCAC TTTCACTGCT
|
2341ACACGACCAG GGGTATACTA CGGCCAATGC TCTGAAATCT GTGGAGCAAA CCAGTTTTAT
|
2401GCCCATCGTC CTAGAATTAA TTCCCCTAAA AATCTTTGAA ATAGGGCCTG TATTTACCCT
|
2461ATAGCACCCC CTCTACCCCC TCTAGAGCCC ACTGTAAAGC TAACTTAGCA TTAACCTTTT
|
2521AAGTTAAAGA TTAAGAGAAC CAACACCTCT TTACAGTGAA ATGCCCCAAC TAAATACTA
|
GENBANK ID: NM_024409.1
DEFINITION HOMO SAPIENS NATRIURETIC PEPTIDE PRECURSOR C (NPPC), MRNA.
VERSION NM_024409.1 GI:13249345
CDS 1..381
/CODON_START=1
1ATGCATCTCT CCCAGCTGCT GGCCTGCGCC CTGCTGCTCA CGCTGCTCTC CCTCCGGCCC
|
61TCCGAAGCCA AGCCCGGGGC GCCGCCGAAG GTCCCGCGAA CCCCGCCGGC AGAGGAGCTG
|
121GCCGAGCCGC AGGCTGCGGG CGGCGGTCAG AAGAAGGGCG ACAAGGCTCC CGGGGGCGGG
|
181GGCGCCAATC TCAAGGGCGA CCGGTCGCGA CTGCTCCGGG ACCTGCGCGT GGACACCAAG
|
241TCGCGGGCAG CGTGGGCTCG CCTTCTGCAA GACCACCGCA ACGCGCGCAA ATACAARGGA
|
301GCCAACAAGA AGGGCTTGTC CAAGGGCTGC TTCGGCCTCA AGCTGGACCG AATCGGCTCC
|
361ATGAGCGGCC TGGGATGTTA G
|
GENBANK ID: M37763.1
DNA LINEAR
DEFINITION HUMAN NEUROTROFHIN-3 (NT-3) GENE, COMPLETE CDS.
VERSION M37763.1 GI:189300
CDS 76..849
/CODON_START=1
GENE 76..849
MAT PEPTIDE 130..846
1TAACACAGAC TCAGCTGCCA GAGCCTGCTC TTAACACCTG TGTTTCCTTT TCAGATCTTA
|
61CAGGTGAACA AGGTGATGTC CATCTTGTTT TATGTGATAT TTCTCGCTTA TCTCCGTGGC
|
121ATCCAAGGTA ACAACATGGA TCAAAGGAGT TTGCCAGAAG ACTCGCTCAA TTCCCTCATT
|
181ATTAAGCTGA TGCAGGCAGA TATTTTGAAA AACAAGCTCT CCAAGCAGAT GGTGGACGTT
|
241AAGGAAAATT ACCAGAGCAC CCTGCCCAAA GCTGAGGCTC CCCGAGAGCC GGAGCGGGGA
|
301GGGCCCGCCA AGTCAGCATT CCAGCCGGTG ATTGCAATGG ACACCGAACT GCTGCGACAA
|
361CAGAGACGCT ACAACTCACC GCGGGTCCTG CTGAGCGACA GCACCCCCTT GGAGCCCCCG
|
421CCCTTGTATC TCATGGAGGA TTACGTGGGC AGCCCCGTGG TGGCGAACAG ARCATCACGG
|
481CGGAAACGGT ACGCGGAGCA TAAGAGTCAC CGAGGGGAGT ACTCGGTATG TGACAGTGAG
|
541AGTCTGTGGG TGACCGACAA GTCATCGGCC ATCGACATTC GGGGACACCA GGTCACGGTG
|
601CTGGGGGAGA TCAAAACGGG CAACTCTCCC GTCAAACAAT ATTTTTATGA AACGCGATGT
|
661AAGGAAGCCA GGCCGGTCAA AAACGGTTGC AGGGGTATTG ATGATAAACA CTGGAACTCT
|
721CAGTGCAAAA CATCCCAAAC CTACGTCCGA GCACTGACTT CAGAGAACAA TAAACTCGTG
|
781GGCTGGCGGT GGATACGGAT AGACACGTCC TGTGTGTGTG CCTTGTCGAG AAAAATCGGA
|
841AGAACATGAA TTGGCATCTC TCCCCATATA TAAATTATTA CTTTAAATTA TATGATATGC
|
901ATGTAGCATA TAAATGTTTA TATTGTTTTT ATATATTATA AGTTGACCTT TATTTATTAA
|
961ACTTCAGCAA CCCTACAGTA TATAAGCTTT TTTCTCAATA AAATCAGTGT GCTTGCCTTC
|
GENBANK ID: NM_000932.1
DEFINITION HOMO SAPIENS PHOSPHOLIPASE C, BETA 3
(PHOSPHATIDYLINOSITOL-SPECIFIC) (PLCB3), MRNA.
VERSION NM_000932.1 GI:11386138
CDS 1..3705
1ATGGCGGGCG CCCAGCCCGG CGTCCACGCG CTGCAGTTGG AGCCGCCCAC CGTGGTGGAG
|
61ACCCTGCGGC GCGGGAGTAA GTTCATCAAA TGGGACGAGG AGACCTCCAG TCGGAACCTG
|
121GTGACCCTGC GTGTGGACCC CAATGGCTTC TTCTTGTACT GGACGGGCCC CAACATGGAG
|
181GTGGACACAC TGGACATCAG TTCCATCAGG GACACACGGA CAGGCCGGTA CGCCCGCCTG
|
241CCCAAGGACC CCAAGATCCG GGAAGTTCTG GGCTTTGGGG GTCCCGATGC CCGGCTGGAG
|
301GAGAAGCTGA TGACGGTGGT GTCTGGGCCA GACCCGGTGA ACACAGTGTT CTTGAACTTC
|
361ATGGCCGTGC AGGATGACAC AGCCAAGGTC TGGTCTGAGG AGCTATTCAA GCTGGCTATG
|
421AACATCCTGG CTCAGAACGC CTCCCGGAAC ACCTTCCTGC GCAAAGCATA CACGAAGCTG
|
481AAGCTGCAGG TGAACCAGGA TGGTCGGATC CCCGTCAAGA ACATCCTGAA GATGTTCTCA
|
541GCAGACAAGA AGCGGGTGGA GACTGCGCTG GAATCCTGTG GCCTCAAATT CAACCGGAGT
|
601GAGTCCATCC GGCCTGATGA GTTTTCCTTG GAAATCTTTG AGCGGTTCCT GAACAAGCTG
|
661TGTCTGCGGC CGGACATTGA CAAGATCCTG CTGGAGATAG GCGCCAAGGG CAAGCCATAC
|
721CTGACGCTGG AGCAGCTCAT GGACTTCATC AACCAGAAGC AACGCGACCC GAGACTCAAC
|
781GAAGTGCTGT ACCCGCCCCT GCGGCCCTCC CAGGCCCGGC TGCTCATCGA AAAGTATGAG
|
841CCCAACCAGC AGTTTCTGGA GCGAGACCAG ATGTCCATGG AGGGCTTTAG CCGCTACCTG
|
901GGAGGCGAGG AGAATGGCAT CCTGCCCCTG GAAGCCCTGG ATCTGAGCAC GGACATGACC
|
961CAGCCACTGA GTGCCTACTT CATCAACTCC TCGCATAACA CCTATCTCAC TGCGGGGCAG
|
1021CTGGCTGGGA CCTCGTCGGT GGAGATGTAC CGCCAGGCAC TACTATGGGG CTGCCGCTGC
|
1081GTGGAGCTGG ACGTGTGGAA GGGACGGCCG CCTGAGGAGG AACCCTTCAT TACCCACGGC
|
1141TTCACCATGA CCACAGAGGT GCCTCTGCGC GACGTGCTGG AGGCCATTGC CGAGACTGCC
|
1201TTCAAGACCT CGCCCTACCC CGTCATCCTC TCCTTCGAGA ACCATGTGGA CTCGGCAAAG
|
1261CAACAGGCAA AGATGGCTGA GTACTGCCGC TCCATCTTTG GAGACGCGCT ACTCATCGAG
|
1321CCTCTGGACA AGTACCCGCT GGCCCCAGGC GTTCCCCTGC CCAGCCCCCA GGACCTGATG
|
1381GGCCGTATCC TGGTGAAGAA CAAGAAGCCG CACCGACGCA GCGCAGGTGG CCCAGACAGC
|
1441GCCGGGCGCA AGCGGCCCCT GGAGCAGAGC AATTCTGCCC TGAGCGAGAG CTCCGCGGCC
|
1501ACCGAGCCCT CCTCCCCGCA GCTGCGGTCT CCCAGCTCTG ACAGCTGCCC AGGCCTGAGC
|
1561AATGGGGAGG AGGTAGGCCT TCACAAGCCC ACCCTGCAGC CTCAGAAGTC TCTCGGTGAC
|
1621GAGCGCCTGA ACCGAGGCCC CTATGTTCTT GGACCTGCTG ACCGTGAGGA TGAGGAGGAA
|
1681GATGAGCAAG AGCAGGAACA GACAGACCCC AAAAAGCCAA CTACAGATGA GGGGACAGCC
|
1741AGCAGCGAGG TGAATGCCAC TGAGGAGATG TCCACGCTTG TCAACTACAT CGAACCTGTC
|
1801AAGTTCAAGT CCTTTGAGGC TGCTCGAAAG AGGAACAAAT GCTTCGAGAT GTCGTCCTTT
|
1861GTGGAGACCA AGGCCATGGA GCAACTGACC AAGAGCCCCA TGGAGTTTGT GGAATACAAC
|
1921AAGCAGCAGC TCAGCCGCAT CTACCCCAAG GGCACCCGCG TGGACTCCTC CAACTACATG
|
1981CCCCAGCTCT TCTGGAACGT AGGGTGCCAG CTTGTTGCGC TCAACTTCCA GACCCTCGAT
|
2041GTGGCGATGC AGCTCAACGC GGGCGTTTTT GAGTACAACG GGCGCAGCGG GTACCTGCTC
|
2101AAGCCGGAGT TCATGCGGCG GCCGGACAAG TCCTTCGACC CCTTCACTGA GGTCATCGTG
|
2161GATGGCATCG TGGCCAATGC CTTGCGGGTC AAGGTGATCT CAGGGCAGTT CCTGTCCGAC
|
2221AGGAAGGTGG GCATCTACGT GGAGGTGGAC ATGTTTGGCC TCCCTGTTGA TACGCGGCGC
|
2281AAGTACCGCA CCCGGACCTC TCAGGGGAAC TCGTTCAACC CCGTGTGGGA CGAAGAGCCC
|
2341TTCGACTTCC CCAAGGTGGT GCTGCCCACG CTGGCTTCAC TTCGCATTGC AGCCTTTGAG
|
2401GAGGGGGGTA AATTCGTAGG GCACCGGATC CTGCCTGTCT CTGCCATCCG CTCCGGATAC
|
2461CACTACGTGT GCCTGCGGAA CGAGGCCAAC CAACCGCTGT GCCTGCCGGC CCTGCTCATC
|
2521TACACCGAAG CCTCGGACTA CATTCCTGAC GACCACCAGG ACTATGCGGA GGCCCTGATC
|
2581AACCCCATTA AGCACGTCAG CCTGATGGAC CAGAGGGCCC GGCAGCTGGC CGCCCTCATT
|
2641GGGGAGAGTG AGGGTGAGGC TGGCCAAGAG ACGTGCCAGG ACACCCAGTC TCAGCAGCTG
|
2701GGGTCTCAGC CGTCCTCAAA CCCCACCCCC AGCCCACTGG ATGCCTCCCC CCGCCGGCCC
|
2761CCTGGCCCCA CCACCTCCCC TGCCAGCACC TCCCTCAGCA GCCCAGGGCA GCGTGATGAT
|
2821CTCATCGCCA GCATCCTCTC AGAGGTGGCC CCCACCCCGC TGGATGAGCT CCGAGGTCAC
|
2881AAGGCTCTGG TCAAGCTCCG GAGCCGGCAA GAGCGAGACC TGCGGGAGCT GCGCAAGAAG
|
2941CATGAGGGGA AGGCAGTCAC CCTCACCCGC CGCCTGCTGG ATGGCCTGGC TCAGGCACAG
|
3001GCTGAGGGCA GGTGCCGGCT GCGGCCAGGT GCCCTAGGTG GGGCCGCTGA TGTGGAGGAC
|
3061ACGAAGGAGG GGGAGGACGA GGCAAAGCGG TATCAGGAGT TCCAGAACAG ACAGGTGCAG
|
3121AGCCTGCTGG AGCTGCGGGA GGCCCAGGTG GACGCAGAGG CCCAGCGGAG GCTGGAACAC
|
3181CTGAGACAGG CTCTGCAGCG GCTCAGGGAG GTCGTCCTTG ATGCAAACAC AACTCAGTTC
|
3241AAGAGGCTGA AAGAGATGAA CGAGAGGGAG AAGAAGGAGC TGCAGAAGAT CCTGGACAGA
|
3301AAGCGCCATA ACAGCATCTC GGAGGCCAAG ATGAGGGACA AGCATAAGAA GGAGGCGGAA
|
3361CTGACGGAGA TTAACCGTCG GCACATCACT GAGTCAGTCA ACTCCATCCG TCGGCTGGAG
|
3421GAGGCCCAGA AGCAGCGGCA TGACCGTCTT GTGGCTGGGC AGCAGCAGGT CCTGCAACAG
|
3481CTGGCAGAAG AGGAGCCCAA GCTGCTGGCC CAGCTGGCCC AGGAGTGTCA GGAGCAGCGG
|
3541GCGAGGCTCC CCCAGGAGAT CCGCCGGAGC CTGCTGGGCG AGATGCCGGA GGGGCTGGGG
|
3601GACGGGCCTC TGGTGGCCTG TGCCAGCAAC GGTCACGCAC CCGGGAGCAG CGGGCACCTG
|
3661TCGGGCGCTG ACTCGGAGAG CCAGGAGGAG AACACGCAGC TCTGA
|
GENBANK ID: D13119.1
DEFINITION HOMO SAPIENS P2 MRNA FOR ATP SYNTHASE SUBUNIT C, COMPLETE CDS.
VERSION D13119.1 GI:285909
CDS 31..456
/CODON_START=1
1TCTCCTGCCA CAGCTCCTCA CCCCCTGAAA ATGTTCGCCT GCTCCAAGTT TGTCTCCACT
|
61CCCTCCTTGG TCAAGAGCAC CTCACAGCTG CTGAGCCGTC CGCTATCTGC AGTGGTGCTG
|
121AAACGACCGG AGATACTGAC AGATGAGAGC CTCAGCAGCT TGGCAGTCTC ATGTCCCCTT
|
181ACCTCACTTG TCTCTAGCCG CAGCTTCCAA ACCAGCGCCA TTTCAAGGGA CATCGACACA
|
241GCAGCCAAGT TCATTGGAGC TGGGGCTGCC ACAGTTGGGG TGGCTGGTTC TGGGGCTGGG
|
301ATTGGAACTG TGTTTGGGAG CCTCATCATT GGTTATGCCA GGAACCCTTC TCTGAAGCAA
|
361CAGCTCTTCT CCTACGCCAT TCTGGGCTTT GCCCTCTCGG AGGCCATGGG GCTCTTTTGT
|
421CTGATGGTAG CCTTTCTCAT CCTCTTTGCC ATGTGAAGGA GCCGTCTCCA CCTCCCATAG
|
481TTCTCCCGCG TCTGGTTGGC CCCGTGTGTT CCTTTTCCTA TACCTCCCCA GGCAGCCTGG
|
541GGAACGTGGT TGGCTCAGGG TTTGACAGAG AAAAGACAAA TAAATACTGT ATTAATAAG
|
GENBANK ID: NM_004530.1
DEFINITION HOMO SAPIENS MATRIX METALLOPROTEINASE 2 (GELATINASE A, 72KD
GELATINASE, 72KD TYPE IV COLLAGENASE) (MMP2), MRNA.
VERSION NM_004530.1 GI:11342665
CDS 290..2272
/CODON_START=1
1TGTTTCCGCT GCATCCAGAC TTCCTCAGGC GGTGGCTGGA GGCTGCGCAT CTGGGGCTTT
|
61AAACATACAA AGCGATTGCC AGGACCTGCG GCGGCGGCGG CGGCGGCGGG GGCTGGGGCG
|
121CGGGGGCCGG ACCATGAGCC GCTCAGCCGG GCAAACCCCA GGCCACCGAG CCAGCGGACC
|
181CTCGGAGCGC AGCCCTGCGC CGCGGACCAG GCTCCAACCA GGCGGCGAGG CGGCCACACG
|
241CACCGAGCCA GCGACCCCCG GGCGACGCGC GGGGCCAGGG AGCGCTACGA TGGAGGCGCT
|
301AATGGCCCGG GGCGCGCTCA CGCGTCCCCT GAGGGCGCTC TGTCTCCTGG GCTGCCTGCT
|
361GAGCCACGCC GCCGCCGCGC CGTCGCCCAT CATCAAGTTC CCCGGCGATG TCGCCCCCAA
|
421AACGGACAAA GAGTTGGCAG TGCAATACCT GAACACCTTC TATGGCTGCC CCAAGGAGAG
|
481CTGCAACCTG TTTGTGCTGA AGGACACACT AAAGAAGATG CAGAAGTTCT TTGGACTGCC
|
541GCAGACAGCT GATCTTGACC AGAATACCAT CGAGACCATG CGGAAGCCAC GCTGCGGCAA
|
601CCCAGATGTG GCCAACTACA ACTTCTTCCC TCGCAAGCCC AAGTGGGACA AGAACCAGAT
|
661CACATACAGG ATCATTGGCT ACACACCTGA TCTGGACCCA GAGACAGTGG ATGATGCCTT
|
721TGCTCGTGCC TTCCAAGTCT GGAGCGATGT GACCCCACTG CGGTTTTCTC GAATCCATGA
|
781TGGAGAGGCA GACATCATGA TCAACTTTCG CCGCTGGGAG CATGGCGATG GATACCCCTT
|
841TGACGGTAAG GACGGACTCC TGGCTCATCC CTTCGCCCCA GGCACTGGTG TTGGGGGAGA
|
901CTCCCATTTT GATGACGATG AGCTATGGAC CTTGGGAGAA GGCCAAGTGG TCCGTGTGAA
|
961GTATGGCAAC GCCGATGGGG AGTACTGCAA GTTCCCCTTC TTGTTCAATG GCAAGGAGTA
|
1021CAACAGCTGC ACTGATACTG GCCGCAGCGA TGGCTTCCTC TGGTCCTCCA CCACCTACAA
|
1081CTTTGAGAAG GATGGCAAGT ACGGCTTCTG TCCCCATGAA GCCCTGTTCA CCATGGGCGG
|
1141CAACGCTGAA GGACAGCCCT GCAAGTTTCC ATTCCGCTTC CAGGGCACAT CCTATGACAG
|
1201CTGCACCACT GAGGGCCGCA CCGATGGCTA CCGCTGGTGC GGCACCACTG AGGACTACGA
|
1261CCGCGACAAG AAGTATGGCT TCTGCCCTGA GACCGCCATG TCCACTGTTG GTGGGAACTC
|
1321AGAAGGTGCC CCCTGTGTCT TCCCCTTCAC TTTCCTGGGC AACAAATATG AGAGCTGCAC
|
1381CAGCGCCGGC CGCAGTGACG GAAAGATGTG GTGTGCGACC ACAGCCAACT ACGATGACGA
|
1441CCGCAAGTGG GGCTTCTGCC CTGACCAAGG GTACAGCCTG TTCCTCGTGG CAGCCCACGA
|
1501GTTTGGCCAC GCCATGGGGC TGCAGCACTC CCAAGACCCT GGGGCCCTGA TGGCACCCAT
|
1561TTACACCTAC ACCAAGAACT TCCGTCTGTC CCAGGATGAC ATCAAGGGCA TTCAGGAGCT
|
1621CTATGGGGCC TCTCCTGACA TTGACCTTGG CACCGGCCCC ACCCCCACAC TGGGCCCTGT
|
1681CACTCCTGAG ATCTGCAAAC AGGACATTGT ATTTGATGGC ATCGCTCAGA TCCGTGGTGA
|
1741GATCTTCTTC TTCAAGGACC GGTTCATTTG GCGGACTGTG ACGCCACGTG ACAAGCCCAT
|
1801GGGGCCCCTG CTGGTGGCCA CATTCTGGCC TGAGCTCCCG GAAAAGATTG ATGCGGTATA
|
1861CGAGGCCCCA CAGGAGGAGA AGGCTGTGTT CTTTGCAGGG AATGAATACT GGATCTACTC
|
1921AGCCAGCACC CTGGAGCGAG GGTACCCCAA GCCACTGACC AGCCTGGGAC TGCCCCCTGA
|
1981TGTCCAGCGA GTGGATGCCG CCTTTAACTG GAGCAAAAAC AAGAAGACAT ACATCTTTGC
|
2041TGGAGACAAA TTCTGGAGAT ACAATGAGGT GAAGAAGAAA ATGGATCCTG GCTTTCCCAA
|
2101GCTCATCGCA GATGCCTGGA ATGCCATCCC CGATAACCTG GATGCCGTCG TGGACCTGCA
|
2161GGGCGGCGGT CACAGCTACT TCTTCAAGGG TGCCTATTAC CTGAAGCTGG AGAACCAAAG
|
2221TCTGAAGAGC GTGAAGTTTG GAAGCATCAA ATCCGACTGG CTAGGCTGCT GAGCTGGCCC
|
2281TGGCTCCCAC AGGCCCTTCC TCTCCACTGC CTTCGATACA CCGGGCCTGG AGAACTAGAG
|
2341AAGGACCCGG AGGGGCCTGG CAGCCGTGCC TTCAGCTCTA CAGCTAATCA GCATTCTCAC
|
2401TCCTACCTGG TAATTTAAGA TTCCAGAGAG TGGCTCCTCC CGGTGCCCAA GAATAGATGC
|
2461TGACTGTACT CCTCCCAGGC GCCCCTTCCC CCTCCAATCC CACCAACCCT CAGAGCCACC
|
2521CCTAAAGAGA TCCTTTGATA TTTTCAACGC AGCCCTGCTT TGGGCTGCCC TGGTGCTGCC
|
2581ACACTTCAGG CTCTTCTCCT TTCACAACCT TCTGTGGCTC ACAGAACCCT TGGAGCCAAT
|
2641GGAGACTGTC TCAAGAGGGC ACTGGTGGCC CGACAGCCTG GCACAGGGCA GTGGGACAGG
|
2701GCATGGCCAG GTGGCCACTC CAGACCCCTG GCTTTTCACT GCTGGCTGCC TTAGAACCTT
|
2761TCTTACATTA GCAGTTTGCT TTGTATGCAC TTTGTTTTTT TCTTTGGGTC TTGTTTTTTT
|
2821TTTCCACTTA GAAATTGCAT TTCCTGACAG AAGGACTCAG GTTGTCTGAA GTCACTGCAC
|
2881AGTGCATCTC AGCCCACATA GTGATGGTTC CCCTGTTCAC TCTACTTAGC ATGTCCCTAC
|
2941CGAGTCTCTT CTCCACTGGA TGGAGGAAAA CCAAGCCGTG GCTTCCCGCT CAGCCCTCCC
|
3001TGCCCCTCCC TTCAACCATT CCCCATGGGA AATGTCAACA AGTATGAATA AAGACACCTA
|
3061CTGAGTGGC
|
GENBANK ID: NN_000852.2
DEFINITION HOMO SAPIENS GLUTATHIONE S-TRANSFERASE PI (GSTP1), MRNA.
VERSION NM_000852.2 GI:6552334
CDS 30..662
1GGAGTTTCGC CGCCGCAGTC TTCGCCACCA TGCCGCCCTA CACCGTGGTC TATTTCCCAG
|
61TTCGAGGCCG CTGCGCGGCC CTGCGCATGC TGCTGGCAGA TCAGGGCCAG AGCTGGAAGG
|
121AGGAGGTGGT GACCGTGGAG ACGTGGCAGG AGGGCTCACT CAAAGCCTCC TGCCTATACG
|
181GGCAGCTCCC CAAGTTCCAG GACGGAGACC TCACCCTGTA CCAGTCCAAT ACCATCCTGC
|
241GTCACCTGGG CCGCACCCTT GGGCTCTATG GGAAGGACCA GCAGGAGGCA GCCCTGGTGG
|
301ACATGGTGAA TGACGCCGTG GAGGACCTCC GCTGCAAATA CATCTCCCTC ATCTACACCA
|
361ACTATGAGGC GGGCAAGGAT GACTATGTGA AGGCACTGCC CGGGCAACTG AAGCCTTTTG
|
421AGACCCTGCT GTCCCAGAAC CAGGGAGGCA AGACCTTCAT TGTGGGAGAC CAGATCTCCT
|
481TCGCTGACTA CAAGCTGCTG GACTTGCTGC TGATCCATGA GGTCCTAGCC CCTGGCTGCC
|
541TGGATGCGTT CCCCCTGCTC TCAGCATATG TGGGCCGCCT CACCGCCCGG CCCAAGCTCA
|
601AGGCCTTCCT GGCCTCCCCT CAGTACGTGA ACCTCCCCAT CAATGGCAAC GGGAAACAGT
|
661GAGGGTTGGG GGGACTCTGA GCGGGAGGCA GAGTTTGCCT TCCTTTCTCC AGGACCAATA
|
721AAATTTCTAA GAGAGCT
|
GENBANK ID: XM_016524.4
DEFINITION HOMO SAPIENS CREATINE KINASE, MITOCHONDRIAL 1 (UBIQUITOUS)
(CENT1) ,MRNA.
VERSION XM_016524.4 GI:17477504
CDS 358..1704
/CODON_START=1
1CGCGCGAGTC TCAGGTCCCG CTAATTACCT GGCGGGTGCT GCCCACCCCT GCCCTCGCGC
|
61ACCTACCGCG GTGGCAGGCG GGAAGGCGGG GCCTGGGGGA GCCCCACCCC TGGAGACTGC
|
121GGCTGGGGCC TCCCTCTCCT CCGCCCGCCC GCCTGCCACT AGCTCATTGC GCCTCTCCTG
|
181CAGTCTGATT GGCACCGGCT CCCATTCCGG CTCCAGCCTC CAATCCGACC CCCATTTCGG
|
241CTGCAGCCTC GGACCTAGCT CCGGCCCTCG GTCTATCCGG TTGCATCCTC CCTCCCTGTT
|
301CCGGATCTTA TCTTGCGCCA GCGCCTACTC CAGGATCCCG TACCGAGACG TCAAGCCATG
|
361GCTGGTCCCT TCTCCCGTCT GCTGTCCGCC CGCCGGGGAC TCAGGCTCCT GGCTTTGGCC
|
421GGAGCGGGGT CTCTAGCCGC TGGGTTTCTG CTCCGACCGG AACCTGTACG AGCTGCCAGT
|
481GAACGACGGA GGCTGTATCC CCCGAGCCAG ACATGGCCAA CTGGACAGCT CCCAGGTAAC
|
541TGCACTAGGT CTAGGCGTCT GTGCCCTCCC TCCATGGTTA CTGGGTACCC CCTCCCCAGC
|
601GCTGAGTACC CAGACCTCCG AAAGCACAAC AACTGCATGG CCAGTCACCT GACCCCAGCA
|
661GTCTATGCAC GGCTCTGCGA CAAGACCACA CCCACTGGTT GGACGCTAGA TCAGTGTATC
|
721CAGACTGGCG TGGACAACCC TGGCCACCCC TTCATCAAGA CTGTGGGCAT GGTGGCTGGA
|
781GATGAGGAGA CCTATGAGGT ATTTGCTGAC CTGTTTGACC CTGTGATCCA AGAGGGACAC
|
841AATGGATATG ACCCCCGGAC AATGAAGCAC ACCACGGATC TAGATGCCAG TAAAATCCGT
|
901TCTGGCTACT TTGATGAGAG GTATGTATTG TCCTCTAGAG TCAGAACTGG CCGAAGCATC
|
961CGAGGACTCA GTCTGCCTCC AGCTTGCACT CGAGCAGAGC GACGAGAGGT GGAACGTGTT
|
1021GTGGTGGATG CACTGAGTGG CCTGAAGGGT GACCTGGCTG GACGTTACTA TAGGCTCAGT
|
1081GAGATGACAG AGGCTGAACA GCAGCAGCTT ATTGATGACC ACTTTCTGTT TGATAAGCCT
|
1141GTGTCCCCGT TGCTGACTGC AGCAGGAATG GCTCGAGACT GGCCAGATGC TCGTGGAATT
|
1201TGGCACAACA ATGAGAAGAG CTTCCTGATC TGGGTGAATG AGGAGGATCA TACACGGGTG
|
1261ATCTCCATGG AGAAGGGTGG TAACATGAAG AGAGTGTTTG AAAGATTCTG CCGAGGCCTC
|
1321AAAGAGGTGG AGAGACTTAT CCAAGAACGT GGCTGGGAGT TCATGTGGAA TGAGCGTTTG
|
1381GGATACATCT TGACCTGTCC ATCTAACCTG GGCACTGGAC TTCGGGCAGG AGTGCACATC
|
1441AAACTGCCCC TGCTAAGCAA AGATAGCCGC TTCCCAAAGA TCCTGGAGAA CCTAAGACTC
|
1501CAAAAACGTG GTACTGGAGG AGTGGACACT GCTGCTACAG GCGGTGTCTT TGATATTTCT
|
1561AATTTGGACC GACTAGGCAA ATCAGAGGTG GAGCTGGTGC AACTGGTCAT CGATGGAGTA
|
1621AACTATTTGA TTGATTGTGA ACGGCGTCTG GAGAGAGGUC AGGATATCCG CATCCCCACA
|
1681CCTGTCATCC ACACCAAGCA TTAACTCCCC ATCGCCAGCT GATGACTCAA GATTCCCAGG
|
1741AGTTCTGCTC ATTCTAATGA TGGCCCATTC TACTTGCTCT GGACCTGCCC CCGCATCCCC
|
1801TGCCTCCATC CTAGTAAAGA CTCCTTGCTA TGCTGC
|
GENBANK ID: NM_001443.1
DEFINITION HOMO SAPIENS FATTY ACID BINDING PROTEIN 1, LIVER (FABP1),
MRNA. VERSION NM_001443.1 GI:4557576
CDS 43..426
1AGAGCCGCAG GTCAGTCGTG AAGAGGGAGC TCTATTGCCA CCATGAGTTT CTCCGGCAAG
|
61TACCAACTGC AGAGCCAGGA AAACTTTGAA GCCTTCATGA AGGCAATCGG TCTGCCGGAA
|
121GAGCTCATCC AGAAGGGGAA GGATATCAAG GGGGTGTCGG AAATCGTGCA GAATGGGAAG
|
181CACTTCAAGT TCACCATCAC CGCTGGGTCC AAAGTGATCC AAAACGAATT CACGGTGGGG
|
241GAGGAATGTG AGCTGGAGAC AATGACAGGG GAGAAAGTCA AGACAGTGGT TCAGTTGGAA
|
301GGTGACAATA AACTGGTGAC AACTTTCAAA AACATCAAGT CTGTGACCGA ACTCAACGGC
|
361GACATAATCA CCAATACCAT GACATTGGGT GACATTGTCT TCAAGAGAAT CAGCAAGAGA
|
421ATTTAAACAA GTCTGCATTT CATATTATTT TAGTGTGTAA AATTAATGTA ATAAAGTGAA
|
481CTTTGTTTT
|
GENBANK ID: NM_001220.1
DEFINITION HOMO SAPIENS CALCIUMCALNODULINDEPENDENT PROTEIN KINASE (CAN
KINASE) II BETA (CZANK2B), MRNA.
VERSION NM_001220.1 GI:10835005
CDS 47..1675
1GCGGCCCGCG TCGACCGAGC GCACGCCCAG CCCCTCCGCC GCCGCCATGG CCACCACGGT
|
61GACCTGCACC CGCTTCACCG ACGAGTACCA GCTCTACGAG GATATTGGCA AGGCGGCTTT
|
121CTCTGTGGTC CGACGCTGTG TCAAGCTCTG CACCGGCCAT GACTATGCAG CCAAGATCAT
|
181CAACACCAAG AAGCTGTCAG CCAGAGATCA CCAGAAGCTG GAGAGACAGG CTCGGATCTG
|
241CCGCCTTGTG AAGCATTCCA ACATCGTGCG TCTCCACGAC AGCATCTCCG AGGAGGGCTT
|
301CCACTACCTG GTCTTCGATC TGGTCACTGG TGGGGAGCTC TTTGAAGACA TTGTGGCGAG
|
361AGAGTACTAC AGCGAGGCTG ATGCCAGTCA CTGTATCCAG CAGATCCTGK AGGCCGTTCT
|
421CCATTGTCAC CAAATGGCCG TCCTCCACAG AGACCTCAAG CCGSAGAACC TGCTTCTGGC
|
481CAGCAAGTGC AAAGGGGCTG CAGTGAAGCT GGCAGACTTC GGCCTAGCTA TCGAGGTGCA
|
541GGGGGACCAG CAGGCATGGT TTGGTTTCGC TGGCACACCA GCCTACCTGT CCCCTGAGGT
|
601CCTTCGCAAA GAGGCGTACG GCAAGCCCGT GGACATCTGG GCATGTGGGG TGATCCTGTA
|
661CATCCTGCTC GTGGGCTACC CACCCTTCTG GGACGAGGAC CAGCACAAGC TGTACCAGCA
|
721GATCAAGGCT GGTGCCTATG ACTTCCCGTC CCCTGAGTGG GACACCGTCA CTCCTGAAGC
|
781CAAAAACCTC ATCAACCAGA TGCTGACCAT CAACCCTGCC AAGCGCATCA CAGCCCATGA
|
841GGCCCTGAAG CACCCGTGGG TCTGCCAACG CTCCACGGTA GCATCCATGA TGCACAGACA
|
901GGAGACTGTG GAGTGTCTGA AAAAGTTCAA TGCCAGGAGA AAGCTCAAGG GAGCCATCCT
|
961CACCACCATG CTGGCCACAC GGAATTTCTC AGTGGGCAGA CAGACCACCG CTCCGGCCAC
|
1021AATGTCCACC GCGGCCTCCG GCACCACCAT GGGGCTGGTG GAACAAGCCA AGAGTTTACT
|
1081CAACAAGAAA GCAGATGGAG TCAAGCCCCA GACGAATAGT ACCAAAAACA GTGCAGCCGC
|
1141CACCAGCCCC AAAGGGACGC TTCCTCCTGC CGCCCTGGAG CCTCAAACCA CCGTCATCCA
|
1201TAACCCAGTG GACGGGATTA AGGAGTCTTC TGACAGTGCC AATACCACCA TAGAGGATGA
|
1281AGACGCTAAA GCCCGGAAGC AGGAGATCAT TAAGACCACG GAGCAGCTCA TCGAGGCCGT
|
1321CAACAACGGT GACTTTGAGG CCTACGCGAA AATCTGTGAC CCAGGGCTGA CCTCGTTTGA
|
1381GCCTGAAGCA CTGGGCAACC TGGTTGAAGG GATGGACTTC CACAGATTCT ACTTCGAGAA
|
1441CCTGCTGGCC AAGAACAGCA AGCCGATCCA CACGACCATC CTGAACCCAC ACGTGCACGT
|
1501CATTGGAGAG GATGCCGCCT GCATCGCTTA CATCCGGCTC ACGCAGTACA TTGACGGGCA
|
1561GGGCCGGCCC CGCACCAGCC AGTCTGAGGA GACCCGCGTG TGGCACCGCC GCGACGGCAA
|
1621GTGGCAGAAC GTGCACTTCC ACTGCTCGGG CGCGCCTGTG GCCCCGCTGC AGTGAAGAGC
|
1681TGCGCCCTGG TTTCGCCGGA CAGAGTTGGT GTTTGGAGCC CGACTGCCCT CGGGCACACG
|
1741GCCTGCCTGT CGCATGTTTG TGTCTGCCTC GTTCCCTCCC CTGGTTCCTG TGTGTGCAGA
|
1801AAAACAAGAC CAGATGTGAT TTGTT
|
GENBANK ID: NM_001677.1
DEFINITION HOMO SAPIENS ATPASE, NA+K+TRANSPORTING, BETA 1 POLYPEPTIDE
(ATP1B1), MRNA.
VERSION NM_001677.1 GI:4502276
CDS 127..1038
1GAATTCATGC TAAATTGCTG GAAGGCTGCG TCTCTGCTGT GGTGTCAGTT CCGGATGCCT
|
61CATCGCCAGG GGCGCGCCGC AGCCACCCAC CCTCCGGACC GCGGCAGCTG CTGACCCGCC
|
121ATCGCCATGG CCCGCGGGAA AGCCAAGGAG GAGGGCAGCT GGAAGAAATT CATCTGGAAC
|
181TCAGAGAAGA AGGAGTTTCT GGGCAGGACC GGTGGCAGTT GGTTTAAGAT CCTTCTATTC
|
241TACGTAATAT TTTATGGCTG CCTGGCTGGC ATCTTCATCG GAACCATCCA AGTGATGCTG
|
301CTCACCATCA GTGAATTTAA GCCCACATAT CAGGACCGAG TGGCCCCGCC AGGATTAACA
|
361CAGATTCCTC AGATCCAGAA GACTGAAATT TCCTTTCGTC CTAATGATCC CAAGAGCTAT
|
421GAGGCATATG TACTGAACAT AGTTAGGTTC CTGGAAAAGT ACAAAGATTC AGCCCAGAGG
|
481GATGACATGA TTTTTGAAGA TTGTGGCGAT GTGCCCAGTG AACCGAAAGA ACGAGGAGAC
|
541TTTAATCATG AACGAGGAGA GCGAAAGGTC TGCAGATTCA AGCTTGAATG GCTGGGAAAT
|
601TGCTCTGGAT TAAATGATGA AACTTATGGC TACAAAGAGG GCAAACCGTG CATTATTATA
|
661AAGCTCAACC GAGTTCTAGG CTTCAAACCT AAGCCTCCCA AGAATGAGTC CTTGGAGACT
|
721TACCCAGTGA TGAAGTATAA CCCAAATGTC CTTCCCGTTC AGTGCACTGG CAAGCGAGAT
|
781GAAGATAAGG ATAAAGTTGG AAATGTGGAG TATTTTGGAC TGGGCAACTC CCCTGGTTTT
|
841CCTCTGCAGT ATTATCCGTA CTATGGCAAA CTCCTGCAGC CCAAATACCT GCAGCCCCTG
|
901CTGGCCGTAC AGTTCACCAA TCTTACCATG GACACTGAAA TTCGCATAGA GTGTAAGGCG
|
961TACCGTGAGA ACATTGGGTA CAGTGAGAAA GACCGTTTTC AGGGACGTTT TGATGTAAAA
|
1021ATTGAAGTTA AGAGCTGATC ACAAGCACAA ATCTTTCCCA CTAGCCATTT AATAAGTTAA
|
1081AAAAAGATAC AAAAACAAAA ACCTACTAGT CTTGAACAAA CTGTCATACG TATGGGACCT
|
1141ACACTTAATC TATATGCTTT ACACTAGCTT TCTGCATTTA ATAGGTTAGA ATGTAAATTA
|
1201AAGTGTAGCA ATAGCAACAA AATATTTATT CTACTGTAAA TGACAAAAGA AAAAGAAAAA
|
1261TTGAGCCTTG GGACGTGCCC ATTTTTACTG TAAATTATGA TTCCGTAACT GACCTTGTAG
|
1321TAAGCAGTGT TTCTGGCCCC TAAGTATTGC TGCCTTGTGT ATTTTATTTA GTGTACAGTA
|
1381CTACAGGTGC ATACTCTGGT CATTTTTCAA GCCATGTTTT ATTGTATCTG TTTTCTACTT
|
1441TATGTGAGCA AGGTTTGCTG TCCAAGGTGT AAATATTCAA CGGGAATAAA ACTGGCATGG
|
1501TAATTTTTTT TTTTTGTTTG TTTTTTGTTT TTTGGCTCTT TCAAAGGTAA TGGCCCATCG
|
1561ATGAGCATTT TTAACATACT CCATAGTCTT TTCCTGTGGT GTTAGGTCTT TATTTTTATT
|
1621TTTTTCCTGG GGGCTGGGGT CGGGGTTTGT CATGGGGGAA CTGCCCTTTA AATTTTAAGT
|
1681GACACTACAG AAAAACACAA AAAGGTGATG GGTTGTGTTA TGCTTGTATT GAATCCTGTC
|
1741TTGACATCTC TTGCCTTGTC CTCCGGTATG TTCTAAAGCT GTGTCTGAGA TCTGGATCTG
|
1801CCCATCACTT TGGCCTAGGG ACAGGGCTAA TTAATTTGCT TTATACATTT TCTTTTACTT
|
1861TCCTTTTTTC CTTTCTGGAG GCATCACATG CTGGTGCTGT GTCTTTATGA ATGTTTTAAC
|
1921CATTTTCATG GTGGAAGAAT TTTATATTTA TGCAGTTGTA CAATTTTATT TTTTTCTGCA
|
1981AGAAAAAGTG TAATGTATGA AATAAACCAA AGTCACTTGT TTGAAAATAA ATCTTTATTT
|
2041TGAACTTTAT AAAAGCAATG CAGTACCCCA TAGACTGGTG TTAAATGTTG TCTACACTGC
|
2101AAAATCCATG TTCTAACATA TGTAATAATT GCCAGGAGTA CAGTGCTCTT GTTGATCTTG
|
2161TATTCAGTCA GGTTAAAACA ACGGACAATA AAAGAATGAA CCGAATTC
|
GENBANK ID: U82535.1
VERSION U82535.1 GI:2149155
CDS 36..1775
/CODON_START=1
MVQYELWAALPGASGVALACCFVAAAVALRWSGRRTARGAVVRA
|
RQKQRAGLENMDRAAQRFRLQNPDLDSEALLALPLFQLVQKLHSRELAPEAVLFTYVG
|
KAWEVNKGTNCVTSYLADCETQLSQAPRQGLLYGVPVSLKECFTYKGQDSTLGLSLNE
|
GVPAECDSVVVHVLKLQGAVPFVHTNVPQSMFSYDCSNPLFGQTVNPWKSSKSPGGSS
|
GGEGALIGSGGSPLGLGTDIGGSIRFPSSFCGICGLKPTGNRLSKSGLKGCVYGQEAV
|
RLSVGPNARDVESLALCLRALLCEDMFRLDPTVPPLPFREEVYTSSQPLRVGYYETDN
|
YTMPSPAMRRAVLETKQSLEAAGHTLVPFLPSNIPHALETLSTGGLFSDGGHTFLQNF
|
KGDFVDPCLGDLVSILKLPQWLKGLLAFLVKPLLPRLSAFLSNMKSRSAGKLWELQHE
|
IEVYRKTVIAQWRALDLDVVLTPMLAPALDLNAPGRATGAVSYTMLYNCLDFPAGVVP
|
VTTVTAEDEAQMEHYRGYFGDINDKNLQKGMKKSVGLPVAVQCVALPWQEELCLRFMR
|
EVERLMTPEKQSS
|
GENBANK ID: NM_000789.1
DEFINITION HOMO SAPIENS DIPEPTIDYL CARBOXYPEPTIDASE 1 (ANGIOTENSIN I
CONVERTING ENZYME) (ACE), MRNA.
VERSION NM_000789.1 GI:4503272
CDS 23..3943
1GCCGAGCACC GCGCACCGCG TCATGGGGGC CGCCTCGGGC CGCCGGGGGC CGGGGCTGCT
|
61GCTGCCGCTG CCGCTGCTGT TGCTGCTGCC GCCGCAGCCC GCCCTGGCGT TGGACCCCGG
|
121GCTGCAGCCC GGCAACTTTT CTGCTGACGA GGCCGGGGCG CAGCTCTTCG CGCAGAGCTA
|
181CAACTCCAGC GCCGAACAGG TGCTGTTCCA GAGCGTGGCC GCCAGCTGGG CGCACGACAC
|
241CAACATCACC GCGGAGAATG CAAGGCGCCA GGAGGAAGCA GCCCTGCTCA GCCAGGAGTT
|
301TGCGGAGGCC TGGGGCCAGA AGGCCAAGGA GCTGTATGAA CCGATCTGGC AGAACTTCAC
|
361GGACCCGCAG CTGCGCAGGA TCATCGGAGC TGTGCGAACC CTGGGCTCTG CCAACCTGCC
|
421CCTGGCTAAG CGGCAGCAGT ACAACGCCCT GCTAAGCAAC ATGAGCAGGA TCTACTCCAC
|
481CGCCAAGGTC TGCCTCCCCA ACAAGACTGC CACCTGCTGG TCCCTGGACC CAGATCTCAC
|
541CAACATCCTG GCTTCCTCGC GAAGCTACGC CATGCTCCTG TTTGCCTGGG AGGGCTGGCA
|
601CAACGCTGCG GGCATCCCGC TGAAACCGCT GTACGAGGAT TTCACTGCCC TCAGCAATGA
|
661AGCCTACAAG CAGGACGGCT TCACAGACAC GGGGGCCTAC TGGCGCTCCT GGTACAACTC
|
721CCCCACCTTC GAGGACGATC TGGAACACCT CTACCAACAG CTAGAGCCCC TCTACCTGAA
|
781CCTCCATGCC TTCGTCCGCC GCGCACTGCA TCGCCGATAC GGAGACAGAT ACATCAACCT
|
841CAGGGGACGC ATCCCTGCTC ATCTGCTGGG AGACATGTGG GCCCAGAGCT GGGAAAACAT
|
901CTACGACATG GTGGTGCCTT TCCCAGACAA GCCCAACCTC GATGTCACCA GTACTATGCT
|
961GCAGCAGGGC TGGAACGCCA CGCACATGTT CCGGGTGGCA GAGGAGTTCT TCACCTCCCT
|
1021GGAGCTCTCC CCCATGCCTC CCGAGTTCTG GGAAGGGTCG ATGCTGGAGA AGCCGGCCGA
|
1081CGGGCGGGAA GTGGTGTGCC ACGCCTCGGC TTGGGACTTC TACAACAGGA AAGACTTCAG
|
1141GATCAAGCAG TGCACACGGG TCACGATGGA CCAGCTCTCC ACAGTGCACC ATGAGATGGG
|
1201CCATATACAG TACTACCTGC AGTACAAGGA TCTGCCCGTC TCCCTGCGTC GGGGGGCCAA
|
1261CCCCGGCTTC CATGAGGCCA TTGGGGACGT GCTGGCGCTC TCGGTCTCCA CTCCTGAACA
|
1321TCTGCACAAA ATCGGCCTGC TGGACCGTGT CACCAATGAC ACGGAAAGTG ACATCAATTA
|
1381CTTGCTAAAA ATGGCACTGG AAAAAATTGC CTTCCTGCCC TTTGGCTACT TGGTGGACCA
|
1441GTGGCGCTGG GGGGTCTTTA GTGGGCGTAC CCCCCCTTCC CGCTACAACT TCGACTGGTG
|
1501GTATCTTCGA ACCAAGTATC AGGGGATCTG TCCTCCTGTT ACCCGAAACG AAACCCACTT
|
1561TGATGCTGGA GCTAAGTTTC ATGTTCCAAA TGTGACACCA TACATCAGGT ACTTTGTGAG
|
1621TTTTGTCCTG CAGTTCCAGT TCCATGAAGC CCTGTGCAAG GAGGCAGGCT ATGAGGGCCC
|
1681ACTGCACCAG TGTGACATCT ACCGGTCCAC CAAGGCAGGG GCCAAGCTCC GGAAGGTGCT
|
1741GCAGGCTGGC TCCTCCAGGC CCTGGCAGGA GGTGCTGAAG GACATGGTCG GCTTAGATGC
|
1801CCTGGATGCC CAGCCGCTGC TCAAGTACTT CCAGCCAGTC ACCCAGTGGC TGCAGGAGCA
|
1861GAACCAGCAG AACGGCGAGG TCCTGGGCTC GCCCGAGTAC CAGTGGCACC CGCCGTTGCC
|
1921TGACAACTAC CCGGAGGGCA TAGACCTGGT GACTGATGAG GCTCAGGCCA CCAAGTTTGT
|
1981GGAGGAATAT GACCGGACAT CCCAGGTGGT GTGGAACGAG TATGCCGAGG CCAACTGGAA
|
2041CTACAACACC AACATCACCA CAGACACCAG CAAGATTCTG CTGCAGAAGA ACATGCAAAT
|
2101AGCCAACCAC ACCCTGAAGT ACGGCACCCA GGCCAGGAAG TTTGATGTGA ACCAGTTGCA
|
2161GAACACCACT ATCAAGCGGA TCATAAAGAA GGTTCAGGAC CTAGAACGGG CAGCGCTGCC
|
2221TGCCCAGGAG CTGGAGGAGT ACAACAAGAT CCTGTTGGAT ATGGAAACCA CCTACAGCGT
|
2281GGCCACTGTG TGCCACCCGA ATGGCAGCTG CCTGCAGCTC GAGCCAGATC TGACGAATGT
|
2341GATGGCCACA TCCCGGAAAT ATGAAGACCT GTTATGGGCA TGGGAGGGCT GGCGAGACAA
|
2401GGCGGGGAGA GCCATCCTCC AGTTTTACCC GAAATACGTG GAACTCATCA ACCAGGCTGC
|
2461CCGGCTCAAT GGCTATGTAG ATGCAGGGGA CTCGTGGAGG TCTATGTACG AGACACCATC
|
2521CCTGGAGCAA GACCTGGAGC GGCTCTTCCA GGAGCTGCAG CCACTCTACC TCAACCTGCA
|
2581TGCCTACGTG CGCCGGGCCC TGCACCGTCA CTACGGGGCC CAGCACATCA ACCTGGAGGG
|
2641GCCCATTCCT GCTCACCTGC TGGGGAACAT GTGGGCGCAG ACCTGGTCCA ACATCTATGA
|
2701CTTGGTGGTG CCCTTCCCTT CAGCCCCCTC GATGGACACC ACAGAGGCTA TGCTAAAGCA
|
2761GGGCTGGACG CCCAGGAGGA TGTTTAAGGA GGCTGATGAT TTCTTCACCT CCCTGGGGCT
|
2821GCTGCCCGTG CCTCCTGAGT TCTGGAACAA GTCGATGCTG GAGAAGCCAA CCGACGGGCG
|
2881GGAGGTGGTC TGCCACGCCT CGGCCTGGGA CTTCTACAAC GGCAAGGACT TCCGGATCAA
|
2941GCAGTGCACC ACCGTGAACT TGGAGGACCT GGTGGTGGCC CACCACGAAA TGGGCCACAT
|
3001CCAGTATTTC ATGCAGTACA AAGACTTACC TGTGGCCTTG AGGGAGGGTG CCAACCCCGG
|
3061CTTCCATGAG GCCATTGGGG ACGTGCTAGC CCTCTCAGTG TCTACGCCCA AGCACCTGCA
|
3121CAGTCTCAAC CTGCTGAGCA GTGAGGGTGG CAGCGACGAG CATGACATCA ACTTTCTGAT
|
3181GAAGATGGCC CTTGACAAGA TCGCCTTTAT CCCCTTCAGC TACCTCGTCG ATCAGTGGCG
|
3241CTGGAGGGTA TTTGATGGAA GCATCACCAA GGAGAACTAT AACCAGGAGT GGTGGAGCCT
|
3301CAGGCTGAAG TACCAGGGCC TCTGCCCCCC AGTGCCCAGG ACTCAAGGTG ACTTTGACCC
|
3361AGGGGCCAAG TTCCACATTC CTTCTAGCGT GCCTTACATC AGGTACTTTG TCAGCTTCAT
|
3421CATCCAGTTC CAGTTCCACG AGGCACTGTG CCAGGCAGCT GGCCACACGG GCCCCCTGCA
|
3481CAAGTGTGAC ATGTACCACT CCAAGGAGGC CGGGCAGCGC CTGGCGACCG CCATGAAGCT
|
3541GGGCTTCAGT AGGCCGTGGC CGGAAGCCAT GCAGCTGATC ACGGGCCAGC CCAACATGAG
|
3601CGCCTCGGCC ATGTTGAGCT ACTTCAAGCC GCTGCTGGAC TGGCTCCGCA CGGAGAACGA
|
3661GCTGCATGGG GAGAAGCTGG GCTGGCCGCA GTACAACTGG ACGCCGAACT CCGCTCGCTC
|
3721AGAAGGGCCC CTCCCAGACA GCGGCCGCGT CAGCTTCCTG GGCCTGGACC TGGATGCGCA
|
3781GCAGGCCCGC GTGGGCCAGT GGCTGCTGCT CTTCCTGGGC ATCGCCCTGC TGGTAGCCAC
|
3841CCTGGGCCTC AGCCAGCGGC TCTTCAGCAT CCGCCACCGC AGCCTCCACC GGCACTCCCA
|
3901CGGGCCCCAG TTCGGCTCCG AGGTGGAGCT GAGACACTCC TGAGGTGACC CGGCTGGGTC
|
3961GGCCCTGCCC AAGGGCCTCC CACCAGAGAC TGGGATGGGA ACACTGGTGG GCAGCTGAGG
|
GENBANK ID: XM_052144.2
DEFINITION HOMO SAPIENS APOLIPOPROTEIN A-IV (APOA4), MRNA.
VERSION XM_052144.2 GI:15314431
CDS 114..1304
/CODON_START=1
1AGTTCCCACT GCAGCGCAGG TGAGCTCTCC TGAGGACCTC TCTGTCAGCT CCCCTGATTG
|
61TAGGGAGGAT CCAGTGTGGC AAGAAACTCC TCCAGCCCAG CAAGCAGCTC AGGATGTTCC
|
121TGAAGGCCGT GGTCCTGACC CTGGCCCTGG TGGCTGTCGC CGGAGCCAGG GCTGAGGTCA
|
181GTGCTGACCA GGTGGCCACA GTGATGTGGG ACTACTTCAG CCAGCTGAGC AACAATGCCA
|
241AGGAGGCCGT GGAACATCTC CAGAAATCTG AACTCACCCA GCAACTCAAT GCCCTCTTCC
|
301AGGACAAACT TGGAGAAGTG AACACTTACG CAGGTGACCT GCAGAAGAAG CTGGTGCCCT
|
361TTGCCACCGA GCTGCATGAA CGCCTGGCCA AGGACTCGGA GAAACTGAAG GAGGAGATTG
|
421GGAAGGAGCT GGAGGAGCTG AGGGCCCGGC TGCTCCGCCA TGCCAATGAG GTGAGCCAGA
|
481AGATGGGGGA CAACCTGCGA GAGCTTCAGC AGCGCCTGGA GCCCTACGCG GACCAGCTGC
|
541GCACCCAGGT CAACACGCAG GCCGAGCAGC TGCGGCGCCA GCTGACCCCC TACGCACAGC
|
601GCATGGAGAG AGTGCTGCGG GAGAACGCCG ACAGCCTGCA GGCCTCGCTG AGGCCCCACG
|
661CCGACGAGCT CAAGGCCAAG ATCGACCAGA ACGTGGAGGA GCTCAAGGGA CGCCTTACGC
|
721CCTACGCTGA CGAATTCAAA GTCAAGATTG ACCAGACCGT GGAGGAGCTG CGCCGCAGCC
|
781TGGCTCCCTA TGCTCAGGAC ACGCAGGAGA AGCTCAACCA CCAGCTTGAG GGCCTGACCT
|
841TCCAGATGAA GAAGAACGCC GAGGAGCTCA AGGCCAGGAT CTCGGCCAGT GCCGAGGAGC
|
901TGCGGCAGAG GCTGGCGCCC TTGGCCGAGG ACGTGCGTGG CAACCTGAGG GGCAACACCG
|
961AGGGGCTGCA GAAGTCACTG GCAGAGCTGG GTGGGCACCT GGACCAGCAG GTGGAGGAGT
|
1021TCCGACGCCG GGTGGAGCCC TACGGGGAAA ACTTCAACAA AGCCCTGGTG CAGCAGATGG
|
1081AACAGCTCAG GCAGAAACTG GGCCCCCATG CGGGGGACGT GGAAGGCCAC TTGAGCTTCC
|
1141TGGAGAAGGA CCTGAGGGAC AAGGTCAACT CCTTCTTCAG CACCTTCAAG GAGAAAGAGA
|
1201GCCAGGACAA GACTCTCTCC CTCCCTGAGC TGGAGCAACA GCAGGAACAG CAGCAGGAGC
|
1261AGCAGCAGGA GCAGGTGCAG ATGCTGGCCC CTTTGGAGAG CTGAGCTGCC CCTGGTGCAC
|
1321TGGCCCCACC CTCGTGGACA CCTGCCCTGC CCTGCCACCT GTCTGTCTGT CTGTCCCAAA
|
1381GAAGTTCTGG TATGAACTTG AGGACACATG TCCAGTGGGA GGTGAGACCA CCTCTCAATA
|
1441TTCAATAAAG CTGCTGAGAA TCTAGCCTC
|
GENBANK ID: M29366.1
DEFINITION HUMAN EFIDERMAL GROWTH FACTOR RECEPTOR (ERBB3) MRNA, COMPLETE
CDS.
VERSION M29366.1 GI:181979
CDS 100..4128
/CODON_START=1
1ACCAATTCGC CAGCGGTTCA GGTGGCTCTT GCCTCGATGT CCTAGCCTAG GGGCCCCCGG
|
61GCCGGACTTG GCTGGGCTCC CTTCACCCTC TGCGGAGTCA TGAGGGCGAA CGACGCTCTG
|
121CAGGTGCTGG GCTTGCTTTT CAGCCTGGCC CGGGGCTCCG AGGTGGGCAA CTCTCAGGCA
|
181GTGTGTCCTG GGACTCTGAA TGGCCTGAGT GTGACCGGCG ATGCTGAGAA CCAATACCAG
|
241ACACTGTACA AGCTCTACGA GAGGTGTGAG GTGGTGATGG GGAACCTTGA GATTGTGCTC
|
301ACGGGACACA ATGCCGACCT CTCCTTCCTG CAGTGGATTC GAGAAGTGAC AGGCTATGTC
|
361CTCGTGGCCA TGAATGAATT CTCTACTCTA CCATTGCCCA ACCTCCGCGT GGTGCGAGGG
|
421ACCCAGGTCT ACGATGGGAA GTTTGCCATC TTCGTCATGT TGAACTATAA CACCAACTCC
|
481AGCCACGCTC TGCGCCAGCT CCGCTTGACT CAGCTCACCG AGATTCTGTC AGGGGGTGTT
|
541TATATTGAGA AGAACGATAA GCTTTGTCAC ATGGACACAA TTGACTGGAG GGACATCGTG
|
601AGGGACCGAG ATGCTGAGAT AGTGGTGAAG GACAATGGCA GAAGCTGTCC CCCCTGTCAT
|
661GAGGTTTGCA AGGGGCGATG CTGGGGTCCT GGATCAGAAG ACTGCCAGAC ATTGACCAAG
|
721ACCATCTGTG CTCCTCAGTG TAATGGTCAC TGCTTTGGGC CCAACCCCAA CCAGTGCTGC
|
781CATGATGAGT GTGCCGGGGG CTGCTCAGGC CCTCAGGACA CAGACTGCTT TGCCTGCCGG
|
841CACTTCAATG ACAGTGGAGC CTGTGTACCT CGCTGTCCAC AGCCTCTTGT CTACAACAAG
|
901CTAACTTTCC AGCTGGAACC CAATCCCCAC ACCAAGTATC AGTATGGAGG AGTTTGTGTA
|
961GCCAGCTGTC CCCATAACTT TGTGGTGGAT CAAACATCCT GTGTCAGGGC CTGTCCTCCT
|
1021GACAAGATGG AAGTAGATAA AAATGGGCTC AAGATGTGTG AGCCTTGTGG GGGACTATGT
|
1081CCCAAAGCCT GTGAGGGAAC AGGCTCTGGG AGCCGCTTCC AGACTGTGGA CTCGAGCAAC
|
1141ATTGATGGAT TTGTGAACTG CACCAAGATC CTGGGCAACC TGGACTTTCT GATCACCGGC
|
1201CTCAATGGAG ACCCCTGGCA CAAGATCCCT GCCCTGGACC CAGAGAAGCT CAATGTCTTC
|
1261CGGACAGTAC GGGAGATCAC AGGTTACCTG AACATCCAGT CCTGGCCGCC CCACATGCAC
|
1321AACTTCAGTG TTTTTTCCAA TTTGACAACC ATTGGAGGCA GAAGCCTCTA CAACCGGGGC
|
1381TTCTCATTGT TGATCATGAA GAACTTGAAT GTCACATCTC TGGGCTTCCG ATCCCTGAAG
|
1441GAAATTAGTG CTGGGCGTAT CTATATAAGT GCCAATAGGC AGCTCTGCTA CCACCACTCT
|
1501TTGAACTGGA CCAAGGTGCT TCGGGGGCCT ACGGAAGAGC GACTAGACAT CAAGCATAAT
|
1561CGGCCGCGCA GAGACTGCGT GGCAGAGGGC AAAGTGTGTG ACCCACTGTG CTCCTCTGGG
|
1621GGATGCTGGG GCCCAGGCCC TGGTCAGTGC TTGTCCTGTC GAAATTATAG CCGAGGAGGT
|
1681GTCTGTGTGA CCCACTGCAA CTTTCTGAAT GGGGAGCCTC GAGAATTTGC CCATGAGGCC
|
1741GAATGCTTCT CCTGCCACCC GGAATGCCAA CCCATGGAGG GCACTGCCAC ATGCAATGGC
|
1801TCGGGCTCTG ATACTTGTGC TCAATGTGCC CATTTTCGAG ATGGGCCCCA CTGTGTGAGC
|
1861AGCTGCCCCC ATGGAGTCCT AGGTGCCAAG GGCCCAATCT ACAAGTACCC AGATGTTCAG
|
1921AATGAATGTC GGCCCTGCCA TGAGAACTGC ACCCAGGGGT GTAAAGGACC AGAGCTTCAA
|
1981GACTGTTTAG GACAAACACT GGTGCTGATC GGCAAAACCC ATCTCACAAT GGCTTTGACA
|
2041GTGATAGCAG GATTGGTAGT GATTTTCATG ATGCTGGGCG GCACTTTTCT CTACTGGCGT
|
2101GGGCGCCGGA TTCAGAATAA AAGGGCTATG AGGCGATACT TGGAACGGGG TGAGAGCATA
|
2161GAGCCTCTGG ACCCCAGTGA GAAGGCTAAC AAAGTCTTGG CCAGAATCTT CAAAGAGACA
|
2221GAGCTAAGGA AGCTTAAAGT GCTTGGCTCG GGTGTCTTTG GAACTGTGCA CAAAGGAGTG
|
2281TGGATCCCTG AGGGTGAATC AATCAAGATT CCAGTCTGCA TTAAAGTCAT TGAGGACAAG
|
2341AGTGGACGGC AGAGTTTTCA AGCTGTGACA GATCATATGC TGGCCATTGG CAGCCTGGAC
|
2401CATCCCCACA TTGTAAGGCT GCTGGGACTA TGCCCAGGGT CATCTCTGCA GCTTGTCACT
|
2461CAATATTTGC CTCTGGGTTC TCTGCTGGAT CATGTGAGAC AACACCGGGG GGCACTGGGG
|
2521CCACAGCTGC TGCTCAACTG GGGAGTACAA ATTGCCAAGG GAATGTACTA CCTTGAGGAA
|
2581CATGGTATGG TGCATAGAAA CCTGGCTGCC CGAAACGTGC TACTCAAGTC ACCCAGTCAG
|
2641GTTCAGGTGG CAGATTTTGG TGTGGCTGAC CTGCTGCCTC CTGATGATAA GCAGCTGCTA
|
2701TACAGTGAGG CCAAGACTCC AATTAAGTGG ATGGCCCTTG AGAGTATCCA CTTTGGGAAA
|
2761TACACACACC AGAGTGATGT CTGGAGCTAT GGTGTGACAG TTTGGGAGTT GATGACCTTC
|
2821GGGGCAGAGC CCTATGCAGG GCTACGATTG GCTGAAGTAC CAGACCTGCT AGAGAAGGGG
|
2881GAGCGGTTGG CACAGCCCCA GATCTGCACA ATTGATGTCT ACATGGTGAT GGTCAAGTGT
|
2941TGGATGATTG ATGAGAACAT TCGCCCAACC TTTAAAGAAC TAGCCAATGA GTTCACCAGG
|
3001ATGGCCCGAG ACCCACCACG GTATCTGGTC ATAAAGAGAG AGAGTGGGCC TGGAATAGCC
|
3061CCTGGGCCAG AGCCCCATGG TCTGACAAAC AAGAAGCTAG AGGAAGTAGA GCTGGAGCCA
|
3121GAACTAGACC TAGACCTAGA CTTGGAAGCA GAGGAGGACA ACCTGGCAAC CACCACACIG
|
3181GGCTCCGCCC TCAGCCTACC AGTTGGAACA CTTAATCGGC CACGTGGGAG CCAGAGCCTT
|
3241TTAAGTCCAT CATCTGGATA CATGCCCATG AACCAGGGTA ATCTTGGGCA GTCTTGCCAG
|
3301GAGTCTGCAG TTTCTGGGAG CAGTGAACGG TGCCCCCGTC CAGTCTCTCT ACACCCAATC
|
3361CCACGGGGAT GCCTGGCATC AGAGTCATCA GAGGGGCATG TAACAGGCTC TGAGGCTGAG
|
3421CTCCAGCAGA AAGTGTCAAT GTGTAGAAGC CCGAGCAGCA GGCGGAGGCG ACGGCCACGC
|
3481GGAGATAGGG CCTACCATTC CCAGCGCCAC AGTCTGCTGA CTCCTGTTAC CCCACTCTCC
|
3541CCACCCGGGT TAGAGGAAGA GGATGTCAAC GGTTATGTCA TGCCAGATAC ACACCTCAAA
|
3601GGTACTCCCT CCTCCCGGGA AGGCACCCTT TCTTCAGTGG GTCTTAGTTC TGTCCTGGGT
|
3661ACTGAAGAAG AAGATGAAGA TGAGGAGTAT GAATACATGA ACCGGAGGAG AAGGCACAGT
|
3721CCACCTCATC CCCCTAGGCC AAGTTCCCTT GAGGAGCTGG GTTATGAGTA CATGGATGTG
|
3781GGGTCAGACC TCAGTGCCTC TCTGGGCAGC ACACAGAGTT GCCCACTCCA CGCTGTACGC
|
3841ATCATGCCCA CTGCAGGCAC AACTCCAGAT GAAGACTATG AATATATGAA TCGGCAACGA
|
3901GATGGAGGTG GTCCTGGGGG TGATTATGCA GCCATGGGGG CCTGCCCAGC ATCTGAGCAA
|
3961GGGTATGAAG AGATGAGAGC TTTTCAGGGG CCTGGACATC AGGCCCCCCA TGTCCATTAT
|
4021GCCCGCCTAA AAACTCTACG TAGCTTAGAG GCTACAGACT CTGCCTTTGA TAACCCTGAT
|
4081TACTGGCATA GCAGGCTTTT CCCCAAGGCT AATGCCCAGA GAACGTAACT CCTGCTCCCT
|
4141GTGGCACTCA GGGAGCATTT AATGGCAGCT AGTGCCTTTA GAGGGTACCG TCTTCTCCCT
|
4201ATTCCCTCTC TCTCCCAGGT CCCAGCCCCT TTTCCCCAGT CCCAGACAAT TCCATTCAAT
|
4261CTTTGGAGGC TTTTAAACAT TTTGACACAA AATTCTTATG GTATGTAGCC AGCTGTGCAC
|
4321TTTCTTCTCT TTCCCAACCC CAGGAAAGGT TTTCCTTATT TTGTGTGCTT TGCCAGTCGC
|
4381ATTCCTCAGC TTCTTCACAG GCACTCCTGG AGATATGAAG GATTACTCTC CATATCCCTT
|
4441CCTCTCAGGC TCTTGACTAC TTGGAACTAG GCTCTTATGT GTGCCTTTGT TTCCCATCAG
|
4501ACTGTCAAGA AGAGGAAAGG GAGGAAACCT AGCAGAGGAA AGTGTAATTT TGGTTTATGA
|
4561CTCTTAACCC CCTAGAAAGA CAGAAGCTTA AAATCTGTGA AGAAAGAGGT TAGGAGTAGA
|
4621TATTGATTAC TATCATAATT CAGCACTTAA CTATGAGCCA GGCATCATAC TAAACTTCAC
|
4681CTACATTATC TCACTTAGTC CTTTATCATC CTTAAAACAA TTCTGTGACA TACATATTAT
|
4741CTCATTTTAC ACAAAGGGAA GTCGGGCATG GTGGCTCATG CCTGTAATCT CAGCACTTTG
|
4801GGAGGCTGAG GCAGAAGGAT TACCTGAGGC AAGGAGTTTG AGACCAGCTT AGCCAACATA
|
4861GTAAGACCCC CATCTCTTT
|
GENBANK ID: X54686
VERSION X54686.1 GI:56909
MCTKMEQAFYHDDSYAAAGYGRSPGSLSLHDYKLLKPTLALNLA
|
DPYRGLEGPGARGPGPEGSGAGSYFSGQGSDTGASLKLASTELERLIVPNSNGVITTT
|
PTPPGQYPYPRGGGSGGGTGGGVTEEQEGFADGFVKALDDLQKMNHVTPPNVSLGASG
|
GPQAGPGGVYAGPEPPPVYTNLSSYSPASAPSGGSGTAVGTGSSYPTATISYLPHAPP
|
FAGGNPAQLGLSRGASAFKEEPQTVPEARSRDATPPVSPINMEDQERIKVERKRLRNR
|
LAATKCRKRKLERIARLEDKVKTLKAENAGLSSAAGLLREQVAQLKQKVMTHVSNGCQ
|
LLLGVKGHAF
|
GENBANK ID: D26307
VERSION D26307.1 GI:450471
METPFYGEEALSGLAAGASSVAGAAGAPGGGGPAPPGRAFPGAP
|
PTSSNLKKQALTLSLAEQGAAGLKPGSATAPSALRPDGAPDGLLASPDLGLLKLASPE
|
LERLIIQSNGLVTTTPTSTQFLYPKVAASEEQEFAEGFVKALEDLHKQSQLGAATAAT
|
SGAPAPPAPADLAATPGATETPVYANLSSFAGGAGPPGGAATVAFAAEPVPFPPPPGA
|
LGPPPPPHPPRLAALKDEPQTVPDVPSFGDSPPLSPIDMDTQERIKAERKRLRNRIAA
|
SKCRKRKLERISRLEEKVKTLKSQNTELASTASLLREQVAQLKQKVLSHVNSGCQLLP
|
QHQVPAY
|
GENBANK ID: NM_012747.1
VERSION NM_012747.1 GI:6981591
MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWA
|
YAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPMEIA
|
RIVARCLWEESRLLQTAATAAQQGGQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQ
|
KMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIV
|
SELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQ
|
TRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVDLFRNLMKSAFVVERQPCMPMHPD
|
RPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTK
|
VMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGL
|
KIDLETHSLPVVVISNICQMPNAMASILWYNMLTNNPKNVNFFTKPPIGTWDQVAEVL
|
SWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLD
|
NIIDLVKKYILALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEGGVTPTWV
|
EKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEA
|
FGKYCRPESQEHPEADPGSAAPYLKTKFICVTPTTCSNTIDLPMSPRTLDSLMQFGNN
|
GEGAEPSAGGQFESLTFDMDLTSECATSPM
|
GENBANK
ID: L26267.1
VERSION L26267.1 GI:425471
REILNPPEKETQGEGPSLFMASTKTEAIAPASTMEDKEEDVGFQ
|
DNLFLEKALQLAKRHANALFDYAVTGDVKNLLAVQRHLTAVQDEN0DSVLHLAIIHLE
|
AQLVRDLLEVTSGSISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRVGADLSLLDR
|
WGNSVLHLAAKEGHDKILGVLLKNSKAALLINHPNGEGLNAIHIAVMSNSLSCLQLLV
|
AAGAEVNAQEQKSGRTALHLAVEYDNISLAGCLLLEGDALVDSTTYDGTTPLHIAAGR
|
GSTRLAALLKAAGADPLVENFEPLYDLDDSWEKAGEDEGVVPGTTFLDMAANWQVFDI
|
LNGKFYEFVFTSDDILPQGDIKQLTEDTRLQLCKLLEIFDPDKNNATLAQKLGLGILN
|
NAFRLSFAPSKTLMDNYEVSGGTIKELVEALRQMGYTEAIEVIQAAFRTPETTASSPV
|
TTAQAHLLPLSSSSTRQHIDELRDNDSVCDSGVETSFRKLSFSESLTGDGPLLSLNKM
|
FHNYGQDGPIEGKI
|
GENEANK ID:
M3435 6.1
VERSION M34356.1 GI:181042
MTMESGAENQQSGDAAVTEAENQQMTVQAQFQIATLAQVSMPAA
|
HATSSAPTVTLVQLPNGQTVQVHGVIQAAQFSVIQSPQVQTVQISTIAESEDSQESVD
|
SVTDSQKRREILSRRPSYRKILNDLSSDAFGVFRIEEEKSEEETSAFAITTVTVPTPI
|
YQTSSGQYIAITQGGAIQLANNGTDGVQGLQTLTMTNAAATQPGTTILQYAQTTDGQQ
|
ILVPSNQVVVQAASGDVQTYQIRTAPTSTIAFGVVMASSPALPTQPAEEAARKREVRL
|
MKNREAARECRRKKKEYVKCLENRVAVLENQNKTLIEELKALKDYCHKSD
|
GENBANK ID:
X68193.1
VERSION X68193.1 GI:53353
MANLERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVAMKFLRAS
|
EEHLEQEYIDLKDRPFFFGLVKYMNSGPVVAMVWEGLNVVKTGRVNLGETNPADSKFG
|
TIRGDFCIQVGRNIIHGSDSVESAEKEIHLWFKPEELIDYKSCAHDWVYE
|
GENBANK
ID: U29200.1
VERSION U29200.1 GI:924934
MANLERTFIAIKPDGVQR
|
GENBANK ID: L35572
VERSION L35572.1 GI:531219
MNVHCAGCERFILDRFLLNVLDRAWHIKCVQCCECKTNLSEKCF
|
SREGKLYCKNDFFRRFGTKCAGCAQGISPSDLVRKARSKVFHLNCFTCMVCNKQLSTG
|
EELYVIDENKFVCKDDYLSSSSLKEGSLNSVSSCTDRSLSPDLQDFLQDDPKETDNST
|
SSDKETANNENEEQNSGTKRRGFRTTIKAKQLETLKAAFAATFKFTRHIREQLAQETG
|
LNMRVIQVWFDNRRSKERRMKQLSALGARRHAFFRSPRRMRPLGGRLDESEMLGSTPY
|
TYYGDYGSDYVAPGGNYDFFAHGPPSQAQSPADSSFLAASGPGSTPLGALEPPLAGPH
|
GADNPRFTDMISHPDTPSPEPGLPGALHPNPGEVFSGGPSPPFPMSGTSGY5GPLSHP
|
NPELNEAAVW
|
GENBANK ID: X55787.1
VERSION X55797.1 GI:296022
MKAAVDLKPTLTIIKTEKVDLELFPSPENECADVPLSTPSSKEM
|
MSQALKSYFSGFTKEQQRRGIPKDPRQWTDTHVRDWVMAVNEFSLKGVDFHKFCMSG
|
AAVCALGKECFLELAPDFVGDILWEELEILQKEDVKPYQVNGANPTYPESCYTSVYFI
|
SYGIEHAQCVPPSEFSEPSFITESYQTLHPISSEELLSLKYENDYPSVILRDPLQTET
|
LQTDYFRIKQEVLTPNNMCLGRASRGKLGGQDSFESVESYDSCDRLTQSWSSQSSFNS
|
LQRVPSYDSFDYEDYPAALPNHKPKGTFKDYVRDRADLNKDKPVIPAAALAGYTGSGP
|
IQLWQFLLELLTDKSCQSFISWTGDCNEFKLSDPDEVARRWGKRKNKPSMNYEKLSRA
|
LRYYYDKNIIHKTAGNAYVYAFVCDLQSLLGYTPEELHAMLDVKPDAD
|
GENBANK ID: M11507.1
DEFINITION Human transferrln receptor
VERSION M11507.1 GI:339515
MMDQARSAFSNLFGGEFLSYTRFSLARQVDGDNSHVENKLAVDE
|
EENADNNTKANVTKPKRCSGSICYCTIAVIVFFLIGFMIGYLGYCKGVEPKTECERLA
|
GTESPVREEFGEDFFAARRLYWDDLKRKLSEKLQSTDFTSTIKLLNENSYVPREAGSQ
|
KDENLALYVENQFREFKLSKVWRDQHFVKTQVKDSAQNSVIIVDKNGRLVYLVENPGG
|
YVAYSKAATVTCKLVHANFGTKKDFEDLYTPVNCSTVIVRAGKITFAEKVPNAESLNA
|
IGVLIYMDQTKFFIVNAELSFFGHAHLGTGDPYTPGFPSFNHTQFPPSRSSGLPNIPV
|
QTISRAAAEKLFGNMEGDCPSDWKTDSTCRMVTSESKNVKLTVSNVLKEIKILNIFGV
|
IKCFVEPDNYVVVGAQRDAWGP0AAKSGVGTALLLKLAQMFSDNVLKQGFQFSRSIIF
|
ASWSAGDFGSVGATEWLEGYLSSLHLKAFTYINLDKAVLGTSNFKVSASPLLYTLIEK
|
TMQNVKHPVTGQFLYQDSNWASKVEKLTLDNAAFPFLAYSGIPAVSFCFCEDTDYPYL
|
GTTMDTYKELIERIPELNKVARAAAEVAGQFVIKLTHDVELNLDYERYNSQLLSFVRD
|
LNQYRADIKEMGLSLQWLYSARGDFFPATSRLTTDFGNAEKTDRFVMKKLNDRVMRVE
|
YHFLSPYVSPKESPFRHVFWGSGSHTLPALLENLKLRKQNNCAFNETLFRNQLALATW
|
TIQGAANALSGDVWDIDNEF
|
GENBANK ID: AAA60255
VERSION AAA60255.1 GI:190927
1mteyklvvvg aggvgksalt iqllqnhfvd eydptledsy rkqvvidget clldildtag
|
61qeeysamrdq ymrtgegflc vfainnsksf adlnlyreqi krvkdsddvp mvlvgnkcdl
|
121ptrtvdtkqa helaksygip fietsaktrq gvedafytlv reirqyrmkk lnssddgtgg
|
181cmglpcvvm
|
GENBANK ID: AAB38309
VERSION AAB38309.1 GI:1497931
1mslvlndlli ccrqlehdra terkkevekf krllrdpeti khldrhsdsk qgkylnwdav
|
61frflqkyiqk eteclrlakp nvsastqasr qkknqeissl vkytikcanr raprlkcqel
|
121lnyimdtvkd ssngalygad csnhllkdil svrkywceis qqqwlelfsv yfrlylkpsq
|
181dvhrvlvari ihavtkgccs qtdglnskkfl dffskaiqca rqeksssgln hilaaltifi
|
241ktlavnfrir vcelgdeilp tllyiwtqhr lndslkevii elfqlqiyih hpkgaktqek
|
301gayestkwrs ilynlydllv neishlgsrg kyssgfrnia vkenllelma dichqvfned
|
361trslelsqsy tttqressdy svpckrkkie lgwevikdhl qksqndfdlv pwlqiatqli
|
421skypaslpnc elspllmils qllpqqrhge rtpyvlrclt evalcqdkrs nlessqksdl
|
481lklwnkiwci tfrgisseqi qaenfgllga iiqgslvevd refwklftgs acrpscpavc
|
541cltlalttsi vpgtvkmgie qnmcevnrsf slkesimkwl ltyqlegdle nstevppilh
|
601snfphlvlek ilvslomknc kaamnffqsv pecehhqkdk eelsfsevee lflqttfdkm
|
661dfltivrecg iekhqssigf svhqnlkesl drcllglseq llnnysseit nsetlvrcsr
|
721llvgvlgcyc ymgviaeeea ykselfqkak slmqcaqesi tlfknktnee trigslrnmm
|
781qlctrclsnc tkkspnkias gfflrlltsk lmndiadick slasflkkpf firgevesmed
|
841dtngnlmeve dgssmnlfnd ypdssvsdan epgesqstig ainplaeeyl skgdllfldm
|
901lkflclcvtt aqtntvsfra adirrkllml idsstleptk sihihmylmi lkelpgeeyp
|
961lpmedvlell kplsnvcsly rrdqdvckti lnhvlhvvkn lgqsnmdsen trdaqgqflt
|
1021vigafwhltk erkyifsvrm alvnclktll eadpyskwai lnvmgkdfpv nevftqflad
|
1081nhhqvrmlaa esinrlfqdt kgdssrllka lplklqqtaf enaylkaqeg mremshsaen
|
1141petldeiynr ksvlltliav vlscapicek qalfalcksv kenglephlv kkvlekvset
|
1201fgyrrledfm ashldylvle wlnlqdteyn lsstpfilln ytniedtyrs cykvliphlv
|
1261irshfdevks ianqigedwk slltdcfpki lvnilpytay egtrdsgmaq qretatkvyd
|
1321mlksenllgk qidhitisni peivvellmt lhepanssas qstdlcdfsg dldpapnpph
|
1381fpshvlkatf ayisnchktk ikaileilak spdsyqkill aiceqaaetn nvykkhrilk
|
1441iyhlfvslll kdiksglgga watvlrdviy tlihylnqrp scimdvslrs fslccdllsq
|
1501vcqtavtyck dalenhlhvl vgtliplvye qvevqkqvld llkylvidnk dnenlyitik
|
1561lldpfpdhvv fkdlrltqqk ikysrgpfsl leeinhflsv svydalplcr leglkdlrrq
|
1621lelhkdqmvd inrasqdnpq dglmvklvvn llqlskmain htgekevlea vgsclgevgp
|
1681idfstiaiqh skdasytkal kltedkelqw tfimltylnn tlvedcvkvr saavtclkni
|
1741latktghsfw eiykmttdpm laylqpfrts rkkflevprf dkenpfegld dinlwiplse
|
1801nhdiwiktlt cafldsggtk ceilqllkpm cevktdfcqt vlpylihdil lqdtneswrn
|
1861llsthvqgff tsclrhfsqt srsttpanld sesehffrcc ldkksgrtml avvdymrrqk
|
1921rpssgtifnd atwldinyle vakvaqscaa hftallyaei yadkksmddq ekrslateeg
|
1981sqsttissls ekskeetgis lqdllleiyr sigepdslyg cgggkmlqpi trlrtyehea
|
2041mwgkalvtyd letaipsstr qagiiqalqn igichilavy lkgldyenkd wcpeleelhy
|
2101qaawrnmqwd hctsvskeve gtsyheslyn alqslrdref stfyeslkya rvkeveemck
|
2161rslesvysly ptlsrlqaig elesigelfs rsvthrqlse vyikwqkhsq llkdsdfsfq
|
2221epimalrtvi leilmekemd nsqrecikdl ltkhlvelsi lartfkntql peralfqikq
|
2281ynsvscgvse wqleeaqvfw akkeqslals ilkqmikkld ascaannpsl kltyteclrv
|
2341cgnwlaetcl enpavimqty lekavevagn ydgessdelr ngkmkaflsl arfsdtqyqr
|
2401ienymkssef enkqallkra keevgllreh klqtnrytvk vqreleldel alralkedrk
|
2461rflckaveny incllsgeeh dmwvtrlcsl wlensgvsev ngmmkrdgmk iptykflplm
|
2521yqlaarmgtk mmgglgfhev lnnlisrism dhphhtlfii lalananrde fltkpevarr
|
2581sritknvpkq ssqldedrte aanrilctir srrpqmvrsv ealcdayill anldatqwkt
|
2641qrkginipad qpitklknle dvvvptmeik vdhtgeygnl vtiqsfkaet rlaggvnlpk
|
2701iidcvgsdgk errqlvkgrd dlrqdavmgq vfqmcntllq rntetrkrkl tictykvvpl
|
2761sqrsgvlewc tgtvpigefl vnnedgahkr yrpndfsafq cqkkmmevqk ksfeekyevf
|
2821mdvcqntqpv fryfcmekfl dpaiwfekrl aytrsvatss ivgyilglgd rhvqniline
|
2881qsaelvhidl gvafeqgkil ptpetvpfrl trdivdgmgl tgvegvfrrc cektmevmrn
|
2941sqetlitlve vllydplfdw tmnplkalyl qqrpedetel hptlnaddqe ckrnlsdidq
|
3001sfdkvaervl mrlqeklkgv eegtvlsvgg qvnlliqqai dpknlsrlfp gwkawv
|
GENBANK ID: AAA59145.1
VERSION AAA59145.1 GI:307058
1mlkpslpfts llflqlpllg vglnttiltp ngnedttadf flttmptdsl svstlplpev
|
61qcfvfnveym nctwnsssep qptnltlhyw yknsdndkvq kcshyltsee itsgcqlqkk
|
121eihlyqtfvv qlqdpreprr qatqmlklqn lvipwapenl tlhklsesql elnwnnrfln
|
181hclehlvqyr tdwdhswteq svdyrhkfsl psvdgqkryt frvrsrfnpl cgsaqhwsew
|
241shpihwgsnt skenptlfal eavvisvgsm gliisllovy fwlertmpri ptlknledlv
|
301teyhgnfsaw sgvskglaes lqpdyserlc lvseippkgg algegpgasp cnqhspywap
|
361pcytlkpet
|
GENBANK ID: AAC50825.1
VERSION AAC50825.1 GI:1117984
1mvaprplrrv vlfyggklcs magnfwqssh ylqwildkqd llkerqkdlk flseeeywkl
|
61qifftnviqa lgehlklrqq viatatvyfk rfyaryslks idpvlmaptc vflaskveef
|
121gvvsntrlia aatsvlktrf syafpkefpy rmnhilecef yllelmdccl ivyhpyrpll
|
181qyvqdmgged mllplawriv ndtyrtdlcl lyppfmiala clhvacvvqq kdarqwfael
|
241svdmekilei irvilklyeq wkntderkem atilskmpkp kpppnsegeq gpngsqnssy
|
301sqs
|
GENBANK ID: AAC50473.1
VERSION AAC50473.1 GI:1314346
1mamssggsgg gvpeqedsvl frrgtgqsdd sdiwddtali kaydkavasf khalkngdic
|
61etsgkpkttp krkpakknks qkkntaaslq qwkvgdkcsa iwsedgciyp atlasidfkr
|
121etcvvvytgy gnreeqnlsd llspicevan nleqnaqene nesqvstdes ensrspgnks
|
181dnikpksapw nsflpppppm pgprlgpgkp glkfngpppp pppppphlls cwlppfpsgp
|
241piipppppic pdslddadal gsmliswyms gyhtgyymgf rqnqkegrcs hsln
|
GENBANK ID: CAC15525
VERSION CAC15525.1 GI:11137517
1mvsrdqahlg pkyvglwdtk srtdeelsfr agdvfhvark eeqwwwatll deaggavaqg
|
61yvphnylaer etvesepwff qcisrseavr rlqaegnatg aflirvsekp sadyvlsvrd
|
121tqavrhykiw rraggrlhln eavsflslpe lvnyhraqsl shglrlaapc rkhepeplph
|
181wddwerpree ftlcrklgsg yfgevfeglw kdrvqvaikv isrdnllhqq mlqseiqamk
|
241klrhkhilal yavvsvgdpv yiltelmakg sllellrdsd ekvlpvsell diawqvaegm
|
301cylesqnyih rdlaarnilv gentlckvgd fglarliked vylshdhnip ykwtapeals
|
361rghystksdv wsfglllhem fsrgqvpypg msnheaflrv dagyrmpcpl ecppsvhklm
|
421ltcwcrdpeq rpcfkalrer lssftsyenp t
|
GENBANK ID: AAB84296
VERSION AAB84296.1 GI:2613135
1tsttvrglna strylfrvra svqqigdwsn tveettlglq saspvqesrv aedgldqqlv
|
61iavvgsvsat cltiiaalla lvclrrsclh rrhtftyqsg sgeetilqfs sgtltltrrp
|
121kpqpeplsyp vle
|
GENBANK ID: X63594.1
VERSION X63594.1 GI:57673
MFQPAGHGQDWANEGPRDGLKKERLVDDRHDSGLDSNKDEDYEQ
|
MVKELREIRLQFQEAPLAAEPWKQQLTEDGDSFLHLAIIHEEKTLTMEVIGQVKGDLA
|
FLNFQNNLQQTPLHLAVITNQPGIAEALLKAGCDPELRDFRGNTPLHLACEQGCLASV
|
AVLTQTCTPQHLHSVLQATNYNGHTCLHLASIHGYLGIVEHLVTLGADVNAQEPCNGR
|
TALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLEN
|
LQTLPESEDEESYDTESEFTEDELPYDDCVFGGQRLTL
|
GENBANK ID: AAB60641
VERSION AAB60641.1 GI:516515
1meqqdqsmke gmgttwllst pqhwlmqqfy netyygrtge fmedfpltll wsvtvsmfpf
|
61ggfigsllvg plvnkfgrkg allfnnifsi vpailmgcsr vatsfeiiii srllvgicag
|
121vssnvvpmyl gelapknlrg algvvpqlfi tvgilvaqif glrnllanvd gwpillgltg
|
181vgaalqllll pffpespryl liqkkdeaaa kkalqtlrgw dsvdrevaei rqedeaekaa
|
241gfisvlklfr mrslrwqlls iivlmggqql sgvnaiyyya dqiylsagvp eehvqyvtag
|
301tgavnvvmtf cavfvvellg rrlllllgfs icliaccvlt aalalgdtvs wmpyisivcv
|
361isyvlghaig pspipallit eiflqssrps afmvggsvhw lsnftvglif pfiqeglgpy
|
421sfivfavic1 lttiyifliv petkaktfie ingiftkmnk vsevypekee lkelppvtse
|
481q
|
GENEANK ID: M29069
VERSION M29069.1 GI:205553
MLSCTTSTMPGMICKNSDLEFDSLKFCFYPEDDDIYFGGRNSTP
|
PGEDIWKKEELLPTFRLSPGRALAEDSLEPANMATEMLLFEADLWSNPAEEEDIFGLK
|
GLSGSSSNPVVLQDCMWSGFSSREKPETVVSEKLPGGCGSLAVGAGTLVPGAAAATSA
|
GHARSGTAGVGRRKAAWLTELSHLDSECVDSAVIFFANKRESMPVATIPASAGPAISL
|
GDHQGLSSSLEDFLSNSGYVEEGGEEIYVVMLGETQFSKTVTKLPTAAHSENAALTPE
|
CAQSGELILKRSDLIQEDHNYAAFPLPYAEDARPLKKPRSQDPLGPLKCVLRPKAPRL
|
RSRSNSDLEDIERRRNHNRMERQRRDIMRSSFLNLRDLVPELVHNEKAAKVVILKKAT
|
EYIHTLQTDESKLLVEREKLYERKQQLLEKIKQSAVC
|
GENBANK ID: M29039.1
VERSION M29039.1 GI:186626
MCTKMEQPFYHDDSYTATGYGRAPGGLSLHDYKLLKPSLAVNLA
|
DFYRSLKAPGARGPGPEGGQGGSYFSGQGSDTGASLKLASSELERLIVFNSNGVITTT
|
PTPPGQYFYPRGGGSGGGAGGAGGGVTEEQEGFADGFVKALDDLHKMNMVTPFNVSLG
|
ATGGPPAGPGGVYAGPEPPPVYTNLSSYSPASASSGGAGAAVGTGSSYPTTTISYLPH
|
APPFAGGHPAQLGLGRGASTFKEEPQTVFEARSRDATPPVSPINMEDQERIKVERKRL
|
RNRLAATKCRKRKLERIARLEDKVKTLKAENAGLSSTAGLLREQVAQLKQKVNTMVSN
|
GCQLLLGVKGHAF
|
GENBANK ID: X56681.1
VERSION X56681.1 GI:34018
METPFYGDEALSGLGGGASGSGGTFASPGRLFPGAPPTAAAGSM
|
MKKDALTLSLSEQVAAALKPAPAPASYPPAADGAPSAAPPDGLLASPDLGLIKLASPE
|
LERLIIQSNGLVTTTFTSSQFLYFKVAASEEQEFAEGFVKALEDLHKQNQLGAGRAAA
|
AAAAAAGGPSGTATGSAPPGGELAPAAAAPEAPVYANLSSYAGAGGAGGAATVAFAAE
|
PVPFPPPPPPGALGFFRLAALKDEPQTVFDVFSFGESFFLSFIDMDTQERIKAERKRL
|
RNRIAASKCRKRKLERISRLEEKVKTLKSQNTELASTASLLREQVAQLKQKVLSMVNS
|
GCQLLPQHQVPAY
|
GENBANK ID: NM_003150.1
VERSION NM_003150.1 GI:4507252
MAQWNQLQQLDTRYLEQLHQLYSDSFFMELRDFLAFWIESQDWA
|
YAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYGHNLRRIKQFLQSRYLEKFMEIA
|
RIVARCLWEESRLLQTAATAAQQGGQANMFTAAVVTEKQQMLEQHLQDVRKRVQQLEQ
|
KMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIV
|
SELAGLLSAMEYVQKTLTGEELADWKRRQQIACIGGFFNICLDRLENWITSLAESQLQ
|
TRQQIKKLEELHQKVSYKGDFIVQHRFMLEERIVVELFRNLMKSAFWERQFCMFMHPD
|
RPLVIKTGVQFTTKVRLLVKFFELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTK
|
VMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGL
|
KIDLETMSLSVVVISNICQMFNAWASILWYNMLTNNFKNVNFFTKPPIGTWDGVAEVL
|
SWQFSSTTKRGLSIEQLTTLAEKLLGFGVNYSGCQITWANFCKENNAGKGESYMVMLD
|
NIIDLVKKYILALWNEGYIMGFISKEREFAILSTKFFGTELLRESESSKEGGVTETMV
|
EKDISGKTQIQSVEFYTKQQLNNMSFAEIIMGYKIMDATNILLSFLVYLYFDIPKEEA
|
FGKYCRFESGEHFEADFGSAAFYLKTKFICVTPTTCSNTIDLPMSPRALDSLMQFGNN
|
GEGAEPSAGGQFESLTFDMELTSECATSPM
|
[0213]
Claims
- 1. A method of increasing the levels of a protein in a Peyer's patch cell, said method comprising delivering to said cell a nucleic acid coding for a protein, wherein absent said increase, the levels of said protein or its mRNA is greater than in a non-Peyer's patch cell.
- 2. The method of claim 1 wherein the protein is a transcription factor or a protein that activates a transcription factor.
- 3. The method of claim 2 wherein the transcription factor or a protein that activates a transcription factor is selected from the group consisting of Jun-B; c-jun related TF, Jun-D; c-jun related TF, STAT 3-signal transducer and activator of transcription 3, NF-kappaβ Tf p105 subunit, S-myc proto-oncogene; myc related, Nm23-M2; nucleoside diphosphate kinase B; metastasis reducing protein, and C-est-l proto-oncogene; p54.
- 4. The method of claim 1 wherein the protein is a receptor, or cell surface antigen,
- 5. The method of claim 4 wherein the protein is a receptor or a transporter.
- 6. The method of claim 1 wherein the protein is selected from the group consisting of nucleoside diphosphate kinases and member of the 14-3-3 family.
- 7. The method of claim 1 wherein the protein is coded for by a gene with an expression Fold Change denoted by a **, *, or number greater than 2.00 in Tables 2 or 3.
- 8. The method of claim 1 wherein the nucleic acid coding for at least 2 proteins is delivered, each of said proteins coded for by a gene with an expression Fold Change denoted by a **, *, or number greater than 2.00 in Tables 2 or 3.
- 9. The method of claim 1 wherein the cell to which the nucleic acid is delivered is a human cell.
- 10. The method of claim 9 wherein the cell is in a Peyer's patch in a human and the nucleic acid is delivered by the oral route.
- 11. The method of claim 9 wherein the cell is not within the body of a human.
- 12. The method of claim 1 wherein the cell to which the nucleic acid is delivered is a rat cell.
- 13. The method of claim 1 wherein a nucleic acid coding for a tumor antigen or foreign peptide is also delivered to the Peyer's patch cell.
- 14. The method of claim 13 wherein the cell to which the nucleic acid is delivered is a human cell.
- 15. A method of decreasing the levels of a protein in a Peyer's patch cell, said method comprising delivering to said cell an anti-sense nucleic acid molecule, a ribozyme nucleic acid molecule, an RNA interference nucleic acid molecule (RNAi), said anti-sense molecule, ribozyme or RNAi nucleic acid being complementary to a sequence of at least 10 nucleotides of the mRNA for said protein, wherein absent said anti-sense molecule, ribozyme or RNAi nucleic acid, the levels of said protein or its mRNA is less than in a non-Peyer's patch cell.
- 16. The method of claim 15 wherein the anti-sense nucleic acid, a ribozyme nucleic acid molecule, an RNA interference nucleic acid molecule is complementary to a sequence of at least 15 nucleotides of the mRNA of the protein.
- 17. The method of claim 16 wherein the anti-sense nucleic acid, a ribozyme nucleic acid molecule, an RNA interference nucleic acid molecule is complementary to a sequence of at least 30 nucleotides of the mRNA of the protein.
- 18. The method of claim 15 wherein the protein is coded for by a gene with an expression Fold Change denoted by a “−”, or a number less that 0.5 in Tables 2 or 3.
- 19. The method of claim 15 comprising delivering to said cell anti-sense nucleic acid molecules, ribozyme nucleic acid molecules, RNA interference nucleic acid molecules, said anti-sense, ribozyme or RNAi nucleic acid being complementary to a sequence of at least 10 nucleotides of the mRNA for at least 5 different protein a, wherein absent said anti-sense, ribozyme or RNAi nucleic acid molecule, the levels of each of said proteins or its mRNA is less than in a non-Peyer's patch cell.
- 20. A method of decreasing the levels of a protein in a Peyer's patch cell, said method comprising delivering to said cell an anti-sense nucleic acid molecule, a ribozyme nucleic acid molecule, an RNA interference nucleic acid molecule said anti-sense, ribozyme or RNAi nucleic acid forming a double-stranded molecule with part or all of the mRNA for said protein, wherein absent said anti-sense, ribozyme or RNAi nucleic acid molecule, the levels of said protein or its mRNA is less than in a non-Peyer's patch cell.
- 21. A method of claims 1, 13, or 15 in which the Peyer's patch cell is an M cell.
- 22. A human cell to which the method of claims 1 has been applied, or the progeny of said human cell.
- 23. A human cell to which the method of claim 13 has been applied, or the progeny of said human cell.
- 24. A human cell to which the method of claim 15 has been applied, or the progeny of said human cell.
- 25. A human cell to which the method of claims 1 has been applied, or the progeny of said human cell.
- 26. A human cell to which the method of claim 13 has been applied, or the progeny of said human cell.
- 27. A human cell to which the method of claim 15 has been applied, or the progeny of said human cell.
- 28. A method for enhancing transport of a drug through the gastrointestinal tract, said method comprising orally administering said drug in a composition that comprises a transport-enhancing protein, said transport-enhancing protein selected from the group consisting of human serum albumin (HSA), clusterin, T-cell surface glycoprotein CD5 precursor, HSP84, and Ca2+pla2, or a homolog that has at least 80% amino acid identity with said transport-enhancing protein over a length of said transport-enhancing protein identical to the homolog.
- 29. A method of claim 28 wherein the homolog has at least 90% amino acid with the transport-enhancing protein over a length of the transport-enhancing protein identical to the homolog.
- 30. A method of claim 28 wherein the transport-enhancing protein is selected from the group consisting of human serum albumin (HSA), clusterin, T-cell surface glycoprotein CD5 precursor, HSP84, and Ca2+ pla2.
- 31. A method to facilitate intracellular trafficking of an antigen that has been orally delivered by itself or as part of a composition or particle, said method comprising administering a protein selected from the group consisting of calreticulin, rab family proteins and ribosomal proteins.
- 32. A chimeric protein comprising the amino acid sequence for calreticulin, rab family proteins and ribosomal proteins and the amino acid sequence for a second polypeptide.
- 33. A method of administering a polypeptide, where said polypeptide is part of a chimeric protein of claim 32, and wherein said chimeric protein is orally administered.
- 34. A method of delivering a vaccine to a target cell, said method comprising utilizing as the target cell a Peyer's patch cell in which a normally upregulated protein or mRNA is further upregulated.
- 35. A method of claim 34 wherein the Peyer's patch cell is an M Cell.
- 36. A method of claim 1 wherein the protein is selected from the group consisting of clusterin, T-cell surface gicoprotein CD5 precursor, HSP84, Ca2+ dependent phospholipase A2 precursor, and the ribosomal proteins, S12, S11, L12, L11, S29, S19, L21, L19, L13, L44, and L36.
- 37. A method of claim 34 wherein the upregulated protein is selected from the group consisting of clusterin, T-cell surface glycoprotein CD5 precursor, HSP84, and Ca2+ dependent phospholipase A2 precursor and the mRNA is for a protein selected from said group.
- 38. A method of claim 1 wherein the protein is selected from the group consisting of cyclin D1, PLC-L, GRB2, ERK3/MAPK6, ERK1, ERK3, JNK2, CD40, CRAF1, C-MYC, PT-α, IL-R, CD40, C-MYC, PKC-α, GSTA1, GATA-2, PLGF, ezrin, HGF activator, hepatocyte growth factor-like protein, NCAD, MNDA, LHX1, TIE-1, NCAML1, CD104, CD44, SRC1, NMDA, TKT, ephrin (type A), Sp1, RAB proteins, PKC, TIR, Jak3, EGR-1, TNK1, CAMK IV, HSP40, HSP70, HSP60, HSO27, fMLP-related receptor, HSP27, glutaredoxin, CREB, gadd153, XPG, XPD, ubiqitin-conjugating enzyme, RAD23, cadherin 2, neural cell adhesion molecule, integrin alpha 3, leukocyte adhesion glycoprotein p150, integrin beta 4, TIE, NCAML1, α3β1 integrin, CD11C antigen, CD104 antigen, CD44, NMDA, TKT, ephrin (type A), and Sp1, a RAB protein, PKC, TfR, bcl-x and caspase-9.
- 39. A method of claim 34 wherein the upregulated protein is selected from the group consisting of cyclin D1, PLC-L, GRB2, ERK3/MAPK6, ERK1, ERK3, JNK2, CD40, CRAF1, C-MYC, PT-α, IL-R, CD40, C-MYC, PKC-α, GSTA1, GATA-2, PLGF, ezrin, HGF activator, hepatocyte growth factor-like protein, NCAD, MNDA, LHX1, TIE-1, NCAML1, CD104, CD44, SRC1, NMDA, TKT, ephrin (type A), Sp1, RAB proteins, PKC, TIR, Jak3, EGR-1, TNK1, CAMK IV, HSP40, HSP70, HSP60, HSO27, fMLP-related receptor, HSP27, glutaredoxin, CREB, gadd153, XPG, XPD, ubiqitin-conjugating enzyme, RAD23, cadherin 2, neural cell adhesion molecule, integrin alpha 3, leukocyte adhesion glycoprotein p150, integrin beta 4, TIE, NCAML1, α3β1 integrin, CD11C antigen, CD104 antigen, CD44, NMDA, TKT, ephrin (type A), and Sp1, a RAB protein, PKC, TfR, bcl-x and caspase-9. and the mRNA is for a protein selected from said group.
- 40. A method of claim 1 wherein the protein is selected from the group consisting of an 1 L-2 receptor, a gamma c chain of an IL-2 receptor, intereron-γ, and a C-C chemokine.
- 41. A method of claim 34 wherein the upregulated protein is selected from the group consisting of an IL-2 receptor, a gamma c chain of an IL-2 receptor, intereron-γ, and a C-C chemokine and the mRNA is for a protein selected from said group.
- 42. A method of claim 1 wherein the protein is selected from the group consisting of cyclin D1, PLC-L, GRB2, ERK3/MAPK6, ERK1, ERK3, PKC-α, GSTA1, GATA-2, and PLGF.
- 43. A method of claim 34 wherein the upregulated protein is selected from the group consisting of cyclin D1, PLC-L, GRB2, ERK3/MAPK6, ERK1, ERK3, JNK2, CD40, CRAF1, C-MYC, PT-α, IL-R, PKC-α, GSTA1, GATA-2, and PLGF and the mRNA is for a protein selected from said group.
- 44. A method of claim 1 wherein the protein is selected from the group consisting of a RAB protein, PKC, and TfR.
- 45. A method of claim 34 wherein the upregulated protein is selected from the group consisting of a RAB protein, PKC, and TfR and the mRNA is for a protein selected from said group.
- 46. A method of claim 1 wherein the protein is selected from the group consisting of Jak 3, EGR-1, TNK1, and CAMK IV.
- 47. A method of claim 34 wherein the upregulated protein is selected from the group consisting of Jak 3, EGR-1, TNK1, and CAMK IV and the mRNA is for a protein selected from said group.
- 48. A method of claim 1 wherein the protein is selected from the group consisting of HSP40, HSP70, HSP60, HSO27, fMLP-related receptor, HSP27, glutaredoxin, CREB, gadd 153, XPG, XPD, ubiquitin, conjugating enzyme, RAD 23, and ataxia telengiectasia.
- 49. A method of claim 34 wherein the upregulated protein is selected from the group consisting of HSP40, HSP70, HSP60, HSO27, fMLP-related receptor, HSP27, glutaredoxin, CREB, gadd 153, XPG, XPD, ubiquitin, conjugating enzyme, RAD 23, and ataxia telengiectasia and the mRNA is for a protein selected from said group.
- 50. A method of decreasing the levels of a protein in a Peyer's patch cell, said method comprising delivering to said cell a DNA molecule coding for an anti-sense nucleic acid molecule, a ribozyme nucleic acid molecule, an RNA interference nucleic acid molecule (RNAi), said anti-sense molecule, ribozyme or RNAi nucleic acid being complementary to a sequence of at least 10 nucleotides of the mRNA for said protein, wherein absent said anti-sense molecule, ribozyme or RNAi nucleic acid, the levels of said protein or its mRNA is less than in a non-Peyer's patch cell.
- 51. A method of increasing the extent to which the function of a protein is carried out in a Peyer's patch cell, said method comprising delivering to said cell a nucleic acid coding for said protein, wherein absent said delivery, the level of said protein or its mRNA is greater in said cell than in a non-Peyer's patch cell.
- 52. A chimeric protein that comprises two or more segments, each of said segments enhancing a different step in the peptide transport process, said steps selected from the group consisting of binding to a cell, transporting the peptide into the cell, transporting the peptide through the cell, and transporting the peptide out of the cell.
- 53. A chimeric protein of claim 52 wherein one of the segments binds to the cell.
- 54. A chimeric protein of claim 52 wherein one of the segments is a protein that is more prevalent in a Peyer's patch cell than in a non-Peyer's patch cell.
- 55. A chimeric protein of claim 52 wherein the cell is a Peyer's patch cell.
- 56. A chimeric protein of claim 55 wherein the cell is an M cell.
- 57. A method of targeting a composition or delivery vehicle to a Peyer's patch cell said method comprising utilizing a composition or vehicle that contains a protein ligand that will specifically bind to a protein that is up-regulated in Peyer's patch cells.
- 58. The method of claim 57 wherein the composition or delivery vehicle comprises a drug or antigen.
- 59. A method of selecting for a ligand that will selectively bind to a target in a Peyer's patch cell, said method comprising contacting a phage library with a protein that is upregulated in Peyer's patch cells.
- 60. The method of claim 59 wherein the protein is attached to a solid substrate.
- 61. A method of claim 1 wherein the protein is selected from the group consisting of HGF activator, ezrin, NCAD, MNDA, and LHX1.
- 62. A method of claim 34 wherein the upregulated protein is selected from the group consisting of HGF activator, ezrin, NCAD, MNDA, and LHX1, and the mRNA is for a protein selected from said group.
- 63. A method of claim 1 wherein the protein is selected from the group consisting of cadherin 2, neural cell adhesion molecule, integrin alpha 3, leukocyte adhesion glycoprotein p150, integrin beta 4, TIE, NCAML1, α3β1 integrin, CD11C antigen, CD104 antigen, CD44, NMDA, TKT, ephrin (type A), and Sp1.
- 64. A method of claim 34 wherein the upregulated protein is selected from the group consisting of cadherin 2, neural cell adhesion molecule, integrin alpha 3, leukocyte adhesion glycoprotein p150, integrin beta 4, TIE, NCAML1, α3β1 integrin, CD11C antigen, CD104 antigen, CD44, NMDA, TKT, ephrin (type A), and Sp1, and the mRNA is for a protein selected from said group.
- 65. A method of promoting enterocyte-M cell conversion, said method comprising orally administering an antigen, antigenic composition, or antigen-carrying particle to a person and either simultaneously with, or prior to, said administration, also orally administering a bacteria, or pro-biotic yogurts, or bacterial component to said person.
Provisional Applications (2)
|
Number |
Date |
Country |
|
60281387 |
Apr 2001 |
US |
|
60302591 |
Jul 2001 |
US |